key: cord-0041835-l6c2y4vw
authors: nan
title: ACVIM ABSTRACTS
date: 2008-06-28
journal: J Vet Intern Med
DOI: 10.1111/j.1939-1676.1999.tb02182.x
sha: cd6de82b70bb7c544716d3b4ad69d63e5e33fdce
doc_id: 41835
cord_uid: l6c2y4vw

nan

PORT H.C. Schott II, C.L. Coursen, S.W. Eberhart, R.F. Nachreiner, K.R. Refsal, S.L. Ewart, and J. V. Marteniuk. College of Veterinary Medicine, Michigan State University, East Lansing, MI. During 1997-98, 67 Michigan horses were confirmed to have equine Cushings disease on the basis of characteristic clinical signs and the results of either a dexamethasone suppression test (DST), a thyrotropin (TRH) stimulaton test, or an elevated serum insulin concentration (Ͼ300 pmol/l). Presenting complaints included hirsuitism, hyperhidrosis, and muscle wasting. A substantial number (52%) had chronic laminitis as the major clinical problem. Changes in endocrine test results were compared after 6 months in horses that were either untreated (NT) or treated with pergolide (P, 2 ug/kg PO, q 24 h) or cyproheptidine (C, 1.2 mg/kg 3/4 PO, q 24 h). Ten horses had died or were euthanatized within the first 6 months with 70% attributable to complications of Cushings disease. As of the start of 1999, 6 month evaluations had been completed for 19 horses and were pending for 19 horses. 19 horses failed to remain on treatment for 6 months or had incomplete follow-up testing. Preliminary results (Table) support that treatment of equine Cushings disease warrants pursuit and that reversal of abnormal endocrine test results (DST/TRH) appears to be better with pergolide (6/9 ϭ 67%) than with cyproheptidine (2/6 ϭ 33%). In addition to being more problematic in terms of sample collection and handling when used under field conditions, preliminary results suggest that measurement of plasma ACTH concentration may be the least reliable diagnostic test for equine Cushings disease. Equine RAO is characterized by the development of clinical signs of airway obstruction and an airspace neutrophilia following exposure of susceptible horses to mouldy forage. We investigated the functional state of blood and airspace neutrophils (PMN) from RAO susceptible horses after a 5 h hay/straw challenge.

Venous blood and bronchoalveolar lavage fluid (BALF) were collected 10 d before and 5 and 24 h and 4, 7 and 14 d after the initiation of the challenge. Respiratory burst activity of purified blood PMN and mixed BALF cells was measured by luminol (produced from PMN only) and lucigenin-dependent chemiluminescence (DCL) both basally and in response to the formylpeptide fMLP Ϫ 1M, Zymosan Activated Plasma Ϫ 10% (ZAP) and phorbol myristate acetate Ϫ 100ng/ml (PMA). Equine neutrophil elastase (ENE) was measured in BALF supernatant as a marker of PMN degranulation, by ELISA and its functional activity measured by cleavage of the chromogenic substrate N-methoxy-ALA-ALA-PRO-VAL p-Nitroanilide. Challenge induced a significant increase in absolute and differential BALF PMN counts at 5 and 24 h.

Basal lucigenin-and luminol-DCL of blood PMN were significantly increased (pϽ0.05) at 24 h after challenge. fMLP-stimulated lucigenin-DCL was increased (pϽ0.05) at 24 h consistent with a primed response. Basal BALF cell lucigeninand luminol-DCL was unchanged following challenge, but fMLP, ZAP and PMA induced luminol-DCL of BALF cells was significantly increased (pϽ0.05) at 5 and 24 h in direct correlation with the increased proportion of PMN.

Concentrations of ENE in BALF measured by ELISA were significantly elevated (pϽ0.05) compared to baseline (median: 3.6 ng/ml; range, 1.2-4.6) at 5 h (55.3; 4.9-360.3), 24 h (35.6; 9.6-15.8) and 4 d (14.7; 5.4-29. 3) after challenge but no functional ENE activity was detectable at any timepoint, consistent with functional inhibition by antiproteases.

These results suggest that blood and BALF PMN are significantly primed in vivo for an enhanced respiratory burst following hay/straw challenge and that on recruitment to the airspaces PMN degranulate. The interaction between reactive oxygen species, proteases and antiproteases in the microenvironment of the pulmonary epithelium may play a role in the pathogenesis of equine RAO. Exercise-induced pulmonary hemorrhage (EIPH) occurs frequently in racehorses. Exercising horses develop severe pulmonary capillary hypertension, and the ensuing high transmural pulmonary capillary pressure contributes to the stress failure of pulmonary capillaries, resulting in EIPH. Nitric oxide (NO) is an endogenous vasodilator substance, which plays an important role in modulating the pulmonary vascular tone. Thus, in the present study, we investigated whether IV administration of nitroglycerin-a known NO donor, would attenuate the exercise-induced pulmonary capillary hypertension, and thereby, affect the incidence of EIPH in strenuously exercising racehorses. Five healthy, sound, exercise-trained Thoroughbred horses were studied at rest and during incremental treadmill exercise performed at 6, 8 and 14.2m/s on a 5% uphill grade in the control (no medications) and nitroglycerin (20g/kg/min, IV) experiments. Galloping at 14.2m/s on a 5% uphill grade elicited maximal heart rate (212 Ϯ 2 beats/min), and the horses could not sustain this workload for Ͼ90s. The nitroglycerin dosage for our experiments was selected based on separate trials in standing horses where it was demonstrated that maximal pulmonary/systemic hemodynamic effects of IV nitroglycerin are elicited at 5g/kg/min, and that increasing the dose 4-fold (to 20g/kg/min) did not cause any ill effects. In control experiments, exercise resulted in a significant (PϽ0.05) progressive increase in right atrial as well as pulmonary arterial, capillary and wedge pressures, and all horses experienced EIPH. Nitroglycerin infusion significantly (PϽ0.05) decreased the right atrial and pulmonary vascular pressures of standing horses while heart rate increased significantly. In the nitroglycerin-infusion experiments, exercise at 6 and 8m/s also resulted in a progressive significant (PϽ0.05) rise in the right atrial as well as pulmonary arterial, capillary and wedge pressures, but these values were found to be significantly (PϽ0.05) less than in the control experiments. However, this did not occur during galloping at 14.2m/s on a 5% uphill grade, when right atrial and pulmonary arterial, capillary and wedge pressures approached values observed in the control experiments, and all horses experienced EIPH. Thus, while IV nitroglycerin significantly attenuated the exercise-induced pulmonary capillary hypertension at sub-maximal workloads, attenuation did not occur during high-intensity exertion and the incidence of EIPH remained unaffected. The objective of this study was to examine the effects of glucose infusion on glucose kinetics in horses during exercise. We hypothesized that increased blood glucose availability would suppress the exercise-induced increment in hepatic glucose production (HGP) but increase whole-body disposal of blood glucose. In random order, 6 Standardbred horses completed two exercise trials consisting of running on a treadmill for 90 min at 34 Ϯ 1% of peak oxygen uptake. In one trial (Glu) glucose was infused for the duration of exercise at a mean rate of 34.9 Ϯ 1.1 mol/kg/min, while in the other trial (Con) an equivalent volume of saline was infused. In both trials, a primed constant-rate infusion of the stable isotopically-labeled tracer [6,6-2 H]glucose was given for measurement of glucose kinetics. Blood samples for determination of plasma glucose concentrations and isotopic enrichment (GCMS analysis) were collected at regular intervals. The rates of appearance (R a ) and disappearance (R d ) of glucose were determined by using a one-pool non-steady-state kinetic model. In Con, glucose R a was assumed to reflect HGP, whereas in Glu HGP was calculated as the difference between the measured total R a and the rate of glucose infusion.

In Glu, plasma glucose increased progressively during exercise (rest: 4.9 Ϯ 0.3 mM; 90 min exercise: 8.2 Ϯ 1.2 mM), whereas plasma glucose in Con was unchanged. In Con, HGP increased from 6.3 Ϯ 1.5 mol/kg/min at rest to 29.6 Ϯ 2.5 mol/kg/min after 90 min of exercise. In Glu, there was complete suppression of the increase in HGP during the first 45 min of exercise. Although HGP increased during the remainder of exercise in Glu, values were 50-60% lower when compared to Con. During exercise, glucose R d increased in both trials. However, between 30 and 90 min of exercise, values were 50-75% higher (PϽ0.001) in Glu than in Con. These results indicate that: 1) exogenous glucose infusion suppresses the exercise-associated increase in HGP in horses during low-intensity exercise; and 2) increased glucose availability enhances utilization of plasma glucose during exercise, as reflected by the higher values for glucose R d in Glu. Importantly, these data demonstrate the utility of the stable-isotope tracer method for determination of glucose flux in horses during exercise. Multiple logistic regression models available in the literature to predict outcome of cows with a definitive diagnosis of right abomasal displacement or abomasal volvulus (RDA/AV) were evaluated using data from the veterinary teaching hospital (VTH) of the FMV Saint-Hyacinthe. A retrospective study was conducted on the medical records of cows admitted to the VTH from 1989 to 1994 with RDA/AV (nϭ295). It was followed by a prospective study conducted on 131 RDA/AV cases admitted to the VTH from 1995 to 1998.

A hundred of these cows were considered non-productive (NP) when discharged while 325 were considered productive (P). We applied the published models (Constable et al JAVMA 198:2077 -2085 and Gröhn et al AJVR 51: 1895 -1899 to every cows. The predicted outcome was categorized either as P or NP and compared to the real outcome. The total correct classification rate (TCCR), sensitivity (Se), specificity (Sp), negative predictive value (NPV) and positive predictive value (PPV) of each model to predict NP were calculated. *Only the AV cases were included for validation of models of Constable et al. Prevalence of NP in this group was higher than in Constable et al's population. These models were less effective in our population than originally published. The models of Gröhn et al were as effective in our population, despite a lower NP prevalence in our study. A low PPV restricts their common use in our VTH. Internal potassium (Kϩ) balance has been evaluated by Fenwick in relation with hypocalcemia (Fenwick et al Austr.Vet.J. 60: 313-314.1983 ). Two types of cattle have been described with respect to red blood cell K concentration (RBCK) (Christinaz et al. J.Physiol. 224: 391-406.1972 ): high RBCK (average ϭ 80 mmol/L of erythrocytes (ER)) and low RBCK (average ϭ 20 mmol/L of ER), the most prevalent phenotype. A distinct syndrome of dairy cattle has been associated with hypokalemia. A first objective of this study was to develop a practical method of measurement for both internal and external Kϩ balances in dairy cows. A second objective was to study the internal and external Kϩ balances variation due to the lactation period and during the day.

Nineteen cows were randomly selected from the University herd with respect to the lactation group and number. Four cows were obtained from the early lactation (EL) group (11 to 30 days in milk (DIM)), 4 from the peak (P) lactation group (31 to 90 DIM), 4 from the late lactation (LL) group (225 or more DIM), 4 from the dry cows (D) group and 3 from the freshly calved (FC) group (1 to 10 DIM). Serum, heparinized blood, urine and milk were collected at 7 moments of the day. Kalemia (SK), RBCK, fractional urinary clearance of potassium (FeK) and milk Kϩ concentration (MLK) were measured.

Mean SK was 4.6 mmol/L (Ϯ 0.3). Mean RBCK was 21.6 mmol/L of ER (Ϯ 3.3). Average FeK was 80.1 mmol/L (Ϯ 33.9). Mean MLK was 43.6 mmol / L (Ϯ 12.3). Mean ingested K (IK) was 293 g / cow (Ϯ 53 g). There were significant variations during the day for RBCK, FeK and MLK. The mean MLK of LL (30.5 mmol / L) was lower than mean MLK (48.3 mmol / L) of the other groups (pϭ0.03). Ingested Kϩ was statistically correlated with FeK (pϭ0.005). There was no correlation between IK and MLK. Thus, this method of evaluation of the potassium status of dairy cows appears feasible. However, due to variations during the day, it is important to collect samples at the same moment every day, when long term Kϩ balance evolution is to be considered. Inflammation or ischemic damage to bowel may alter motility in affected bowel or even in ''normal'' bowel adjacent to affected areas. The purpose of this research was to evaluate the effects of short-term ischemia on the activity and responses of adjacent small intestine (SI).

Jejunal samples were taken from 9 ponies at sites proximal and distal to SI made ischemic for 60-90 minutes. General activity patterns, responses to electrical field stimulation (EFS)-induced neuronal depolarization, and responses to norepinephrine (NE) were compared to the responses of a section of SI taken prior to ischemic insult.

Both proximal and distal segments had evidence of decreased contractility. Contraction frequency was decreased in longitudinal muscle taken from sites proximal and distal to the ischemic SI, as compared to normal SI from the same horse. Distal sections had lower contraction frequency than proximal sections. Circular muscle strips were also affected, but to a lesser degree. The contractile response to EFS was less in proximal and distal longitudinal muscle strips kept at low tension as compared to normal SI. At high tension, distal sections relaxed less in response to EFS than did normal SI. In response to NE, proximal and distal longitudinal muscle strips were less contractile initially and proximal strips did not relax as much as controls during the second phase. Proximal circular muscle strips had a prolonged relaxation response to NE.

The results indicate even short term ischemia can significantly affect the adjacent ''normal'' bowel. Discrepancies between proximal and distal SI motility patterns and alterations in the response to NE would be of particular concern in postoperative patients and could lead to clinical ileus or slowed transit. If similar changes occurred with enteritis or peritonitis, abnormal transit or absorption could result. Gastric ulcers are common in performance horses. The purpose of this study was to determine the efficacy of omeprazole paste in treating gastric ulcers and to determine a dosage regimen to prevent recurrence of gastric ulcers in Thoroughbred horses in race training. In a multicentre clinical study, 100 Thoroughbred horses with endoscopically verified gastric ulcers induced by race training were used. At each trial site, replicates of four horses were formed on approximately Day 2 based primarily on baseline gastric ulcer scores and secondarily on sex. Within replicates, one horse was randomly allocated to a control group, sham dosed with an empty syringe, and the other three horses received omeprazole orally at 4 mg/kg bwt once daily for 28 days. Following endoscopy on Day 27, omeprazole-treated horses were again blocked primarily based on gastric ulcer score and secondarily on sex. Within blocks of three, horses were randomly allocated to sham dosing with an empty syringe, or to treatment with omeprazole at 2.0 mg/kg once daily, or 4.0 mg/kg once daily for 30 days. Original sham dosed horses continued as controls for 57 days.

At Day 27 (after 28 daily doses) gastric ulcers were completely healed in 77% of omeprazole treated horses, compared to 4% in controls, and the severity of the ulcers was reduced from baseline in 92% of treated horses, compared to 32% of controls (PϽ0.01). After 30 additional daily doses, ulcer scores were reduced or unchanged in 84% and 88% of horses treated with 2 or 4 mg/kg/day, respectively, compared to 16% for controls (PϽ0.01). There was no significant (PϽ0.20) difference in the change in ulcer scores between horses treated with omeprazole at either 2 or 4 mg/kg/day for that additional 30 daily dose period.

These results clearly demonstrate that omeprazole paste, administered at 4 mg/ kg bwt once daily for 28 days, was effective in healing gastric ulcers in Thoroughbred race horses in training, while 2 mg/kg bwt once daily effectively prevented recurrence of gastric ulcers. Intravenous lidocaine has been used for the treatment of postoperative ileus (POI) in people. The purpose of our study was to investigate its usefulness in the treatment of equine POI and proximal duodenitis-jejunitis (PDJ). A doubleblinded multicenter study was undertaken. Horses with a diagnosis of POI or PDJ and Ն20 liters of reflux or refluxing Ͼ12 hours were given lidocaine or a saline placebo (bolus of 1.3 mg/kg followed by 0.05 mg/kg/minute for 24 hours). Comparisons were made in terms of reflux volume, physical parameters, pain, complications, and days hospitalized. Comparisons were also made between data collected before, during and after lidocaine therapy on trial horses and other horses given lidocaine in a non-blinded fashion.

Significantly more cases receiving lidocaine stopped refluxing during the lidocaine infusion or within 6 hours of discontinuing the lidocaine than did saline controls. 63% of POI cases and 50% of PDJ horses stopped refluxing within 6 hours of discontinuing the iv drip. 59% stopped refluxing during the infusion. By 12 hours after treatment, 79% of treated horses had stopped refluxing. All lidocaine-treated cases had significantly less reflux during the infusion than prior to treatment. No significant differences were detected in heart rate, respiratory rate, or temperature. POI cases treated with lidocaine were discharged 4 days earlier than either PDJ cases or saline controls. Side effects included muscle fasciculations, ataxia, delayed detection of laminitis pain, and potentially increased incisional infection rates.

In summary, lidocaine is an inexpensive motility modifier that appears to be both relatively safe and at least moderately effective for the treatment of equine ileus. However, the results suggest it does not simply act by inhibiting increased sympathetic bowel tone, as has been theorized.

The purpose of this study was to evaluate the effect of erythromycin lactobionate (EM) on myoelectric activity (MA) of the ileum, cecum and pelvic flexure of horses during the post-operative(PO) period and the post-recovery(PR) period (Ն 8 days PO). In 8 mature horses, 16 bipolar electrodes were implanted into the ileum(4), cecum(6) and pelvic flexure(6), and the jejunum was rubbed vigorously to mimic surgical trauma. At approximately 4, 16, and 24 hr PO, and during the PR period, 0.5 mg/kg EM was administered IV and MA was recorded. Recordings were evaluated by visual observation and by computer. Ratios of activity indices for 5-and 15-min segments before and after EM were compared using a generalized linear models approach and Duncan's multiple range test. During the PO period, decreased MA and alteration of the normal motility patterns of the gut were most pronounced in the cecum and least pronounced in the ileum. MA was essentially absent in the cecum 4 hr PO. The activity index was significantly greater following EM in the ileum during all PO sessions, but not during the PR session, in the cecum only during the PR session, and in the pelvic flexure during the PO and the PR sessions. During one 15-min period following EM for each region of the intestine, the activity index was decreased compared to before EM.

Intravenous EM has an effect on MA of equine large and small intestine, and could be useful as a prokinetic drug for horses. The prokinetic effect of EM is not the same for different regions of the intestine nor is it the same during the PO period compared to the PR period. Because the effects EM administered during the PO period are not always the same as those administered after recovery, caution must be exercised when extrapolating the results of prokinetic studies carried out in normal animals to those with PO ileus or other dysmotilities. This study was designed to evaluate the control mechanisms of normal equine jejunal activity, particularly in regards to the neurotransmitters acetylcholine (ACH), norepinephrine (NE), substance P (SP), and nitric oxide (NO). Samples of normal jejunum, oriented in the plane of either the longitudinal (LM) or circular muscle (CM), were evaluated in vitro for their response to the neurotransmitters and for evidence of release of the neurotransmitters following electrical field stimulation (EFS). Samples were also evaluated histochemically for markers for ACH, SP, and NO.

ACH contracted all muscle strips. Atropine altered EFS responses in a manner that suggested ACH may contract LM and low tension CM but that ACH can relax high tension CM.

NE produced a transient contractile response in LM and relaxed CM. During EFS, the response to adrenergic blockade indicated that NE relaxed LM and high tension CM, but contracted low tension LM.

SP increased the tone of all muscle strips. From EFS studies in the presence of a neurokinin-1 receptor blocker, it appeared that SP could either contract or relax jejunal muscle, depending upon muscle and stimulation parameters. SPlike immunoreactivity was present within the myenteric plexus and was partially colocalized with choline acetyltransferase-like immunoreactivity.

Sodium nitroprusside decreased the tone of high tension LM. NO synthase inhibitors altered the EFS response such that NO appeared to relax CM and high tension LM but contracted low tension LM. NADPH-diaphorase activity was demonstrated within the myenteric plexus.

These results suggest all 4 agents may function within the equine jejunum but that different situations and types of stimulation may alter the type of neurotransmitter release and corresponding muscle activity. Equine protozoal myeloencephalitis (EPM) is an emerging disease of critical importance to all horse industries. The disease is caused by the apicomplexan protozoan, Sarcocystis neurona; however, to date, S. neurona infection of horses has not been induced using molecularly-characterized sporocysts. We report here the induction of such infection in previously naïve horses.

Six horses were purchased and acclimated to an opossum-proof sand lot and a complete pelleted diet. Horses were negative by western blot for serum S. neurona IgG. Sporocysts were recovered from opossums (Didelphis virginiana pigra) and were categorized on the basis of 6 different genomic DNA sequences. Only sporocysts identified in this manner as S. neurona were used to challenge horses. Horses received either 1 or 6 consecutive daily doses of 5 ϫ 10 5 sporocysts by nasogastric tube and were then subjected to serial neurologic examination and sampling of blood and CSF. At 4 months, the challenged horses were necropsied.

Horses challenged with a single dose of S. neurona seroconverted (N ϭ 2) and became western blot-positive in CSF. Seroconversion occurred between 19 and 26 days after challenge and antibodies were present in the CSF by 40 days. These horses did not develop convincing signs of neurologic disease. Contemporaneous unchallenged horses neither seroconverted nor displayed neurologic signs. Multiple sequential blinded samples submitted for western blot testing showed a very high degree of within-horse correlation. Horses challenged with 6 daily doses of S. neurona (N ϭ 2) developed unequivocal neurologic signs including limb weakness and ataxia. Findings on histopathologic examination of the CNS of horses given multiple doses were typical of EPM but no organism was identified or recovered.

Characterized S. neurona sporocysts can induce clinical neurologic disease and seroconversion when administered by nasogastric tube to naïve horses. Clostridium difficile is associated with watery diarrhea and hemorrhagic, necrotizing enterocolitis in neonatal foals. The purpose of this study was to characterize isolates of C. difficile obtained from Thoroughbred foals with enterocolitis on a breeding farm over a two year period. Fourteen foals developed diarrhea between the age of 1 and 20 days. Fecal samples were cultured on cefoxitin-cycloserine-fructose (for C. difficile) as well as XLT4 agar plates and in selenite enrichment broth (for Salmonellae). An immunoassay was utilized to detect the presence of toxin A (Enterotoxin) in fecal samples. The presence of toxin A and B genes in cultured C. difficile isolates was evaluated by utilizing PCR. Genetic finger-printing of strains was performed using PCR. Antibiotic susceptibility testing was performed utilizing the Etest method.

All 14 fecal samples were culture positive for C. difficile, and negative for Salmonellae. Toxin A was detected in 6/11 fecal samples tested. All 14 isolates of C. difficile were positive for the presence of toxin A and B genes. Five distinct strains were identified. Eight of 12 isolates tested for metronidazole susceptibility were determined to be resistant. Nine of 9 isolates were considered sensitive to vancomycin. All eight metronidazole-resistant isolates were of one strain type.

This report describes the presence of toxin genes in and toxin production by C. difficile isolates cultured from 14 foals with diarrhea. These findings point to a diversity of strain types on one farm, however these strains were grouped with respect to time and antimicrobial susceptibility patterns. The finding of metronidazole resistance is interesting considering its paucity in isolates cultured from human patients with C. difficile enterocolitis. We have previously demonstrated that hemagglutinin (HA) gene DNA vaccination with or without IL-6 DNA coadministration, and influenza virus infection, all generate protective, but different, immune responses in horses. A study was performed to investigate the regional immunoregulatory mechanisms associated with these different immune responses.

Horses were vaccinated with IL-6/HA DNA (Group1) or HA DNA only (Group 2) on three occasions using the PowderJect-XR gene gun. Group 3 horses were infected with influenza virus and Group 4 were controls. Nasal and serum antibody isotype responses were studied in all horses, and protection from challenge infection was studied in a subset of Groups 1 & 2. Animals from each group were euthanized; 14 days after the third vaccination (Groups 1& 2) or influenza infection (Group 3). Influenza virus-specific lymphoproliferative responses were determined in peripheral blood lymphocytes (PBLs) and lymph node lymphocytes (LNLs). The IL-2, IL-4 and IFN-␥ mRNA production in these lymphocyte populations was also measured by QRT-PCR.

DNA vaccination prevented clinical disease and controlled viral shedding in both Groups 1 & 2, and was associated with IgGa and IgGb responses. Primary influenza virus infection (Group 3) produced identical IgG sub-isotype responses, but also generated a nasal IgA response. DNA vaccination was associated with lymphoproliferative responses in PBLs and inguinal LNLs, while influenza virus infection was associated with responses in PBLs, and hilar LNLs. The inguinal LNL lymphoproliferative responses in IL-6/HA DNA vaccinates (Group 2) were higher than in the HA DNA vaccinates (Group 1). Examination of cytokine production profiles indicates that these protective immune responses subsequent to DNA vaccination, or infection, are associated with different regional regulatory mechanisms. Our ability to design novel strategies to prevent infectious disease in the young calf is restricted by our limited understanding of how non-immunoglobulin maternal factors contribute to the immune system of the newborn. There is indirect evidence in cattle that maternal immune cells and antigen-specific immune cell responses are transferred to the calf. The aim of this study was to provide definitive genetic evidence for the transfer of cells from the cow to the newborn calf. This was achieved by using a sensitive and specific PCR-based assay to search calf immune tissues for maternal cells. The non-inherited allele of the bovine MHC BoLA-DRB3 gene was selected as a genetic marker for maternal cells since this is a highly polymorphic gene and therefore likely to be different between dam and calf. Genomic DNA was isolated from the PBMCs of ten Holstein cow-calf pairs. The BoLA-DRB3 genotype of each individual was determined using a technique combining PCR, denaturing gradient gel electrophoresis and automated sequencing. Four cow-calf pairs in which the non-inherited maternal BoLA-DRB3 allele (NIMDA) differed from the calf BoLA-DRB3 alleles were selected for study. Calves were fed 2 liters of fresh colostrum from their dam within 6 hours of birth, and maintained on commercial milk replacer. Calves were euthanized at 48-60 hours of age and multiple tissues collected at necropsy. Enriched lymphocyte populations were harvested from the intestinal epithelium, lamina propria, and Peyer's patches. The cow and calf BoLA-DRB3 alleles were aligned and PCR NIMDA-specific primers designed. Using these primers the maternal allele was successfully amplified from intraepithelial lymphocytes (2/4 calves), Peyer's patch (3/4 calves), mesenteric lymph node (2/4 calves), spleen (2/4 calves), and precolostral PBMCs (3/4 calves). The distribution of the NIM-DA varied between calves. Further studies using NIMDA-specific primers and NIMDA-specific DNA probes for in situ PCR on tissue sections of intestine and lymph nodes showed a homogeneous population of NIMDA-positive cells scattered throughout lymph node cortices and Peyer's patches. No positive cells were observed in sections using control primers and probes. These findings provide evidence for the transfer of maternal cells from the cow to the newborn calf. The presence of viable maternal immune cells in calf lymphoid tissues would suggest a role in calf immune system function or development. Clostridium difficile is associated with enterocolitis in adult horses and foals. Difficulty in isolating this organism through culture has likely led to it being overlooked in many cases. C.difficile exerts its effects through the production of exotoxins, but since non-toxigenic strains occur, definitive diagnosis requires identification of either toxins in feces, or the ability of isolates to produce toxins. This study evaluates the association of C.difficile with equine enterocolitis and examines the discepancy between bacterial culture and toxin identification.

Anaerobic culture of fecal samples for C.difficile was performed using cycloserine-cefoxitin fructose agar (CCFA) on all cases of colitis involving foals and adult horses at the Ontario Veterinary College from March to December 1998. The organism was identified by colonial and Gram stain morphology, plus the production of l-proline-aminopeptidase. An ELISA was used to detect the presence of Toxin A and/or Toxin B in fecal samples. Normal horses and foals were also sampled.

24 cases of colitis in adult horses were sampled. C.difficile toxins were identified in 7 (29%), but C.difficile was only isolated from 2 of these. A nontoxigenic strain of C.difficile was isolated from one animal. 13 cases of enterocolitis in foals were sampled. C.difficile enterocolitis was diagnosed in 4 (31%) by ELISA and C.difficile was isolated from 3 of these. One non-toxigenic strain was isolated.

C.difficile was not isolated from 259 adults and 37 foals with normal feces. C.difficile toxin was only detected in feces of 1 of 58 normal adults (1.7%) and 0 of 10 normal foals.

To evaluate the discrepancies between bacterial culture and toxin assays in diagnosis, six fecal samples from which C.difficile was isolated were stored at 4 0 C and cultured daily. Survival time under these conditions varied from less than one to 46 days. The persistence of toxins was evaluated as well. 3 toxin positive fecal samples stored at 4 0 C were repeatedly tested and toxin was detected for greater than 30 days. Further, 4 toxigenic strains were grown in cooked meat broth (CMB) medium to induce toxin production. Toxin persisted in CMB and in feces stored at 4 0 C for greater than 30 days. The variability in survival of the organism when compared to the persistence of toxin and the rarity of toxin in healthy horses suggests that a diagnosis of C.difficile enterocolitis can be made in the absence of successful culture of the organism. Although the term laminitis indicates an inflammatory process, there are, to our knowledge, no previous reports of the involvement of inflammatory mediators in the onset of equine laminitis. In fact, the role of inflammation in early laminitis has been questioned due to the paucity of white blood cells in the laminitic digit. We investigated the gene expression of the pivotal inflammatory cytokine interleukin-1 beta (IL-1b) by cellular components of the palmar digital vasculature and laminar tissue in the early stages of laminitis. Horses were anesthetized 2-3 hours after administration of black walnut extract (BW, nϭ5) or placebo (nϭ3); the time point was dictated by the onset of neutropenia in the BW horses. Hemodynamic measurements were performed in one front foot while the digital vessels and laminar tissue in the opposite foot were fixed via formalin perfusion prior to tissue collection. In situ hybridization using equine-specific riboprobes for IL-1b was performed. Whereas no IL-1b message was apparent in control laminar tissues, there was marked IL-1b expression by endothelial cells of laminar capillaries in laminitic equine digits. No expression of IL-1b was noted in the palmar digital vessels, nor in the digital arterioles or venules. These results suggest a role of inflammation in the early laminitic disease process. Importantly, we have demonstrated gene expression of IL-1b by cell components of the laminar capillary wall, suggesting that the inflammatory process may be a local phenomenon within the laminitic digit.

AND AVIRULENT RHODOCOCCUS EQUI. S. Giguère and J.F. Prescott. Ontario Veterinary College, University of Guelph, Guelph, Ontario.

The virulence of R. equi for foals relies on the presence of a 85-or 90-kb plasmid. Immunocompetent mice infected with virulent R. equi develop a type 1 immune response characterized by the production of interferon (INF)-␥ and rapidly clear the infection. In contrast, induction of a type 2 response characterized by the production of interleukin (IL)-4 leads to the development of a severe pneumonia. We hypothesized that the 85-kb plasmid of R. equi mediates virulence by modulating the cytokine response of infected foals.

Eight 3-week old pony foals were infected intrabronchially with virulent R. equi strain 103 containing an 85-kb plasmid (103ϩ), 8 foals were infected with the plasmid cured derivative (103-), and 6 control foals received only saline. Half of the foals in each group were euthanized at 3 days postinfection and the remaining half at 14 days postinfection. After euthanasia, CD4ϩ T helper lymphocytes were purified from the bronchial lymph nodes (BLN) using immunomagnetic separation. Messenger RNA (mRNA) expression for IL-1␣, IL-1␤, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12 p35, IL-12 p40, INF-␥, TNF-␣ and ␤-actin was measured quantitatively using reverse transcription-competitive PCR.

All foals infected with 103ϩ had lesions ranging from mild to moderate consolidation of the cranioventral lung lobes on day 3 to severe pyogranulomatous pneumonia on day 14, whereas the foals of the other groups showed no gross lesions. All the foals infected with R. equi developed a type 1 immune response characterized by strong IL-2 and INF-␥ mRNA expression. IL-1␣, IL-1␤, IL-4, IL-5, IL-12 p40 and TNF-␣ mRNA expression was not detected. In general, foals infected with 103ϩ produced higher IL-2 and IL-6 mRNA expression than those infected with 103-or the controls. IL-10 mRNA expression was similar in the 2 groups of R. equi infected foals but could not be detected in the controls. IL-12 p35 mRNA expression was considerably higher in 103ϩ infected foals when compared to those infected with 103-but was not detected in the controls. On day 3, mean INF-␥ mRNA expression was slightly higher in 103ϩ than in 103-infected foals. In contrast, on day 14 when strain 103-was completely cleared from the lungs, mean INF-␥ mRNA expression was significantly (P Ͻ 0.01) greater in 103-infected foals. Despite a significant increase in bacterial numbers between day 3 and day 14 in 103ϩ infected foals, INF-␥ mRNA expression did not change in this group.

These results suggest a role for plasmid encoded products in downregulating INF-␥ production as part of the pathogenesis of R. equi infection in foals. Introduction of DNA encoding a single antigen stimulates a highly specific immune response to the expressed protein. In the case of antigens for which cloned genes are available, this enables direct vaccination without the need for purification of recombinant protein. This approach offers considerable advantages for generating monoclonal antibodies (mAbs) to recently cloned molecules, including equine cytokines. There are currently few monoclonal antibodies recognizing equine cytokines, and the availability of these reagents would provide a potent and novel means of characterizing equine immune responses. A study was performed to generate mABs to equine interleukin 2 (eq IL-2), employing biolistic DNA vaccination techniques to immunize mice. The eq IL-2 gene was subcloned into a suitable plasmid vector, coated onto gold beads, and administered percutaneously to the abdominal skin of Balb/c mice using a PowderJect-XR gene gun; 7.5g of plasmid DNA was given to each mouse on three occasions. Mice with the greatest immune response to eq IL-2 were selected by ELISA using supernatant from a Chinese Hamster Ovary (CHO) cell line expressing recombinant equine IL-2 (rEq IL-2) as the capture antigen. Fusion of splenocytes to NS-1 myeloma cells was performed. A paired ELISA was developed to select hybridomas. CHO cell supernatants were used as capture antigens to identify hybridomas. Positive hybridomas were cloned twice by limiting dilution. Functional assays were performed by evaluating the ability of anti-eq IL-2 mABs to block ConA-stimulated lymphocyte proliferations. Antibody specificity was confirmed with immunoblot assays and by affinity purification of equine IL-2. Development of eq IL-2 ELISA and ELISPOT detection systems was also undertaken. Overall this approach to mAb production, and these specific anti-IL-2 reagents, represent potent tools for examining equine immune responses. Viable larvae of infective L3 stage Haemonchus contortus were utilized to generate cell populations for in-vitro propagation in a tissue culture environment. A variety of laboratory strategies were applied to validate the identify of H. contortus-derived cell populations including biochemical profile analysis for detecting the expression of phosphorylhydrolase, and aminopeptidase-M (ApM, zinc-metaloprotease) like activity utilizing enzyme-specific substrates (e.g. nitrophenylphosphate (pNPP), leucine-para-nitroanaline (leucine-pNA)). Significance of these experimental finding are directly related to the known expression of both phosphorylhydrolase, and ApM like biochemical activity by cell types populating the luminal surface of the nematode digestive system.

Immunoprotective properties of antigenic fractions expressed by H. contortusderived cell populations was assessed by administering two IM injections of detergent solubilized protein (100 ug) to healthy sheep (nϭ8) at 14-day intervals. Animals were then challenged per-os with infective L3 stage H. contortus larvae (nϭ10,000). Compared to negative reference controls, vaccinated sheep displayed reduction in abomasal parasite burders. Applying polyclonal primary antibody harvested from immunoprotected sheep, a spectrum of detergent solubilized antigens expressed by intact H. contortus larvae were recognized. Similarly, immunohistochemical analysis utilizing ovine polyclonal antibody recognized antigens expressed by anatomical structures consistent with the digestive system of H. contortus. The objective of the study was to compare antibody levels to BVDV measured by virus neutralization (VN) and ELISA. Forty-seven cattle entering a feedlot vaccine trial were tested for BVDV antibodies, by ELISA and by VN for type I (NADL strain) and type II BVDV (NVSL 125 strain). Also, a subgroup of samples (7) showing a greater type II than type I BVDV titer were also VN tested using the Oregon and Singer strains. The ELISA was performed at Biovet, using the procedure provided by the manufacturer (BioX). VN testing was performed at the Animal Health Laboratory of the University of Guelph. A correlation coefficient was computed between ELISA result and the log-transformed VN titer.

By ELISA, 18 samples were positive and 29 samples were negative. All samples negative on the ELISA had VN titer Յ 1:3 for type I (NADL) and type II BVDV. Correlation coefficient was high between ELISA result and VN titers for each strain, ranging from 0.81 to 0.95. All samples with ELISA results Ն 0.89 had at least one VN titer Ն 1:256. If, on these samples, VN had only been performed on one strain, titers may have been as low as 1:32. Moreover, we did not find that VN was useful in differentiating between type I and type II BVDV, as the same differences were observed between various type I strains as between type I and type II strains. An increasing number of horses are diagnosed with EPM, based on clinical neurological signs and CSF Western blot analysis. Clinical signs in some horses are inapparent to mild, whereas other horses have severe neurologic signs which may result in prolonged treatment. The purpose of this study was to determine whether use immunoglobulin concentrations (IgG, IgM) produced in the CSF can be used to evaluate the immune response to EPM infection. In order to screen for humoral response, total IgG and IgM levels were determined.

Horses, used in the study, were divided into three groups: control (nϭ5, CSF EPM Western blot negative animals), I (nϭ5, CSF EPM Western blot positive that improved with treatment), and S (nϭ5, CSF EPM Western blot positive that either deteriorated or stayed static after treatment). CSF samples were tested in all of the horses at Day 0, prior to treatment with ponazuril, Day 28, after 28 days of treatment (5-10mg/kg ponazuril (toltrazuril sulfone), PO, Q24hr), and Day 120, 3 months after the cessation of treatment. CSF IgM and IgG concentrations were determined by ELISA.

All horses in the study were showing clinical signs for greater than 1 month duration at the time of testing. In all groups of horses, total IgG and IgM levels correlated, such that increases or decreases in total IgG corresponded with changes in IgM, respectively. The control group had lower total CSF IgG and IgM concentrations when compared to EPM positive animals. Horses which showed a marked improvement in clinical signs (Group I) showed more significant changes in IgM and possibly IgG concentrations than horses which did not improve (Group S). Comparisons of average IgG and IgM levels between groups was difficult because of the range of baseline averages between horses. Impending death in calves with diarrhea and dehydration has been associated with acidemia, hyperkalemia, bradycardia, and cardiac arrhythmias. A decrease in heart rate (HR) of 8 beats per minute (bpm) has been reported for each 1 mEq/L increase in serum or plasma potassium concentration ([K ϩ ]) in a small number of calves with diarrhea (Ann Rech veter 1973; 4:99-111) , but no relationship was found in a larger data set (3rd International Symposium on Neonatal Diarrhea, 1980:375-381) . The purpose of this study was to further examine the relationship between HR and [K ϩ ] in calves.

Data was obtained from 4 studies involving calves less than 21 days of age that were healthy (n ϭ 62), or had naturally-acquired (n ϭ 36) or experimentallyinduced (n ϭ 62) diarrhea and dehydration. The normal HR and [K ϩ ] for healthy calves were 111 Ϯ 20 bpm (mean Ϯ SD), and 4.8 Ϯ 0.4 mEq/L, respectively. For calves with diarrhea and dehydration, HR ranged from 46 to 180 beats/min, serum [K ϩ ] from 1.9 to 11.9 mEq/L, and venous blood pH from 6.73 to 7.46. Linear regression using dummy variable coding of 419 data points from 98 calves indicated that when [K ϩ ] Ͻ8.0 mEq/L, HR increased linearly with [K ϩ ], such that: HR ϭ 107 ϩ 3.5[K ϩ ] (R 2 ϭ 0.83). Of 16 calves with diarrhea and HR Յ70 bpm (below the 95% confidence interval for normal HR), 10 had [K ϩ ] Ͻ5.5 mEq/L and 6 had [K ϩ ] Ͼ9.5. We conclude that a weak association between HR and [K ϩ ] exists in calves with diarrhea, and that bradycardia (HR Յ70 bpm) is of minimal value in predicting the presence of hyperkalemia. German shepherd dogs (GSD) are predisposed to enteropathies such as inflammatory bowel disease (IBD) and small intestinal bacterial overgrowth (SIBO), but to date the aetiology of these conditions is unknown. Both IBD and SIBO may be the result of local immune dysregulation. The aim of the present study was to examine cytokine mRNA expression in the intestinal mucosa of GSDs with enteropathies.

Biopsies of duodenal mucosa were taken from GSDs with small intestinal enteropathies (group 1, nϭ16) and control dogs (group 2, nϭ12), either during endoscopy or immediately post mortem. Cytokine mRNA expression, for interleukin (IL) -2, IL-4, IL-5, IL-10, IL-12p40, Interferon (IFN) -gamma, Tumor necrosis factor (TNF) -alpha and transforming growth factor (TGF) -beta, was determined by semi-quantitative reverse transcriptase polymerase chain reaction. Results were expressed relative to glyceraldehyde-3-phosphate dehydrogenase mRNA expression within the same sample.

IL-2, IL-5, IL-12p40, IFN-gamma TNF-alpha and TGF-beta mRNA expression in group 1 dogs was significantly greater than in group 2 dogs (pϽ0.01 for all). IL-4 and IL-10 mRNA was only detected in three and 24 respectively of all 28 samples, with no significant differences between groups. Further there were no significant differences between group 1 dogs subclassified as IBD or SIBO. Cytokine mRNA expression was reassessed after treatment with antibiotics, in 5 group 1 dogs with SIBO. Both TNF-alpha and TGF-beta mRNA expression declined significantly from pre-treatment values.

This study demonstrates that GSDs with IBD and SIBO have increased expression of mRNA for a variety of cytokines, suggesting heightened mucosal immune responses in both conditions. Feline pancreatitis is a notoriously difficult disorder to diagnose antemortem; lack of a sensitive and specific test, along with clinical and clinicopathologic presentation that may mimic other disease states contribute to the problem. Serum amylase and lipase are unreliable indicators of pancreatic disease in the cat. Histopathologic examination, is considered the ''gold-standard'' for antemortem diagnosis of feline pancreatitis. Preliminary findings and clinical impression have indicated that a radioimmunoassay for trypsin-like immunoreactivity in feline serum (fTLI) might be useful for the antemortem diagnosis of pancreatitis.

In this prospective study, 30 cats with clinical signs consistent with pancreatitis, including lethargy, anorexia, vomiting or abdominal pain, underwent surgical biopsy of the pancreas in addition to other routine diagnostic tests. Blood samples were drawn from fasted cats on the morning of their biopsies and serum fTLI concentrations were determined by species-specific radioimmunoassay. Haematologic and serum biochemical analyses were performed by standard automated laboratory methods. Pancreatic biopsies were categorized into 4 groups on the basis of histopathology as being either a normal pancreas (nϭ10); mild (nϭ7), moderate (nϭ6) or severe (nϭ7) pancreatitis. Pancreatic biopsies were compared with serum fTLI concentration, and haematologic and serum biochemical findings, using the Kruskal-Wallis nonparametric analysis of variance (AN-OVA) test. There was no significant difference between the 4 histopathologic groups with respect to the fTLI values (pϭ0.41). Median fTLI concentrations were 51g/L (range 18-Ͼ200g/L) for cats with a normal pancreas; 136g/L (range 12-Ͼ200g/L) for cats with mild pancreatitis; 110g/L (range 28-Ͼ200g/L) for cats with moderate pancreatitis, and 32g/L (range 24-86g/L) for cats with severe pancreatitis. There were no significant differences in any of the haematologic or biochemical parameters measured among the four histopathologic groups (pϾ0.05).We conclude that in cats that present with signs compatible with pancreatitis, serum fTLI is poorly associated with the severity of inflammation as judged by pancreatic histopathology. Although feline inflammatory bowel disease (IBD) is a well-recognized clinical syndrome, it is still poorly understood. We examined cats with naturally occurring IBD to further characterize this syndrome.

Eleven cats consecutively diagnosed with IBD between June 1998 and September 1998 comprised the study population. All had histologic lesions compatible with lymphocytic-plasmacytic enteritis and/or gastritis. Endoscopic biopsies of gastric mucosa were tested for urease activity and evaluated by cytology for the presence of spiral organisms consistent with Helicobacter spp. Fecal cytology was evaluated for the presence of spore-forming rods, spirochetes, and leukocytes. Fecal material was cultured for Salmonella spp. and Campylobacter jejuni. We assessed feces also for Cryptosporidium parvum using IFA and PCR; for Giardia by ELISA and IFA; for C. perfringens enterotoxin by ELISA; for enteric viruses by electron microscopy; and for enteric parasites by zinc sulfate flotation. In addition, serum was collected for feline trypsin-like immunoreactivity (fTLI), cobalamin, and folate concentration determinations. Sera were assayed for C. parvum and Toxoplasma gondii antibodies by ELISA.

All fecal cultures and electron microscopy results were negative. In all cats, Giardia ELISA and IFA were negative and no parasitic ova were found by zinc sulfate flotation. One cat was positive for C. perfringens enterotoxin, but sporeforming rods were not observed from fecal cytology. While C. parvum oocysts were not detected in feces of any cat, serum antibodies were detected in 6/11 (5 of 6 were positive for IgA). One C. parvum seropositive cat was also positive for T. gondii IgM. All other cats had negative T. gondii serology. Helicobacter spp. was identified in 6/11 cats (54%). Serum fTLI (85 Ϯ56g/L) was elevated in 8/11 (73%) while serum cobalamin (466 Ϯ407ng/L) was decreased in 6/11. Serum folate concentrations were normal in all cats.

Detection of infectious agents was uncommon. The presence of C. parvum antibodies suggests present or prior infection. Elevated serum fTLI concentrations suggest concurrent pancreatitis. Decreased serum cobalamin concentrations may indicate decreased ileal absorption. Further study of cats with IBD is required to determine the significance of elevated fTLI, decreased cobalamin, and exposure to C. parvum. The effect of reduced frequency of administration of misoprostol on its ability to prevent aspirin-induced gastric injury was evaluated. Twenty-four randomsource dogs were divided into 4 groups which received aspirin and misoprostol as follows: Group I, 25 mg/kg aspirin PO TID and placebo PO TID; Group II, 25 mg/kg aspirin PO TID and misoprostol 3 ug/kg PO TID; Group III, 25 mg/ kg aspirin PO TID, misoprostol 3 ug/kg PO BID and placebo PO QD; and Group IV, 25 mg/kg aspirin PO TID, misoprostol 3 ug/kg PO QD and placebo PO BID for 28 days. Groups were stratified for Helicobacter status based on results of 'CLO test'. Gastroscopy was performed on days 9, 5, 14 and 28. Each region of the stomach was evaluated separately and visible lesions were scored on a scale of 1 (submucosal hemorrhage) to 11 (perforating ulcer). Median total score for each group was compared at each day using a Kruskal-Wallis test. Median total score within each group between days was compared using a Kruskal-Wallis test.

No difference in total score was identified between Group I and IV on any day. Significant differences in total score (p Յ 0.05) were found between Groups II and III compared to Groups I and IV on day 5. Significant difference was observed on Day 14 between the total score of Group III and Group IV, but not between Group III and Group I. Group III had a significantly lower score (p Յ 0.05) than Groups I, II and IV on day 28. Study indicated that misoprostol 3 ug/kg PO BID dosing may be as effective as misoprostol 3 ug/kg PO TID dosing at preventing aspirin-induced gastric injury. Gastric erosions were present in all dogs receiving misoprostol in the study. The lack of efficacy of TID dosing on days 14 and 28 may be related to higher salicylate concentrations in Group II dogs or individual variation within the small study population. Immunoglobulin E (IgE)-mediated hypersensitivity to luminal-derived antigens may play a causative role in canine idiopathic inflammatory bowel disease (IBD). The study aimed to characterize the IgE-related immune response of the gut-associated lymphoid tissue (GALT) in healthy and IBD-affected dogs.

Tissue specimens from the gastrointestinal (GI) tract and mesenteric lymph node (mln) of 9 control and 20 diseased dogs were investigated. In situ hybridization for mRNA specific for IgE and interleukin-4 (IL-4), the key cytokine for isotype switching to IgE, and immunohistochemistry for IgE-protein and two mast cell markers, tryptase and chymase, were performed on consecutive sections. Counts of positive cells (ϩ) were expressed per mm 2 and statistically analyzed. Histopathology revealed increased numbers of plasma cells in the GI mucosa of diseased dogs. Nevertheless, IgE mRNAϩ cells were rarely detected (median, 0 cells/0.3mm 2 ; range, 0-130). Most IgE mRNAϩ cells were found in mlns (healthy/diseased: median, 13/8 cells/mm 2 ; range, 0-130/0-63). The signal pattern of IL-4 mRNA was similar to that of IgE mRNA. In contrast to IgE mRNA, cells expressing IgE on their surface were located throughout the GI mucosa; diseased dogs displayed more IgEϩ cells than controls (healthy/diseased: median, 5/40 cells/0.3mm 2 ; range, 0-202/0-468; pϭ0.0001). Total mast cell numbers did not differ between controls and diseased dogs, nor was there a shift in their subtypes.

Thus, local IgE synthesis as assessed by IgE mRNA does not occur to a significant degree in the GALT of either healthy or IBD-affected dogs but rather in associated mlns. The increased number of IgE protein-bearing cells in dogs with IBD may offer new perspectives in regard to causative and therapeutic interventions. In man, a serum albumin:effusion albumin (SA-EA) gradient Ն 1.1 discriminates the presence of portal hypertension. A prospective study of dogs with hepatoportal disease and other conditions associated with transudative abdominal effusions was done to examine their SA-EA gradients. Dogs (nϭ56) presenting consecutively to our hospital over 24 months had simultaneous sampling of ascites and serum. Cytologic evaluation and refractometer fluid protein concentration were done immediately to establish inclusion criteria. Samples were centrifuged within 1 hour, supernatant or sera separated and stored frozen at Ϫ70 C until thawed for batched analyses. Albumin was determined using the bromocresol green method. Total protein was determined using an automated biuret reaction. Each dog underwent appropriate diagnostic tests to elucidate conditions causing their effusion (e.g. CBC, chemistry profile, urinalysis, bile acids, coagulation assessments, abdominal ultrasonography, thoracic radiography, echocardiography, colorectal scintigraphy, and/or visceral biopsies). A definitive diagnosis was determined in each case. Significant differences were tested using nonparametric methods and an ␣ of 0.05. Twenty-nine dogs had hepatoportal disease (Grp 1) including: cirrhosis/fibrosis (nϭ25), congenital portosystemic shunts (postsurgical portal hypertension, enteritis, nϭ3), and portal thromboembolism (nϭ1). Twenty-seven dogs had miscellaneous disorders (Grp 2): malignancy (nϭ7), congestive heart failure (nϭ5), pancreatitis (nϭ5), protein losing enteropathy (nϭ3), thromboembolism (nϭ2), protein losing nephropathy (nϭ2) and one each with fluid overload, vena cava compression, and bile duct rupture.

Results: Significantly greater median values for age, weight, RBC MCV, concentrations of fibrinogen, albumin, and creatinine, amylase activity, and fluid nucleated cell count, RBC count and albumin concentration, occurred in Grp 2. Significantly greater values for the partial thromboplastin time occurred in Grp 1. The median SA-EA gradients were similar in each group: 1.4 (0.7-3.1) in Grp 1 and 1.30 (0.80-3.30) in Grp 2. In dogs with hepatoportal disorders, 26/ 29 had an SA-EA gradient Ն 1.1; 14/29 had a serum albumin Ͻ 2.0 gm/dl, 19/ 29 a fluid albumin Յ 0.2 gm/dl, and 27/29 fluid total protein Ͻ 2.5 gm/dl. In dogs with other disorders, 19/27 had an SA-EA gradient Ն1.1; 5/27 a serum albumin Ͻ 2.0 gm/dl, 6/27 a fluid albumin Յ 0.2 gm/dl, and 13/27 fluid total protein Ͻ 2.5 gm/dl. As in man, portal hypertension indicated by an SA-EA gradient Ն 1.1, seemingly is a common factor in formation of transudative abdominal effusions. OF AN ENZYME-LINKED IMMUNO SORBENT ASSAY FOR THE MEASURE-MENT OF FELINE TRYPSIN-LIKE IMMUNOREACTIVITY IN Serum feline trypsin-like immunoreactivity (fTLI) has been shown to be useful in the diagnosis of various exocrine pancreatic disorders in cats. Serum fTLI is markedly subnormal in cats with exocrine pancreatic insufficiency. Also, cats with pancreatitis often have elevated serum fTLI concentrations. To date radioimmunoassay was the only method available to determine fTLI in serum. The goal of this project was to develop and validate an enzyme-linked immuno sorbent assay (ELISA) for quantitative analysis of fTLI in cat serum.

A capture sandwich ELISA was developed using feline trypsin (purified from feline pancreata) and antiserum against feline trypsin raised in New Zealand White rabbits and purified by affinity chromatography using immobilized feline trypsin. The captured trypsin was identified using the same purified polyclonal antiserum after bioatinilation, a commercially available streptavidin-labeled horseradish peroxidase preparation, and a horseradish peroxidase substrate. The assay was validated by determination of sensitivity, linearity, accuracy, precision, and reproducibility. The linearity of the assay was determined by evaluating dilutional parallelism. Five serum samples with serum fTLI concentrations ranging from 6.4 to 136.6g/l were diluted 1/2, 1/4, and 1/8. Accuracy of the assay was tested by spiking five different serum samples with feline trypsin solutions in concentrations of 7. 81, 15.63, 31.25, and 62 .5g/l. Precision and reproducibility were evaluated by determining intra-assay and inter-assay variability of five different serum samples, respectively. A reference range for serum fTLI by ELISA was determined by measuring serum fTLI in serum samples from 63 clinically healthy cats.

The sensitivity of this assay was determined to be 1.23 g/l. Observed to expected ratios for dilutional parallelism ranged from 78.5 to 140.8% for the five different serum samples. Observed to expected ratios for spiking recoveries of the five samples ranged from 82.0 to 101.8%. Intra-assay variability of five different samples ranged from 9.9 to 11.1% and inter-assay variability ranged from 10.2 to 21.7%. The reference range (mean Ϯ2SD) for serum fTLI in healthy cats measured by ELISA was determined to be 12g/l to 82g/l.

We conclude that the fTLI ELISA described here is sufficiently sensitive, linear, accurate, precise, and reproducible for clinical application in the diagnosis of pancreatic disorders in cats. The goal of this study was to develop a method for the simultaneous separation and quantification of 3-O-methyl-D-glucopyranose (methylglucose), L-rhamnose (rhamnose), D(ϩ)xylose (xylose), sucrose, and lactulose in dog urine by high pressure anion exchange liquid chromatography and pulsed amperometric detection. The method was validated by determination of dilutional parallelism, spiking recovery, intra-assay variability (nϭ10), and inter-assay variability (nϭ10) using three different samples.

At a flow rate of 1ml/min the 5 sugars were separated using a NaOH gradient (0-15min: 0.004M NaOH, 15-16min: continuously increasing from 0.004M to 0.02M NaOH, 16-17.5min: continuously increasing from 0.02M to 0.078M NaOH, 17.5-24min: 0.078M NaOH, 24-27min: continuously increasing from 0.078M NaOH to 0.198M NaOH, and 27min: 0.198M NaOH). Approximate elution times were 14.5min for methylglucose, 15.8min for rhamnose, 22.7min for xylose, 23.8min for sucrose, and 30.1min for lactulose. Observed to expected ratios for all 5 sugars and all 3 samples were 77.6 to 106.9% (94.0 Ϯ8.5%; mean ϮSD) for a 1/2 dilution, 85.2 to 121.4% (100.0 Ϯ9.5%) for a 1/4 dilution, and 91.6 to 163.7% (108.1 Ϯ17.8%) for a 1/8 dilution of the three different samples. Also, observed to expected ratios for all 5 sugars and all 3 samples were 87.8 to 116.1% (102.3 Ϯ6.4%) when a standard solution containing 100mg/l of methylglucose, rhamnose, xylose, and sucrose and 50mg/l of lactulose was added to each sample, 85.5 to 104.0% (97.5 Ϯ5.7%) when the standard solution in a dilution of 1/2 was added, 89.3 to 111.3% (99.9 Ϯ5.8%) when the standard solution in a dilution of 1/4 was added, 89.7 to 110.0% (99.6 Ϯ5.5%) when the standard solution in a dilution of 1/8 was added, and 96.6 to 116.7% (103.0 Ϯ5.5%) when the standard solution in a dilution of 1/16 was added. The intraassay coefficients of variation were 1.6, 3.4, and 4.7% for methylglucose, 1.6, 2.0, and 3.6% for rhamnose, 2.7, 1.4, and 1.1% for xylose, 9.8, 3.4, and 4 .0% for sucrose, and 3.2, 3.3, and 3.3% for lactulose. Finally, the inter-assay coefficients of variation were 3.2, 5.7, and 4.2% for methylglucose, 4.3, 5.4, and 6.4% for rhamnose, 3.3, 5.0, and 4.2% for xylose, 9.4, 9.9, and 9 .4% for sucrose, and 6.1, 4.9, and 2.7% for lactulose.

We conclude that the method described here to simultaneously separate and quantify methylglucose, rhamnose, xylose, sucrose, and lactulose in canine urine is linear, accurate, precise, and reproducible. Recovery of inert sugars in urine can be used as a marker for gastrointestinal permeability and mucosal function. A test solution containing a mixture of inert sugars is given orally and urinary recoveries of these inert sugars are determined.

The urinary bladders of seven healthy research dogs were completely emptied immediately prior to oral administration of 100ml of a solution containing 1.0g of 3-O-methyl-D-glucopyranose (methylglucose), 2.5g of L-rhamnose (rhamnose), 2.5g of D(ϩ)xylose (xylose), and 2.5g of lactulose. Urine samples were collected every 2hrs for 12hrs. Urinary recoveries of the inert sugars were determined by high pressure anion exchange liquid chromatography and pulsed amperometric detection. The percent of recovery (%R) of total recovery (R) after 12hrs was calculated for each sugar and time-point.

The mean %R for all 4 inert sugars exceeded 86% at 6hrs with a standard deviation of Յ 8.1% and 94% at 8hrs with a SD Յ 2.4%.

We conclude that cumulative urine collection for 6 or 8 hours after an oral dose of a solution containing methylglucose, rhamnose, xylose, and lactulose is sufficient for estimation of urinary recovery of these 4 inert sugars in healthy dogs. Urinary recoveries of inert sugars can be used as markers for gastrointestinal permeability and mucosal function. Traditionally, L-rhamnose (rhamnose) and lactulose have been utilized for these studies in dogs. Recently, D(ϩ)xylose (xylose) and 3-O-methyl-D-glucopyranose (methylglucose) have been added for intestinal permeability and mucosal function testing. Finally, sucrose has been used separately for gastric permeability testing. The objective of this project was to evaluate whether the simultaneous use of 2, 4, or 5 of these sugars would lead to alterations in the urinary recovery of any one of the other sugars within an 8 hour sampling period.

Seven healthy research dogs were enrolled into this study. The bladders of the dogs were catheterized and completely emptied prior to oral administration of 100ml of a solution of either 2 (2.5g rhamnose, 2.5g lactulose), 4 (1g methylglucose, 2.5g rhamnose, 2.5g xylose, 2.5g lactulose), or 5 (1g methylglucose, 2.5g rhamnose, 2.5g xylose, 10g sucrose, 2.5g lactulose) sugars. Urine produced over the subsequent 8 hours was collected and urinary recoveries determined by high pressure anion exchange liquid chromatography and pulsed amperometric detection. Urinary recoveries of rhamnose and lactulose were compared between the 2-, 4-, and 5-sugar tests using repeated measures of variance, while urinary recoveries of methylglucose and xylose between the 4-and the 5-sugar tests were compared using a paired two-sided t-test.

The urinary recovery of sucrose in the 5-sugar test was 1.1 Ϯ1.8% (mean ϮSD). For rhamnose there was no significant difference (pϭ0.14) between urinary recoveries in the 2 (27.9 Ϯ4.4%), 4 (26.2 Ϯ6.2%), and 5 (33.6 Ϯ8.5%) sugar tests. Also, there was no significant difference (pϭ0.69) between urinary recoveries of lactulose in the 2 (3.7 Ϯ2.6%), 4 (4.7 Ϯ4.7%), or 5 (5.9 Ϯ5.9%) sugar tests. Finally, there was no significant difference between urinary recoveries of xylose (pϭ0.52) in the 4 (28.8 Ϯ7.2%) and 5 (31.3 Ϯ8.0%) sugar tests or between urinary recoveries of methylglucose (pϭ0.24) in the 4 (66.0 Ϯ18.6%) and 5 (79.0 Ϯ18.8%) sugar tests.

We conclude that in healthy dogs intestinal permeability of rhamnose and lactulose within 8 hours of oral application are not altered by concurrent administration of xylose, methylglucose, and sucrose. Furthermore, we conclude that within 8 hours of oral administration intestinal permeability of rhamnose, xylose, and lactulose and mucosal absorption of methylglucose are not altered by concurrent administration of sucrose to healthy dogs. A state, known as ''leaky gut'' syndrome, can exist where the tight junctions between small intestinal epithelial cells widen enabling compounds to diffuse between the enterocytes. Many studies have used ''non-metabolizable'' markers to quantify the extent of passive absorption in the small intestine. However, the potential exists for these markers to be fermented in the small intestine by resident bacteria. Fermentation as indicated by the production of short-chain fatty acids (SCFA), would result in the breakdown and disappearance of these markers. Therefore, this study was conducted to determine the potential ability of intestinal bacteria to ferment these ''inert'' markers.

Feces represent a diverse source of intestinal bacteria that are relatively easy to obtain. As such, feces collected from 3 dogs, were used as the enteric bacteria inoculum source to conduct an in vitro fermentation of the following substrates: beet pulp (positive control), alpha-cellulose (negative control), mannitol, L-rhamnose, lactulose, D-xylose, melibiose, raffinose, stachyose, cellobiose, 3-O-methylglucose, and polyethylene glycol (PEG). Each substrate was anaerobically incubated with enteric bacteria inoculum and growth media for 6, 12, and 24 h.

When data were pooled across all fermentation times and donors, total average short-chain fatty acid (SCFA) concentrations (avg 12.65 mmol/g OM) were highest (p Ͻ 0.05) for melibiose, D-xylose, stachyose, lactulose, raffinose, L-rhamnose, and mannitol. Fermentation of cellobiose and beet pulp resulted in moderate levels of total SCFA (avg 3.39 mmol/g OM), with minimal detection of SCFA (avg 0.01 mmol/g OM) from 3-O-methylglucose, PEG, and alpha-cellulose. Acetate concentrations were highest (p Ͻ 0.05) for raffinose, stachyose, and melibiose, with propionate production being higher (p Ͻ 0.05) for mannitol, lactulose, D-xylose, and L-rhamnose. Butyrate production was highest (p Ͻ 0.05) for cellobiose and lactulose. With the exception of 3-O-methylglucose, PEG, and alpha-cellulose, fermentation increased (p Ͻ 0.05) as fermentation time increased from 6 to 24 h. Results indicated that 3-O-methylglucose and PEG were virtually non-fermentable by intestinal bacteria, further validating their use as inert markers. Results further revealed substantial fermentation of the remaining markers, which may result in bias interpretation of data from previous intestinal permeability studies. The purpose of this retrospective study was to characterize imaging findings in cats with confirmed upper gastrointestinal inflammatory bowel disease (IBD), and to relate these findings to clinical signs and histologic changes. Medical records for 33 cats with a clinical and histopathologic diagnosis of upper gastrointestinal IBD were reviewed for signalment, clinical signs, clinicopathologic findings, radiographic and ultrasonographic findings, and results of endoscopic examination. Histologic findings were reviewed and characterized by severity and type of inflammatory infiltrate.

All cats had one or more clinical signs (e.g. vomiting, diarrhea, weight loss, and anorexia) consistent with IBD. Lymphocytic-plasmacytic infiltrates of increasing cellularity were observed in histologic sections from cats with mild, moderate and severe IBD. Crypt distortion, villous blunting and fusion, and fibrosis were more commonly seen in moderate to severe IBD. Clinicopathologic findings included anemia, leukocytosis or leukopenia, hypocholesterolemia, and hyper-or hypoproteinemia in some, but not all cats. No survey radiographic abnormalities were found in 9 cats with mild, moderate, or severe IBD. One of 3 cats had abnormalities in a contrast study. In 13/17 (76%) cats, abdominal ultrasonography revealed several intestinal abnormalities (e.g., poor wall layer definition, focal thickening) and enlarged abnormal mesenteric lymph nodes with hypoechoic changes consistent with a diagnosis of IBD. Ultrasonographic abnormalities were consistently associated with histologic abnormalities. Endoscopic observation revealed findings (e.g., erythema, plaques, mucosal friability) consistent with inflammation in 9/18 (50%) cats. Abnormal endoscopic findings were not always associated with histologic abnormalities.

Clinical signs and ultrasonographic findings appeared to have the best correlation with histologic grade in feline IBD. Radiography was not sensitive in detecting intestinal inflammation, but ultrasonography detected abnormalities in most cases. Endoscopy was useful in detecting inflammation, although many cases had normal endoscopic findings. In feline upper gastrointestinal IBD, abdominal ultrasonography identified more abnormalities than upper gastrointestinal endoscopy and should be considered in the medical investigation of feline IBD. Colonoscopy is commonly performed in dogs with signs of large bowel disease. In humans, the overall rate of complications is about 0.1% and mortality rates between 0.008% and 0.02% have been reported. Complications in dogs are believed to be rare, but no studies are available to support this contention. The purpose of this study was to characterize the type and frequency of complications associated with performing colonoscopy in dogs with signs of large bowel disease.

Medical records from 301 dogs that had 349 colonoscopic procedures performed between April 1984 and June 1998 were retrospectively reviewed. Preparation consisted of withholding food for 24 hours, administering multiple warm water enemas, and in 285 cases, giving Golytely. All dogs were examined while under inhalant gas general anesthesia using flexible gastroscopes by staff clinicians or by house officers strictly supervised by staff clinicians.

The median age was 6 years. There were 190 males and 159 females of 72 different pure breeds. There were 52 mixed breed dogs. Clinical signs were present for a median of 14 weeks prior to colonoscopy. The most common indications for colonoscopy were chronic large bowel diarrhea (142), chronic mixed bowel diarrhea (65), hematochezia (61), and tenesmus or dyschezia (28). Colonoscopy was performed by an experienced senior clinician in 109 (31.3%) procedures.

Serious complications occurred in only 2 procedures (0.6%), and consisted of one case each of colonic perforation and rectal hemorrhage after biopsy with a rigid forceps. Both dogs survived. Vomiting was associated with Golytely administration in 15 procedures (5.3%). Minor transient complications were noted after 7 procedures (0.2%) and included lethargy, pain, pyrexia, vomiting, diarrhea, premature ventricular contractions, and acute vestibular disease. Some of these complications could have been related to the underlying disease or to other diagnostic procedures performed.

In this study, complications associated with colonoscopy were uncommon (6.9% of procedures) and when they occurred were usually minor and transient, despite the lack of endoscopic experience of many of the clinicians. Colonoscopy appears to be a safe procedure. Apoptotic cell death accompanies cholestatic hepatic disease. Since cholestatic disorders are associated with increased serum and tissue bile acid concentrations and bile acids are known hepatotoxins, it is likely that bile acids contribute to the ongoing pathology in many chronic hepatopathies. We and others have demonstrated that hydrophobic bile acids induce apoptosis in primary rat hepatocyte cultures and have used this in vitro model to study the mechanisms associated with bile acid induced hepatotoxicity. Since hepatocyte growth factor (HGF) has been shown to protect neuronal and gastric epithelial cells from apoptosis, we explored the role of HGF in modulating bile acid induced hepatocyte apoptosis. Rat hepatocytes were isolated by collagenase perfusion and plated on cover slips or tissue culture flasks coated with Type I collagen in Minimal Eagles Medium supplemented with 10 % fetal calf serum. Four hours after plating, experiments were initiated by adding 50 um glycochenodeoxycholate (GCDC) and hepatocytes evaluated by Hoechst staining for morphologic evidence of apoptosis (chromatin condensation and nuclear fragmentation). The effect of hepatocyte growth factor (HGF) and epidermal growth factor (EGF) on GCDC induced apoptosis was evaluated by pretreating cultures for 15 minutes with 50 ng/ml of HGF or EGF prior to the addition of the bile acid. Treatment with GCDC alone induced apoptosis in 29.7Ϯ 3.2 % of hepatocytes. HGF significantly reduced the amount of GCDC induced apoptosis by 60.2 Ϯ 7.8 % while EGF had little effect (19.1 Ϯ 8.9% reduction in apoptosis). The protective effect of HGF was prevented in the presence of 50 uM wortmannin, an inhibitor of phosphoinositol-3-OH kinase. HGF mediated cytoprotection was accompanied by phosphosphorylation of protein kinase B (PKB) as determined on immunblots of cell extracts with phosphospecific antibodies. Pretreatment with 50 uM wortmannin prevented HGF mediated activation of PKB. HGF mediated protection against bile acid induced apoptosis in rat hepataocytes may involve sequential activation of PI3K and PKB. Since HGF is produced by nonparenchymal cells in the liver, we hypothesize that it exerts a paracrine effect on hepatocytes to promote cell survival. The effects of a gastrostomy tube (G-tube) on gastric emptying were evaluated utilizing scintigraphy in 13 cats (complete block design). In order to differentiate between administration route (ingestion vs infusion) and the presence of the gastrostomy tube (present or not present), gastric emptying was compared between three combinations: 1) no G-tube, food ingested; 2) G-tube present, food infused; 3) G-tube present, food ingested. Thirteen cats were accommodated to a commercial canned diet (CNM-CV Purina Inc.) for 2 weeks. The diet was labeled with 99m Tc-disofenin. After ingestion, gastric images were taken at 12 intervals for 5 hours.

Gastric emptying was not significantly affected by either the presence of the G-tube or the route of administration of food into the stomach. Canine pancreatic lipase (cPL) is required for our ongoing studies of canine lipases, but to our knowledge is not available commercially. The purification of cPL from canine pancreatic juice, but not from pancreatic tissue, has been reported previously. Given the logistic difficulties associated with collection of pancreatic juice in dogs the objective of this project was to purify cPL from dog pancreas.

Dog pancreata were collected from research dogs that were sacrificed for unrelated research projects after humane euthanasia. After removal of gross fat pancreatic tissue was sliced in small cubes and crushed in 100ml acetone using a Polytron, and filtered through a Buchner funnel. In order to completely remove all fat this procedure was repeated a total of 8 times, using acetone and a chloroform butanol mixture. The final extract was resuspended in approximately 50ml of ethyl ether, and filtered in the Buchner funnel to dryness. Five grams of the delipified pancreatic extract were further purified by extracting the enzymes in a tris-buffer containing two different protease inhibitors, benzamindine and phenylmethylsulfonyl fluoride. After centrifugation the supernatant was saved and further purified by anion exchange chromatography on a mono-Q column, gel-filtration on a Sephacryl S-100 column, and cation exchange chromatography on a Source-S column using a NaCl gradient.

The table shows protein yield, specific lipolytic activity per mg protein, and total lipolytic activity after each purification step for a typical purification.

Canine pancreatic lipase was successfully purified from canine pancreatic tissue. The purified product showed a single band on sodium dodecyl sulfate polyacrylamide gel electrophoresis with a molecular weight of approximately 50,700. The identity of the product was confirmed by N-terminal amino acid sequencing of the first 25 amino acid residues which showed the sequence Lys-Glu-Val-X-Phe-Pro-Arg-Leu-Gly-X-Phe-Ser-Asp-Asp-Ser-Pro-Trp-Ala-Gly-Ile-Val-Glu-Arg-Pro-Leu. Twenty of 23 identified amino acid residues matched corresponding residues of porcine pancreatic lipase.

We conclude that using the described protocol canine pancreatic lipase can be successfully purified from canine pancreatic tissue. Bromide (Br) is a binary compound of the element bromine and other common cations, in this case potassium (KBr). It is an adjunctive treatment for dogs with epilepsy, particularly those that are refractory to phenobarbital. Bromide is no longer manufactured by pharmaceutical companies in the United States and must be obtained as a reagent grade chemical from chemical supply companies. Since Br is a salt of hydrobromic acid (Hϩ Br-), it should remain stable indefinitely. However there are no data on the stability of Br in solution over time nor on the effects of storage conditions (refrigerator vs. room temperature; clear plastic container vs. brown glass).

Eight different one liter KBr solutions were made by weighing 250 gm of KBr powder and adding enough distilled water to make a one liter solution. Four solutions were put into clear plastic containers and 4 were put into brown glass containers. Two of each container types were placed in a refrigerator (4ЊC) for 1 year, and two were kept at room temperature (25ЊC) for 1 year. To assimilate daily dosing conditions, a small portion was removed daily from one container type under the two different storage conditions. The concentration of KBr was measured in each container at monthly intervals using ion exchange high performance liquid chromatography(Dionex Model 4000 HP2C).

The physical condition of the bromide did not change over a 12 month period, nor were there significant changes in the Br concentration of each container. We concluded that Br was stable in solution over a 1 year period and that it does not matter if Br is stored in clear or brown containers, plastic or glass containers, or if it is stored at room or refrigerator temperatures. If some patients are manifesting poor seizure control, it not likely because of instability of Br and the types of storage conditions described here. Phenobarbital (PB) is the drug of choice for control of canine epilepsy. It induces hepatic enzymes and can be hepatotoxic and/or decrease T4 in some dogs. At times, PB needs to be discontinued but it is unknown how long liver enzyme induction and decreases in T4 persist following discontinuation. The purpose of this study was to characterize changes in total T4 (TT4), free T4 (FT4), liver enzymes (ALT, ALP, GGT), albumin, TSH and cholesterol following discontinuation of long-term PB administration in normal dogs.

Twelve normal dogs were administered PB at a dose of 4.4-6.6 mg/kg PO BID for 27 weeks. Following discontinuation of PB (week 27), blood was collected for analysis at varying intervals for 10 weeks. Results were compared to those from the end of the PB trial.

Comparison to pre-treatment values showed serum ALT, ALP, TSH and cholesterol to be significantly higher at week 27, while TT4 and FT4 were significantly lower. GGT and albumin were unchanged. Serum ALT, ALP, and cholesterol were significantly decreased from week 27 by weeks 5, 1, and 2, respectively, post withdrawal. Serum GGT was significantly increased above week 27 at week 1 post withdrawal and remained above baseline until week 9. Serum albumin was significantly increased from week 27 at weeks 2 and 5-9 post withdrawal. Serum TSH was not significantly different from week 27 at any time during the post withdrawal period. Serum TT4 was significantly increased from week 27 at weeks 1, 2, and 4-10 post withdrawal. Serum FT4 was significantly increased above week 27 at weeks 5-8 post withdrawal.

This study documents that changes in liver enzymes (ALT, ALP, GGT) and cholesterol induced by PB resolve 1-5 weeks after withdrawal of the drug in normal dogs treated for 27 weeks. Therefore, it can be recommended that liver parameters be evaluated at least 6 weeks after discontinuation of PB, and significantly abnormal findings should lead the clinician to re-evaluate the dog for hepatotoxicity or other primary liver disease. In addition, TT4 and FT4 decreases resolved 1 and 5 weeks after withdrawal, respectively. In dogs with suspected hypothyroidism, it is recommended that thyroid values be evaluated at least 6 weeks following cessation of PB. Feline hyperesthesia syndrome is a commonly recognized but poorly understood disorder characterized by paroxysmal agitation, focal spasms of the thoracolumbar epaxial muscles, vocalization, biting of the caudal trunk and pelvic limbs, and exaggerated tail movements. Pharmacological therapy including prednisone, amitriptyline, phenobarbital, carnitine, and coenzyme-Q 10 is often unrewarding. Five cats with compatible signs underwent a battery of tests which included a complete neurological examination, a CBC, biochemistry profile, spinal radiographs, electromyography (EMG), and histological, histochemical, and immunocytochemical evaluation of fresh frozen muscle biopsy specimens. Infectious disease screening tests (FeLV, FIV, Toxoplasma gondii (nϭ4) and Feline syncytia-forming virus (FSV) (nϭ1), cerebrospinal fluid (CSF) analysis (nϭ3) and electroencephalography (nϭ1) were performed. Four of five cats had a chronic, intermittent to progressive clinical course over a 1 to 2 year period before presentation. All cats were between 5 and 8 years of age with no apparent sex predilection. No neurological deficits were detected in any of the cats; however, zones of apparent hyperpathia were present in thoracolumbar epaxial muscles in 4 cats. Hematological and biochemical parameters were within normal limits with the exception of elevated globulin levels in 2 cats. Spinal radiographs were normal in all cats. Spontaneous EMG activity was found in a multifocal distribution within thoracolumbar epaxial muscles. The majority of spontaneous activity was found in the mid-thoracic segments and consisted of fibrillation potentials, positive sharp waves, complex repetitive discharges, and trains of giant motor unit potentials. No abnormalities were found in appendicular muscles. Infectious disease testing, CSF analysis, and electroencephalography were unremarkable in those cats tested with the exception of a positive FSV titer (1: 16) in 1 cat. Epaxial muscle biopsies (5/5) contained numerous rimmed vacuoles, the contents of which were positively labeled with monoclonal antibodies against paired helical filaments and ␤-amyloid. Vacuoles were not observed in muscles from 10 unaffected cats. The rimmed vacuoles and antibody labeling patterns are similar to that described in inclusion body myositis/myopathy in humans. Dogs in status epilepticus often need to be heavily sedated or anesthetized to halt seizure activity. Such measures preclude the administration of oral anticonvulsants. In those patients already receiving an adequate dose of phenobarbital, the ability to safely and effectively administer a loading dose of potassium bromide (KBr) intrarectally may allow for improved short and long-term seizure control. The purpose of this study was to determine the peak drug concentrations and bioavailability of an intrarectal KBr loading dose in dogs, as well as to evaluate the safety and potential side-effects of a 24-hour intrarectal loading protocol. Four normal adult female-spayed hound dogs, weighing an average of 22.3 kg (range: 19.1-26 kg), were used in a two-way crossover design. Each dog was administered a loading dose (600 mg/kg) of sterile KBr solution (concentration 250 mg/ml) over 24 hours, via six intrarectal (IR) boluses (100 mg/ kg, q 4h). Serum samples for bromide and potassium (K ϩ ) concentrations were obtained every 2 hours during the loading period, and weekly thereafter for bromide, until the concentrations were below the limit of quantitation. At this point, two dogs were re-loaded over 24 hours as a continuous rate intravenous infusion. The gold chloride method was used to determine serum bromide concentrations. The average serum bromide concentration after IR loading was 0.92 mg/ml (range: 0.81-1.11 mg/ml), and after IV loading was 1.18 mg/ml (range: 1.13-1.22 mg/ml). The average peak serum K ϩ concentration during KBr loading was 5.87 mEq/L (range: 5.5-6.8 mEq/L) and 5.7 mEq/L (range: 5.6-5.8 mEq/ L) for IR and IV loading, respectively (normal range: 3.5-5.5 mEq/L). Mean half-life (t 1/2 ) of IR KBr was 488.8 hours, or 20.4 days. A side-effect of both IR and IV KBr loading was mild sedation, and of IR loading was transient diarrhea. Preliminary bioavailability (F) of intrarectally administered bromide was calculated in 2 dogs (FϭAUC {rectal}/ AUC {intravenous}) to be 57.7 %. Results indicate that KBr is well absorbed rectally and that a 24-hour intrarectal loading protocol is safe to administer in normal dogs. Periodic monitoring of serum phenobarbital (PB) concentrations (PBC) in epileptic dogs is important because seizure control correlates best with serum PBC and not dosage. It has been recommended that serum PBC be measured at either trough (zero hour) or peak (three to six hours post dosing) times, but this can be inconvenient due to the difficulty in scheduling around a set dosing interval. The purpose of this study was to evaluate trough and peak serum PBC in epileptic dogs to determine whether there are significant differences in serum PBC occurring throughout a dosing interval.

Fourteen epileptic dogs receiving PB on a B.I.D. schedule for a minimum of three weeks were entered in this study. No dog had received any known cytochrome P450-inducing or inhibiting drugs within three months prior to the study. Blood samples were collected after a 12 hour fast prior to PB dosing (trough), and three and six hours post dosing. All serum PBC were determined using a fluorescence polarization immunoassay validated for dog serum. For each dog, trough, three hour and six hour serum PBC were compared using an analysis of variance (ANOVA) followed by a Fisher's LSD test. Trough and both peak concentrations for each dog were also compared to determine whether drug concentrations were in different therapeutic categories which were defined, for the purposes of this study, as subtherapeutic (Ͻ15 ug/ml), low therapeutic (16-25 ug/ml), mid therapeutic (26-35 ug/ml), high therapeutic (36-45 ug/ml), and supratherapeutic (Ͼ45 ug/ml).

The duration of treatment ranged from one to 120 months with a median of 19 months. The median dose was 6.0 mg/kg/day with a range of 2 to 10.9 mg/ kg/day. There was no statistically significant difference among mean trough, three hour and six hour PBC. In addition, for 13 of 14 dogs (93%), the serum PBC were in the same therapeutic category at both peak and trough samples. One dog, which was receiving the highest dose of PB per day (10.9 mg/kg/day), had a trough and six hour PBC in the mid therapeutic range but a three hour PBC in the high therapeutic range.

To date, this ongoing study suggests that there is no significant difference in trough and peak serum PBC in epileptic dogs. Therefore, coordination of timing of blood samples, which is inconvenient for both clients and clinicians, is probable unnecessary when evaluating serum PBC in most dogs. The one dog receiving the highest daily dose of PB had a wider daily variation in PBC, and we are currently evaluating additional dogs to determine whether a higher daily dose is associated with greater variations in serum PBC. The purpose of this report is to discuss the results of computed tomography(CT)-guided brain biopsy in 50 dogs, with respect to the diagnostic yield of the procedure and post-operative clinical complications.

CT-guided stereotactic brain biopsies were done in 50 dogs with clinical signs of cerebral dysfunction that had lesions evident on brain imaging (CT or magnetic resonance imaging [MRI] ). Dogs were presented to the University of California-Davis Veterinary Medical Teaching Hospital between November 1996 and September 1998. One to four core biopsy samples of the imaged lesion were obtained from each dog. Crush preparations for immediate histological interpretation were prepared from each core sample. The remainder of each core sample was formalin fixed.

In 22 dogs the neuropathologic diagnosis from stereotactic biopsy (including both crush preparations and paraffin sections) was compared with that made from tissue obtained from subsequent surgical resection or at necropsy.

After the biopsy procedure, 41 dogs were closely monitored for clinical signs of complications, seven dogs were taken immediately for craniotomy, and two dogs were euthanatized.

The final diagnosis was in agreement with the stereotactic biopsy diagnosis in 20 of 22 dogs. In 17 other dogs without follow-up, stereotactic brain biopsy provided a diagnosis of a specific primary brain tumor.

Of the 41 dogs available for evaluation of postoperative complications, 36 recovered without apparent complications. Of the remaining five dogs, complications included transient epistaxis (1 dog), transient exacerbation of cerebellar signs (1 dog), obtundation progressing to coma (1 dog), and intractable seizures (2 dogs). The last three dogs all had large primary brain tumors, and had received high doses of phenobarbital and glucocorticoids prior to biopsy.

Results of this study suggest that CT-guided stereotactic brain biopsy provides an accurate histopathological diagnosis of the majority of brain lesions detected by CT or MRI, with a low complication rate. Inherited canine motor neuron disease (Hereditary Canine Spinal Muscular Atrophy) (HCSMA) was first identified in Brittany Spaniels in 1979. The pathological and clinical features of the disease are similar to the human disease, amyotrophic lateral sclerosis, and have been well described, but biochemical data on a large number of affected animals has not been reported. This retrospective study characterize the pattern of laboratory findings and relevant histopathological changes in a large number of dogs with inherited HCSMA. We reviewed medical records of 54 affected dogs (January 1993-December 1998) including 43 affected adult dogs (mean age 5.6 years) heterozygous (HTZs) for HCSMA and 11 affected ho ozygote (HMZs) pup (mean age 13 wks). Laboratory data included complete blood counts, serum chemistries, CSF analysis, T3 and T4 measurements, urinalysis, and necropsy findings. Serum levels of vitamin E were measured in 7 HMZs and 14 HTZs. Except for the the clinical signs of HCSMA, all animals were normal on physical examination, were ambulatory and were able to eat and drink. A mild regenerative anemia was identified in 43% of the HTZs and 77% of the HMZs. Other abnormalities included increases (2.6-fold) in AST (SGOT), and ALP in ϳ15% of the HTZs. Hypoglobulinemia and hypoalbuminemia were present in ϳ32% of the HTZs. Serum levels of vitamin E in the HMZs were significantly lower (Pϭ0.001) than the HTZs or the age matched controls. Histologically, the livers of both HTZs and HMZs were generally unremarkable except for only rare, micronodular inflammatory foci. A few crypts were mildly dilated in the small intestine of several HTZs. Denervation muscle atrophy was present in all dogs; focal muscle necrosis was observed in several older HTZs.

The hematologic data were not compatible with RBC destruction; there was no evidence of blood loss. We interpreted the anemia as reduced erythropoiesis, possibly related to chronic disease. The mild liver lesions may be associated with the elevation in AST (SGOT) and ALP. Additional sources of increased AST could include skeletal muscle and RBCs. The cause of low serum levels of albumin and immunoglobulins is unclear, because there was no significant intestinal pathology, renal protein loss, or nutritional deficit. Low levels of the antioxidant vitamin E in HCSMA are consistent with similar findings reported in equine motor neuron disease, and suggest a role for oxidant injury in HCSMA. The significance of the abnormal laboratory findings in a limited number of dogs with HCSMA warrant further study to elucidate their potential association with the disease process. Fourteen miniature wirehaired dachshunds (MWHD) were evaluated for repetitive muscle contractions (twitching), seizures and hypnic jerks. Age of onset ranged from 6 to 13 years of age (median 7 years) and 5 males and 9 females were affected. Neurological examination was normal except for the observed twitching, and neither muscle atrophy, weakness or exercise intolerance were evident. Twitching occurred spontaneously (11/14) and could be elicited by sudden movements in the visual field (14/14), sudden changes in light intensity (10/ 14), and sudden noise (7/14). The seizures included impaired consciousness, extended or paddling limbs, foaming at the mouth, vocalizing and urinating. Occasionally the seizures followed a violent train of twitching (3/12). Hypnic jerks occurred at rest or when asleep. Laboratory evaluations including complete blood counts, serum chemistry profiles, and cerebrospinal fluid analysis were within normal limits.

In humans, histological and ultrastructural evaluation of muscle biopsy specimens has proven valuable in establishing a diagnosis in cases of progressive myoclonic epilepsy. Fresh frozen and formalin fixed biopsies from the triceps and vastus lateralis muscles were evaluated from 7 affected dogs. In muscles from 5 of 7 dogs, intense periodic acid-Schiff (PAS) positive, diastase resistant inclusions (polyglucosan bodies) were present beneath the sarcolemma and between myofibrils. Ultrastructurally, glycogen particles, dense granular material and filamentous aggregates were present in subsarcolemmal spaces. A peripheral nerve specimen was available from one dog and showed similar polyglucosan bodies in the axoplasm of myelinated fibers. Filamentous accumulations of PAS positive, diastase resistant material may be associated with phosphofructokinase deficiency, branching enzyme deficiency, polyglucosan body disease, polysaccharide storage myopathy, and Lafora disease. The clinical presentation of progressive myoclonic epilepsy with the absence of muscle weakness, the lack of hypoglycemia or liver disease, and the presence of polyglucosan bodies within the muscle biopsies is consistent with a diagnosis of Lafora disease in the MWHD. The underlying metabolic abnormality in Lafora disease is as yet unknown. The clinical presentation, muscle immunohistochemistry, and immunophenotype of invading myocytotoxic T lymphocytes were evaluated in 7 young Newfoundlands with a newly recognized breed associated polymyositis. Age of disease onset, sex distribution of affected dogs, frequency of specific clinical signs, and serum biochemical abnormalities were collectively evaluated. Fresh frozen muscle biopsies were examined with histochemical stains as well as with the immunoreagent SPA-HRPO. In situ immunophenotyping of T lymphocytes was evaluated using monoclonal antibodies against canine lymphocyte CD4 and CD8 antigens in frozen muscle biopsy sections.

The Newfoundlands (4 males and 3 females) ranged in age from 6 months to 5 years of age at the time of disease onset. The most common presenting sign was exercise-induced weakness (7/7 dogs). Other common findings included generalized appendicular and masticatory muscle atrophy (5/7 dogs); dysphagia (4/7 dogs); regurgitation (4/7 dogs); and voice change/respiratory stridor (4/7 dogs). Generalized muscle pain was not a feature in any of the dogs.

Biochemical analysis revealed variable elevations in CK ranging from normal (3/7) to 5867, 6620, 8830, and 17598 IU/L in the remaining 4 dogs. Other abnormalities included hypercholesterolemia (3/7) and hypothyroidism (2/5). Concurrent immune mediated myasthenia gravis was not present in any of the 6 dogs that were tested.

Muscle histopathology was similar in all but one case, consisting of multifocal areas of lymphocytic, plasmacytic infiltration in an endomysial distribution. There was cellular invasion of non-necrotic myofibers. The one exception demonstrated predominantly degenerative changes (myonecrosis and fibrosis). All cases had prominent sarcolemmal labeling either within the serum or directly on the dog's muscle biopsy, a finding rarely observed in other causes of polymyositis and in masticatory myositis. Immunophenotyping of the invading lymphocytes revealed primarily CD8ϩ cells with less prominent labeling for CD4ϩ lymphocytes.

These findings are identical to those associated with human familial polymyositis. It is postulated that interactions between ICAM-1 (on targeted myofibers) and LFA-1 (expressed on the invading CD8ϩ lymphocytes) allows these T cells to selectively migrate into inflamed muscle and adhere to MHC-1 positive myofibers. The above sarcolemmal staining strongly suggests an immune-mediated etiology against a component of the sarcolemmal membrane itself. Myelography is currently the preferred means of diagnosing canine intervertebral disc disease. However, myelograms can cause worsening of neurological signs and seizures. The aim of this study was to describe the computed tomographic (CT) appearance of acute intervertebral disc herniations in dogs, and to compare the relative accuracy of myelography and CT at localizing herniated disc material. Twenty dogs with acute intervertebral disc herniations causing paraparesis were used. The dogs were imaged using a third generation CT scanner. Based on the neurological examination, transverse scans were acquired at 3mm intervals between T10 and L4, or L3 and S3. Following the CT scans, lumbar myelograms were performed by subarachnoid injection of iohexol. Hemilaminectomies were then performed to decompress the spinal cord based on the CT and myelographic appearance. The CT scans and myelograms were randomized and 6 clinicians with differing levels of clinical experience identified the position of herniated disc material in each case. The CT and myelographic findings were compared with the surgical findings.

On transverse CT images, the normal spinal cord was delineated by epidural fat over the disc spaces. Herniated disc material was clearly visible in the vertebral canal as a heterogeneous hyperattenuating mass. For the 6 reviewers, CT was 90% and myelography was 88% accurate at identifying the major site of disc herniation. Lateralization of disc material was correctly predicted in 96% of dogs with CT and 92% of dogs with myelography. We conclude that acutely herniated mineralized disc material is easily identifiable on CT scans. Moreover, CT is slightly more accurate than myelography at localizing the disc material when assessed by observers of differing clinical experience.

(GE Sytec SRi)(Omnipaque, Nycomed) The breeds of dog represented included 14 dachshunds, 3 cross breeds, 1 toy poodle, 1 cocker spaniel and 1 peekapoo.

The full extent of disc herniation was predicted in 84% of the cases with CT and 80% of the cases with myelography. In some animals, the subarachnoid space was characterized by increased attenuation cranial and caudal to the site of disc herniation. This was identififed as hemorrhage at surgery. The purpose of this study is to report the technique and results of transarticular process pinning for initial vertebral alignment and stabilization, prior to fixation with vertebral body pins and polymethylmethacrylate cement (PMMA), in thoracolumbar and lumbosacral vertebral column fracture/luxations. Eighteen dogs were examined at times varying from hours to days post-trauma, with signs localized to the thoracolumbar or lumbosacral spinal cord. All but three had non-ambulatory paraparesis; four were paraplegic. Lateral projections only were done during plain radiography and myelography. Survey vertebral radiographs confirmed a fracture/luxation in all dogs. Additional fractures were identified in nine dogs: four of the pelvis and/or pelvic limb long bones, and five of the caudal vertebrae.

Routine dissection of epaxial musculature was done with the dogs in sternal recumbency. Manual traction and reduction was done by means of bone holding forceps, and the articular processes aligned. A Kirschner wire of appropriate size was driven through the aligned articular processes in a medial to ventrolateral direction. This was done bilaterally in nine dogs, and unilaterally in nine, due to the presence of either fractured processes or planned hemilaminectomy. The K-wires were cut and crimped. Further stabilization involved placement of vertebral body pins and PMMA. Steinmann pins were used in seven dogs, and negative threaded pins in two dogs. In nine dogs, positive threaded pins were used. The bent ends of the trans-articular process K-wires were incorporated in the PMMA. Closure was routine, and post-operative radiographs were obtained in all dogs.

Two months post-operatively, six dogs were ambulatory with minimal gait abnormalities, six dogs were ambulatory with mild neurological deficits, and one dog was ambulatory with marked neurological deficits. Three dogs were lost to follow-up. Two dogs were euthanatized.

The technique of trans-articular process pinning facilitates vertebral alignment and stabilization. The technique effectively maintains reduction and stability of the vertebral fracture-luxation, reducing the potential of spinal trauma during manipulation and placement of vertebral body pins. Reduction is also maintained during the critical phase of PMMA placement and polymerization. Inborn errors of metabolism are caused by genetic defects resulting in abnormal synthesis, metabolism, transport or storage of biochemical compounds. In people, over 100 neurometabolic disorders have been identified, most of which are inborn errors of organic acid (OA) or amino acid (AA) metabolism. Although quantification of urinary OA is optimal for diagnosis of most metabolic disorders, determination of CSF OA and AA may be necessary for diagnosis of neurodegenerative disorders involving abnormalities of CNS oxidative metabolism. Ratios of lactate to pyruvate and 3-OH butyrate to acetoacetate have been used for evaluation of the redox couple NADϩ/NADH in the blood. Elevated blood alanine concentration is also an indicator of disordered pyruvate metabolism. The object of this study was to establish reference ranges for CSF OA and AA (including alanine), and CSF lactate/pyruvate and 3-OHbutyrate/acetoacetate ratios in healthy dogs under general anesthesia and 10 minutes after death.

Ten healthy dogs, as determined by physical and neurological examinations, CBC and a biochemistry panel, were used. All dogs were anesthetized, and CSF drawn from the cerebellomedullary cistern. An aliquot of the CSF was immediately frozen on dry ice for OA and AA determination; total RBC and WBC counts, WBC differential count, and total protein were determined on a 2nd aliquot. The dogs were then euthanatized and a 2nd CSF sample drawn for the same analyses. The brain and spinal cord from each dog was removed and examined for gross and histologic abnormalities. Four dogs were identified with microscopic inflammatory CNS lesions despite having normal clinical pathologic data, including CSF analyses, and were eliminated from the study. For the 6 remaining dogs, CSF OA concentration was determined by gas chromatography-mass spectrometry; CSF AA concentration was determined by quantitative column chromatography.

All 18 AA and 29 of 31 OA assayed were detectable in the CSF. No significant difference was found between the OA and AA levels of the dogs under anesthesia and following euthanasia. The lactate/pyruvate ratios differed significantly from the ratios of a group of clinically normal dogs studied at the University of Georgia, and substantially from the ratios reported for canine blood. The 3-OH butyrate/acetoacetate ratios and alanine levels were not significantly different from those of the University of Georgia dogs. Therefore, 3-OH butyrate/acetoacetate ratios and alanine concentration may be more reliable than lactate/pyruvate ratios in detecting disorders of CNS metabolism in the dog. The purpose of this study is to determine if Degenerative Myelopathy (DM) of German Shepherd dogs could be caused by a defect in the gene that encodes the canine hepatic alpha (␣) tocopherol transfer protein (␣TTP). This protein is responsible for the binding and transfer of ␣tocopherol between biological membranes and for maintaining plasma Vitamin E levels and it has been detected solely in hepatocytes. There is conflicting evidence in the literature regarding Vitamin E levels in dogs with DM; levels have been low in serum or tissue in some studies but have been normal in others. We decided to determine whether or not a genetic defect might cause impaired utilization of ␣tocopherol in liver cells of dogs with DM, similar to that seen in humans with familial Ataxia with Vitamin E Deficiency (AVED). This disease is caused by defects in the human ␣TTP gene and there are distinct similarities in clinical signs and progression to DM. The ␣TTP mRNA is expressed at high levels in liver and at low levels in lung, retina, heart, kidney, skin and other tissues. We therefore isolated total RNA from the liver of a normal dog. The RNA was reverse transcribed and then amplified using degenerate primers. Primer selection was based on the cDNA sequences for human and rat ␣TTP. Products were sequenced directly in both directions. We were able to identify about 600 base pairs of the 3' end of the canine ␣TTP coding region, which represents 72 % of the whole protein. The homology of the determined amino acid sequence for canine ␣TTP was 95 % between dog and human and 90 % between dog and rat. Almost all genetic defects causing AVED in humans lie within the region for which we now have sequence data for canine ␣TTP. We are now conducting reverse transcriptase polymerase chain reaction and sequence analysis of canine ␣TTP on liver RNA isolated from 10 dogs with histologically confirmed DM. Glutamate is the most abundant excitatory neurotransmitter in the central nervous system (CNS). However, excessive extracellular levels of glutamate are neurotoxic, and glutamate is incriminated as a mediator of secondary tissue damage following acute CNS injury. The aim of this study was to measure the concentration of glutamate in cerebrospinal fluid (CSF) from dogs with acute and chronic compressive thoracolumbar spinal cord injuries due to intervertebral disc herniation. CSF samples were taken from the cerebellomedullary cistern (CMC) and lumbar subarachnoid space from 8 normal dogs, 13 dogs with acute spinal cord injuries and 11 dogs with chronic spinal cord compression. The samples were frozen at Ϫ80ЊC for subsequent high-performance liquid chromatography (HPLC) analysis of glutamate concentration. HPLC was performed on derivatized CSF samples using ultraviolet detection. CSF glutamate concentrations in dogs with spinal cord injuries were compared with those of the normal dogs using the Wilcoxon Signed Rank test.

The results demonstrated that focal spinal cord injuries do not affect the glutamate concentration in CSF taken from the CMC. However, dogs with severe, acute thoracolumbar disc herniations had significantly elevated glutamate concentrations in their lumbar CSF when compared with the control dogs (pϽ0.01). Moreover, the severity of their clinical signs was directly related to the glutamate concentration (r s ϭ0.6, pϭ0.011). Dogs with chronic compressive thoracolumbar lesions also had significantly elevated lumbar CSF glutamate concentrations when compared to the control dogs (pϽ0.01). These results suggest that excitotoxicity may play a role in both acute and chronic canine spinal cord compression. Therapeutic strategies to counter excitotoxic damage may therefore be useful in the management of such conditions and to correlate the glutamate concentration with injury severity. The purpose of this report is to describe the clinical signs, radiographic and pathological findings, and treatment of two dogs with extradural spinal synovial cysts. Affected dogs were a German short-haired pointer mixed breed dog (dog 1, female, 10 years-of-age) and a Mastiff (dog 2, neutered male, 1.5 years-ofage).

In both dogs, physical and neurological examinations confirmed the presence of progressively worsening spinal cord dysfunction (thoracolumbar in dog 1 and cervical in dog 2) of at least four months duration. Results of a complete blood count, serum biochemical tests, urinalysis, thoracic radiography, and abdominal ultrasound were unremarkable. Plain spinal radiographs, lumbar cerebrospinal fluid (CSF) analysis, and lumbar myelography were done in both dogs. Results of CSF analysis in both dogs revealed an albuminocytologic dissociation. Myelography of dog 1 demonstrated a right-sided extradural lesion compressing the spinal cord at T13-L1, and in dog 2 a bilateral extradural spinal cord compression was evident at C5-6 and C6-7.

Each dog was treated by means of surgical decompression (hemilaminectomy in dog 1 and dorsal laminectomy in dog 2), and extradural cystic mass removal. Histopathological examination of the excised material confirmed a solitary synovial cyst in dog 1, and multiple synovial cysts in dog 2. Both dogs are clinically normal eighteen months (dog 1) and two years (dog 2) following completion of surgery.

Solitary or multiple synovial cysts should be considered as a possible cause of extradural spinal cord compression in dogs. Synovial cysts result most likely from degenerative changes of the vertebral column, however trauma may be a causative factor. It appears that surgical decompression by means of laminectomy and synovial cyst excision provide satisfactory long-term return to normal neurological function in dogs. The center of pressure (COP) is a point on the ground that represents the centroid of force distribution an a force plate. The location of the COP is mapped by force plate analysis. In human beings, movements of COP (postural sway) are affected by certain neurological diseases. The objective of this pilot study was to measure and compare the COP movements in normal horses and in horses with neurological disease.

The subjects were 6 normal horses and 5 horses with cervical stenotic myelopathy. The horses stood with both fore hooves or both hind hooves placed squarely on an in-ground force plate. For each condition, movements of the COP were recorded during four 10 second periods using a sampling rate of 2,000 Hz. The variables calculated for each 10 second period were the average radius of the COP path, average velocity of COP movement, and mediolateral and craniocaudal range of COP motion. The results were also displayed as a stabilogram, which plots the craniocaudal movements against the mediolateral movements of COP. Comparisons between the normal and neurological groups were made using ANOVA (pϽ0.05). All COP variables were significantly greater in the neurological group than in the normal group suggesting a deficit in balance.

The results of this pilot study suggest that COP analysis is a potentially valuable, non-invasive diagnostic tool in horses with neurological disease and in monitoring their response to therapy.

Feldman, WJ Hornoff, and TG Nyland. School of Veterinary Medicine, UC Davis.

For inclusion in this prospective study, each dog must have had persistent hypercalcemia, increased serum ionized calcium concentrations, low-normal to low serum phosphorus concentrations, normal or increased serum parathyroid hormone (PTH) concentrations, undetectable serum PTH related protein concentrations, and a solitary parathyroid mass visualized ultrasonographically with a 10MHz transducer. Eight dogs (4-16 years of age) met the above criteria and were included in the study. The ranges of their serum concentrations evaluated included calcium (13.2-14.6 mg/dl, reference range: 9.9-11.4 mg/dl); ionized calcium (1.45-1.85 nmol/l, reference range: 1.12-1.35 nmol/l); phosphorus (1.6-3.2 mg/dl, reference range: 3.0-5.5 mg/dl); and PTH (4.9-19.5 pmol/dl, reference range: 2-13 pmol/dl). The parathyroid masses were 0.06-0.14 cm 3 in volume. Each dog was sedated with propofol for approximately 10 minutes to prevent movement during the injection procedure. With ultrasound guidance, a 27 gauge needle was inserted into the parathyroid mass. Ethanol (96%) was slowly injected until diffusion throughout the mass was observed or a volume of ½ of the calculated mass volume was achieved.

Serum total and ionized calcium concentrations decreased to normal or subnormal values within 48 hours of the injection procedure in 6/8 dogs. One of the other 2 dog was then re-injected resulting in normalization of the calcium concentrations, the other dog's calcium concentrations normalized within 5 days of the initial injection. Serum PTH and phosphorus concentrations returned to within the normal range in all dogs within 24 hours of the injection (the second injection in the dog that received 2). Five dogs were hypocalcemic 2-5 days post injection. One dog required transient calcium and vitamin D supplementation. No dog displayed any adverse reactions to the injections or any other side effects. All dogs were closely monitored for 6-12 months. Chemistry panels including PTH concentrations remained within normal limits in 7 of 8 dogs for the duration of the study, as well as complete resolution of the clinical signs associated with hypercalcemia. Increased calcium concentrations were present at 1 and 2 months post injection in 1 dog and the owners elected to surgically remove the still present parathyroid mass. We conclude that ultrasound guided PEI therapy appears to be a safe and efficacious alternative to surgical therapy for PHPTH in most dogs. PEI therapy has been used extensively in the last 10 years for the treatment of solitary thyroid adenomas as well as for other endocrine and non-endocrine tumors in humans. Four 11-15 year old neutered domestic shorthair cats (2 male) with hyperthyroidism were included in a prospective study to evaluate PEI therapy for the treatment of unilateral hyperthyroidism in cats. All cats had increased serum thyroxin (T 4 ) concentrations (4.0, 5.2, 7.0, and 8.4 g/dl, reference range: 1.1-3.9 g/dl), a palpable thyroid nodule and clinical signs consistent with hyperthyroidism. Unilateral disease was diagnosed based on nuclear scintigraphy with unilateral uptake of pertechnetate ( 99m Tc). An enlarged solitary thyroid mass was identified ultrasonographically in all 4 cats using a 10MHz transducer. One cat had a mass with a cystic appearance. The thyroid mass volumes were 0.20, 0.33, 0.74, and 0.84 cm 3 . Intravenous propofol sedation was utilized to prevent movement during the injection procedure which lasted approximately 10 minutes. A 27 gauge needle was inserted into the thyroid mass with ultrasound guidance. Ethanol (96%) was slowly injected until diffusion throughout the mass was observed or a volume of ½ of the calculated mass volume was achieved. All 4 cats received a single injection.

Serum T 4 and free T 4 concentrations became normal or subnormal in all cats within 48 hours of the injection. These values remained below or within the reference range for the duration of the 6 month study. All clinical signs of hyperthyroidism were reported by the owners to have resolved within one week of the treatment. No cats exhibited clinical signs of hypothyroidism or required thyroid supplementation. Repeat nuclear scintigraphy performed in all cats 3 months after the injection procedure was normal in 1 cat and showed evidence of faint residual increased 99m Tc uptake in 3 cats. No severe biochemical or clinical complications were observed as a result of the injection or during the study. A transient voice change was noted by the owners of 2 out of the 4 cats. This occurred within a few days of the injection and resolved 6-8 weeks later.

In conclusion, PEI therapy may be an efficacious and safe therapy for the treatment of unilateral hyperthyroidism in cats. The pharmacokinetics of troglitazone was characterized in healthy cats following single dose IV and oral administration of the drug. Five healthy adult cats (4.5 Ϯ 0.1 kg) were studied after IV (5 mg/kg) and oral (40 mg/kg) administration of troglitazone using a paired, randomized cross-over design. Blood and urine samples were collected following drug administration and plasma and urine troglitazone concentrations were determined by high performance liquid chromatography.

Area-moment analysis was used to calculate pharmacokinetic parameters for troglitazone. Following IV administration, the terminal phase half-life of troglitazone was 1.1 Ϯ 0.1 h. Troglitazone distributed to a small central compartment of 0.15 Ϯ 0.09 L/kg which approximated blood volume. Steady-state volume of distribution was 0.23 Ϯ 0.15 L/kg. Mean total clearance of troglitazone was 0.33 Ϯ 0.04 L/h/kg. Absorption of troglitazone was rapid following oral administration with a first-order absorption rate constant of 0.70 Ϯ 0.52 h Ϫ1 . Peak plasma troglitazone concentrations of 2.8 Ϯ 0.8 mg/L were obtained at 1.1 Ϯ 0.6 h following oral administration. The oral bioavailability of troglitazone was low averaging 7 Ϯ 3%.

The general disposition pattern of troglitazone is similar to that reported for humans and other animals with some exceptions. Total clearance, half-life, bioavailability and elimination of troglitazone by non-renal clearance mechanisms is comparable to that reported in human and animal studies. However, steadystate volume of distribution was somewhat lower in cats. PEI has been used successfully, with few adverse effects, for the treatment of people with solitary thyroid adenomas as well as for those with primary hyperparathyroidism and a variety of non-endocrine tumors. The ethanol injection causes necrosis of the tissue. The purpose of this study was to evaluate the safety and efficacy of PEI for the treatment of bilateral hyperthyroidism in cats. Six cats (4 female), between the ages of 11 and 16 years (median 11 years) were included in the study. For inclusion, each cat must have met the following criteria: clinical signs typical of hyperthyroidism, increased serum total (tT4) and free T4 (fT4), bilateral thyroid enlargement demonstrated with radioactive pertechnetate scan and cervical ultrasound, no previous treatment and no concurrent illness unrelated to the hyperthyroidism. The tT4 concentrations were 3.1, 6.0, 6.9, 9.4, 9.4, 15.4 (ref. range 0.8-2.6 ) and the volume of the larger thyroid lobe in each cat was 0.2, 0.4, 0.3, 0.4, 0.7, 0.2 cm 3 , respectively (normalϭ0.06cm 3 ). Each cat was anesthetized (15-25 min) while a 27 gauge needle was directed into both thyroid lobes (1 cat) or the larger thyroid lobe (5 cats) with ultrasound guidance. 100% ethanol was slowly injected until there was visual evidence of complete infiltration (target dose-½ thyroid volume). tT4 and fT4 were monitored daily for 5 days, then every 2 weeks. Ionized calcium was also monitored daily for 5 days following the injection and results remained within the reference range. The first cat died within 12 hours of having both thyroid lobes injected, thus the remaining 5 cats had only the larger lobe treated initially. tT4 and fT4 decreased into the reference range within 72 hours post-injection in all cats. At the time of writing this report, 4 of 5 cats remain euthyroid (2 cats at 6 weeks, 1 cat at 4 weeks, 1 cat at 2 weeks). Recurrence of hyperthyroidism (T4ϭ5.0, fT4ϭ4.16, bilateral 99 T c uptake) occurred in one cat 2 weeks post injection. Injection of the contralateral lobe did not result in permanent euthyroidism and failure of the initial injection is suspected. Transient dysphonia (2/5 cats), Horner's Syndrome (2/5 cats) and mild gagging (2/5 cats) were noted, each sign dissipating within 2-4 weeks. A transient laryngeal paralysis that resolved after 2 weeks, was detected with ultrasound in one cat. These preliminary results suggest that staged PEI may be safe and effective for the treatment of bilateral hyperthyroidism in cats. This study describes a population of cats with a histologic diagnosis of thyroid adenomatous hyperplasia (TAH) with normal serum thyroxine concentrations and the absence of clinical hyperthyroidism.

Medical records from the Veterinary Hospital of the University of Pennsylvania were searched from 1988 to 1998 for all cats with a complete necropsy and a post mortem diagnosis of TAH and euthyroxinemia. Exclusion criteria included cats with a serum thyroxine level greater than 3.5ug/dl, a previous diagnosis of hyperthyroidism, treatment with antithyroid medication, 131 I therapy or thyroidectomy. Medical records were reviewed for presenting complaint, medical history, clinical signs, complete blood count, serum chemistry, urine analysis, coagulation screen, serum thyroxine (T 4 ) concentration, imaging studies, necropsy diagnosis and histopathology.

Twenty six cats with TAH and normal or low T 4 concentration were identified. The average serum T 4 concentration was 1.65 ug/dl (range: 0.2-3.3 ug/dl, normal 1-3.5 ug/dl). Four cats had more than one serum T 4 measured ranging from 2 months to 4.5 years after the first concentration was drawn. The average of the second measurement was 1.3 ug/dl (0.6-2.1 ug/dl). The average age at necropsy was 14.25 years (7-20.5). Castrated males and spayed females were equally represented. 60% of cats had a normal body weight. Signs typical of feline hyperthyroidism such as polyphagia, hyperactivity, tachycardia, regurgitation, increased nail growth, avoiding heat, or increased fecal volume were not reported in any of these cats. Clinical abnormalities included anorexia (77%), muscle weakness (65%), weight loss (54%), vomiting (46%), dyspnea (42%), PU/PD (38%), a palpable thyroid gland (38%), mentation changes (27%), gallop rhythm (15%), diarrhea (15%), pulmonary crackles (12%), and alopecia (8%). One cat had a cardiac murmur. The cats were necropsied after euthanasia (88%) or spontaneous death (12%). Post mortem findings varied considerably and included chylothorax, diabetes mellitus, dirofilariasis, heart disease, hepatic lipidosis, neoplasia, or renal disease with no prevalence of any one disease. Because of the strong association between hyperthyroidism and cardiac disease, cats were carefully evaluated for cardiac changes. 81% had cardiac disease at necropsy, including myocardial fibrosis (38%), hyaline arteriopathy (38%), endocardial fibrosis (19%) and myocarditis (12%). Only one had hypertrophic cardiomyopathy.

We conclude that thyroid adenomatous hyperplasia may occur in euthyroid cats. A role for dietary fiber in the treatment of diabetes mellitus is well accepted. However, the long-term benefits of soluble fiber versus insoluble fiber remain incompletely characterized. The purpose of this study was to compare the effects of three commercial diets, one with increased amounts of soluble fiber (HSF), one composed principally of insoluble fiber (HIF), and one low in fiber (LF), on the glycemic control of dogs with naturally occurring insulin-dependent diabetes mellitus.

Six dogs with diabetes mellitus were identified and determined to be free of concurrent disease. All dogs were well regulated with NPH insulin administered at 12-hour intervals. Low plasma C-peptide concentrations in all dogs were consistent with endogenous insulinopenia. A blinded, crossover study was designed with dogs randomly assigned to a sequence of three diets. Daily food intake was divided into two equal meals fed at 12-hour intervals and caloric intake was held consistent throughout the study. Each diet was fed exclusively for 4 weeks with a one-week transition period between diets. Body weight, insulin dose, and concentrations of serum fructosamine, albumin, and 10-hour serial blood glucose concentrations were determined following each 4-week period.

There were no significant differences in body weight, insulin dosage per kilogram of body weight, or serum albumin concentration between diets. Mean glucose concentration (mg/dl) was lower (pՅ0.05) for HIF (217) when compared to LF (336) and also tended to be lower when compared to HSF (312). Fructosamine concentrations were lower for HIF when compared to HSF and LF, and mean minimum and maximum glucose concentrations tended to be lower for HIF (163, 280) when compared to LF (250, 403) and HSF (247, 374) but these trends did not reach statistical significance.

In conclusion, when compared with diets higher in soluble fiber or low in fiber, a diet containing principally insoluble fiber may improve glycemic control in dogs with naturally occurring insulin-dependent diabetes mellitus.

HYPOTHYROID HORSES. B. A. Breuhaus. College of Veterinary Medicine, North Carolina State University, Raleigh, NC.

The following study was performed to measure resting thyroid stimulating hormone (TSH) and TSH response to thyrotropin releasing hormone (TRH) in normal and hypothyroid horses. Blood was drawn from nine clinically normal horses and assayed for resting concentrations of TSH, total thyroxine (TT4), free thyroxine (fT4), total tri-iodothyronine (TT3), and free tri-iodothyronine (fT3). TSH and thyroid hormone responses were measured after administration of TRH and the horses then were placed on propylthiouracil (PTU), 4 mg/kg PO daily in their feed, for 6 weeks. Resting concentrations of TSH and thyroid hormones were measured weekly. TRH response tests were repeated at the end of the PTU administration period.

Mean resting concentrations of TSH, TT4, fT4, TT3, and fT3 (mean Ϯ standard deviation) were 0.45 Ϯ 0.28 ng/ml, 21 Ϯ 9 nmol/L, 13 Ϯ 3 pmol/L, 1.2 Ϯ 0.7 nmol/L, and 3.1 Ϯ 1.6 pmol/L, respectively. After administration of TRH, TSH peaked at 45 minutes (0.89 Ϯ 0.5 ng/ml). TT3 and fT3 peaked at 2 hours (2.8 Ϯ 0.9 nmol/L and 7.4 Ϯ 3.2 pmol/L) and TT4 and fT4 peaked at 4 hours (42 Ϯ 13 nmol/L and 25 Ϯ 6 pmol/L). During PTU administration, TSH rose steadily to reach 1.34 ng/ml by the 6 th week. TT4, fT4, TT3, and fT3 decreased to 5 Ϯ 6 nmol/L, 6 Ϯ 5 pmol/L, 0.3 Ϯ 0.4 nmol/L, and 0.8 Ϯ 1.0 pmol/L, respectively. After PTU administration, TSH response was exaggerated (peak 3.64 ng/ml) and thyroid hormone response was delayed and blunted. TT4 increased from 5 Ϯ 6 to 19 Ϯ 16 nmol/L and fT4 increased from 6 Ϯ 5 to 12 Ϯ 8 nmol/L at 6 hours. TT3 increased from 0.3 Ϯ 0.4 to 0.8 Ϯ 0.8 nmol/L at 4 hours and fT3 increased from 0.8 Ϯ 1.0 to 1.8 Ϯ 2.1 pmol/L at 2 hours.

The data suggest that measurement of TSH in conjunction with thyroid hormones, either at rest or in response to TRH, may be useful in the diagnosis of hypothyroidism in horses. Calcipotriene is a vitamin D analog that is used topically for the treatment of psoriasis in humans. The accidental ingestion of calcipotriene has been associated with life-threatening hypercalcemia in dogs. Traditional treatment of hypercalcemia from vitamin D and its analogs using steroids, diuretics, and fluids, with or without salmon calcitonin, can be prolonged and labor intensive. The purpose of this study was to determine the effectiveness of pamidronate disodium, a diphosphonate, in the treatment of hypercalcemia and hyperphosphatemia in dogs.

Data on pamidronate treatment (7 cases) was collected from referring veterinarians treating calcipotriene toxicoses. Pamidronate disodium (1.3-2 mg/kg) was administered to dogs that had developed hypercalcemia (Ͼ12.5 mg/dl) and hyperphosphatemia (Ͼ6.5 mg/dl) secondary to accidental ingestion of calcipotriene. Serum calcium, phosphorus, BUN, creatinine, and clinical status were monitored prior to and following treatment with pamidronate. Monitoring of calcium and phosphorus continued a month or more following calcipotriene ingestion.

Before treatment with pamidronate, serum calcium, phosphorus, BUN, and creatinine levels were above normal laboratory ranges, and dogs showed clinical signs of vomiting, gagging, depression, and anorexia. In addition, the calcium and phosphorus product (Ca x P) was indicative of the potential for tissue calcification and renal failure. Average laboratory values are given in the table.

In most cases, significant reduction of serum calcium and phosphorus was seen within 24-48 hours of a single treatment. Usually, calcium and phosphorus levels stayed normal and clinical signs resolved throughout the remainder of time the dogs were monitored. The data suggests that pamidronate disodium is a useful adjunct in the treatment of hypercalcemia secondary to ingestion of calcipotriene in dogs. The objective of this report is to describe the clinical syndrome seen with ingestions of calcipotriene in dogs. Data from over 50 cases of accidental canine Dovonex (calcipotriene) exposures was collected over the phone from animal owners and veterinarians. Dovonex contains 0.005% calcipotriene, a potent vitamin D 3 analogue, and is used for the treatment of psoriasis in humans. Rodent studies appear to greatly underestimate the toxicity of calcipotriene to dogs. Our data suggests that ingestions of 40-60 g calcipotriene/kg body weight or greater have resulted in severe hypercalcemia (Ͼ16 mg/dl), and calcium x phosphorus products of Ͼ130. Approximately 50% of cases developed serum calcium concentrations of Ͼ14 mg/dl, 30% had phosphorus concentrations between 7.4 and 12.3 mg/dl, and 30% had BUN concentrations between 45-148 mg/dl. The onset of clinical signs occurs within 24-72 hours and includes depression, vomiting, anorexia, diarrhea, and weakness. Elevations in BUN and creatinine occur by 72 hours. 20% of dogs either died or were euthanized. Hyperphosphatemia and hypercalcemia develop by 12-24 hours and can last for weeks. Calcium x phosphorus products above 60, and the long elimination half-life of vitamin D 3 metabolites promote soft tissue mineralization, especially in the GI tract, kidney, or vascular tissue.

Calcipotriene is a structural analogue of calcitriol, the active form of vitamin D 3 , and readily binds to natural vitamin D 3 receptors. Hypercalcemia occurs due to increased intestinal absorption of calcium, increased bone resorption of calcium, and decreased renal excretion of calcium. Treatment requires aggressive decontamination and is aimed at reducing serum calcium and phosphorus concentrations. The prolonged half-life of calcipotriene necessitates monitoring and treatment for weeks. Dovonex exposure should be considered as a differential in cases of acute, severe hypercalcemia. The nonsteroidal antiinflammatory drug carprofen and thyroxine (T4) are highly bound by serum proteins. We postulated that carprofen would influence thyroid fuynction tests in dogs. For this study, 21 healthy dogs, 13 males and 8 females, weighing from 14-43 kg, were treated with 2.2-3.3 mg/kg q12h of carprofen (Rimadyl) orally. Serum samples were drawn before and at 2 and 5 weeks of treatment. Serum total T4 (TT4) and TSH were measured by immunoassay. Free T4 (FT4) was measured by modified equilibrium dialysis (Nichols). The following results were obtained: Carprofen caused mild but significant depression of serum TT4 and TSH, with 4 dogs falling below the normal range (11 nM) and 3 having undetectable TSH values. Although there was a trend for FT4 to fall and FFT4 to rise, these changes were not significant. We propose the following mechanism: 1) carprofen initially displaced T4 from serum and cellular binding sites resulting in an initial elevation of FT4; 2) TSH secretion was inhibited by negative feedback; 3) T4 secretion was reduced until FT4 returned to pretreatment values. TSH remained low possibly because the pituitary intracellular FT4 remained elevated despite a normal serum FT4. In summary, dogs on carprofen therapy should ideally be assessed for hypothyroidism with FT4 by dialysis and TSH measurements.

WITH DIABETES MELLITUS. Rebecka S. Hess, H. Mark Saunders, Thomas J. Van Winkle, and Cynthia R. Ward. School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

The goal of the study was to characterize concurrent disorders in dogs with diabetes mellitus. To this end, a retrospective study was performed. Medical records were reviewed in detail. A low dose dexamethasone suppression (LDDS) test was considered consistent with a diagnosis of hyperadrenocorticism (HAC) if the 8 hour cortisol concentration was greater than 1 g/dl, and an ACTH stimulation test was considered consistent with a diagnosis of HAC if the 2 hour cortisol concentration was greater or equal 22 g/dl. A TSH stimulation test was considered consistent with a diagnosis of hypothyroidism if the basal serum T 4 was Ͻ1.5 g/dl and the increase after stimulation was less than twofold with an absolute increase of Ͻ2 g/dl. Acute pancreatitis was diagnosed based on clinical signs and histopathology or ultrasonography. A hypoechoic pancreas with hyperechoic peripancreatic mesentery was considered consistent with a diagnosis of acute pancreatitis.

The study included 221 dogs with diabetes mellitus. Over 50% of dogs had normal complete blood counts. Abnormal changes in the chemistry screen included hypochloremia (127 dogs, 57%) and increased serum ALT concentration (163 dogs, 74%) and serum ALKP activity (188 dogs, 85%). Venous pH and ionized calcium were measured in 121 and 87 dogs respectively, and were abnormally low in 56 (25%) and 41 (18%) dogs, respectively. Lipemia was observed in 92 (42%) dogs. Partial thromboplastin time (PTT) and prothrombin time (PT) were measured in 42 dogs, and were prolonged in 8 (4%) and 3 (1%) dogs, respectively. Results of urinalyses showed that 174 dogs (79%) had glucosuria, 165 (75%) had hypersthenuria, 108 (49%) had proteinuria, 91 (41%) had hemoglobinuria, 75 (34%) had ketonuria, and 65 (29%) had bilirubinuria. Aerobic urine culture was performed in 159 dogs (72%); 34 dogs (21%) had aerobic bacterial growth. E. Coli was the most common genera of bacteria cultured (14 dogs, 41%). Hyperadrenocorticism was diagnosed in 53 dogs (24%) based on clinical signs and a LDDS test (45 dogs) or an ACTH stimulation test (12 dogs). Eight dogs (4%) were diagnosed as hypothyroid based on a TSH stimulation test (7 dogs) or low T 4 and high TSH concentrations (1 dog). Acute pancreatitis was diagnosed in 30 dogs (14%) based on ultrasonography (27 dogs) or necropsy (5 dogs). We conclude that dogs with diabetes mellitus have many concurrent disorders including HAC, urinary tract infection, acute pancreatitis, and hypothyroidism. The goal of this study was to evaluate the glycemic response to insulin treatment in dogs with diabetes mellitus. To this end, a retrospective study was performed. Insulin treatment was reviewed based on data obtained prior to referral, at the time of initial examination, and at the time of clinical control of diabetes mellitus. Insulin treatment was characterized by determining the type and dose of insulin, the range of blood glucose concentration during insulin treatment, the time of blood glucose nadir, and the insulin duration of action. Insulin duration of action was defined as the number of hours after insulin administration in which blood glucose concentration remained below 200 mg/dl. Results are presented as mean Ϯ SD.

Two hundred and twenty one dogs with diabetes mellitus were examined between 1993 and 1998. Of these dogs, 127 were treated with insulin prior to referral, mostly with NPH insulin (79 dogs, 62%). Prior to referral, 69 dogs (54%) were treated with once daily insulin, 57 dogs (45%) were treated with twice daily insulin, and 1 dog (1%) was treated with regular insulin every 2 hours. Dogs were treated with a mean insulin dose of 1.2Ϯ0.8 IU/kg and a range of 0.1-5.3 IU/kg. The mean minimum blood glucose concentration prior to referral was 153Ϯ152 mg/dl and the mean maximum blood glucose concentration was 297Ϯ187 mg/dl. At the time of initial examination, 195 dogs had a blood glucose curve performed, and most dogs (155, 79%) were given NPH insulin. The majority of dogs (141, 72%) were treated with twice daily insulin, 34 dogs (17%) were treated with once daily insulin, the mean insulin dose was 0.7Ϯ0.6 IU/kg, and the range was 0.1-6.9 IU/kg. The mean minimum blood glucose concentration at the time of initial examination was 168Ϯ101 mg/dl and the mean maximum blood glucose concentration was 382Ϯ133 mg/dl. Mean blood glucose nadir was observed 6.0Ϯ4.1 hours after insulin administration, and insulin duration of action was 11.1Ϯ4.3 hours. At the time of clinical control of diabetes mellitus, 83 dogs had a glucose curve performed. The mean insulin dose was 0.7Ϯ0.3 IU/kg, the range was 0.2-1.6 IU/kg, the mean minimum blood glucose concentration was 158Ϯ94 mg/dl, the mean maximum blood glucose concentration was 304Ϯ111 mg/dl, the mean blood glucose nadir was observed 5.3Ϯ3.7 hours after insulin administration, and insulin duration of action was 10.2Ϯ4.6 hours. Once clinical control was achieved, only 5 dogs (6%) had an insulin duration of action greater than 12 hours. We conclude that although 54% of diabetic dogs were treated with once daily insulin prior to referral, most dogs (94%) require twice daily insulin treatment. The effect of age on glucose tolerance and body composition have gone unreported to date in the domestic cat and was the purpose of this study.

Twenty young (1.04 Ϯ 0.05 y; Y) and twenty old (8.43 Ϯ 0.42 y; O) cats were fed a baseline diet for 60-d. Cats were weighed weekly and feed intakes were adjusted to maintain body weight. Before and after the dietary period, glucose (GTT) and insulin (ITT) tolerance tests were conducted and body composition was determined by dual energy X-ray absorptiometry. Young cats had significantly lower fasted body weights (3.65 Ϯ 0.08 kg vs 4.10 Ϯ 0.08 kg, Y and O cats respectively, pϽ0.001), total body fat (1106 Ϯ 60 g vs 1389 Ϯ 59 g, Y and O cats respectively, pϽ0.001), percent body fat (28.9 Ϯ 1.4% vs 34.2 Ϯ 1.4%, Y and O cats respectively, pϽ0.01), total lean body mass (2463 Ϯ 43 g vs 2644 Ϯ 44 g, Y and O cats respectively, pϽ0.01), higher percent lean mass (68 Ϯ 1 % vs 65 Ϯ 1 %, Y and O cats respectively, pϽ0.05), lower total body lean mass ϩ bone mineral content (2495 Ϯ 45 g vs 2688 Ϯ 45 g, Y and O cats respectively, pϽ0.01) and total body bone mineral content (32.5 Ϯ 2.2 g vs 44.8 Ϯ 2.2 g, Y and O cats respectively, pϽ0.01). The GTT showed that young cats had higher glucose effectiveness (0.014 Ϯ 0.001 min Ϫ1 vs 0.007 Ϯ 0.001 min Ϫ1 , Y and O cats, respectively, pϽ0.003) and glucose concentration at tϭ0 estimated by extrapolating the prediction of the glucose kinetics model to the moment of injection (thus cardiovascular mixing is not included) (393 Ϯ 12 mg/dl vs 351 Ϯ 13 mg/dl, Y and O cats, respectively, pϽ0.03). The ITT showed that old cats had a significantly greater area above the glucose curve and under baseline compared with young cats (Ϫ2419 Ϯ 246 mg*h/dl vs Ϫ3147 Ϯ 246 mg*h/dl, Y and O cats, respectively, pϽ0.05).

This study is, to the best of our knowledge, the first to show age-related differences in body composition in cats. Glucose homeostasis in cats is subject to vary with advancing age, as reported in other species. Whether this is due to age-related changes in body composition is unknown, but should be taken into consideration in future clinical studies which compare glucose metabolism between young and old cats. The purpose of this study was to determine the efficacy of once daily insulin therapy using protamine zinc analine insulin (PZI) alone compared with PZI and oral vanadium. Thirteen cats with naturally-occurring diabetes mellitus were randomly assigned to receive once daily injections of PZI alone or PZI combined with 45 mg vanadium dipicolinate orally for 16 weeks in a parallel study design. A thorough physical examination, CBC, serum biochemical analysis, serum thyroxine concentration, urinalysis and tests for FeLV and FIV was performed on each cat. Emaciated, ketotic, dehydrated, or debilitated cats were excluded from entry into the study.

All cats were randomly assigned to receive PZI alone (1-3 units q 24 hrs SQ initially) or PZI plus oral vanadium (45 mg q 24 hr PO). Every cat was fully evaluated before and at 4, 8, 12, and 16 weeks after entry into the study by a complete history, physical examination, body weight, serial blood glucose curves, serum fructosamine, serum biochemistry profile and urinalysis. Insulin dosage was adjusted based on clinical signs, serum fructosamine and serial blood glucose curves. Pre and post treatment values for serum fructosamine, fasting blood glucose (FBG), body weight, and insulin dose were compared using a Student's t-test.

All were domestic shorthaired cats; 3 were spayed females and 10 were male neutered cats. The median age of the cats was 10 years. Median insulin dose was higher (5 U) in the cats treated with PZI alone compared with cats treated with PZI and oral vanadium (3U). Signs of diabetes mellitus, such as polydipsia, polyuria, resolved in the PZI and vanadium treated cats and these cats experienced only mild weight loss (0.25 lbs) during therapy. Side effects included mild anorexia and vomiting which resolved upon temporary withdrawal of the vanadium. Clinical signs improved but did not resolve and weight loss (0.75 lbs) was more pronounced in cats treated with PZI alone compared with the vanadium treated group.

The mean change in serum fructosamine was greater, but not statistically different, in the vanadium treated group (191Ϯ 95 mg/dl) compared with those cats treated with PZI alone (54Ϯ43 mg/dl). Oral vanadium compounds appear to be a viable adjunct therapy when combined with long-acting insulin (PZI) in cats suffering from diabetes mellitus. Thrombocytopenia is a rare but well recognized side effect of methimazole (Tapazole) treatment in cats. Methimazole has also been implicated in producing a bleeding tendency in cats with a normal platelet count. Because of that, some have recommended not using methimazole to make cats euthyroid prior to surgery, in the belief that this bleeding tendency would increase the bleeding associated with surgery and therefore surgical risk. In this study, we investigated for hemostatic abnormalities caused by the administration of methimazole to cats with hyperthyroidism. Thirteen hyperthyroid cats were evaluated before and again after 3-4 weeks after treatment with methimazole (5-15 mg/day). Parameters evaluated included serum total and free T4, platelet count, prothrombin time, activated partial thromboplastin time, thrombin clotting time, and buccal mucosal bleeding time. After treatment, the median serum concentrations of total and free T4 fell to within reference range. Median platelet count was normal before treatment and increased slightly after treatment but the change was not significant; no cat became thrombocytopenic. All coagulation parameters were normal in all cats, both before treatment and after methimazole administration. The pretreatment buccal mucosal bleeding times (range, 30-90 sec) was similar to the feline reference range (60-120 sec). After treatment, buccal mucosal bleeding times tended to increase slightly (range, 45-65 sec), but the values did not rise above reference range limits and the change was not significant.

In conclusion, results of this study failed to identify a subclinical bleeding tendency in hyperthyroid cats treated with methimazole. The drug does indeed cause thrombocytopenia in a few cats and may produce an undefined bleeding tendency in other cats (even less commonly); but methimazole does not appear to induce a bleeding tendency in all cats treated. However, if a bleed tendency associated with methimazole is suspected, determination of a buccal mucosal bleeding time prior to surgery may be justified. Two commercially available L-thyroxine products (HϭHeska, DϭDaniels) were compared. Oral dosages were given at 22 ug/kg b.i.d. and IV at 10 ug/kg to 6 radio-thyroidectomized male beagles. Oral medication was given for a minimum of 2 weeks prior to obtaining samples. Repeatability of serum TT4 concentrations over a 5 day period was also determined at times 0, 2, 4, 6, and 8 hrs after dosing. Total thyroxine was assayed using an RIA validated for canine serum. Data analyses were performed using model independent approaches by computer (PC NonLin) and manual methods. IV kinetic analyses found T 1/2 beta (terminal T1/2) to be 19.9Ϯ8.4 hrs, Volume of distribution at steady state (Vss) to be 0.44Ϯ0.11 L/kg, and total body clearance (Cl) to be 0.018Ϯ0.007 L/hr/kg. Oral kinetic analyses revealed no significant differences between H and D with the exception of Cmax (PϽ0.05, See table). Relative bioavailability based on AUC (H/D) was 0.87 with no significant difference found between products. Comparison of coefficient of variance for repeatability of L-thyroxine concentrations between H and D indicated no significant differences. This study was designed to evaluate the accuracy of available glucose measuring devices as commonly used in dogs. Comparisons were made between blood glucose results obtained from each device and those obtained on the same sample using a standard dry chemistry laboratory unit (Ortho-Clinical Diagnostics vitros 500) as the gold standard via a simple linear regression. To estimate the difference between glucose values obtained from each device and from dry chemistry, 95% confidence intervals (CIs) for the median difference were calculated.

Venous samples were assayed according to manufacturers' directions using systems including iSTAT (Heska Sensor Devices), Glucometer Encore (Miles Inc; Enc), ExacTech R.S.G. (MediSense, Inc; RSG), Glucometer Elite (Miles Inc; Elite), Glucometer 3 (Miles Inc; Gf3), and Accu-Chek Easy (Boehringer Mannheim Corp; Esy). Samples (n ϭ 110; glucose range 41 mg/dl Ϫ 596 mg/dl) were collected in lithium heparin tubes and assayed within 10 minutes. In each case the device (m) significantly predicted the dry chemistry value (y), but R2 values varied. Overall, R2 and linear equation for each device were: iSTAT R2 ϭ 0.99; y ϭ m1.03-5.5; Enc R2 ϭ 0.98; y ϭ m1.18 ϩ 2.30; RSG R2 ϭ 0.87; y ϭ m1.06 ϩ 66.68; Elite R2 ϭ 0.95; y ϭ m1.11 ϩ 19.68; Gf3 R2 ϭ 0.87; y ϭ m0.80 ϩ 18.53; Esy R2 ϭ 0.92; y ϭ m0.96 ϩ 7.21. The samples were divided into 3 subsets based on glucose values. R2 values were much lower for all devices in the subset where glucose was Ͻ100 mg/dl. Individual results often varied markedly from the dry chemistry value. Median differences between dry chemistry and the devices ranged from Ϫ7 mg/dl (95% CI:(Ϫ23,2)) for Gf3 to 63 mg/dl (95% CI:(55,69)) for RSG.

Although all devices were able to predict the dry chemistry glucose values, some provided closer estimates than others, with the iSTAT providing excellent accuracy. The accuracy of each device was less at lower blood glucose values, which is unfortunately the very range where accuracy is most important. All of the devices had occasional readings markedly different than the dry chemistry unit, which could have led to clinically inappropriate treatment choices. The purpose of this study was to determine the adequacy of digoxin dosing in dogs with naturally occurring heart disease at the onset of treatment and during chronic therapy as reflected by serum digoxin concentrations (D conc ) measured 6 to 8 hours after the morning dose. We also examined the relationship of D conc to the prescribed digoxin dose and to body size, BUN, serum creatinine and potassium concentrations, and to a variety of other clinical parameters. Additionally, we evaluated the utility of serum digoxin measurements for the evaluation of suspected digoxin intoxication and for the purpose of re-dosing.

In 66 dogs in which oral digoxin was initiated 7-10 days prior to sampling, D conc was Ն 0.9 ng/ml and Յ 2.5 ng/ml in 44 dogs (66.7%). The D conc was Ͻ 0.9 ng/ml in 18 dogs (27.3%), and it was Ͼ 2.5 ng/ml in 4 dogs (6.0%). Of 62 serum samples obtained from 47 dogs treated chronically (Ͼ 1 month) with oral digoxin, the D conc was Ն 0.9 ng/ml and Յ 2.5 ng/ml in 42 samples (67.7%) from 28 dogs. The D conc was Ͻ 0.9 ng/ml in 8 samples (12.9%) from 8 dogs, and it was Ͼ 2.5 ng/ml in 12 samples (19.3%) from 11 dogs. Of 21 serum samples obtained from 17 dogs because of suspected digoxin intoxication, the D conc was Ͼ 2.5 ng/ml in 10 samples (47.6%). The D conc was Ն 0.9 ng/ml and Յ 2.5 ng/ ml in 9 samples (42.9%), and Ͻ 0.9 ng/ml in 2 samples (9.5%). A D conc Ն 0.9 ng/ml and Յ 2.5 ng/ml was achieved 11/12 dogs re-dosed due to suspected digoxin toxicity and in 3/7 dogs with sub-therapeutic D conc.

Signs of digoxin intoxication and high D conc (Ͼ 2.5 ng/ml) were significantly associated with high BUN and serum creatinine concentrations and with the concurrent administration of other cardiac medications (ACE inhibitors and diuretics).

In conclusion, clinical signs of digoxin toxicity and high D conc can largely be avoided during oral digitalization when the initial dose is 0.003 to 0.004 mg/kg twice daily. Digitalis intoxication, often erroneously suspected when serum digoxin levels are in or below the accepted therapeutic range, develops most commonly in dogs on chronic therapy that are receiving multiple cardiac medications. The efficacy of ecadotril (ECAD), a neutral endopeptidase inhibitor, was examined in dogs with moderate heart failure (HF) (left ventricular ejection fraction, LV EFϭ30%-40%) produced by multiple intracoronary microembolizations. Dogs were randomized to 3 months oral therapy with ECAD (100 mg once daily, nϭ5) or to placebo (PL, nϭ4). LV EF, LV end-systolic volume (ESV), end-diastolic volume (EDV), and plasma norepinephrine (PNE) concentrations were measured before (PRE) and after 3 months of therapy (POST) and the results shown in the table.

In PL treated dogs, EDV, ESV, and PNE increased and EF decreased significantly after 3 months of treatment. In contrast, therapy with ECAD preserved, ESV, EDV and EF and did not elicit a significant rise in PNE. Conclusion: Longterm oral therapy with ECAD prevents or, at the very least, attenuates progressive LV systolic dysfunction and LV chamber dilation in dogs with experimentallyinduced HF. The purpose of this study was to assess the effects of systemic hypertension (HT) on echocardiographic and radiographic cardiovascular variables in cats compared to a healthy population of geriatric cats. Secondary objectives were to determine if there were any relationships between these findings and age or systolic blood pressure (SBP).

Group 1 consisted of 15 healthy cats over 8 years of age with normal SBP, and no evidence of cardiovascular disease on physical exam, ECG or echocardiogram. Group 2 consisted of 15 hypertensive cats (SBPϾ180mmHg based on an average of 4 measurements taken at 3 different times within 24 hours). Echocardiographic evaluation in each cat included standard 2-D, M-mode, Doppler measures, as well as four different aortic root dimensions. Fifteen objective variables were measured and two subjective scores determined from right lateral and dorsoventral radiographic views.

LV wall thickness tended to be greater in the HT group but still within accepted clinical limits of normal. Significant differences between groups were found in all of the aortic root measures (except annulus). The ratio of proximal ascending aorta to annulus was also significantly different between group 1 and 2 (1.05:1 Ϯ 0.09 vs 1.33:1 Ϯ 0.13, respectively). A ratio of 1.2:1 or greater was found in 14 of 15 HT cats. There was a significant positive correlation between this ratio and SBP measure. Of the 17 radiographic parameters, only aortic undulation score was considered significant (0.06 Ϯ 0.2 vs 0.8 Ϯ 1.1), however, there was no correlation between the degree of SBP elevation and aortic undulation score. There was a significant positive relationship between age and some measures indicating horizontal inclination of the cardiac silhouette.

In summary, measures of the aortic root demonstrate aortic dilation in hypertensive cats. Furthermore, the presence of a wavy aorta is more pronounced in hypertensive compared to healthy older cats. In a previous study, angiotensin converting enzyme (ACE) inhibition failed to reduce the LV chamber or cardiomyocyte remodeling which invariably occurs with chronic volume overload hypertrophy induced by mitral regurgitation (MR) in dogs. Whether the failure to prevent LV remodeling with ACE inhibition was due to incomplete prevention of myocardial angiotensin-II (ANG II) formation and subsequent activation of the ANG II type-1 (AT 1 ) receptor remained unclear. We tested the hypothesis that specific AT 1 receptor antagonism would influence LV and cardiomyocyte remodeling and function with chronic MR..

Six normal adult mongrel dogs (NL) were compared to 13 dogs with chronic MR, 6 untreated (MR) and 7 treated with the AT 1 receptor antagonist irbesartan (MRI-I). Systemic and pulmonary vascular resistance increased two-fold in chronic MR and normalized in MRϩI dogs as LV stroke volume improved significantly. LV end-diastolic dimension/wall thickness ratio increased in MR and MRϩI (7.3Ϯ0.3 and 7.1Ϯ0.3) compared to NLs (3.6Ϯ0.3, pϽ.05) as resting cardiomyocyte length increased in both MR. and MRϩI vs. NLs (164Ϯ1.0 and 174Ϯ0.8 vs. 139Ϯ0.6um, pϽ0.05). Velocity of isolated cardiomyocyte contractile shortening decreased in MR vs.NLs (60Ϯ1 vs 71Ϯ1 um/sec, pϽO.O5) and improved in MRϩI (69Ϯ1 um/sec, pϽ0.05 compared to MR.). LV ACE activity and ANG II levels increased two-fold in MR dogs (pϽ0.05) and normalized in MRϩI dogs.

AT 1 receptor blockade in chronic MR improved forward stroke volume and systemic vascular resistance but failed to prevent LV chamber remodeling and cardiomyocyte lengthening, suggesting that ANG II activation of the AT 1 receptor does not significantly contribute to LV and myocyte remodeling in chronic MR. The normalization of cardiac ACE activity and ANG II levels with AT 1 receptor antagonism may have contributed to improved cardiomyocyte contractile function. The objective of this study was to determine the effect of chronic ACE-inhibition with enalapril on renal function in dogs with compensated mitral regurgitation (MR).

Blood samples from 116 dogs involved in a study of the efficacy of enalapril in delaying the onset of heart failure in naturally-occuring MR in client-owned dogs were evaluated. Serum creatinine concentrations (Cr) were determined at the outset of the study, and at 2 weeks and 3, 6, 9, and 12 months after institution of either enalapril or placebo in a randomized, double-blinded fashion. Without breaking the code, Cr were compared between groups 1 (enalapril or placebo) and 2 (opposite of group 1) at each time point. In addition, the percentage of dogs in which Cr rose more than 35% from baseline values and the change in Cr from baseline to 6 and 12 months' therapy were compared between groups 1 and 2.

There were no differences between groups 1 and 2 in any of the parameters evaluated. No dogs from either group became azotemic during the study and none dropped out of the study due to worsening azotemia.

We conclude that chronic enalapril therapy of up to 12 months' duration does not appear to have a deleterious effect on renal function, based on Cr in dogs with MR, prior to the onset of heart failure. Dilated cardiomyopathy (DCM) is a primary myocardial disease that is inherited in at least 20% of affected human beings. Causative mutations in both the actin gene and dystrophin gene have been identified. DCM has also been demonstated to be familial in some breeds of dogs including Doberman Pinschers, Boxers and Newfoundlands, although causative mutations have not been identified.

The purpose of this study was to evaluate DNA from Doberman Pinschers with DCM for the presence of mutations within the cardiac actin gene. DNA was extracted from 16 Doberman Pinschers with DCM. The diagnosis of DCM was based upon echocardiographic documentation of left ventricular dilation and systolic myocardial dysfunction (%SFϽ 20%) in the absence of congenital heart disease, or clinically significant acquired valvular dysfunction. DNA from 10 control dogs with normal echocardiograms was also extracted and analyzed. Polymerase chain reaction (PCR) and Single Stranded Conformational Polymorphism (SSCP) techniques were used for mutation analysis. PCR primers were developed using the published human sequences of the major actin exons. PCR conditions were optimized for canine products and PCR was performed to develop a product for SSCP analysis. SSCP was used to evaluate each exon for evidence of mutations. Molecular analysis did not reveal any mutations or polymorphisms within the exons of the actin gene in dogs with dilated cardiomyopathy. We conclude that mutations within the exons of the cardiac actin gene are unlikely to be the cause for inherited dilated cardiomyopathy within this breed of dog. In people, reduced plasma concentrations of B vitamins and subsequent hyperhomocysteinemia are risk factors for thrombotic disease. The purpose of this study was to determine whether plasma B vitamin and homocysteine concentrations play a role in the pathogenesis of feline cardiomyopathy and arterial thromboembolism (ATE). Fasting plasma concentrations of homocysteine and vitamins B 6 , B 12 , and folate were measured in 29 cats with ATE and cardiomyopathy [ATE group; diagnosed by typical physical examination findings of ATE and either an echocardiogram (echo), necropsy, or both], 27 cats with cardiomyopathy and no history of ATE (CM group; diagnosed by echo), and 29 healthy cats (based on a normal physical examination and echo). Mean vitamin B 12 concentration was significantly lower in ATE cats (866Ϯ367 pg/ml) and CM cats (939Ϯ389 pg/ml) compared to healthy controls (1650Ϯ700 pg/ml; pϽ0.001). In addition, mean vitamin B 6 concentration was significantly lower in ATE cats (3247Ϯ1215 pmol/ml) and CM cats (3200Ϯ906 pmol/ml) compared to healthy cats (4380Ϯ1302 pmol/ml; pϭ0.005). No differences were found between groups in folate or homocysteine concentrations. There was a negative correlation between vitamins B 6 (pϽ0.005), B 12 (pϽ0.001), and folate (pϭ0.059) and echocardiographic left atrial size. Although homocysteine and B vitamin concentrations were not correlated with medication type or dosage, they were correlated negatively with age. Multivariate analysis revealed that vitamin B 12 concentration was the only significant predictor of left atrial size. The results of this study suggest that, although homocysteine and B vitamins do not appear to play a role in ATE, B vitamin concentrations appear to be altered in feline cardiomyopathy and may play a role in the pathogenesis of the disease. Percutaneous occlusion of patent ductus arteriosus (PDA) is an established therapeutic modality in human medicine. Small case reports and abstracts have suggested that this technique is applicable in dogs with PDA. Transarterial ductal occlusion was attempted in 43 dogs between January 1994 and December 1998. Three of the dogs had undergone unsuccessful attempts at surgical correction prior to attempted occlusion. There were 36 females and 7 males with a mean age of 13Ϯ 16 months and a mean weight of 7.6 Ϯ.5.8 (range 2.1-25) kg. Following selective angiography and morphologic classification of ductal anatomy, occlusion was performed using 1-7 standard 0.038 Gianturco vascular occlusion coils (Cook Inc., Bloomington, Indiana).

Occlusion was accomplished in 37 of the 43 dogs (86%). The minimal ductal diameter of the dogs that could not be occluded was significantly greater (5.4 Ϯ 2.5mm) than that of the dogs that could be occluded (2.5Ϯ 0.9mm). Additionally 4 of the 6 dogs that could not be occluded had type III ductal morphology. All three dogs which had previously undergone surgery were successfully occluded. Two dogs required a second procedure. Twenty two dogs had complete occlusion based on post-deployment angiography. The remaining 15 dogs had trivial residual flow. Complications included pulmonary embolization (4), partial aortic deployment (1), aortic embolization (4) and arterial hemmorrhage with hematoma formation (1). Coils in the pulmonary artery were left in place. All coils that embolized into the aorta were retrieved witout complication using a Nitinol gooseneck snare catheter (MicroVena, Inc). There were no fatalities. We conclude that percuatneous tranarterial ductal occlusion using Gianturco vascular occlusion coils is a viable therapy for PDA in dogs. The structure and function of the heart are determined by the interaction between the extracellular matrix (ECM), specific cell receptors (integrins), the cytoskeleton and intrinsic genetic regulation of cell function. Structurally, integrins mediate the attachment of the cardiac myocyte to the ECM and transmit the mechanical contraction force from the actin cytoskeleton to the extracellular matrix. Integrins also transfer mechanical and chemical information from the extracellular matrix into the cells and modulate cell phenotype-specific expression and gene transcription. We tested the hypothesis that the interaction between myocardial integrins and the ECM is altered during the ventricular remodeling which occurs in volume overload associated with mitral regurgitation.

Ten dogs with experimental mitral regurgitation (MR) induced by percutaneous chordae tendinae rupture were studied for 2 weeks (2, MR-2wk), 1 month (4, MR-1m) or six months (4, MR-6m) and were compared to normal dogs (3, N) and dogs with chronic spontaneous mitral insufficiency (3, MR-CS). Hemodynamics at baseline, induction and sacrifice and echocardiograms at baseline and sacrifice were evaluated. Cardiac myocytes were isolated at sacrifice and in vitro adhesion of viable myocytes to collagen I, collagen IV, laminin, and fibronectin were assayed. Adhesion to each substrate was similar and collagen I is used for illustration.

A significant increase in myocyte adhesion to collagen I (A-C1) was noted in MR-2wk compared to N and MR-CS (40% vs 16% & 18%, respectively). In MR-1m, A-C1 in each dog was not significantly different from N and MR-CS. In MR-6m, 2 dogs had significant increase in A-C1 (48%) and 2 dogs had A-C1 consistent with N and MR-CS (19%). Echocardiographically, the MR-6m showed the greatest increase in mass and left ventricular diameter. Hemodynamic data indicated more severe disease in MR as compared to MR-CS. One of the MR-6m with increased A-C1 had clinical pulmonary edema and marked increased Pa wedge pressures, PVR, and LA/Aortic ratio compared to other MR-6m and MR-CS, but SV, SVR, and EF consistent with MR-CS. Increased cardiac myocyte adhesion was noted at the initiation of MR (MR-2wk) when transmural wall stress is high and collagen remodeling is most active. This suggests that the integrin activity is highest at the initial stress of MR and may normalize in compensated chronic MR. Familial Dysrhythmia of Boxer dogs (FDBD) is an inherited disease characterized by syncope and sudden death. The objective of this study was to determine the prevalence of ventricular dysrhythmias in asymptomatic boxer dogs.

Ambulatory ECGs were obtained in 143 boxer dogs using three-channel Holter monitoring recorders and analyzed with a Delmar Holter analysis system using prospective, user-interaction. All dogs were free of historical or clinical evidence of arrhythmia or syncope, and all recordings were Ͼ20 hours in duration. Age, gender, number and grade of ventricular extrasystoles were determined. Dysrhythmias were graded as follows: 0ϭno dysrhythmia, 1ϭsingle uniform ventricular premature complexes (VPCs), 2ϭcouplets, bigeminy, trigeminy, or multiform, 3ϭtriplets, RonT, or ventricular tachycardia.

Eighty females (56%) and 63 males (44%) with a median age of 4 years (6 months to 12 years) were examined. The number of VPCs ranged from zero to 62,622. The median number of VPCs was 10. Of the 143 dogs, 24(17%) had zero VPCs, 63(44%) had Ͼ0 and Ͻ 50, 28(19.5%) had Ͼ50 and Ͻ500, and 28(19.5%) had Ͼ500. Of the 119 dogs with ventricular ectopy, 47(40%) were grade 1, 42(35%) were grade 2,and 30(25%) were grade 3, with a median of grade 2. Dogs were divided into 3 age groups: Ͻ3 yrs, Ն3 and Յ6 yrs, and Ͼ6 yrs. VPC number and grade were significantly different among age groups, with both number and grade increasing with age. VPC number and grade were not significantly different with respect to gender. There was a strong correlation between VPC number and grade.

Results of this study indicate that some asymptomatic boxer dogs have frequent ventricular dysrhythmias of variable grade. Routine ambulatory ECG monitoring may be an important diagnostic modality in asymptomatic boxer dogs, especially those with a family history of FDBD. The tricyclic antidepressant (TCA) / serotonin reuptake inhibitor (SRI) clomipramine (CLO) can increase heart rate, slow intracardiac conduction and increase intra-ocular pressure (IOP) in man. It is therefore recommended to use CLO with caution in humans with cardiovascular disease or glaucoma. The purpose of the study was to test whether the same precautions are necessary in dogs.

The ECG and heart rate of dogs were recorded telemetrically. The IOP was measured by tonometry. In Part I, dogs (nϭ8) received placebo or 20 mg/kg CLO PO in a two-way cross-over. In Part II, dogs received 4 or 12 mg/kg CLO PO in a two-way cross-over and the response compared to the pretreatment period. CLO had no effect on heart rate or cardiac rhythm at 4 mg/kg. At dosages of 12 and 20 mg/kg, CLO produced a non statistically significant bradycardia, and changes to the cardiac rhythm (sino-atrial block, second degree atrio-ventricular block and ventricular escape beats) were noted in Յ4% of recordings. The changes to the cardiac rhythm always occurred during periods of low heart rate and are a normal ''physiological'' response in dogs to a slowing of the heart rate. The observed cardiovascular actions of CLO should have no adverse effects in most dogs with congestive heart failure and might even be beneficial in some cases. CLO did not produce any of the potentially dangerous stimulatory effects (tachycardia and arrhythmias) described with TCAs in man. CLO had no effect on the IOP in dogs.

Few precautions should be needed with CLO in dogs with either cardiovascular disease or glaucoma. Further trials are recommended in dogs with severe bradycardia or decompensated congestive heart failure. Indications for myocardial biopsies include, myocarditis, doxorubicin cardiotoxicity, cardiomyopathies, neoplasia, amyloidosis, and glycogen storage disease. Myocardial biopsies are traditionally done via a transvenous endomyocardial technique. In veterinary medicine, this usually requires general anesthesia. Because of inherent difficulties with the procedure, risk of general anesthesia, and owner reluctance to consent to the procedure, endomyocardial biopsies are infrequently performed in veterinary medicine. The purpose of this study was to develop an alternative myocardial biopsy method that could be done on an outpatient basis.

A Bard Monopty biopsy needle (20 gauge) was selected for the procedure. The length of needle penetration was 11 mm. Full thickness sample biopsies were taken from the apical regions of the left and right ventricular free walls of a cadaver heart. With outflow occlude, the left and right ventricular cavities were filled with saline under high pressure to assess potential leakage from the biopsy sites. Minimal saline leakage occurred. With owners informed consent, ultrasound-guided biopsies were taken from the hearts of three dogs with evidence of clinical disease. Multiple biopsies (2-3) were taken from each dog. The biopsy sites chosen were in the apical regions (two from the right side and one from the left). The dogs were lightly sedated with ketamine and diazepam and monitored with continuous ECG. Post-biopsy the dogs were assessed for hemorrhage. pneumothorax and arrhythmia. Myocardial samples were successfully recovered from all three dogs. Transient ventricular arrythmias were seen in all dogs at the moment of biopsy. There were no significant post-op complications.

In conclusion, ultrasound-guide myocardial biopsies may be a safe, effective alternative to transvenous endomyocardial biopsies. Boxers are afflicted with an inherited ventricular arrhythmia (VA) that causes syncope and sudden death. The purpose of this study was to determine the morphology of spontaneous VA in Boxers using 12 lead ECGs and to compare this morphology to pace mapping in dogs of similar somatotypic conformation. A standardized 12 lead ECG was recorded from 22 Boxers with spontaneous VA. Pace mapping was performed in 7 other dogs under general anesthesia. The left ventricle (LV) was accessed via the femoral artery and the right ventricle (RV) was accessed via the femoral and jugular veins using 8.5Fr introducers. The distal two electrodes of a steerable 7Fr quadrapolar electrophysiologic catheter (1-mm interelectrode spacing) were used for pacing. The following 7 intracardiac sites were paced from the LV: apex, mid-septum, outflow tract, caudal basilar region below mitral valve; and from the RV: apex, mid-septum, and outflow tract (RVOT). The pacing cycle length was constant at 333 ms for 30 seconds. Twelve lead ECGs were recorded. The amplitude of the positive and negative deflections of the premature QRS complexes were measured in the Boxers to determine the polarity of each lead during VA. Similarly, measurements from all pacing sites in all leads were done to determine the site that most closely templated the most common morphology of the VA from the Boxers. Of the 22 VA from the Boxers, a positive QRS morphology was present in 18 (82%) dogs in the caudal leads (II, III, aVF) and 19 (86%) dogs in the left precordial leads (V2-V6). Lead I was positive in 12 (55%) and V1 was positive in 15 (68%). The terminal and delayed forces in V1 were negative in 9 of 22 (41%) dogs with positive caudal leads. The transition lead (earliest precordial lead with R/S ratio Ͼ 1) was V2 in 6 of 22 (27%) dogs and V3 in 1 dog with positive caudal leads. The paced sites that approximated the spontaneous VA were the RV mid-septum and RVOT. Circumferential pace mapping in 2 dogs did not allow further regionalization in the RVOT to the septum or free wall. In conclusion, spontaneous VA in the Boxer predominately has a positive morphology in leads that correspond to a site of origin from the basilar RV. Although specific mapping in the Boxer is required to identify the site of VA origin, these findings suggest that exploration of the basilar RV for disease is required. While elevated plasma homocysteine (hyperhomocysteinemia) is now recognized as an independent risk factor in human thrombovascular diseases, this has not been evaluated in cats. Therefore, we investigated whether plasma homocysteine concentrations were altered in cardiomyopathic cats with congestive heart failure and thromboembolism.

Fasting venous whole blood samples were collected from 30 sequentially admitted cats with cardiomyopathy and congestive heart failure (CHF). Plasma was promptly prepared and frozen (Ϫ70ЊC) for homocysteine analysis by mass spectometry. Twelve of these 30 cats (9(, 3&) had only CHF (6 with 3 mol/L) averaged 6.4mmol/L higher than normal cats (pϭ0.22). While plasma homocysteine was higher in cats who had CHF with TE than with CHF only, this was not significant. Left atrial dimension and LA:Ao ratio were larger in cats who had CHF and TE vs CHF alone (pϽ0.01). Cardiac dimensions did not correlate with plasma homocysteine concentrations. There were no statistically significant associations between plasma homocysteine concentrations, age, weight, or gender.

Thus, hyperhomocysteinemia was detected in cats who had CHF and arterial thromboembolim. This may represent an acquired deficiency, a nutritional defect, or a unique genetic susceptibility. The purpose of this study was to determine the changes, if any, in plasma volume and/or neuroendocrine levels in renal hypertensive cats. Previous studies have demonstrated that hyperaldosteronism is a frequent finding suggesting variable activation of the Renin-Angiotensin-Aldosterone system. There are many other neuroendocrine variables that are involved in vascular resistance and plasma volume control, which need to be evaluated to better ascertain overall cause and effect scenarios. It is important to interpret neuroendocrine status with respect to plasma volume and renal handling of electrolytes which should have predictable changes. These interactions have not been addressed by previous studies.

Eighteen normotensive (control) cats and 4 renal hypertensive cats were compared with respect to plasma volume (PV), plasma renin (PRA), aldosterone (ALD), atrial natriuretic peptide (ANP), epinephrine (E), norepinephrine (NE), fractional excretion of electrolytes and urine protein to creatinine ratio. Plasma volume was determined by I-125 labeled albumin. The means for the control (C) and hypertensive (H) cats were as follows: Age-yrs (4.4C, 13.3H), weightkg (4.59C, 5.17H), systolic blood pressure-mmHg (136.4C, 224.0H), BUN-mg/ dl (25.7C, 37.1H), creatinine-mg/dl (1.2C, 2.2H), PRA-ng/ml/hr (1.25C, 0.03H), ANP-pg/ml (332.9C, 427.2H), ALD-pg/ml (102.4C, 107.0H), E-pg/ ml (266.0C, 134.8H), NE-pg/ml (389.4C, 600.3H) and PV-ml/kg (29.34C, 33.06H). There were no significant changes in plasma volume or neuroendocrine levels between groups.

In conclusion, there were no significant changes in plasma volume or neuroendocrine levels in these renal hypertensive cats. In addition, all hypertensive cats had normal aldosterone levels, which is in direct contradistinction from previous studies. The number of cats in this study was very small and a larger population is needed to support these findings. The efficacy and practicality of the cardiac event recorder in identifying or eliminating transient cardiac arrhythmias as the cause of syncope in clinical patients was investigated. In a prospective study, 37 dogs were evaluated. Inclusion criteria included 1) history of one or more episodes of syncope within the preceding 14 days, 2) no evidence of systemic disease that could result in syncope, and 3) a negative routine electrocardiogram performed at the time of presentation. A King of Hearts cardiac event recorder was used and the monitoring duration was 7 (nϭ32) to 14 (nϭ5) days. Owners completed an activity log of the date and time that any clinical signs occurred, the activity of the patient at the time of clinical signs, and a brief description of the episode.

When used for a period of 7 to 14 days, the cardiac event recorder demonstrated the culpability of cardiac arrhythmias in 17 (45.9%) dogs. Clinical signs did not occur in 20 (54.1%) dogs during the recording period. Cardiac arrhythmias were demon-strated to be the cause of syncope in 10 (58.8%) of 17 cases exhibiting clinical signs during the recording period. Cardiac arrhythmias were ruled out as the cause of syncope in 7 (41.2%) of these cases. None of the dogs were encumbered by the unit which weighs 100 gm. It is concluded that the cardiac event recorder is an effective and practical diagnostic tool in the assessment of dogs with a recent history of syncope and in the detection of transient cardiac arrhythmias. The purpose of the study was to determine whether tubulointerstitial or glomerular abnormalities have a greater negative impact on renal function.

Renal tissue from 39 dogs who had serum creatinine measured within 24 to 36 hours of death or euthanasia was examined using quantitative morphometric techniques. Measurements included relative volume fractions of tubules, interstitium, glomeruli, and capillaries, in addition to glomerular area, glomerular capillary tuft area, Bowman's space area, Bowman's capsule harmonic mean thickness, and volume weighted mean volume of the glomerulus. Regression analysis was performed to determine if there was a significant correlation between these measurements and serum creatinine concentration.

Renal diseases identified included chronic interstitial nephritis (18), glomerulonephritis (11), amyloidosis (3), nephrocalcinosis (1), and granulomatous nephritis (1). Normal renal tissue from five dogs was also examined. Serum creatinine measurements ranged from 52 umol/L (0.6 mg/dl) to 1205 umol/L (13.6 mg/dl). Statistically significant (P Յ 0.05) correlations with serum creatinine concentration were identified for interstitial volume fraction (r 2 ϭ 0.34, r ϭ 0.58), tubular volume fraction (r 2 ϭ Ϫ0.31, r ϭ Ϫ0.56), glomerular area (r 2 ϭ 0.16, r ϭ 0.4), Bowman's space area (r 2 ϭ 0.26, r ϭ 0.51), Bowman's capsule harmonic mean thickness (r 2 ϭ 0.20, r ϭ 0.45), and volume weighted mean volume of the glomerulus (r 2 ϭ 0.11, r ϭ 0.33).

Based on the measurements performed in this study, tubular and interstitial abnormalities have a greater negative impact on renal function than do glomerular abnormalities. This is similar to findings in human beings with renal disease. The implication is that therapy directed at preserving tubular function and normal interstitial architecture will have greater positive effect on renal function than therapy directed at the glomerulus. Ingestion of proteins of animal origin result in an increase in glomerular filtration rate (GFR) and renal plasma flow (RPF). Recent studies in rats and humans indicate that such renal responses are absent or blunted when vegetable protein, and particularly soy protein is ingested. Renal damage in remnant kidney rats has been ameliorated when soy protein has been substituted for casein, and altered hemodynamic responses have been proposed as one possible mechanism.

We examined effects of protein meals on GFR and RPF of both normal and remnant kidney dogs to determine if protein source influenced the magnitude of protein effects. In 4 normal dogs casein, soy meal, semipurified soy flakes, and purified soy protein were tested. In 7 remnant kidney dogs casein, purified soy protein, and liver were tested. For each test, the dog was fasted for 16 hours, baseline measurements of GFR (exogenous creatinine clearance) and RPF (PAH clearance) were made, dogs were fed an amount of test protein consumed with a normal meal, and measurements (GFR, RPF) were continued for 4 or 5 hourly collection periods after feeding.

Similar increases in GFR and RPF occurred regardless of protein source in both normal and remnant kidney dogs. Responses expressed as percent of baseline values were less in remnant kidney dogs than in normal dogs, particularly for RPF.

We conclude that protein source was not a significant factor in postprandial renal hemodynamic responses in either normal or remnant kidney dogs. However, a renoprotective effects of soy protein in dogs is not excluded by our study since in other species other mechanisms with potential for imparting renoprotection have been described.

INDEX OF NATURALLY OCCURRING CANINE CHRONIC RENAL FAILURE J.E.Bauer 1 , R.C. Crocker 1 , D.Senior 2 , L. Nagode 3 , J.Rawlings 4 P.Markwell 4,,, 1 Texas A&M Univ., 2 Louisiana State Univ., 3 The Ohio State Univ., 4 Waltham Centre for Pet Nutrition.

Early stages of chronic renal failure (CRF) are characterized by balanced effects between renal injury and renal compensations. In the early stages renal function is adequate and thus rarely recognized. Serum creatinine measurements are frequently used diagnostically but patients with high normal values (1.3-2.0 mg/dl) may have early renal failure and be overlooked. By the time clinical disease occurs loss of renal functional mass may be so extensive that end-stage uremia rapidly develops. Thus, earlier indices of CRF would allow diet or other therapies to be instituted prior to generalized progression. Thirty dogs with naturally occurring CRF and 16 age-matched control dogs were evaluated as part of a two-center study. The CRF dogs were subdivided into early vs moderate CRF based on serum creatinine concentrations (Cr) and glomerular filtration rates (GFR). Sera and free-catch urine samples were obtained after withholding food overnight. Serum biochemistry profiles, concentrations of parathyroid hormone (PTH), and calcitriol, and urine concentrations of microprotein, creatinine, and eicosanoids (PGE 2 and TxB 2 ), were analyzed. Comparisons were performed using Kruskal-Wallis ANOVA at pϽ0.05. Calcitriol and albumin concentrations were not significantly different in any group. Serum calcium, phosphorus, and PTH concentrations were different only between control and moderate CRF dogs. However, urine PGE 2 /Creatinine, (PG/Cr) urine protein/creatinine (Pr/Cr) ratios, and BUN were different from controls in both CRF dog groups. Most notable was a Ͼ4-fold decrease in urine PG/Cr in affected dogs in both the mild (1084 pg/mg)and moderate (666 pg/mg) CRF groups (controlϭ4374 pg/mg). Regression analysis indicated strong inverse correlation (r 2 ϭ0.54, pϽ0.0001)between log(urine PG/Cr) and Cr. An inverse correlation between log(GFR) and Cr and direct relationship between log(urine PG/Cr) and GFR were also found. Correlations with BUN or urine Pr/Cr were not strong due to high variability. Strong correlation between urine PG/Cr and dogs with early CRF along with large numerical differences between normal and affected dogs suggests this measurement may help identify geriatric and canine populations with early CRF. Previous studies in our laboratory demonstrated that cats with partial nephrectomy exhibit glomerular hypertension (Am J Physiol 269:R1008, 1995), an adaptive change that has been associated with progressive renal injury in laboratory rodents and dogs. In human beings (N Engl J Med 334:939, 1996) , laboratory rodents (J Clin Invest 77:1993 , 1986 , and diabetic dogs (Kidney Int 46:161, 1994) , a renoprotective effect of inhibition of converting enzyme has been causally linked to reductions in glomerular capillary pressure. We tested the hypothesis that treatment with the angiotensin converting enzyme inhibitor, benazepril, would lower glomerular capillary pressure in cats with induced chronic renal insufficiency.

Following reduction in renal mass, thirty-two cats were randomly divided into four groups (nϭ8 each) on the basis of urinary inulin clearance (glomerular filtration rate, GFR). Each group then received once daily oral dosing with benazepril as follows: Group 1 (0 mg/kg); Group 2 (0.25-0.50 mg/kg); Group 3 (0.50-1.00 mg/kg); and Group 4 (1.00-2.00 mg/kg) for 6 months. The cats were studied by radiotelemetric blood pressure implants, renal clearance, and renal micropuncture techniques. Data were analyzed by ANOVA using a model incorporating treatment effect (and time effect where repeated measurements were made).

Compared to group 1, the glomerular capillary pressure was significantly lower in groups 2-4, systolic arterial blood pressure was significantly lower in groups 2 and 3, mean and diastolic arterial blood pressure were significantly lower in group 3, renal plasma flow was significantly higher in group 4, and GFR was significantly higher in groups 3 and 4. We conclude that benazepril treatment reduced glomerular capillary pressure and systemic arterial blood pressure while sustaining or increasing renal plasma flow and GFR in cats with chronic renal insufficiency. A blinded, multicenter, prospective clinical trial assessed the effects of enalapril (EN) versus standard care in dogs with naturally occurring, idiopathic glomerulonephropathy (GN). Twenty-nine adult dogs with membranous (16) and membranoproliferative (13) GN were identified for study. Dogs were randomly assigned to receive either EN (0.5 mg/kg PO 12-24 h) (nϭ16) or placebo (nϭ14) for six months (one dog was treated first with the placebo and then with EN). All dogs were treated with low-dose aspirin (0.5-5 mg/kg PO 12-24h) and fed Hills k/d diet. At baseline there was no difference in serum creatinine (SrCr), systolic blood pressure (SBP), or glomerular histologic grade between groups, however the urine protein/creatinine ratio (UP/C) was greater in the EN treatment group compared with the placebo treatment group (8.7Ϯ4.4 vs. 4.7Ϯ2.3).

After six months of treatment the change in UP/C from baseline was significantly different between groups (EN ϭ Ϫ4.2Ϯ1.4 vs. 1.9Ϯ0.9 in the placebo group). When data were adjusted for changes in GFR (UP/C x SrCr) a similar significant reduction was noted (Ϫ6.3Ϯ10.5 vs 8.3Ϯ10.1). The change in SBP after six months of treatment was also significantly different between groups (EN ϭ Ϫ16.7Ϯ7.0 vs 6.8Ϯ6.8 mmHg in the placebo group). Response to treatment was categorized as a) improvement (Ն 50% reduction in UP/C with stable SrCr) (assigned a value of 2), b) no progression (Ͻ 50% reduction in UP/C with stable SrCr) (value of 1), and c) progression (Ͼ 50% increase in UP/C and/or SrCr or euthanasia due to renal failure) (value of 0). Response to treatment was significantly better in the EN treated dogs (1.4Ϯ0.8) compared with the placebo treated dogs (0.3Ϯ0.5). These results suggest that EN treatment is beneficial in dogs with naturally occurring idiopathic GN. Systemic arterial hypertension is thought to be a common complicating factor in feline chronic renal failure (CRF). If this is translated into glomerular capillary hypertension, it may contribute to progressive loss of functioning nephrons. The aim of this study was to determine the incidence of hypertension in cases of feline CRF and to compare urine protein excretion in hypertensive and normotensive cats with similar degrees of renal dysfunction.

Fifty two cats with a diagnosis of stable CRF were entered into the study. Systolic arterial blood pressure (SABP) was measured using an indirect Doppler technique. Hypertension was diagnosed as SABP Ն175 mmHg which was persistent or associated with ocular lesions. Spot urine samples were collected by cystocentesis and urine protein to creatinine ratio measured. Normotensive cats over 12 years of age were paired with hypertensive cats of similar body weight and plasma creatinine concentration and compared using the Wilcoxon signed rank test.

Fifteen of the 52 cats with CRF had SABP of Ն175 mmHg giving an incidence of 28.8% for hypertension associated with CRF. All the cats with hypertension were 12 years of age or older, compared with only 19 of the 37 normotensive cats. These data show that systemic hypertension occurs in 29% of our feline CRF population with a tendency to occur in older animals. Hypertension was associated with greater urinary protein loss suggesting systemic hypertension may be reflected in raised glomerular capillary pressure. The high osmolality of normal feline urine is an important defence mechanism preventing bacterial colonization of the urinary tract. Cats with chronic renal failure (CRF) lack the ability to concentrate urine and may be more susceptible to bacterial urinary tract infection (UTI). The aims of this study were to assess the incidence and prevalence of UTI in cats with CRF and to identify the number of cats in which UTI recurred following treatment.

Thirty six cats with a diagnosis of stable CRF where urine samples had been collected by cystocentesis on 4 or more occasions (1 to 2 months between each sampling), were included in the study. A complete urinalysis was performed, including microscopic urine sediment examination and quantitative bacterial cultures. Blood samples were collected and the plasma creatinine concentration assayed. Data are expressed as mean Ϯ SD and cats with and without UTI were compared using an unpaired Student's t test.

A total of 268 urine samples (mean of 7.4 samples per cat) were analysed, 22 of which contained significant numbers of bacteria, giving a prevalence of UTI of 8.2%. Eleven of the 36 cats with stable CRF had significant bacteriuria on one or more occasions giving an incidence of 30.5%. Recurrent episodes of UTI occurred in six cats. In all cases, the bacteria cultured were identified as E coli. Comparing cats with UTIs to those where no UTI was detected, the two groups did not differ significantly in age (14.1 Ϯ 3.2 compared to 11.4 Ϯ 5.8) or urine specific gravity (1.015 Ϯ 0.003 compared to 1.017 Ϯ 0.004). Females were over-represented in the UTI group (8 of 11 or 73%) and under represented in the group with no evidence of UTIs (7 of 25 or 28%).

These data suggest that UTIs are very common in female cats with stable CRF. Recurrent episodes of UTI may be a factor in the progression of CRF but any association between bacterial UTI and progressive deterioration in renal function is difficult to prove as, once detected, UTIs were promptly treated with appropriate antibacterial drugs in these cases of CRF. The objective of this study was to validate a cocktail kinetic approach for the simultaneous measurement of glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) in the dog.

Six healthy Beagle dogs were randomly assigned in a three-period cross-over study of intravenous bolus administration of iohexol (64.7 mg/kg), PAH (10 mg/ kg) and an iohexol/PAH mixture. A one-mL blood sample was obtained before, then 2, 5, 10, 15, 20, 30 and 45 minutes, and 1, 1.5, 2, 3.5, 6 and 8 hours after the administration. PAH and iohexol were determined simultaneously by a validated HPLC method. Data were analysed using non compartmental and bicompartmental approaches.

Two stereoisomers, exo-iohexol (quantitatively the most important) and endoiohexol, were identified. The limits of quantification for the endo-, exo-iohexol and PAH assay methods were 2, 9 and 1 g/mL, respectively. The accuracy values for PAH and iohexol were 6.3 %, 1.8 % and 1.3 % respectively. No metabolites of PAH were detected. The total plasma clearance values for PAH and exo-iohexol were 13 Ϯ 2.3 mL/kg/min and 2.9 Ϯ 0.3 mL/kg/min, respectively. No significant effect of coadministration of PAH and iohexol was observed on the clearance of either drug.

In conclusion, this approach allows an easy simultaneous determination of GFR and ERPF in experimental studies. Non compartimental approach should be also recommended for the calculation of ERPF and GFR. General anesthesia (GA) and non-steroidal anti-inflammatory drugs (NSAIDs) have been reported to cause renal dysfunction in dogs. Renal function was investigated in 26 normal, healthy dogs undergoing GA for student performed ovariohysterectomies. Due to the inexperience of the students, the procedure was usually protracted. The dogs were given one of 3 NSAIDs: ketorolac (0.5 mg/ kg), ketoprofen (1 mg/kg), or carprofen (4 mg/kg). All dogs were over 5 kg, healthy, and were presented for routine ovariohysterectomies at the Onderstepoort Veterinary Academic Hospital. All dogs were premedicated with acetyl promazine (0.05 mg/kg subcutaneously), and a NSAIDs, induced with thiopentone (10-15 mg/kg), and maintained on 2% halothane. None of the dogs were given intra-venous fluids during the surgery.

Renal function was assessed prior to surgery, 24, and 48 hours post surgery. Renal function and integrity was evaluated using serum urea and creatinine, fractional clearance of sodium (FC Na ), urine enzymes (GGT and ALP) and urinalysis.

The duration of the GA ranged from 1½-4 hours, with an average of 2 hours. There was no change over time in urine specific gravity, serum urea and creatinine, urine enzyme activity, and urine enzyme activity expressed as a ratio to creatinine that were indicative of renal dysfunction. The only statistically significant change was a decrease in FC Na 24 and 48 hours post surgery. A few dogs showed increases in renal tubular epithelial cells on urine sediment examination and concurrent increase in urine enzyme activity, 24 and 48 hours post surgery. However, this was neither a statistically nor a clinically significant finding.

It was concluded that renal function and integrity remained unaffected in this sample of 26 anesthetised healthy dogs that were given NSAIDs without concurrent intra-venous fluids. Benazepril is an ACE inhibitor which has been used to treat chronic heart failure in dogs. Aged dogs, which tend to suffer from heart disease, often also have renal insufficiency. Benazepril may be a suitable drug to use in these dogs as its active metabolite, benazeprilat, is excreted via both biliary and urinary routes. In this study, pharmacokinetic (PK) and pharmacodynamic (PD) parameters for benazepril were tested in dogs with experimental renal insufficiency.

Dogs received either no treatment (control) or a normal dose (0.5 mg/kg, nϭ5) or a 20-fold overdose (10 mg/kg, nϭ4) of benazepril PO SID for 15 consecutive days both before and after surgery. Reduction of renal mass to ¼ of normal was achieved via right-side nephrectomy and ligation of the branches of the left renal artery. Plasma concentrations of benazepril and benazeprilat were measured by a GCMS method.

The 1/4 th kidney model resulted in increases in BUN to 30 mg/dL and plasma creatinine to 2.0 mg/dL and reductions in RPF by 37% and GFR by 30%. Treatment with either dose of benazepril produced no significant change in these parameters. Concentrations of benazeprilat, assessed by AUC(0→24h) values, were not different pre and post-surgery. Plasma ACE values were reduced with benazepril to a similar extent pre and post-surgery. Benazepril was well tolerated in all dogs.

It is concluded that this model of renal insufficiency did not lead to any significant changes in the PKs or PDs of benazepril, administered at both a normal dose and with a 20-fold overdose. Benazepril appears to have a high safety margin, and no dose adjustment should be needed, in dogs with renal insufficency. This may be due to the dual biliary and urinary excretion of its active metabolite. Products containing extracts of the saw palmetto plant, Serenoa repens, are available as over the counter therapy for prostatic hyperplasia in men. The goal of this study was to evaluate the effect of Serenoa repens on canine prostatic hyperplasia and to assess whether the doses administered had any adverse effects. Twenty mature dogs with prostatic hyperplasia were assigned to 3 groups based on prostatic volume/kg body weight. All dogs were treated orally 3 times a day for 91 days: 8 dogs received 1500 mg/day; 6 dogs received 300 mg/day; and 6 dogs received canned dog food meatballs without medication. Dogs were observed at least 3 times a day for abnormal clinical signs. A CBC, serum biochemical profile, urinalysis, urine culture, abdominal radiography, prostatic ultrasonography, semen evaluation and culture, and serum testosterone concentrations were performed before therapy and at the midpoint and end of therapy. At the termination of treatment, necropsies were performed. Individuals conducting and interpreting the test results were blinded as to the treatment groups of the dogs. Treatment did not affect prostatic weight, prostatic volume, or prostatic histologic scores for hyperplasia. No significant differences were found in semen characteristics, caudal abdominal radiographs, prostatic ultrasound, or serum testosterone concentrations between groups. No beneficial or adverse effects related to treatment with Serenoa repens were found. Renal insufficiency was induced experimentally in 5 cats by 7/8 nephrectomy. As compared to pretreatment, the nephrectomised cats had statisically significant (pϽ0.01) increases in plasma urea and creatinine and reductions in creatinine clearance (assessed via creatinine clearance). Systolic, diastolic and mean blood pressure, measured telemetrically, and plasma levels of plasma renin, angiotensin I and II and aldosterone were also increased significantly (pϽ0.05). Benazepril administered at a dose of 2.5mg PO for 2 weeks produced significant (pϽ0.05) reductions in angiotensin II, aldosterone and all three blood pressure parameters.

A total of 11 cats with chronic renal failure including proteinuria received benazepril (0.25-1 mg/kg PO SID) or no ACE inhibitor (control) for 12 to 24 weeks. As compared to the control group, the benazepril treated cats had lower plasma urea and creatinine values.

There were no changes in urine protein values in the control group (nϭ5) during the trial whereas all benazepril treated cats (nϭ6) showed marked reductions in urine protein values during treatment.

It is concluded that the ACE inhibitor benazepril may be useful in the treatment of chronic renal failure in cats. The purposes of this study were to evaluate blood pressure, renal function and the renin angiotensin aldosterone system in cats with autosomal dominant polycystic kidney disease (ADPKD), and to evaluate the response of these parameters to amlodipine. Four adult cats with ADPKD and four age-matched, healthy control cats were studied. All cats were instrumented with a radiotelemetry device for 24-hour hemodynamic monitoring. Renal function was assessed by measuring glomerular filtration rate (GFR), effective renal plasma flow (ERPF), renal blood flow (RBF), filtration fraction (FF), blood urea nitrogen (BUN) and creatinine (Cr). GFR was determined by 3H inulin clearance and RBF by 14C-tetraethylammonium bromide clearance. Plasma renin activity (PRA), aldosterone (Aldo), and atrial natriuretic peptide (ANP) were measured. All evaluations were performed at baseline and repeated after 7 days of amlodipine therapy at a dose of 0.625mg/cat. At baseline, control cats had significantly higher median systolic, mean, and diastolic pressures (pϽ0.0001) compared to ADPKD cats. Amlodipine decreased median systolic, mean, and diastolic blood pressures (pϽ0.0001) in both ADPKD and control cats. Peak amlodipine effect usually occurred within 3 hours of administration. Renal function was not different between ADPKD and control cats at baseline other than a mild increased BUN concentration in one ADPKD cat. Amlodipine did not lead to significant changes in any renal function tests. ADPKD cats had significantly higher PRA (pϭ0.0286) and Aldo concentrations (pϭ0.0286) at baseline. Amplodipine did not cause significant changes in evaluated hormones, and no difference was noted between ADPKD and control cats.

Hypertension was not documented ADPKD cats. Amlodipine successfully reduced blood pressure in normotensive cats and did not adversely affect renal function. ADPKD cats may have overactivity of the RAAS. Dogs with renal disease may develop systemic hypertension (SHT). In human medicine, treatment of SHT is considered once systolic blood pressure (SBP) values exceed 140 mmHg because of an increasing risk of cardiovascular and cerebrovascular complications. In veterinary medicine, SHT is numerically defined as SBP greater than 2 standard deviations from a normotensive population of dogs. Recognized consequences of SHT in humans include hypertensive retinopathy, cardiomyopathy, encephalopathy, and enhanced progression of renal failure. The purpose of this prospective study was to evaluate the prevalence of SHT in 42 dogs with chronic renal failure (CRF), the incidence of end-organ damage in relation to blood pressure, and the impact of SHT on mortality in renal failure-hypertensive (RFH) and renal failure-non-hypertensive (RFNH) populations. Blood pressures were measured using oscillometric techniques and care was taken to avoid stress-induced hypertension.

Hypertensive dogs (SBPϾ160 mmHg) were divided into two groups: group 1 having SBPϭ160-180 mmHg and group 2 having SBPϾ180 mmHg. Eight of 42 dogs (19.0%) were included in group 1 and twelve (12/42; 28.6%) were included in group 2. None of the dogs in group 1 developed recognized clinical consequences of hypertension. In group 2 dogs, hypertensive retinopathies were recognized in 4/12 (33.3%). Hypertrophic cardiomyopathy was recognized in 1 dog (1/12; 8.3%). Rapid progression of renal failure was seen in (6/12; 50%) of the cases. Findings consistent with hypertensive encephalopathy were suspected in 3/12 dogs (25%). Percent of dogs alive after 1, 3, 6, 9, and 12 months were 58.3%, 22.2%, 11.1%, 11.1% and 0% (RFH dogs) and 100%, 95.8%, 76.5%, 60%, and 50% (RFNH dogs), respectively.

The preliminary results of this study indicate a systolic blood pressure of 160-180 mmHg seems to be benign and appears not to influence the progression of CRF. However, some animals with normal or mildly elevated blood pressure may develop higher pressure values. Sustained hypertension (Ͼ180 mmHg) is common in dogs with CRF and may lead to important clinical consequences. Clinical recognition of hypertension in CRF is important as SHT appears to significantly decrease survival time in CRF patients. A double blind, crossover, placebo controlled study was done in intact adult dogs (nϭ8) to determine if SAMe, an important methyl and GSH donor, can attenuate adverse effects of high dose chronic prednisone (Pred) therapy. A pilot study in 4 adult dogs, determined that co-administration of Pred (1-3 mg/ kg/ day) and SAMe (20 mg/kg/day minimum dose) did not affect bioavailability or pharmacokinetics of either substance (24 hrs, 21 to 42 days).

A loading dose of Pred (4 mg/kg for 5 days) was followed by 2.2 mg/kg PO SID for 12 weeks. Dogs received either SAMe (20 mg/kg minimum dose) or an identical appearing Placebo (Pla), on an empty stomach, in two divided doses/ day. Crossover occurred on day 43. Blood and urine samples, ICG clearance, and liver biopsies were collected on day 0 and designated intervals thereafter. Parameters evaluated included: CBC, biochemistry profiles, glucocorticoid induced alkaline phosphatase (G-ALP) activity, and concentrations of haptoglobin, total bile acids, RBC TBARs, and blood GSH and GSSG. Samples were collected after a 12-hr fast and before treatments. Tissues (days: 0, 42, 84) were stained with H & E and PAS. Morphometry was done using NIH freeware. Differences within and between groups were tested using a paired T test and two sample T test; respectively.

Morphologic changes in liver suggest that SAMe-Pred does not alter vacuolation, glycogen accumulation, or cell size heterogeneity. Pla-Pred significantly increased ALP and G-ALP (days 28 & 42), bile acids (fractional change, day 42), and decreased TBARs (days 7-42), GSH (fractional change, days 14-42), and GSSG (7-42 days). SAMe-Pred significantly increased ALP and G-ALP (day 28), and decreased TBARs (days 7-42), GSH (fractional change, days 14-42), and GSSG (day 42). On inspection, bile acids and % ICG retentions were lower and ICG clearance and GSH higher in SAMe-Pred intervals.

Despite the small number of dogs and expected large individual variation in response to glucocorticoids, Pred significantly reduced RBC GSH, GSSG and TBARs in all dogs. SAMe modified the influence of Pred on GSSG and (on inspection) GSH. We conclude that oral administration of the nutraceutical SAMe may improve hepatocellular handling of organic anions (e.g. bile acids, ICG), attenuate ALP and G-ALP induction, and beneficially alter glutathione stores/metabolism in dogs given chronic high dose glucocorticoid therapy. We examined the medical records of in 14 dogs with ultrasonographically identified gallbladder (GB) mucoceles and recorded the clinical, biochemical and histological findings and treatment outcome. In all dogs abdominal ultrasound revealed an enlarged GB with either a kiwi or stellate like bile pattern. Eight breeds were represented with an increased incidence in Cocker Spaniels (4/14). Body weight and age ranged from 6 to 36 kg (median:12 kg) and 4 to 17 years (median: 9.5 yrs), respectively. Clinical signs included: vomiting (12/14), anorexia (11/14), lethargy (9/14), polyuria/polydipsia (5/14), diarrhea (2/14) and a history of diabetes mellitus (2/14). Physical exam findings included: abdominal pain (6/13), icterus (6/13), hyperthermia (4/13) and a palpable abdominal mass (1/13). Serum biochemical evaluation showed increased alkaline phosphatase (13/14, median 11.6X, range 1-55X), alanine aminotransferase (11/14, median 6.5X, range 1-101X), ␥-glutamyl transpeptidase (11/13, median 4.7X, range 1-66.7X) and bilirubin (11/13, median 7.6X, range 1-74X). GB histopathology in 10/14 dogs confirmed the presence of a mucocele and identified mucosal hyperplasia (10/10), mural necrosis (9/10) and suppurative cholecystitis (5/10). Three dogs without GB biopsies had macroscopic evidence of a mucocele and GB wall necrosis. Surgery was done in 10 dogs (9 cholecystectomies and 1 cholecystotomy). Acute GB rupture was identified in 3 dogs and a previous rupture suspected in 4 dogs on histopathology and/or by the presence of GB wall adhesions at surgery. Aerobic bacterial cultures of bile were positive in 6/ 9 dogs. Four dogs died in the immediate post-operative period from bile peritonitis (2), pneumonia(1) and an unrelated cardiomyopathy (1). The other 6 dogs were alive and well at least 2 months post-operatively. Two dogs died of GB rupture pior to surgical intervention. One dog was euthanized due to chronic renal failure. One dog treated medically (choleretics and antibiotics) was asymptomatic for 1 year. Identification of the characteristic kiwi or stellate pattern to bile in the GB accurately identified the presence of a GB mucocele. In dogs with biochemical evidence of hepatobiliary disease, GB mucoceles were frequently associated with mural necrosis (12/13) and/or cholecystitis (9/13). These findings suggest that when GB mucoceles are identified by ultrasound, a combination of surgery (cholecystectomy) and medical treatment (antibiotics) should be contemplated. Fine needle aspiration with cytology has been frequently advocated as a diagnostic tool for the evaluation of liver disease. The correlation of cytology to histopathology, however has not been evaluated in dogs and cats with liver disease. This retrospective study was performed to determine the diagnostic accuracy of hepatic cytology when compared to the histologic diagnosis.

Thirty-three cases were evaluated. Thirty-two cases (7 cats, 25 dogs) having both liver cytology and histopathology performed within 24 hours of each other were included in this study. One case had an inadequate cytologic sample for evaluation. Liver cytology samples were obtained via ultrasound guidance and histopathologic samples were obtained either via ultrasound, laparoscopy, surgery or at necropsy. All cytologic and histologic samples were reviewed by one investigator (VG and BP respectively) for the predominant diagnostic features. The results were compared and the correlation of cytology to histopathology was graded as correlation, partial correlation where cytology revealed part but not all of the diagnosis, or no correlation. A 2X2 contingency table analysis was utilized to determine correlation versus partial or no correlation.

The results indicate only 9 cases (28%) were correlated. Seven cases (22%) had partial correlation and 16 cases (50%) had no correlation. The lack of correlation between the cytologic and histopathologic diagnosis was significant (PϽ0.001). Correlation was found in 0 of 3 cases of lipidosis, 2 of 6 cases of vacuolar degeneration, 3 of 11cases of hepatitis, 4 of 9 cases of neoplasia and 0 of 3 other conditions.

In summary, the results of this preliminary study found the cytologic diagnosis to have a poor correlation with the histopathologic diagnosis in dogs and cats with liver disease. The greatest correlation was observed in cases of hepatic neoplasia (44%). Unexpected hepatotoxicity was associated with the administration of stanozolol (Winstrol-V; 1-4 mg/cat/day PO) in 16/21 cats enrolled in two separate studies. One study was evaluating the effects of stanozolol in a colony of 18 research cats (12 healthy, 6 with naturally occurring chronic renal failure), and the other study was evaluating the clinical response of client-owned cats with severe gingivitis/stomatitis to stanozolol. The cats in the chronic renal failure study (RF) were divided into two groups and received stanozolol (25 mg IM on day one, followed by 2 mg stanozolol PO q12h) or placebo for four weeks, followed by a two-week washout period, after which the groups were reversed. In the gingivitis-stomatitis study (GS), cats were administered 1 mg stanozolol PO q24h. Most cats in the RF study stopped eating or had a significantly reduced food intake within 7-10 days of initiating stanozolol administration. Serum alanine transaminase (ALT) activity was significantly elevated in 14/18 RF cats when tested during and up to two weeks after stanozolol administration. Serum alkaline phosphatase activity (SAP) was mildly increased in only 3 cats. Four cats in the RF study had ALT Ͼ1000 U/L after only two weeks of stanozolol administration and were removed from the study. All 4 of these cats had coagulopathies consistent with vitamin-K antagonism, and 3 were hyperbilirubinemic. Administration of vitamin K resolved the coagulopathy in 3 cats within 48 hours. All cats survived and liver enzymes were normal in all cats tested more than 4 weeks after discontinuing stanozolol. In the GS cats, 2/3 developed evidence of severe hepatic failure 2-3 months after initiating stanozolol therapy. Anorexia was present for one week and one month, respectively, when the cats presented for reevaluation. Both cats were hyperbilirubinemic, and coagulopathies were present in both. Serum ALT was elevated in one cat, but normal in the other. SAP was elevated in both cats. The cat with the most severe hyperbilirubinemia did not survive. Histopathologic evaluation of liver biopsies from 3 cats in the RF study and both cats in the GS study demonstrated severe, diffuse, centrilobular hepatic lipidosis and cholestasis, without evidence of significant hepatocellular necrosis. The use of stanozolol in cats is not recommended until additional toxicity studies can be performed.

THE CAT. S. Tasker 1 , P. Cripps 2 and A. Mackin 3 . University of Edinburgh, Scotland 1 ; University of Liverpool, England 2 ; and Mississippi State University, MS 3 . Counting platelets in cats is frequently inaccurate and susceptible to procedural errors. The purpose of our study was to determine the relationship between 'gold standard' hemacytometer manual platelet counts and other methods of counting feline platelets, namely estimation of platelet numbers from examination of either a stained blood smear or a commercially-available supravital stain and proprietary slide (Zynocyte, MA), platelet counting using several different bench top centrifuge-type hematology analyzers (QBC VetAutroread, Idexx, ME; VS/2000, Zynocyte, MA), and automated platelet counts performed in an external laboratory using a standard impedance-based analyzer (Baker System 9110ϩ, Biochem Immunosystems, PA). The effects on Baker counts of using two different anticoagulants (EDTA and sodium citrate) for stored and transported samples were also determined.

Hemacytometer platelet counts were performed on venous blood taken from 49 sick cats (9 with thrombocytopenia and 40 with platelet numbers within normal range), and compared with counts obtained by other methods via Pearson correlation coefficients and Least Squares regression analysis. Baker counts were performed a median of 2 hours after sample collection; all other counts were done immediately after collection. Multiple linear regression analysis was used to determine the effect of time between sampling and analysis for Baker counts. For all of the above analyses, statistical significance was taken as PϽ0.05. For each counting method, sensitivity, specificity and diagnostic accuracy for differentiating low from normal platelet counts was also determined.

All of the platelet counting methods evaluated had correlation (r) values of under 0.8. Correlation (r) values obtained: blood smear 0.776, Baker EDTA 0.579, Baker citrate (corrected for citrate dilution) 0.629, QBC 0.538, VS/2000 0.505, Zynocyte slide 0.329. Platelet clumping precluded calculation of platelet numbers in 9 out of 49 blood smears, all of which had adequate hemacytometer counts. Time between collection and counting had no effect on Baker platelet counts obtained with both EDTA and citrate samples. Sensitivity, specificity and diagnostic accuracy respectively for each method were: blood smear 67%, 93%, 88%; Baker EDTA 100%, 16%, 33%; Baker citrate 100%, 38%, 49%; QBC 44%, 97%, 88%; VS/ 2000 100%, 40%, 51%; and Zynocyte slide 43%, 66%, 62%.

In conclusion, no counting method was found to consistently obtain reliable results. Based on our results, we recommend that stained blood smear platelet estimations or, ideally, hemacytometer counts are performed when analyzer counts are abnormal or inconsistent with clinical findings. Citrate is preferable to EDTA as an anticoagulant for samples stored and transported for later platelet counting by hematology analyzer.

TREATMENT OF CANINE VON WILLEBRAND DISEASE M. Brooks and J. Catalfamo. Comparative Coagulation Section, Diagnostic Laboratory, Cornell University, Ithaca, NY.

The efficacy of cryoprecipitate (cryo) for surgical prophylaxis and correction of the bleeding tendency caused by canine von Willebrand disease (vWD) was investigated. Six vWD-affected dogs, (nϭ2 type 1, nϭ2 type 2, nϭ2 type 3) were evaluated over a 4 year period. Cryo was prepared by thawing canine fresh frozen plasma at 4 C, and the % yield and potency (U/ml) of factor VIII and von Willebrand factor (vWF) in representative cryo units was determined. In a series of infusion studies, response to cryo was monitored in type 2 and 3 vWD dogs through serial measurement of their plasma vWF concentration (vWF:Ag), factor VIII coagulant activity (fVIII:C), and determination of buccal bleeding time (BT). Cryo was given pre and post-operatively (nϭ3 castration, nϭ2 cruciate repair, nϭ5 dentistry) and clinical response to dose (UvWF/kg) was evaluated by monitoring Hct, vWF:Ag, and observation of the surgical wound. In a retrospective review, the cryo dose (UvWF/kg) to control bleeding from cutaneous or mucosal sites (nϭ18 events for 5 dogs) was tallied. Signs of fever, vomiting, diarrhea, urticaria, dyspnea, or hemolysis within 24 h. of cryo transfusion were recorded for each dog.

At study entry, all dogs had history of 1 or more episodes of abnormal bleeding and had marked prolongation of BT (Ͼ12 minutes). Cryo units (nϭ15) had median vWF yield of 42%, potency of 4.96 UvWF/ml, and ratio of vWF:fVIII of 1.1. Cryo dose correlated with post-infusion plasma vWF:Ag (rϭ0.89), but not with factor VIII:C (rϭ0.13). In response to a single cryo infusion (12 UvWF/ kg), plasma vWF:Ag peaked at ½ h., and returned to baseline at 24 h. post infusion. Shortening of BT was readily demonstrated in type 1 and 2 vWD dogs at a dosage range of 5.6 to 11.5 UvWF/kg. Transfusion of up to 22 UvWF/kg did not shorten BT in type 3 vWD dogs. Preoperative dosages of 14 to 30 UvWF/ kg induced plasma vWF:Ag response of 19 to 63%, sufficient for normal intraoperative hemostasis in all dogs. Postoperative transfusion to sustain plasma vWF:Ag Ն10% maintained hemostasis for 48 hr post-op. In most cases, dosages of 5.5 to 9 UvWF/kg were sufficient to stop cutaneous or mucosal bleeds. No adverse reactions were observed after cryo transfusion. These studies indicate that cryo is safe and highly effective for treating vWD. The BT is useful for diagnosis but does not accurately predict surgical hemostasis, and BT response differs for vWD subtypes. Optimizing treatment regimens to balance cost and efficacy will require specific measurement of vWF to determine cryo potency and patient response. Crotalus viridis viridis, the prairie rattlesnake, is the only species of poisonous snake present in northeastern Colorado and a common cause of envenomation. This study was performed to define clinically relevant variables and to identify optimal treatment modalities.

Canine snakebite cases diagnosed at the Colorado State University Veterinary Teaching Hospital from 1989 to 1998 were identified by medical record review. Objective measures of outcome included mortality, days hospitalized, cost, and laboratory abnormalities. A multivariate regression analysis was performed to test for significant effects on outcome of clinical variables and treatments.

One hundred cases of canine snakebite were identified; the majority occurred between May and September. The majority of the dogs were 3 mo-12 yrs of age (median 3.7 yrs) and were bitten on the head (78/96) in the late afternoon. There was no sex predilection. The median time to presentation was 1 hour (range 15 min-13 hrs). Swelling at the bite was the primary finding. Principal initial laboratory findings were thrombocytopenia (44/50), leukocytosis (37/70), echinocytosis (48/52), and prolonged activated clotting time (8/86); thrombocytopenia, leukocytosis and prolonged activated clotting times progressed over 24 hrs in some dogs. Ninety four dogs were hospitalized; 48 were discharged the following day. Antibiotics (87 dogs), intravenous crystalloid fluid therapy (84 dogs), glucocorticoids (83 dogs), antihistamines (55 dogs) and antivenin (23 dogs) were the most common treatments. One dog died. Smaller dogs were hospitalized longer than larger dogs. Antivenin had no significant effect on days hospitalized but was associated with a higher platelet count after treatment and a higher total hospital bill.

The bites of the prairie rattlesnake are associated with significant morbidity but low mortality. Antivenin use and dosage should be reassessed for dogs bitten by this species of rattlesnake. We reviewed 50 cases of confirmed feline heartworm disease (FHWD) seen at North Carolina State University from 1985 through 1997.

The M:F was 28:22 (56% males; no evidence of male over-representation compared to the hospital reference population of 8400 cats [4474:3926, 57% male]). The mean age was 6.35 (SDϭ4.4; 1-19 years. Forty-two cats were domestic (84%), with 31 DSH and 11 DLH. There was no difference between proportions of exotic and domestic cats, compared to the control population. FHWD was diagnosed less often in the 4th quarter of the year. There is no evidence of increasing prevalence from 1985-1997. Owners reported 13 of 48 cats (27%) to be housed totally indoors, 33 (69%) indoors and outdoors, and 2 (4%) totally outdoors. Presenting signs included dyspnea (24 cats, 48%), cough (19 cats, 38% and sudden death (5 cats, 10%). Vomiting was reported in 19 cats (38%), with frequent vomiting being noted in 8 (16%). Only 1 of 8 cats (13%) was microfilaria-positive. ELISA was positive for antigen in 37 of 43 cats (86%) and for antibodies in 19 of 22 cats (86%). Three cats (14%) with FHWD were antibody negative. Heartworms were detected in 14 of 33 cats (42%) by echocardiography. Eosinophilia was detected in 43% (18/42) of cats with FHWD, significantly more often than in the control population. Thoracic radiographs (nϭ41) showed 76% (31/41) to have pulmonary artery enlargement. Pulmonary parenchymal abnormalities (Ϯ hyperinflation) were recognized in 76% (31/41), with a bronchointerstitial pattern being most common. Median survival for 48 cats was 1.5 years; in cats living beyond the day of presentation, it was 4 years. Survival of 11 cats treated with sodium caparsolate was not significantly different from those not receiving adulticide. The relationship of Helicobacter felis a bacterium observed in the stomachs of cats, to gastric disease is unclear. The objective of this study was to determine if H. felis infection alters gastric morphology, cytokine expression, and secretory function in cats. Five SPF, Helicobacter free cats were studied before and for one year after inoculation with H. felis (ATCC 49179). Four SPF, uninfected cats served as controls.

All five H. felis inoculated cats became colonized as determined by urease activity, histopathology, PCR, culture and transmission electron microscopy of serial gastric biopsies. Uninoculated cats remained Helicobacter free. The body and cardia were more heavily colonized than the pyloric antrum. Mild gastric inflammation was detected in infected and uninfected cats, but was more extensive in infected cats. There was a weak correlation (Tau .311, P ϭ0.02) between colonization density and the degree of inflammation. No upregulation of mucosal IL-1a, IL-1b or TNF-a was detected by RT-PCR in any cat. Lymphoid follicles and atrophy were observed almost exclusively in the pylorus of infected cats. Gradual seroconversion (IgG) was observed in 4/5 infected cats, with ELISA values peaking at 4-15x baseline. There was no correlation between seroconversion and the number of organisms observed, the degree of gastric inflammation, or the number of lymphoid follicles. The gastric secretory axis, assessed by fasting plasma gastrin and pentagastrin stimulated gastric acid secretion was similar in both infected and uninfected cats.

These findings suggest that H. felis infection induces mild gastric inflammation and marked lymphoid follicle hyperplasia, but does not perturb gastric secretory function in cats. The purpose of this study was to determine the effectiveness of canine lyophilized IgG in the treatment of dogs naturally infected with canine parvovirus. Forty-three dogs that presented consecutively to Auburn University for treatment of severe parvoviral enteritis were admitted to the study and randomly assigned to either the Conventional Treatment group (Group 1-Nϭ22) or the IgG group (Group 2-Nϭ21). All dogs received identical treatment (lactated Ringers solution 6.6 ml/kg/day, enrofloxacin 5 mg/kg IV q 12 h, ampicillin 22 mg/kg IV q 8 h, metoclopramide 1 mg/kg/24 h CRI, and potassium chloride 4 mEq/L) until signs of gastroenteritis subsided. Dogs in Group 2 were also given lyophilized canine IgG (mean dosage 163 mg/kg) on the first day of hospitalization. Partial parenteral nutrition (PPN) was given to dogs on fluids Ͼ5 days and hetastarch or plasma (22 ml/kg) was administered if serum albumin dropped below 1.0 g/dl or peripheral edema developed. There was no difference between Groups 1 and 2 for neutrophil count (1684/L vs 2331/L), lymphocyte count (1354/L vs 1548/L), age (13.5 wks vs 16 wks), and body weight (9.2 kg vs 10.6 kg). Hospitalization time (4 days vs 7 days) and # hours on IV fluids (77 h vs 137 h) were significantly decreased (p Ͻ.01) in Group 2 vs Group 1. Dogs in Group 2 began eating after 68 h (2.8 d) and exhibited a firm stool by 74 h (3.1 d), whereas dogs in Group 1 did not begin eating until 134 h (5.6 d) and developed a firm stool after 148 h (6.2 d). There was no difference in survival rate (Group 1: 18/22, 82%; Group 2: 19/21, 90%). In Group 1, 7 dogs received PPN, 6 dogs received hetastarch, and 2 dogs received plasma; additional therapy was not administered to any of the dogs in Group 2. In conclusion, dogs receiving lyophilized IgG as adjunctive therapy for CPV enteritis had decreased hospitalization time, reduced severity of disease, and reduced cost of treatment compared to dogs treated with conventional therapy alone.

A previous study showed that 8% of cats within the United States had Cryptosporidium parvum IgG in serum suggesting that exposure to this pathogen was common. The purpose of this study was to determine the duration of oocyst shedding and the temporal serum C. parvum specific IgA, IgM, and IgG responses in experimentally inoculated cats.

Eight adult cats were shown to be seronegative for C. parvum specific IgG and oocysts on 2 separate dates prior to being inoculated orally with 1 x 10 6 C. parvum oocysts. Thin fecal smears were made of each cat's feces daily until 30 days post-infection (PI) and then twice weekly until day 85. Starting day 85, methylprednisolone acetate was administered at 20 mg/kg, IM, weekly for 3 weeks. Fecal smears were then made daily from days 85-115 and then twice weekly until the termination of the experiment on day 140. An immunoflourescent antibody assay (Merifluor Cincinnati, Ohio) was applied to each thin fecal smear to aid in detection of C. parvum oocysts. Sera were collected weekly and were assayed in ELISA for detection of C. parvum-specific IgA, IgM, and IgG.

All cats shed oocysts with a prepatent period of 5 to 9 days. All cats were subclinically infected, but oocysts were shed intermittently for 2 to 23 days. When methylprednisolone acetate was administered, oocysts had not been detected in the feces of any cat for between 55 to 77 days. Diarrhea developed and oocysts were found in the feces of all cats following the third methylprednisolone acetate injection. All 8 cats developed detectable serum IgM, IgG, and IgA levels PI. On day 140, 7 of 8 cats were seropositive for IgM and all 8 cats were seropositive for IgG and IgA. In general, magnitude of serum IgA responses was greater than IgM or IgG.

This study suggests cats can be chronically infected with C. parvum and have detectable levels of serum antibodies for months after infection. Toxoplasma gondii infection of cats is common but usually subclinical; ocular inflammation is one manifestation of disease. The purpose of this study was to determine whether clinical ocular toxoplasmosis occurs in kittens infected transplacentally or in the neonatal period.

Young adult, pregnant queens (n ϭ 3) were purchased and shown to be seronegative for T. gondii IgM and IgG, FIV antibodies, coronavirus antibodies, and FeLV p27 antigen. Queen 1 was inoculated orally with 300 T. gondii tissue cysts and queened 3 healthy kittens 17 days later. Queens 2 and 3 were inoculated orally with 1000 T. gondii tissue cysts and queened 5 kittens each, 1 and 8 days later, respectively. Only 1 kitten from Queen 3 survived.

All 3 queens seroconverted but ocular lesions were not detected. Ocular lesions developed in 6 of 9 surviving kittens. Bilateral, multifocal, progressive lesions of the tapetal choroid and retina developed in 1 kitten from Queen 1, 66 days after birth. In 2 kittens from Queen 2, anterior uveitis, characterized by mild flare, cells, and small keratic precipitates, was detected at 50 days after birth in 1 kitten and 72 days in the other. The anterior uveitis had resolved by day 56 and 77, respectively. Bilateral, multifocal, lesions of the tapetal choroid and retina were also detected on day 50 and 62, respectively in these kittens. Chorioretinal lesions but not anterior uveitis were detected day 66 in 2 additional kittens from Queen 2 and day 80 in the kitten from Queen 3. At the time of abstract submission, active chorioretinal lesions in the kitten from Queen 1 were present 97 days after initial detection. Chorioretinal lesions in 4 kittens from Queen 2 resolved, leaving mild tapetal color change or areas of hyperreflectivity 14 (1), 50 (2), and 56 (1) days after initial detection; lesions in the Queen 3 kitten are static but have not resolved after 40 days. Trichomonads are rarely seen in the feces of cats with diarrhea. When identified, trichomonads are regarded as dubious pathogens; relegated to simple overgrowth of indiginous fauna. We observed large numbers of trichomonads, resistant to antimicrobial therapy, in feces from cats with uncomplicated large bowel diarrhea.

Diarrhea with concurrent trichomonas infection was diagnosed in 32 cats during a 20 month period. Signalment, origin, clinicopathologic findings, and prior treatments were recorded. Trichomonads were seen in fresh feces examined in saline at 40X magnification or after culture of feces in Modified Diamonds Me-dia@37ЊC. Fecal samples from 20 healthy indoor cats and 100 feral cats were examined to determine the prevalence of trichomonas in geographically comparable populations.

Cats with trichomonas ranged in age from 3mos-13yrs with 75% Ͻ1 yr of age at the time of diagnosis. The origin of 30 cats was traced to a multiple-cat environment (cattery or adoption agency). Two cats developed diarrhea after addition of an infected kitten into the home. Cats were native to North Carolina(26), Virginia(3), Connecticut(2), or Tennessee(1). Duration of diarrhea ranged from 2days to 3yrs, was large-bowel consistency, malodorous, and often dribbled from an inflamed anus. Further evaluation of diarrhea included a CBC(4), chemistry profile(3), UA(3), FeLV/FIV test(26), fecal flotation (19), Giardia antigen test (14), Auramine-O stained smear for Cryptosporidium (14), Gram-stained smear for Clostridia(12), colonic mucosal biopsy(2), FIP or Toxo titer(2), and abdominal ultrasound exam(1). Coexisting enteric infection was documented (Isospora(3), Toxascaris, Giardia, or Giardia and Cryptosporidium) in only 6 cats. Colonic mucosal biopsy revealed marked lymphoplasmacytic colitis, typhlitis, and enteritis(1), and mild lymphoplasmacytic colitis(1). Treatments included paromomycin(25), fenbendazole (19), metronidazole (17), furazolidone(15), pyrantel pamoate(15), sulfadimethoxine(15), albendazole(6), trimethoprim sulfadiazine(4), tylosin(3), enrofloxacin(3), amoxicillin(2), clindamycin(2), and erythromycin(2). Resolution of diarrhea correlated with disappearance of trichomonads during treatment of many cats, however organisms and diarrhea after discontinuation of treatment was prevalent. Trichomonads were not recovered from the feces of any feral or indoor cats.

Trichomonas may be a causal agent of diarrhea in cats. Using the described techniques, trichomonads were not part of the indiginous fauna of healthy domestic or feral cats. Feline heartworm (HW) infection is a growing concern for veterinarians in HW endemic areas. The purpose of this study was to determine the prevalence of HW in cats in a HW endemic region and to compare the performance of currently available serologic tests against a necropsy gold standard. 330 adult cats (46% male, 54% female) euthanized at a local animal control facility were examined within 2 hours of death. Blood was collected from the vena cava for serologic testing, and the heart and lungs were dissected for the presence of HW. Serum was assayed for FeLV antigen (ag), FIV antibody (ab), and for HW ag and ab.

Adult HW (n ϭ 1-4) were identified in 19 (6%) cats. HW infection was not correlated with FeLV or FIV, but male cats were slightly over represented. Ag tests detected 68-79% of HW and were highly specific. Four of six cats with false-negative ag results on 1 or more tests had only a single male worm. Ab tests detected 32-89% of HW. False positives were more common (10-23%) with ab than ag tests. Negative ab tests occurred in some ag-positive cats with HW identified at necropsy.

Feline HW in this region is as common as FeLV (6%) The gastrointestinal tract is the most common anatomic location of lymphoma in cats, with most descriptions of gastrointestinal lymphoma being poorly differentiated (lymphoblastic or immunoblastic). The purpose of this study is to describe the clinical features of cats with well differentiated lymphocytic gastrointestinal lymphoma, and to determine response to therapy and prognostic factors. Sixty-five cats with gastrointestinal lymphoma were evaluated at the Veterinary Specialty Hospital of San Diego (VSHSD) between 1988 and 1996. Of these, 39 cats were determined to have well differentiated lymphocytic lymphoma. Cats with a histologic diagnosis with biopsy obtained endoscopically (97%) or surgically (3%) were considered for study. All biopsies were reviewed by a single pathologist (JLC). The most common clinical signs were vomiting (87%), weight loss (79%), anorexia (53%), diarrhea (53%), and lethargy (47%). Nine percent had neither vomiting nor diarrhea. An abdominal mass was palpated in 26% of cats while 32% had thickened gastrointestinal loops. Twenty-six cats were treated, 23 of whom were given prednisone and chlorambucil. Fourteen (61%) achieved complete remission (CR). The disease-free interval (DFI) of those who achieved CR ranged from 5.75 to 24 months (median 15.5 months, 6 cats still in CR). The overall survival ranged from 0.33 to 25 months (median 12 months), and the median survival of those who achieved CR was 17.5 months. There was no significant difference in DFI or survival due to age, sex, breed, palpable abdominal mass, retroviral status, hypoalbuminemia, or localization of tumor. In conclusion, cats with well differentiated lymphocytic gastrointestinal lymphoma treated with a relatively simple protocol have a higher CR rate and overall survival times than in cats previously reported with poorly differentiated gastrointestinal lymphoma treated with more complex protocols. Endoscopic biopsy was highly useful for obtaining a diagnosis, and may result in early detection of gastrointestinal lymphoma in cats. Due to the limited accessibility of the nervous system, the treatment of brain tumors via gene therapy offers unique possibilities. Previous studies using stereotactic injections of viral vectors only induced focal transduction. Since viral particle size permits blood brain barrier passage, we hypothesized that delivery of an adenoviral vector by selective arterial catherization would permit significant tumor transduction in vivo with minimal side effects to the patient.

Six dogs with the diagnosis of intracranial neoplasm were entered in this study in accordance with the Biosafety and Research Animal Resources Center guidelines. Fluoroscopy guided carotid catheterization through the right femoral artery was performed under anesthesia, and 20 ul of 5x 10 10 adenovirus (human adenovirus type 5 with an E1 deletion) carrying the ␤-galactosidase gene (LacZ marker) was injected selectively at the tumor level. After five days of isolation, surgery was performed and tumor, brain and skin samples were obtained to assess the extent of transduction using X-gal staining. Complete blood count and serum chemistries were collected prior to injection and surgery, and two weeks post surgery. Euthanasia was performed in two patients due to post-operative complications. Tissue transduction was assessed postmortem in both cases.

The tumors were histopathologically indentified as meningioma (5) and choroid plexus carcinoma (1) and were located in the forebrain (3), midbrain (1) and caudal fossa (2). Selective transduction of the neoplasms was identified in four of six dogs. In one dog, both the neoplasm and brain tissue were transduced, and no transduction was noted in the neoplasm of another dog. One dog underwent a second craniotomy four months after diagnosis to remove the remaining neoplasm. Expression of the X-gal staining was still present in the neoplasm only.

We have demonstrated that fluoroscopy guided selective intra-arterial injection of adenoviral vectors for gene therapy of spontaneous occurring canine intracranial neoplasms is possible, effective, safe, and more diffuse and extensive than that previously documented with stereotactic viral vector delivery. We are now in an excellent position to assess the effect of specific genes in vivo on canine neoplasms, and begin therapeutic clinical trials for dogs with brain cancer. Cutaneous lymphoma comprises 3 to 8% of all lymphoma reported in dogs and is generally classified as epitheliotropic (usually T-cell) or nonepitheliotropic (usually B-cell). Historically, the treatment of cutaneous lymphoma has been unrewarding. Few reports of long term remissions or survival times exist. The optimal chemotherapeutic protocol is unknown.

Recently, the alkylating agent, lomustine (CCNU), was reported to be a useful rescue agent in dogs with refractory multicentric lymphoma. The lipophilic nature of the drug and ease of administration make it an attractive agent for the treatment of cutaneous lymphoma. The purpose of this pilot study was to determine if lomustine is useful in the treatment of cutaneous lymphoma in dogs.

Seven dogs with cutaneous lymphoma (5 epitheliotropic and 2 nonepitheliotropic) were evaluated. All dogs were diagnosed by histologic evaluation of biopsies. Two dogs had all lesions surgically excised prior to treatment. Five dogs had nonresectable disease. All dogs received lomustine at a dose of 50 mg/ m 2 PO q 21 days until relapse. Complete remissions were achieved in all dogs and ranged from 2 to 15 months. The 2 dogs whose lesions were surgically excised prior to chemotherapy had the longest remissions (7 and 15 months). The two dogs with nonepitheliotropic lymphoma had the shortest remissions (2 and 3 months). Two dogs died of unrelated disease while still in complete remission.

Lomustine appears to have activity against cutaneous lymphoma, especially the epitheliotropic form. Alterations in cisplatin accumulation in cells resulting in resistance is multifactorial. A decrease in drug influx, an increase drug efflux, or modifications in ion transport mechanisms have been observed in cisplatin resistant cell lines by others. The objective of research was to investigate the HCO 3 Ϫ /Cl Ϫ exchange inhibitor SITS (4-acetamido-4Ј; isothiocyanostilbene-2,2Ј-disulfonic acid). Our hypothesis to be tested was that a high intracellular chloride ion concentration (via SITS exposure) lowers the concentration of the cytotoxic aquated cisplatin species resulting in cisplatin resistance. Using a canine osteosarcoma cell line established in our laboratory, we exposed cells to cisplatin with or without concomitant exposure to SITS. Cell survival was determined using the Cell Titer 96 AQ ueous One Solution Cell Proliferation Assay. In COS31 cisplatin sensitive cells cultured in the presence of SITS in chloride-containing medium, sensitivity to cisplatin significantly decreased after only one exposure to cisplatin. At fixed concentrations of cisplatin, sensitivity to cisplatin significantly decreased as the concentration of SITS exposure increased. Cisplatin undergoes activation to its toxic form when the chloride ligands are replaced by water, thereby forming a charged electrophile, which reacts with DNA and other nucleophilic sites. It has been proposed that a high extracellular chloride concentration favors the native form of cisplatin and a low chloride concentration within the cell shifts the equilibrium to the aquated cytotoxic form of cisplatin. The data presented indicates that inhibiting HCO 3 -/Clexchange with SITS leads to a dose-dependent form of cisplatin resistance. Our laboratory findings would suggest that the level of one ion or inhibiting an ion transport system could lead to a cascade of effects within the cell, which may ultimately lead to drug resistance.

TREATMENT FOR RELAPSING CANINE LYMPHOMA. Hahn KA, Nolan ML. University of Tennessee-Knoxville. L-asparaginase is an enzyme that inhibits protein synthesis by the depletion of sources of L-asparagine, which is necessary for transformed lymphoid cells to proliferate. Canine lymphoma is a predominantly B-cell tumor with widespread disease; without treatment, dogs with lymphoma usually survive 1-2 months. Previously untreated dogs with lymphoma will respond to L-asparaginase therapy. A prospective study evaluated the use of L-asparaginase as single agent therapy in dogs with lymphoma that relapsed following single agent Adriamycin chemotherapy (30 mg/m 2 , five 3 week cycles). Dogs were given 10,000 IU/m 2 (5,000 IU/ml) as an intramuscular injection 15 minutes following premedication (Benadryl, 1 mg/kg) once every 4 weeks. Dogs achieving either a partial response (PR) or complete response (CR) following treatment initiation were continued on L-asparaginase every 4 weeks thereafter until relapse. Eighteen dogs were treated. Eleven dogs (61.1%) achieved a complete remission (CR) with a median time to relapse of 24 weeks, four dogs (22.2%) achieved a partial remission (PR) with a median time to progressive disease (PD) of 6 weeks, and three dogs (16.7%) did not respond (NR) to therapy. The asparaginase was well tolerated and no toxicoses were observed (allergic reactions, urticarial reactions). Others have reported that more than 90% of dogs with previously untreated lymphoma achieve a CR or PR with L-asparaginase therapy with a median time to relapse of 30 weeks. In our study, 83.3% achieved a CR or PR using Lasparaginase therapy with an overall median time to relapse of 21 weeks. We concluded that single agent L-asparaginase should be considered in the treatment of dogs with relapsing lymphoma. The major cause of treatment failure in cancer patients is tumour invasion and metastasis. The inability of local therapy to eradicate metastatic cancer presents a challenge in the therapy of residual or metastatic disease. Laser immunotherapy is a novel cancer treatment utilizing local selective chromophore-enhanced photothermal laser treatment to reduce tumour burden and expose tumour antigens while the immunoadjuvant concomitantly stimulates a systemic anti-tumour immune response against the remaining cells of the tumour. Laser immunotherapy employs: (1) an infrared laser (805 nm); (2) a photosensitizer (indocyanine green [ICG]); and (3) an immunoadjuvant (glycated chitosan gel [GCG] ). The purpose of this study was to investigate immunotherapy for the treatment of metastatic cancer (e.g. feline vaccinosarcoma) utilizing the Dunning R3327-MatLu rat prostatic cancer model. Twenty-five (3 groups) Copenhagen rats were injected subcutaneously in the left flank with 10 6 MatLu cells. Laser immunotherapy was performed on day 13 (Group I ϭ early) or on day 33 (Group II ϭlate) with intratumour injection (200 L) of the photosensitizer (0.25% ICG) and immunoadjuvant (1% GCG) solution followed by noninvasive laser irradiation (10 minutes at 2W). Group III was an untreated control. Rats were sacrificed and necropsied on day 42.

Rats treated with laser immunotherapy early (Group I) had significantly fewer mean (ϮSE) metastases (2.13 Ϯ 1.85) than the controls (7.0 Ϯ 3.15) (pϽ0.05). Similarly, Group I had significantly less mean primary tumour volume (124.9 Ϯ 33.7 mm 3 ) than the controls (274.5 Ϯ 38.8 mm 3 ) (pϽ0.05). Rats treated later (Group II) did not have significantly fewer metastases (3.29 Ϯ 1.52) or less primary tumour volume (245.8 Ϯ 30.0 mm 3 ) than controls (pϾ0.28).

This study demonstrated the efficacy of laser immunotherapy as an adjunctive therapy for the control of metastatic cancer if given early. In future, further studies are needed to elucidate the mechanism of action of laser immunotherapy. The precise mechanisms of sarcoma formation at sites of previous injections in cats are not known. Carcinogenesis is a multistage process that is associated with gain-of-function or loss-of function of oncogenes and tumor suppressor genes (TSGs). Expression of the TSG p53 and the oncogenes mdm-2 and c-kit are altered commonly in soft-tissue sarcomas in human beings.

In order to define possible mechanisms of tumorigenesis at injection sites, we evaluated the expression of c-kit, p53, and mdm-2 by immunohistochemical methods in 102 archived injection-site sarcomas. We also compared the expression of these genes between tumors with different histologic characteristics.

Most of the tumors, independent of histologic type, had positive staining for either c-KIT (74%) or P53 (72%). Fifty-one percent of the tumors had positive staining for both. Nearly half (47%) of the tumors had positive staining for MDM-2. Tumors with positive staining for both mdm-2 and p53 (36%) had more anaplastic features than the other tumors. The high prevalence of positive staining for P53 and c-KIT suggest that expression of these genes may be involved in development of sarcomas at injection sites. (17), anorexia (14), weight loss (10), dyspnea (8), vomiting (6) and coughing (3). Eight cats were receiving oral prednisone at the time of admission. Physical exam findings included depression (21), dyspnea (16), dehydration (13), hypothermia (8), and icterus (5). Common clinicopathologic abnormalities included anemia (58%), neutrophilia (56%), thrombocytopenia (47%), hyponatremia (78%), hypocalcemia (73%), hypoalbuminemia (54%), elevated BUN (54%), elevated bilirubin (52%), hypokalemia (48%), hyperglycemia (48%), elevated ALT (32%) and ALP (20%), acidosis (17%), and elevated creatinine (17%). In 6 cats, PT and PTT were measured and were elevated in 2 and 6 cats, respectively. Antithrombin III was low in the 1 cat in which it was measured. Thoracic radiographs were available for review in 14 cats and common findings included pleural effusion (8), uneven vascular diameter between lung lobes (7), noncircumscribed pulmonary consolidations (6), enlargement and blunting of caudal pulmonary arteries (5), oligemia in the periphery of 1 or more lung lobes (4), atelectasis (3), and single well-demarcated thoracic masses (3). One cat had a normal thoracic radiograph. PTE was suspected antemortem in only 4 cats. Histologic lesions were classified according to the location of the thrombus (venous, 8; capillary, 9; arterial, 20) ; distribution (focal, 6; multifocal, 14; diffuse, 9); and chronicity (peracute, 1; acute, 13; subacute, 7; chronic, 8). Underlying conditions identified at necropsy included cardiac disease (18), neoplasia (10), DIC (5), protein-losing enteropathy (4), protein-losing nephropathy (4) , IMHA (2), sepsis (2), and trauma (1). Two cats had long term (Ͼ30 days) dialysis catheters placed and in both, blood clots were visualized antemortem at the tip of the catheter or in the right atrium. Diseases that may have predisposed cats to developing PTE were identified in 14 cats (47%). PTE was the direct cause of death in 4 cats, a contributor to death in 17 cats, and an incidental finding in 8 cats. The cysteinyl leukotrienes (LTC4, LTD4, and LTE4) are inflammatory mediators derived from the lipoxygenation of arachidonic acid. LTC4 and LTD4 within the lung can increase mucous secretion, increase vascular permeability, impair mucociliary clearance, and cause bronchoconstriction. Leukotrienes have been suggested to be important mediators in many forms of bronchial asthma in people. Agents that inhibit lipoxygenase or block the leukotriene receptors have been recently added to the therapeutic options available for human asthmatics. LTE4 is the stable end product of both LTC4 and LTD4 metabolism. LTE4 is excreted in the urine and urine levels may be used as an indicator of lipoxygenase activity in the patient. The potential ex vivo generation of mediators in urine samples from urinary tract disease patients remains a poorly defined area. Studies in people have revealed substantially elevated urinary LTE4 levels in many types of asthmatic patients. A report of urinary LTE4 levels in a feline model has noted a 2-3 fold increase in urinary LTE4 following the induction of allergic bronchitis.

The purpose of this pilot study was to obtain preliminary data investigating whether urinary LTE4 levels are elevated in feline patients with naturally-occurring bronchitis of presumed allergic etiology (''feline asthma'') when compared to a control population of normal cats and a separate population of cats with lower urinary tract disease (LUTD). Urine samples were collected via cystocentesis from cats with the clinical diagnosis of bronchitis (nϭ16), LUTD in the form of urinary tract infection or cystic calculi (nϭ6), and normal cats (nϭ4). Urinary LTE4 levels (pg/ml) were determined by use of a commercially available ELISA assay (Oxford Biomedical Research, Inc., Oxford, MI). Urinary LTE4 levels are referenced to urine creatinine concentration (mg/ml) measured using a modified kinetic Jaffe method. Mean urinary LTE4/creatinine (pg/mg) ratios (meanϮSD) for the bronchitic, normal, and LUTD-afflicted populations were 31.5 Ϯ 53.9, 33.8 Ϯ 13.5, and 57.7 Ϯ 98.9 respectively. No statistically significant difference (pϽ0.05) between the means was present. Our results suggest that the pathophysiology of feline allergic bronchitis may differ from human asthma and experimentally-induced feline eosinophilic lower airway disease in the degree of lipoxygenase activity contributing to clinical signs. Further study appears warranted before anti-leukotriene therapies could be recommended for treatment of this condition in cats.

WITH ASTHMA. EA Rozanski, and AM Hoffman, Tufts University School of Veterinary Medicine, North Grafton MA.

Lower airway diseases, such as asthma, are a common problem in cats. Clinical signs of asthma include coughing, wheezing and respiratory distress. These signs are believed to represent bronchoconstriction. If so, clinical signs should resolve following treatment with a beta-2 agonist. Barometeric whole-body plethysmography (BWBP) detects experimental bronchoconstriction in cats. The purposes of this study were to evaluate BWBP and to determine the effect of therapy with aerosol albuterol, in cats with naturally occurring asthma.

Eight cats with asthma were evaluated using BWBP. Pulmonary mechanics analyzer software (XA Biosystem, Buxco Electronics) was used to analyze the box pressure signals which were dynamically calibrated to the derivative of a known volume (pseudoflow signal). The following variables were computed: Peak inspiratory pseudo-flow (PIF), peak expiratory pseudo-flow (PEF), tidal volume (TV), end-inspiratory pause (EIP), end-expiratory pause (EEP), frequency (f), expiratory time (Te), inspiratory time (Ti), relaxation time (RT, time for box pressure to decay to 30% of total box pressure during expiration), Pause ([Te/Rt] Ϫ1), and enhanced pause (PENH-(Te/[0.3 xRT]-1 x PEF/[PIF x0.67]). Baseline measurements were made from all cats. Aerosol albuterol was then administered to 5 cats from a pressurized-metered dose inhaler, specially designed for cats, and the cats re-tested. Results from asthmatic cats were compared with a group of normal healthy cats and the effects of albuterol were assessed (with ␣ set at 0.05).

No differences between groups were detected in f, TV, PEF, PIF, EIP, Te or Ti. However, the values for EEP, Pause, PENH were significantly higher and the RT lower in the asthmatic cats. Therapy with albuterol resulted in significant improvement in Pause and PENH values. In conclusion, BWBP derived variables effectively characterized lower airway obstruction and its immediate reversal by treatment with a beta-2 agonist. Using BWBP, a rapid diagnosis of lower airway obstruction and its subsequent reversal may be made in cats with asthma. To our knowledge, mucociliary clearance rate (MCCR) has not been evaluated in the cat. The goal of this study was to develop a protocol for measuring MCCR cats, to determine MCCR in normal anesthetized cats and to determine the effect of theophylline on MCCR in cats.

Six normal adult cats were anesthetized with propofol and a droplet of the radionuclide 99m Technetium-macro aggregated albumin was placed endoscopically at the carina. Dynamic acquisition scintigraphic scanning was performed with the larynx as the end point. MCCR was calculated by dividing the distance the droplet travelled by the frame rate. Each cat was scanned six times; three times following placebo and three times following the administration of 25 mg/ kg per os of sustained release theophylline (Slo-bid). Serum theophylline levels were measured during scanning to assure therapeutic levels.

MCCR in normal adult cats anesthetized with propofol was 2.22 Ϯ 0.28 cm/ min. MCCR in cats receiving theophylline was 2.18 Ϯ 0.35 cm/min. Theophylline administration did not significantly affect the MCCR.

Theophylline has been demonstrated to increase MCCR in humans, horses, dogs and rats. This study determined MCCR in normal anesthetized cats and found that it was not influenced by the administration of theophylline. Bronchoalveolar lavage (BAL) in dogs is generally performed through a bronchoscope, limiting accessibility to clinicians with specialized equipment. To increase availability of this procedure, a non-bronchoscopic technique was developed. A 122 cm, 16 FR Levin type polyvinyl stomach tube (Sherwood Medical Co., St. Louis, MO) was modified using sterile technique. The distal fenestrations were cut off and the end tapered. The proximal end was shortened by 40-55 cm. Nine dogs (9-26kg) were anesthetized by injection, placed in dorsal recumbency, and intubated. The BAL tube was passed through the tracheal tube into the airways until resistance was felt, then slightly retracted, rotated, and readvanced to insure a snug fit. Radiographs showed the tube to be in the right (7/ 9) or left (2/9) caudal lobe. A 25 ml bolus of saline was infused by syringe, followed by 5 ml of air. Suction was applied immediately using the same syringe. This procedure was repeated 4 times for a total volume of 125 ml. Fluid retrieved from boluses 2&3 and 4&5 were combined for analysis. Oxygen was provided for 10 min following BAL. Oxygen saturation was measured by pulse oximetry 1,3,5,10,15, and 20 min post-BAL. Thoracic radiographs were taken 48 hr post-BAL.

Recovered fluid was consistent with BAL fluid obtained bronchoscopically. The mean recovery volume for all boluses combined was 84 ml(67%). Foam was visible in 42/45 specimens. Mean white cell counts were Ͼ300/l. Mean macrophage counts from boluses 1, 2&3, and 4&5 were 71%, 85%, and 88%, respectively.

Oxygen saturation was Ն95% in 50/54 measurements. No clinical or radiographic signs of complications occurred.

This technique is an effective, simple, inexpensive, and safe method for nonbronchoscopic BAL in dogs.

Schermerhorn, J. Pembleton-Corbett, B. Kornreich. NYSCVM, Cornell University, Ithaca, NY.

All cats with pulmonary thromboembolism (PTE) confirmed by necropsy over a 23 year period from 1975 to 1998 were included in this retrospective study. Affected cats were identified by a computer search of the NYSCVM database, using the hospital's diagnostic codes for the following conditions: pulmonary thromboembolism, lung infarction due to thrombosis, thrombosis of the pulmonary artery, and lung thrombosis. Twenty-eight cases were identified using these search parameters; of these, 17 cases were suitable for inclusion in the study. No sex predilection for was detected in affected cats (47% male vs. 53% female). The median age at the time of death was 11 years (range 10 months to 18 years; nϭ15). However, the age distribution was bimodal (peaks centered at 0-2 and 10-12 years of age). The median body weight was 3.8 kg. (range 2.3 to 5.2 kg.; nϭ15). PTE occurred in association with another disorder in most cats (95%). In ϳ75% of cases, PTE was associated with a common feline disorder: neoplasm (nϭ6), pancreatitis (nϭ2), anemia (nϭ2), cardiac disease (nϭ1), FIP (nϭ1), and hepatic lipidosis (nϭ1). Other disorders associated with PTE included: glomerular nephritis, pneumonia, and encephalitis. Respiratory distress that immediately preceded death was recorded in the medical record of 63% of cats with PTE. In cats with primary cardiac or pulmonary disease and in anemic cats, respiratory distress was usually attributed to progression of the known pathology; in the remaining cats that had dyspnea, the onset of respiratory distress was generally attributed to the complications of severe multisystemic illness. However, PTE was not suspected as the cause of dyspnea in any of the cats included in this study. In those cats with confirmed PTE but without significant cardiac or pulmonary disease, the clinical signs of PTE were similar to those reported for other species: an acute onset of tachypnea and dyspnea which fails to improve with oxygen therapy. Thoracic radiographs were normal or had non-specific changes such as prominent interstitial and alveolar markings, pulmonary edema, and vascular changes. We conclude that PTE occurs in the cat but is rare. In this study, PTE was found in association with a variety of common feline disorders and complicated the clinical management and, in some instances, directly caused the death of affected cats. It appears from the findings outlined here that the same criteria used to raise the clinical suspicion for PTE in the dog can also be applied to the cat.

HYDROGEN TESTING. L. Hansson 1 , J.M. Steiner 2 , D. A. Williams 2, 1 Regional Animal Hospital, Helsingborg, Sweden, 2 Texas A&M University.

Estimation of alveolar hydrogen concentration is important in breath hydrogen testing. Alveolar hydrogen concentration can be estimated by measuring the hydrogen concentration in the expiratory air and estimating the dilution of the alveolar air with room air. This is accomplished by measuring the CO 2 in the expiratory air and comparing it to the presumed alveolar CO 2 concentration of 5%. CO 2 concentrations in canine expired air were 2.29Ϯ0.02 (%, meanϮSD) in one report (Ludlow et al, JVIM, 9: 191, 1995) , but in an initial study of 155 samples from 7 dogs we observed CO 2 concentrations of 0.89Ϯ0.34. This degree of room air contamination limits the ability to correctly calculate alveolar hydrogen concentration. The objective of this study was to evaluate changes in the collection method that might reduce the contamination of breath samples with room air.

Breath samples from 10 healthy mix-breed experimental dogs were collected using both a snug-fitting and a loose-fitting standard anesthetic induction mask attached to a reservoir bag via a two-way non-rebreathing valve, and a modified, ''reduced dead space'' (RDS) snug-fitting system with a shorter valve adapter and foam lining the inner walls of the anesthetic mask. Samples from the reservoir bag were transferred by syringes and analyzed directly or transferred to vacuum transport tubes via a plastic syringe (S), via a three-way tube fill adapter with high (H) or medium (M) pressure manual expression, or via a three-way tube fill adapter with one opening plugged (P). H 2 and CO 2 were analyzed within three hours of sampling by electrochemical and thermal conductivity, respectively. Additional samples were saved in transport tubes at room temperature for analysis at 4 and 19 days post sampling.

Breath CO 2 concentration was significantly greater (pϭ0.032; nϭ7) with the snug fitting mask (2.01Ϯ0.76) compared to the loose fitting mask (1.19Ϯ0.76). Breath CO 2 concentration was also significantly greater (pϭ0.0034; nϭ10) with the RDS system (2.68Ϯ0.92) compared to the regular snug-fitting collection system. There was a significant difference (pϭ0.0007; nϭ9) of % CO 2 loss between the four different transfer methods (mean % CO 2 lossϮSD: 17.9Ϯ0.099 (S), 19.4Ϯ0.15 (H), 34.8Ϯ0.29 (M) and 5.3Ϯ0.063 (P)). There was no significant change (pϭ0.177 and pϭ0.074, respectively) of % CO 2 and H 2 concentrations after storage of breath samples in transport tubes for 4 or 19 days.

We conclude that reducing dead space in the collection system reduces the dilution of alveolar gases. Transfer to a transport tube via a three-way tube fill adapter with one opening plugged resulted in minimal loss of CO 2 , and both CO 2 and H 2 were stable in transport tubes for at least 19 days. This study evaluated the effect of coadministration of d-␣-tocopheryl polyethylene glycol-1000 succinate (TPGS), a water-soluble vitamin E, on the absorption kinetics of orally administered cyclosporin A (CsA, Sandimmune) in healthy dogs.

Four healthy, adult dogs were used in a randomized crossover study design. Each dog was given a single oral dose of CsA at 10 mg/kg: two dogs were given CsA alone and two dogs were given CsA thoroughly mixed with 10 IU/ kg TPGS. Blood samples were drawn via jugular catheter at 0, ½, 1, 2, 4, 6, 8, 10, 12, 14, and 24 hours post-administration. After a seven-day washout period, the procedure was repeated with each group receiving the alternate treatment. Whole blood CsA levels were determined by high-pressure liquid chromatography by an independent laboratory.

Data were compiled into CsA alone and CsA/TPGS groups, and CsA concentration versus time graphs were created for each group. The areas under the concentration versus time curves (AUC), absorption rates (Kabs), half-lives (t½), maximum concentrations (Cmax) and times to maximum concentration (Tmax) were calculated. Group means were analyzed with paired t-tests. For the CsA/ TPGS group, AUC and Cmax means were significantly greater than CsA group means. No significant difference was found between group means for Kabs, t½, or Tmax. Significance was set at p Յ 0.05. Values are shown below as group mean Ϯ standard deviation.

TPGS easily forms micelles at low concentrations and these micelles can enhance absorption of lipophilic substances such as CsA. In addition, TPGS has been shown to inhibit p-glycoprotein-mediated countertransport of substances from the blood into the intestinal lumen. The increased CsA bioavailability shown with TPGS coadministration is likely due to both these mechanisms. TPGS does not interfere with cytochrome P450, as previously used ''CsA sparing'' agents do, and has no reported adverse systemic effects. Coadministration of TPGS should safely enable significant CsA dose reduction. Resultant cost savings may make CsA therapy feasible for greater numbers of veterinary clients. The influence of food composition on cat urinary pH has been extensively studied whereas the relationship between urinary pH and meal frequency is poorly documented. The purpose of this study was to compare the effect of meal pattern and nature of food (dry vs. canned) on cat urinary pH.

Eight spayed adult cats were successively adapted to 2 meal patterns (all day long (24h) or 1 hour meal (1h)), using 3 commercial maintenance dry cat foods (D) and two canned foods (C) for 2 weeks. The amounts of food offered were 90 g/day for the dry foods and 350 g/day for the canned food. After adaptation, urine samples were obtained by cystocenthesis just before (T0) and 3, 6 and 9 hours following renewal of the food. Cystocenthesis were performed twice on different days on each animal and for all time points. Urine pH was determined with an electrode on fresh urine sample. Significant (pϽ0.05) differences between feeding patterns, nature of foods and time points were assessed by repeated measure ANOVA.

Results are summarized in the figure Figure: Urinary pH over time as a function of feeding pattern and food (dry (D: mean of 3 foods) versus canned (C: mean of 2 foods))(meanϮsem ; values at each time point with different superscript differ at pϭ0.05).

The present study shows that the nature of food (dry vs canned) as well as the feeding pattern influence post prandial urinary pH. Only all day long feeding of dry food minimizes the rise in urinary pH following renewal of the food.

WEIGHT AND BODY COMPOSITION FOLLOWING GONAD-ECTOMY IN CATS. 1 P. Nguyen, 1 H. Dumon, 1 L. Martin, 2 V. Biourge, 2 R. Sergheraert. 1 Nantes National Veterinary School (Nantes, France) and 2 Royal Canin Research Center (Vannes, France). The gonadectomy may predispose to obesity by removal of hormones that stimulate behavior resulting in more physical activity or act as satiety factors. A high energy density level in the food has also been described as a factor predisposing to obesity in humans and laboratory animals. This study was conducted to compare the effects of dietary fat and energy density of the diet on body weight (BW) and body composition changes following gonadectomy in cats compared to intact controls.

Twelve males and 12 females, 8-mo. old, short-hair cats were purchased from an inbred SPF colony and housed in 8 group cages of 3 animals of the same sex and initial BW. At 9 mo. of age, 2 groups of females (GF) and 2 groups of males (GM) were neutered whereas the 2 other groups of females were ligatured (EF) and the remaining 2 groups of males were left intact (EM). Half of the cats were fed ad libitum a low fat (LF), low energy (10.3 % fat, 3500 kcal ME /kg) complete balanced extruded diet and the other half a high fat (HF), high energy food (20.9 % fat, 4300 kcal ME/kg) so that to have 8 treatment groups based on sex (M/F), sexual status (neutered/intact) and diets (LF/HF). The ingredients used and the composition were similar between the two diets except for the starch, fat and dietary fiber contents.

Food consumption for each group was measured daily. Individual BW and body condition scores were recorded weekly. After 26 week of feeding, body fat was determined after a single injection of labelled water (H 2 18 O).

All cats gained BW, but males more than females, neutered animals more than intact ones, and cats fed the HF diet more than those consuming the LF one. Both neutering and fat led to higher energy intake, body weight gain, body condition score and body fat content. Reverse cholesterol transport (RCT) concerns cholesterol movements from peripheral cells via plasma towards the liver, the only organ in which elimination of cholesterol from the body is possible, by transformation into biliary acids. RCT is initiated by efflux of unesterified cholesterol from cells into HDL (containing apolipoprotein A-I) following by esterification in these lipoproteins (LP). Movements towards the liver involve two possible mechanisms: direct uptake of HDL (or HDL cholesteryl esters) and/or cholesteryl esters, or exchanges with VLDL and LDL (containing apolipoprotein B100) and uptake by the liver of these LP. Relative importance of these 2 are presumably different between species.

Two men and two dogs received a 14 h perfusion of deuterated leucine (as endogenous marker of apolipoproteins A-I and B100, 10 mmol/kg/h) and of [1-2 13 C] acetate (as endogenous marker of cholesterol, 4 mmol/kg/h). Blood samples were collected every 15 minutes during the first two hours then hourly over 12h for men and 22h for dogs. VLDL, LDL and HDL were isolated by ultracentrifugation. Unesterified cholesterol and cholesteryl ester, apolipoproteins A-I and B100 were isolated in each LP fraction. The samples were analysed for isotopic enrichment using GC/MS for leucine and GC-C-IRMS for cholesterol. Results were analysed by compartmental modelisation using SAAM II program. The analysis required the development of an integrated model taking into account both turnover of apolipoproteins A-I and B100 and turnover of cholesterol in the various LP fractions.

This protocol allowed us to quantify the different processes involved in RCT (LP secretion, cholesterol esterification and exchanges between LP, lipolysis, LP uptakes). In humans the RCT occures essentially (2/3) through the indirect pathway (via VLDL and LDL) whereas in dogs RCT occures exclusively by the way of direct uptake of both entire HDL (30%) and HDL cholesteryl ester (70%). These differences could explain in part the low prevalence of atherogenic lesions in the canine species compared to man. Our objective was to evaluate low density and very low density lipoprotein (LDLϩVLDL) oxidation in vitro as a measure of resistance to oxidative stress in exercising sled dogs. We hypothesized that antioxidant supplementation would mitigate the effect of exercise-induced oxidative stress, as measured by lag time and Vmax of LDLϩVLDL oxidation. Sixty-two sled dogs were randomly divided into 3 gender-, age-, and ability-matched groups: a sedentary group; an exercise group; and an exercise group supplemented daily for 5 weeks with 400 IU of vitamin E, 5 mg of ␤-carotene, and 20 mg of lutein. Exercise, preceded and followed by 72 h of rest, consisted of dogs running an average of 72.5 km a day for 3 consecutive days. Supplementation was blinded and placebo-controlled.

Oxidation lag time, a measure of LDLϩVLDL antioxidant status, increased significantly during exercise and after 72 h of rest in the supplemented exercise group (mean Ϯ SE pre-exercise lag time ϭ 16.7 Ϯ2.7 min; day 1ϭ 29 Ϯ2.6; day 3 ϭ 27.8 Ϯ2.3; 72 h post-exercise ϭ 32.6 Ϯ3.6). Oxidation lag time was also prolonged after rest in the non-supplemented exercise group (pre-exercise ϭ 24.2 Ϯ2.7, 72 h post-exercise ϭ 41.8 Ϯ2.4, p Ͻ 0.01), but not during exercise (day 1 ϭ 30.7 Ϯ2.9; day 3 ϭ 28.9 Ϯ2.4). No significant effects of exercise or supplementation were found in the propagation rates (Vmax) of LDLϩVLDL oxidation. Exercise induced significant decreases in concentration of LDLϩVLDL cholesterol fractions in both supplemented and non-supplemented exercise groups. There was therefore no measurable effect of supplementation on plasma LDLϩVLDL concentration.

These results demonstrate that dietary supplementation of canine endurance athletes with antioxidants delays LDLϩVLDL oxidation during exercise, suggesting that antioxidant administration increases resistance to exercise-induced oxidant stress. Furthermore, exercise followed by 72 h of rest increases LDLϩVLDL resistance to oxidation suggesting an effect of training on antioxidant capacity. In order to evaluate the beneficial effects of vitamin E supplementation in sled dogs participating in long distance races, 8 Alaskan Huskies were randomly supplemented with Vitamin E (E group, 1000 IU alpha-tocopherol/d) or placebo (P group) for 1 month before and during a 10 day race. Plasma antioxidant status (PAS), plasma VIT E, polyunsatured/satured fatty acid ratio (P/S), urinary creatinine and urinary Isoprostanes (IsP), were determined before and after a 10 consecutive day race. All dogs were fed similar high protein, high fat diets.

In P group, post race values (mean Ϯ standard deviation) of PAS, P/S, VIT E, decreased significantly as compared to pre race values (1.52 Ϯ 0.28 vs 0.91 Ϯ 0.35 mmol/l ; 1.05 Ϯ 0.09 vs 0.98 Ϯ 0.08 ; 29.7 Ϯ 10.1 vs 24.5 Ϯ 13.4 mol/l, respectively). IsP levels increased from 102.9 Ϯ 11.2 to 261.2 Ϯ 37.6 pmol/mmol creatinine.

In E group, only PAS post race value was significantly reduced from 1.45 Ϯ 0.37 to 1.12 Ϯ 0.31 mmol/l. Plasma VIT E and P/S levels were also reduced, but not significantly: 69.5 Ϯ 13.2 vs 57.8 Ϯ 17.6 mol/l and 1.06 Ϯ 0.11 vs 1.04 Ϯ 0,08. IsP levels increased from 111.2 Ϯ 20.7 to 184.7 Ϯ 26.3 pmol/ mmol creatinine.

Endurance exercise induces significant changes in antioxydant status and lipid peroxidation markers which appear partly attenuated with vitamin E supplementation.

TESTING, SERUM TOTAL MAGNESIUM AND IONIZED MAGNESIUM CONCENTRATIONS IN HEALTHY ADULT BEAGLES FED 0.01% AND 0.1%Mg DIETS HS Allen*, LJ Barton*, A Guzik † , C Kirk ‡ , K Wedekind ‡ , and PR Fox*. *The Animal Medical Center, † Louisiana State Univ. ‡ Hill's Science and Technology Center.

We evaluated parenteral magnesium tolerance testing (PMTT), serum ionized magnesium (iMg), and total serum Mg (TMg) in 10 healthy adult beagles (4F, 6M) fed a Mg depleted diet (0.01% Mg) for 28 days, followed by a Mg repleted diet (0.1% Mg) for 14 days. PMTT (0.2mEq/kg Mg infused IV over 4 hours) was performed at three different intervals: at the end of depletion (day 28), at the end of repletion (day 42), and after a 48 hour fast following the repletion diet (day 44). Serum TMg and iMg were determined on days 0 (baseline), 7, 14, 21, 28 during the depletion trial. The effects of diets supplemented with saturated and polyunsaturated fatty acids on canine neutrophil membrane fluidity and phagocytosis was investigated. Forty adult dogs were divided into 4 groups (nϭ10) and a low fat basal diet was supplemented with either safflower oil (SFO), beef tallow (BT), linseed oil (LSO), or Menhaden fish oil (MHO) for 28 days at a dosage of 18 g oil per 100 g basal diet. The four diets had P/S ratios of 0.4, 0.98, 4.9, and 5.3 for BT, MHO, SFO and LSO respectively. The % Kcals from n-3 fatty acids was 0.3, 0.3, 8.9, and 19.6 for SFO, BT, MHO, and LSO respectively. Neutrophils were assayed for membrane fluidity and phagocytosis. Membrane fluidity was assessed using fluorescence polarization and calculated anisotropy. Phagocytosis was determined using flow cytometry and quantified as the percent cells that ingested 0, 1, 2, 3, 4, or Ͼ 4 fluorescent microspheres.

Statistical analyses revealed that membrane fluidity and phagocytosis is linearly correlated. The two n-3 treatment groups had significantly greater membrane fluidity compared to the SFO and BT groups and the SFO had increased membrane fluidity compared to the BT group. Analysis of the phagocytosis data revealed that there was no significant difference between the groups in the number of cells that ingested 1 or 2 beads. However, the LSO and MHO groups had significantly greater uptake of 3, 4, and Ͼ 4 beads. Strikingly, the MHO and LSO groups also had a significantly greater number of cells that participated in phagocytosis compared to the SFO and BT groups.

Diets containing 18 and 20 carbon n-3 fatty acids results in incorporation of 20 and 22 carbon n-3 fatty acids into the membrane resulting in an increase in fluidity. However, it required 2 X the amount of n-3 fatty acids in the LSO group to produce a similar response in membrane fluidity and phagocytosis as observed in the MHO treatment group. Diets containing 20 carbon n-3 fatty acids increase membrane fluidity even at a P/S ratio of 1.0. It is not the dietary P/S ratio or total PUFA, but rather the contribution of long chain n-3 fatty acids, which increases membrane fluidity and improve phagocytosis. It remains unclear what effect diets comprised of different n-3 sources (18 vs. 20 carbons) with the same n-6 /n-3 ratio have on neutrophil membrane composition and function. Therefore, we investigated the effects of diets containing either 18 or 20 carbon n-3 fatty acids on canine neutrophil superoxide and leukotriene (LTB) production and fatty acid composition. Forty adult dogs were divided into 4 groups (nϭ10) and a low fat basal diet was supplemented with either safflower oil (SFO), beef tallow (BT), linseed oil (LSO), or Menhaden fish oil (MHO) for 28 days at a dosage of 18 g oil per 100 g basal diet. Dietary fat provided 40.8 % of Kcals and the n-6/n-3 ratios of the diets were 101, 9.7, 0.38, and 0.34 for the SFO, BT, LSO and MHO groups respectively. Neutrophils were isolated from peripheral blood, stimulated and assayed for superoxide and LTB production. LTB 4 and LTB 5 were separated by HPLC and quantified by ELISA. Superoxide anion production was quantified and fatty acid analysis of neutrophil membranes was performed using GLC.

Statistical analyses (p Ͻ 0.05) revealed that MHO group had significantly less LTB 4 than the other three groups. The MHO group also had significantly greater LTB 5 than the other three groups. The LSO group also had significantly greater LTB 5 production than the SFO and BT groups. The LSO and MHO groups had significantly lower superoxide production compared to the SFO and BT groups. Fatty acid analysis revealed that the MHO group had significantly greater incorporation of long chain n-3 fatty acids (20:5, 22:5, and 22:6) into the neutrophil membrane. The LSO group also had significant, but to a lesser degree, incorporation of 20:5 and 22:5, but no 22:6 was observed. We conclude that 18 and 20 carbon n-3 fatty acid are differentially incorporated into the cell membrane at the same n-6/n-3 ratio, resulting in a differential reduction of pro-inflammatory mediators. Thus, it is the type (18 vs. 20 carbon) and amount of n-3 fatty acids and not simply the n-6/n-3 ratio that differentially modifies membrane composition and cellular function. Serum ferritin (an iron storage protein) levels are related to total body iron stores in both humans and dogs. Serum ferritin, in dogs, is usually assayed by species specific antibody-driven reactions. These assays are difficult to develop and not readily available. In this report we evaluate the measurement of serum ferritin, using a commercially available kit, in normal dogs and in dogs with microcytic, non-regenerative anemia.

Fifty healthy adult dogs of various breeds and both sexes, were sampled to determine the appropriate reference interval for canine serum ferritin. Ferritin was assayed by an immunoturbidimetric assay with polyclonal anti-human ferritin antibodies (Tina-quant [a] Ferritin, Boehringer M.), using Boehringer M./ Hitachi 911 instrumentation. The assay was previously validated for precision, linearity and recovery percentage. Thirty dogs with microcytic, non-regenerative anemia and low serum iron concentrations were also selected. In these cases history, physical findings and laboratory findings and clinical follow-up were used to differentiate between iron deficiency and anemia of chronic inflammation (ACI).

The reference interval assessed for ferritin in normal dogs was 80-120 ng/ml (mean ϭ 98 Ϯ 11). In the 30 cases of anemia, the ferritin concentration ranged from 20 to 730 ng/ml (mean ϭ 184 ng/ml). In the subgroup of anemic patients affected by true iron deficency (n ϭ 10), ferritin levels ranged from 20 to 77.5 ng/ml (mean ϭ 48 ng/ml). In the remaining dogs (n ϭ 20), affected by ACI, the serum ferritin levels ranged from 83.3 ng/ml to 730 (mean 504 ng/ml). An unexpected finding was that five additional dogs, affected by porto-systemic shunts and associated microcytic anemia, had both low serum iron and ferritin concentrations. This finding is in contrast to that reported by other investigators.

Canine serum ferritin can be detected by a simple and accurate method and can be utilized in the diagnosis and management of iron deficiency anemia. Moreover our reference range in normal dogs, is narrower than previously reported with other techniques. The importance of dietary fiber in maintenance of normal colonic health and treatment of colonic disease is becoming well accepted in dogs. However, the cat is an obligate carnivore that evolved on diets low in carbohydrates and fiber.

There have been few studies reported examining the effects of fiber on feline colonic function. This pilot study was conducted to determine if insoluble dietary fiber had an effect on fecal short chain fatty acid (SCFA) production, and if the presence of fiber altered fecal nitrogen excretion. Twelve neutered, healthy, adult, mixed breed cats were allocated into 2 dietary groups of 6 cats, fed individually in a randomized cross-over design. Cats were provided food based on individual caloric needs for weight maintenance. Body weight was monitored weekly and food consumption was recorded daily. Initially all cats were fed a maintanence diet (MD) (1% fiber) for 2 weeks, then cats were divided into the test groups and fed either a moderate fiber (MF) diet (9% insoluble fiber) or a high fiber (HF) diet (17% insoluble fiber) for 2 weeks. At the end of each period, feces were collected for 48 hr to determine fecal output, and after this, fecal samples were collected immediately upon defecation, snap frozen in liquid nitrogen, and stored at Ϫ80ЊC until analyzed. Samples were extracted and analyzed for SCFA concentration by gas chromatography. Total fecal nitrogen was determined by the Leco Analysis System after converting the samples to vapor in a high temperature oven. The cats consumed all diets readily and maintained their body weights throughout the study. Cats consuming the MF & HF diets had significantly higher concentrations of acetate and propionate, but not butyrate or total SCFA than cats consuming MD. No differences were found between MF & HF, although cats consuming the HF diet tended to have a higher SCFA conc. As expected, cats consuming the HF diets also produced the most feces (P Ͻ 0.05) compared to the MF or MD cats. Fecal nitrogen (FN) values increased (P Ͻ 0.05) in the cats consuming diets containing more insoluble fiber, but were not significantly different between the MF and HF diets. The increase in FN correlated with: 1) the increase in fecal dry weight (p ϭ 0.009, r ϭ 0.472), 2) the total SCFA concentrations (p ϭ 0.0039, rϭ 0.417), and 3) the dietary protein concentration (p ϭ 0.0026, r ϭ 0.434). These data support previous in vitro work showing that the colonic microflora in cats can ferment insoluble fiber to SCFA, which may influence colonic health. Further, increased nitrogen in the feces of cats consuming insoluble fiber is important, because it may suggest reduced dietary protein digestibility. Alternatively, increased FN excretion could be due to the increased SCFA (and concurrent production of hydrogen, methane, carbon dioxide and water) that ''traps'' ammonia in the feces as ammonium ion. Each year a number of dogs participating in the Iditarod Trail Sled Dog Race develop myopathies. The objective of this study was to determine the role of vitamin E in limiting the extent of this muscle damage by investigating the hypothesis that dogs with higher prerace plasma vitamin E concentrations would perform better and experience less muscle damage than dogs with lower vitamin E concentrations.

Venous blood samples were collected from dogs participating in the 1998 Iditarod Race within 30 days of the start of the race (P) (nϭ751) and at the finish (F) after running 1159 miles (nϭ197). Blood was also collected from dogs that did not complete the race (nϭ158). Plasma was analyzed for vitamin E concentration and creatine kinase (CK) activity.

Prerace vitamin E concentrations varied from 7.7 ug/ml to 112 ug/ml. Median, 25% and 75% percentiles for prerace values were 24.9 ug/ml, 20.1 ug/ml and 31.8 ug/ml respectively. There was no significant difference between the median plasma vitamin E concentration of the dogs at each time (P: 24.9 ug/ml; R: 25.4 ug/ml; F: 24.3 ug/ml), (Pϭ0.17). There was no correlation between a dog's prerace plasma vitamin E concentration and either the finishing time (R 2 ϭ0.0003) or the distance it travelled, if it failed to complete the race (R 2 ϭ0.005).

The median plasma CK concentration of R-dogs (2229 iu/l) was significantly greater than F-dogs (715 iu/l), (PϽ0.001) and both R-and F-dogs had median CK values that were significantly greater than at time P; (PϽ0.001). R-dogs with plasma CK values Ͼ 10,000 iu/l (nϭ39), had median prerace plasma vitamin E concentrations that were similar to R-dogs with CK values that were Ͻ 10,000 iu/l (nϭ119): (24.8 iu/l vs. 24.3 iu/l), (Pϭ0.3). There was no association between a dog's prerace plasma vitamin E concentration and its CK activity when it retired (R 2 ϭ0.0006).

From these results, there does not appear to be any link between a dog's prerace plasma vitamin E concentration and its performance in the Iditarod Trail Sled Dog Race or in the extent of muscle damage based on CK activity. Volatile fatty acids (VFAs) are the primary end products of anaerobic microbial fermentation in the mammalian gastrointestinal tract. They maintain intestinal mucosal integrity, promote intestinal fluid/electrolyte balance, influence carbohydrate and lipid metabolism, and provide metabolic energy. Because cats are carnivores with relatively short, nonvoluminous gastrointestinal tracts, it might be expected that VFA production would be less than in other species. Values have not been established in vivo for cats, so the purpose of our study was to measure VFAs in the gastrointestinal tracts of healthy adult cats fed a free-choice commercial dry cat food. The gastrointestinal tracts were removed en bloc from the cadavers of 14 random source cats immediately following euthanasia. The tracts were divided into 6 sections (stomach, duodenum, jejunum, ileum, proximal colon, and distal colon), and the luminal contents collected, centrifuged and analyzed for acetate, proprionate, butyrate, isobutyrate, isovalerate, and valerate using gas chromatography. The pH in each segment and colonic osmolarity were also measured.

Mean total VFA concentrations ([Total VFA], mmol/L), total VFA amounts (Tot VFA, mol), and pH are reported below. Total VFA concentrations and the distribution of individual VFAs in the proximal and distal colon were comparable to those reported in the forestomach of ruminants and in the large intestines of other animals. Small intestinal VFA concentrations in the cats were higher than those found in other species; this is consistent with recent reports that normal cats harbor high numbers of small intestinal bacteria. Luminal pH varied throughout the intestines of the cats in a pattern similar to that reported in other species. Although VFA concentrations in the cats were high, the total VFA amounts were very low due to the small gastrointestinal tract volume, and little metabolic energy is probably provided by VFAs in cats. VFAs are likely to have local beneficial effects, however, as reported in other species. Conjugated linoleic acid (CLA) refers to a group of isomers of linoleic acid. In growing mice, rats, and chickens, consumption of CLA decreases body fat content 57-70%, 23%, and 22%, respectively. CLA supplementation to adult mice resulted in significantly less body fat (Ϫ46%) and more lean body mass (ϩ9%) when compared with non-supplemented mice. Therefore, CLA may be useful in weight reduction programs in cats or dogs. The purpose of our study was to evaluate the influence of CLA supplementation on body composition in healthy adult cats.

MATERIALS AND METHODS Twelve three-year-old cats (6 males and 6 females) were fed an adult maintenance diet (FM; Feline Maintenance, Hill's Pet Nutrition Inc, Topeka, KS) to maintain weight prior to the study. Following this period, body composition was determined by dual energy x-ray absorptiometry (DEXA; QDR 1000/W, Hologic Inc., Waltham, MA), and cats were assigned to one of two study groups based on body fat content. One group was fed FM supplemented with CLA (1%), and the other group was fed FM supplemented with sunflower oil (1%); diets were isoenergetic. Cats were fed to maintain body weight throughout the study. Food intake was measured daily, and body weight measured weekly. Body composition using DEXA was performed at 4 and 8 weeks.

RESULTS Food intake, body weight, percent lean body mass, and percent body fat did not differ significantly between groups during the study.

DISCUSSION CLA consumption by healthy adult cats did not apparently influence body composition. Several possible explanations exist. Cats have decreased delta-6-desaturase activity; therefore, they may metabolize CLA differently from other species. Adult cats were studied, and CLA consumption may influence body composition to a greater degree in growing animals. It is possible that consumption of a greater quantity of CLA or a longer study period may have resulted in changes in body composition. Lastly, a difference may have been observed if a greater number of cats had been studied. CONCLUSION Although CLA consumption by rats, mice, chickens, and human beings is associated with alteration in body composition (less adipose tissue and greater lean body mass), it did not influence body composition in these healthy adult cats. Bovine papillomavirus (BPV) DNA has been detected in the majority of sarcoids examined to date. These studies have focused on cases located primarily in the Northeast region of the United States, and Europe (primarily Switzerland). The majority of tumors in these studies have bovine papillomavirus type 1 (BPV-1) DNA found in them with a much smaller percentage having BPV-2 type DNA. In all studies to date viral DNA was detected in tumor tissue alone, and was absent from normal equine skin and other tissues tested.

The purpose of this study was to assess the prevalence of BPV-1 and BPV-2 DNA in tumor tissue and normal skin samples collected from horses living in the Western United States. The polymerase chain reaction (PCR) was used to screen equine tissue samples for the presence of viral DNA. One hundred fifty four tissue samples from 60 horses were collected and analyzed for the presence of BPV-1 or BPV-2. Tissue samples were collected from tumors (sarcoids) and from normal skin at close and distant proximity to the tumor sites. Tissues were harvested, immediately fixed in 10% formaldehyde routinely processed and paraffin embedded. A 50-micron section was used for DNA extraction. Primers known to amplify a 280 base pair region of the E5 early gene of both BPV-1 and BPV-2 were used to detect viral DNA. Restriction enzyme cleavage patterns of the amplified fragment was then performed to determine papillomavirus types. Negative controls included three equine warts, skin from three unaffected horses, a cutaneous melanoma, cutaneous lymphoma, and a cutaneous squamous cell carcinoma. In addition, swabs were taken of the skin of one affected horse to determine if viral shedding from the tumor site could contaminate the surface of normal skin. A bovine fibropapilloma was used as a positive control. 91 out of 98 equine sarcoids were positive for bovine papillomaviral DNA. 7 of the positive samples were sequenced and shown to match 100% with expected sequence patterns for BPV-1 and BPV-2. Approximately 50% of the tumors examined in this study had restriction enzyme patterns consistent with BPV-2. Twenty-nine of the 43 samples of normal skin taken from affected horses were positive for papillomavirus DNA.

This represents the first report of the presence of viral DNA in normal skin samples from horses affected with equine sarcoids. There appears to be a large variation in the prevalence of viral subtypes in tumors from different geographic regions. Bovine papillomavirus (BPV) is one of a family of small DNA viruses. These viruses are capable of inducing epithelial or fibroepithelial tumor in several species including cows, horses, dogs, rabbits and man. Specifically, two of the bovine papillomavirus gene products are capable of inducing transformation in cultured fibroblasts. Viral DNA has been detected in the majority of equine sarcoids examined to date, and expression of viral genes is likely to be a factor in initiation of tumorigenesis in equine sarcoids.

The purpose of this study was to attempt to detect and quantify expression of the BPV transforming gene, E5, in equine sarcoids. Equine sarcoids and normal skin from affected and unaffected horses were collected and immediately frozen in liquid nitrogen before storage at Ϫ70C. After extraction, a known quantity of protein from each sample was incubated with agarose beads covalently coupled to S aureus Protein A (Immunopure Plus, Pierce) and an anti-E5 polyclonal antibody. Following incubation, samples were washed and bound protein eluted from the beads. Eluted proteins were electrophoresed on a 14% polyacrylamide gel and transferred to a PVDF membrane. A western blot technique using a chemilumenescence detection system was used to detect and quantify the E5 protein. The 7 kDa, E5 protein was detected in both positive controls and equine sarcoids, but not in normal skin from unaffected horses. A difference in the quantity of expression was detected between samples. This represents the first confirmation of expression of bovine papillomavirus transforming proteins in equine sarcoids.

NOVA SCOTIA DUCK TOLLING RETRIEVERS. Mark Rishniw. College of Veterinary Medicine, Cornell University, Ithaca, NY.

Pulmonic stenosis has been identified in 2 Nova Scotia Duck Tolling Retrievers (NSDTR) in the last 2 years. A cardiac screening program was established by the NSDTR club to examine the prevalence of auscultable cardiac disease within the breed and determine if a breed predisposition could be identified.

105 presumptively healthy NSDTR between 3 months and 10 years of age were independently screened by auscultation by 1 of 8 clinicians (7 cardiologists, 1 internist). 10/105 dogs had auscultable abnormalities: 6 had soft left-sided apical systolic murmurs, 3 had soft left-sided basilar systolic murmurs. One dog had an audible extra heart sound, but was not evaluated further. Complete 2D and Doppler echocardiographic examinations were performed on 6/9 dogs with murmurs. 4 of these dogs had mild mitral insufficiency (3/4 dogs were Ͼ5 years) and 2 had physiologic (flow) murmurs diagnosed by exclusion. Incidental mild pulmonic insufficiency was identified in 3 of the 6 dogs examined echocardiographically.

These data suggest that NSDTR have little auscultably detectable congenital cardiac disease. Mild (presumably acquired) mitral valve disease is occasionally detected in older dogs. Whether the breed is over-represented with respect to this lesion cannot be determined at this time. Prevalence of non-auscultable cardiac disease, such as cardiomyopathy, cannot be determined by this study. Percutaneous balloon pericardiotomy (PBC) has been performed in people and in a small number of dogs as a treatment for recurrent pericardial effusion with tamponade (PET). We have found this technique useful in the management of dogs with malignant PET.

Three dogs with inoperable intrapericardial neoplasia and PET were studied. Under general anesthesia, a 16G over the needle catheter was inserted into the pericardial sac (PS), percutaneously, at the right 5th intercostal space. Contrast material was injected to outline the PS and confirm the catheter location fluoroscopically. Using a 0.038in guide wire, the catheter was replaced with an 8.5Fr sheath introducing catheter (SIC) through which a 14mm, 4cm balloon dilating catheter (BDC) was placed into the PS. The SIC was removed and BDC positioned across the parietal pericardium. Three dilations, each of 3 minutes' duration, were performed and the BDC deflated and removed. In 1 (Dog 2), this was followed by a series of dilations culminating with a 20mm, 4cm BDC, placed (without SIC) over the guide wire.

There were no important complications (pain has been managed with a preoperative fentanyl patch and/or oxymorphone, PRN). No dog has had significant recurrence of effusion and each has been released 1 day post-procedure (PP). Dog 1 was euthanatized 41 weeks PP due to metastatic disease, without recurrence of PET. Dogs 2 and 3 are asymptomatic and free of pericardial effusion 42 and 10 weeks PP.

We conclude that percutaneous balloon pericardiotomy appears to be a safe, economical, and effective method for palliative treatment of recurrent PET and may be the preferred treatment in dogs with recurrent PET and limited life expectancy due to intrapericardial neoplasia. Human studies and animals models suggest an association exists between viral myocarditis and development of DCM. While many dogs with DCM belong to breeds with a recognized pattern of presumed heritable cardiomyopathy, a remaining subpopulation of dogs with DCM belongs to assorted, atypical dog breeds. Viral myocarditis may contribute to the development of cardiomyopathy in this latter group of dogs. The objective of this study was to perform DNA extraction and polymerase chain reaction analysis on paraffin-embedded archived myocardial samples from dogs of both populations to screen for canine parvovirus, adenovirus types 1 and 2, and herpesvirus.

Paraffin-embedded myocardial samples from 10 dogs of atypical breeds, 8 Doberman pinschers, 2 Boxers, and 3 Cocker spaniels with DCM (%FSϽ22%, increased LVIDd) were screened for viral genomic material by PCR analysis. DNA was extracted from the myocardium using a phenol-chloroform extraction technique following xylene dissolution of paraffin, and proteinase K digestion. Sets of PCR primers were designed for canine parvovirus, adenovirus types 1 and 2, and canine herpesvirus. DNA extracted from both viral cultures and paraffin-embedded tissues of dogs with a confirmed clinical diagnosis of viral infection with each agent were used as positive controls. Successful PCR amplification reaction conditions were established for all viral primer sets using the positive control DNA samples.

Canine parvovirus, adenovirus type 2, and herpesvirus viral nucleic acid were not amplified from any of the cardiomyopathic samples. Polymerase chain reaction analysis for canine adenovirus type 1 amplified a band of similar size from both the positive controls and one cardiomyopathic sample from a five month old German Shepherd. Sequence analysis of the product confirmed it to be canine adenovirus.

We conclude that canine parvovirus, adenovirus types 1 and 2, and herpesvirus are not commonly associated with clinical DCM in dogs. The techniques of DNA extraction and PCR analysis for viral genome may be successfully performed on archived paraffin-embedded myocardial samples in dogs. Similar studies may be warranted to evaluate for presence of genomic material from other canine viral agents, such as canine distemper virus, by modifying the technique to include a reverse-transcription PCR reaction. Rabbit coronavirus (RbCV) infection-induced myocarditis results in cardiac chamber dilatation and myocyte hypertrophy. We have shown that the gross, histopathologic, and morphometric changes of RbCV infection are accompanied by systolic left ventricular dysfunction and a constellation of ECG abnormalities including ventricular tachyarrhythmias and QT interval prolongation that suggest that infection enhances vulnerability to ventricular fibrillation. The mortality rate following RbCV infection is 60%, with sudden death (unexpected and unexplained death of a rabbit between 8 hour observation intervals) accounting for approximately half of those deaths. The purpose of this investigation was to clarify the pathophysiology of sudden death associated with RbCV infection.

Six male New Zealand White rabbits weighing 2.5-3.0 kg. were purchased from a commercial supplier. The animals were housed individually at 21ЊC with a standardized light-dark cycle and fed rabbit diet and water ad libitum. A radiotransmitter (TL11M2-C50-PXT, Data Sciences, Minneapolis, MN) was surgically implanted. This transmitter included 2 ECG leads, an intraarterial catheter secured in the femoral artery, and a temperature sensor. The relative strength of the transmitter's signal was used to calculate an index of the animal's physical activity. Data were recorded continuously for 60 seconds every 15 minutes, 24 hours per day.

Following a 10 day acclimation period, instrumented rabbits were innoculated with 0.2 ml. of 10 3 RID 50 coronavirus stock into the marginal ear vein. Pressure recording capability was lost in 2 of the 6 rabbits within 10 days of transmitter implant. Of the 6 infected rabbits, 3 died suddenly. Analysis of telemetry data revealed that sudden death in these rabbits was preceded by 1 to 4 hours of inactivity, progressive hypotension and sinus tachycardia. Terminally (within 1 hour of death), hypothermia, sinus bradycardia with dramatically decreased QRS voltages, and severe hypotension occurred.

We conclude that despite the presence of ventricular ectopy and QT prolongation caused by RbCV infection, sudden death appears to be the result of cardiogenic shock rather than ventricular arrhythmia. Absolute and relative heart size in normal cats was determined by correlating heart size and selected skeletal structures. This study used 100 cats considered cardiologically normal on radiography Ϯechocardiography. Results were subjected to statistical analysis.

Standardized measurements were made of the long and short axes of the heart, mid-thoracic vertebrae, and other structures in normal feline thoracic radiographs. The measurements were recorded in millimeters as well as the number of thoracic vertebral lengths spanned by each dimension beginning with T4 in the lateral radiograph. The long and short axis measurements of the heart expressed in vertebral lengths were added to yield vertebral heart size (VHS) comparable to a reported study in dogs.

The normal feline VHS was 7.5v Ϯ 0.3 SD in lateral radiographs. The long axis dimension correlated moderately with the length of 3 sternebrae from S2-4. The short axis dimension correlated well with the length of 3.2 vertebrae from T4-6. The short axis dimension in ventrodorsal and dorsoventral radiographs was 3.4v Ϯ 0.2 SD.

Heart size based upon body size is more reliable than absolute dimensions as an indicator of cardiomegaly. The VHS method is easy to use and encourages objective assessment of heart size. It is helpful in determining cardiomegaly, as well as in comparing heart size in sequential radiographs. A radiographic study of 100 normal adult dogs showed that a vertebral scale system for measuring heart size was applicable in various breeds of dogs with different chest shapes (1). The applicability of this method in puppies and growing dogs was not determined. The aims of the present study were to determine normal heart size in puppies at 3 months of age and assess relative changes in heart size with maturity.

Lateral and dorsoventral radiographs were made of 11 normal puppies at 3, 6, and 12 months of age. The lengths of the long and short axes of the heart were compared to the number of thoracic vertebrae beginning with T4. The values were then added to yield the vertebral heart size (VHS). The average VHS at 3 months was 10.1v; at 6 months it was 9.9v ; and at 12 months it was 10.0v. The differences in heart size between age groups were not significant.

This study indicates that the VHS method for determining heart size in immature dogs is useful and the values obtained are essentially the same as in adult dogs (9.7v).

1. Buchanan JW and Bucheler J. Vertebral scale system to measure canine heart size in radiographs. J Am Vet Med Assoc 1995; 206: 194-199 Clinical monitoring of digoxin plasma concentration is necessary because of both a large inter-animal variation in digoxin pharmacokinetics and the small ratio of toxic/therapeutic concentrations. Digoxin concentration data from clinical monitoring are used to adapt dose regimens. Hierarchical mixed effects modeling of data from clinical monitoring can be used to identify factors which are covariables for model parameters, possibly improving dose calculations and predictions.

We examined 161 cases of dogs receiving digoxin (32 prospective and 129 retrospective). Samples for digoxin analysis were taken at steady state, after known dose, dose interval and dose-to-sample interval. Covariables examined included plasma creatinine, serum potassium, body weight x (x ϭ 0.75, 1), body surface area, age and the formulation administered. Initial modeling identified 19 cases with markedly (5-10 fold) slower absorption: these cases were unique in that they had been admitted to hospital within hours prior to dosing. Using the remaining 142 cases, a one compartment open model for oral administration and multiple step-wise regression, the following potentially useful covariables were identified: Clearance ϭ f(Ln{Creatinine}, Age), Volume/F ϭ f(Serum Potassium, Formulation, Age) and Ka ϭ f(Weight).

The best model found enabled prediction of individual digoxin clearance as Cl ϭ [2.939-(1.159*creatinine)]*100 mL/h/kg (creatinine expressed as Ln[mg/ dlϩ1]) (r 2 ϭ 0.26) and V d /F ϭ 21.267-(1.773*K ϩ ) L/kg (K ϩ in mEq/L) (r 2 ϭ 0.64). Population mean parameters (cv%) were Cl ϭ 203.0 mL/h/kg (34%), V d / F ϭ 13.2 L/kg (21%) and k a ϭ 0.990 h Ϫ1 (51%). These parameters and regression equations could be used to aid dose calculations and the underlying model illustrates some reasons for individual departure from expected dose-concentration relationships. Nitrates are potentially beneficial in the treatment of heart failure because they may increase systemic venous capacitance and reduce ventricular filling pressures. Isosorbide mononitrate (ISMN) was evaluated in a randomized, blinded, and placebo-controlled study using 6 normal dogs (Ͻ 15 kg). Technetium-labeled red blood cells (RBCs) were used to follow changes in blood volume distribution between the thorax and the abdomen. Each dog was orally dosed with placebo, 2, 3, and 4 mg/kg ISMN on separate days with a two-week washout period between randomized dosings. On the day of each study, RBCs were labeled in vitro with technetium-99m and administered intravenously. Information obtained after labeling included measurement of blood pressure (BP), packed cell volume (PCV), and heart rate (HR), and scintigraphic imaging of the thorax and abdomen. The drug or placebo was administered followed by repeated measures of the aforementioned variables at 15, 30, 45, 60, 90, 120, 150, 180, 210, and 240 minutes. Plasma ISMN concentration was determined at 60 minutes. Scintigraphic counts were corrected for biological and physical decay. Regional counts were expressed as a percentage of the whole.

No differences were detected in BP (Pϭ0.61), PCV (Pϭ0.92), HR (Pϭ0.92), thoracic blood volume percentage (TBVP) (Pϭ0.34), or abdominal blood volume percentage (ABVP) (Pϭ0.34) between placebo and any dose of ISMN. Quadratic curves decreasing with time (primary decline within first 60 minutes) were noted at all doses of ISMN and placebo for HR (20 % decrease, PϽ0.0001), PCV (7 % decrease, PϽ0.0001), and TBVP (19% decrease, PϽ0.0001), as well as an increase over time (primary rise within first 60 minutes) for ABVP (9 % increase, PϽ0.0001). Blood pressure did not change (Pϭ0.38). Mean plasma ISMN concentration 60 minutes after dosing was 0 ng/ml with placebo, 1,248 ng/ml with ISMN 2 mg/kg, 2,105 ng/ml with ISMN 3 mg/kg, and 2,352 ng/ml with ISMN 4 mg/kg (minimum human therapeutic concentration ϭ 100 ng/ml).

The use of technetium labeled RBCs to document blood volume redistribution following oral administration of ISMN in normal dogs failed to detect a shift in blood volume from the thorax to the abdomen at the doses tested, compared to placebo, despite adequate absorption of the drug. The significant decrease in TBVP, HR, and PCV and the increase in ABVP across time for all doses and placebo can potentially be explained by acclimation to the environment and splenic sequestration of blood over the four hours.

ADULT DOGS. Mark Rishniw. College of Veterinary Medicine, Cornell University, Ithaca, NY.

Mild pulmonic insufficiency (PI) is commonly identified by color Doppler echocardiography in adult dogs without recognizable pulmonic valve disease. It is usually found incidentally while evaluating other cardiac pathology and is generally not considered part of the pathologic processes (unless pulmonic stenosis, heartworm disease or pulmonary arterial hypertension exist). However, the prevalence of PI in normal adult dogs is unknown.

25 normal adult dogs between 9 months and 13 years of age were examined by color Doppler echocardiography for presence of PI. The pulmonic valve was imaged in a right-sided short-axis parasternal view in all cases, optimizing with zoom functions for the pulmonic valve where necessary. No dog had echocardiographic evidence of structural cardiac disease. Pulmonary artery pressures were not measured in any dog. The degree of PI was semi-quantified (trace, mild, moderate, severe) by examining the size of the color Doppler insufficiency jet. 23/25 (92%; 95%CI ϭ 73%-99%) dogs had evidence of PI: 16 dogs had trace PI, 5 had mild PI and 2 had moderate PI. Spectral Doppler of the insufficiency jets in the dogs with moderate PI showed peak and end-diastolic velocities Ͻ2.0m/s, consistent with normal pulmonary artery pressures.

These data suggest that in normal adult dogs trace or mild PI is commonly detected by color Doppler echocardiographic evaluation of the pulmonic valve and moderate PI is observed occasionally. The prevalence of incidental PI in normal adult dogs is similar to that reported in normal adult humans. Hypertrophic cardiomyopathy (HCM) is a clinically important disease in both humans and domestic cats, manifested by cardiac hypertrophy and myocyte disarray which can result in heart failure and sudden death. The disease is familial in humans, resulting from mutations in genes that determine the structure and function of cardiac contractile proteins. Recent observations indicate that HCM in the cat is also familial, supporting the hypothesis that human and feline HCM share related molecular pathogenesis. We propose to test this hypothesis using complementary mutation screening of candidate genes and gene mapping approaches. Identification of the genetic basis of feline HCM is expected to provide a valuable natural model for pathogenetic investigations and therapeutic trials which should benefit both humans and cats.

Neither cDNA nor genomic DNA sequences of the candidate sarcomeric genes have been published in the cat. Normal cDNA sequences were generated from control cats which were greater than 7 years of age and judged to have normal cardiac architecture by echocardiography or measurements at necropsy. Work was begun on ␤-cardiac myosin heavy-chain (␤-MHC), cardiac troponin-T (cTNT), and cardiac myosin binding protein-C (MYBPC) because mutations in these three genes are thought to contribute most to familial HCM in humans. Polymorphic markers are being tested in a family of Persian cats with a high incidence of HCM and an inheritance pattern strongly suggestive of autosomal dominant transmission. Direct mutation screening is conducted on samples from clinical HCM (confirmed by echocardiography or necropsy) cases with a familial history.

Sequence homology between cat and human is greater than 90% for all three genes investigated to date (cTNT, ␤-MHC and MYBPC). Direct sequencing of candidate genes for mutations in ten unrelated affected cats has revealed neutral polymorphisms (seven in cTNT, two in ␤-MHC and eight in MYBPC) that do not determine disease, but which result in restriction site polymorphisms and so are suitable for linkage analysis. Recently, we have identified several intronic polymorphic markers in both MYBPC and B-MHC genes. While these data continue to support the hypothesis that familial HCM in the cat may share a similar pathogenesis to that in humans, no disease associated mutations have been identified to date. Prognosis for dogs with subvalvular aortic stenosis (SAS) varies with lesion severity. Mild lesions may not compromise quality of life or longevity, but moderate to severe lesions often lead to syncope, exertional weakness, congestive heart failure, and sudden cardiac death. Doppler-derived peak left ventricular to aortic pressure gradient (PG) is the method most often used for quantifying severity of SAS. Gradients are often categorized as mild (PG Յ 50 mmHg), moderate (PG Ͼ 50 and Ͻ 100 mmHg), or severe (PG Ն 100 mmHg). The purpose of this study was to determine the change in PG in young Newfoundlands with SAS.

Medical records from all Newfoundlands with SAS evaluated between July 1988 and July 1998 were reviewed retrospectively to identify untreated dogs examined by Doppler echocardiography at least twice during the first year of life. Twenty-three dogs (13 female, 10 male) were identified. Age at the initial exam ranged from 2 to 7 mos (medianϭ4 mos), while age at the second exam ranged from 3 to 12 mos (medianϭ8 mos). The median PG increased from 56 mmHg (range, 25-210) at the first exam to 117 mmHg (range, 32-263) at the second exam. The median PG change from exam 1 to exam 2 was 48 mmHg ranging from a decrease of 60 mmHg to an increase of 123 mmHg. The PG increased by Ͼ25 mmHg in 15 dogs, decreased by Ͼ25 mmHg in 1 dog, and changed Ͻ25 mm Hg in 7 dogs. The increment in PG affected severity classification in 16 (70%) of the dogs. Three dogs changed from mild to moderate, 8 dogs from moderate to severe, and 5 dogs from mild to severe.

This study documents the progressive nature of SAS in some Newfoundlands during the first year of life. The degree of disease progression is sufficient in some dogs to affect prognosis and therapeutic decisions. The syndrome of gastric distention and volvulus (GDV) occurs commonly in large breed dogs and may prove fatal in approximately 20% of cases. Approximately 43% of these cases develop cardiac arrhythmias that may contribute to mortality. Most of these arrhythmias are ventricular in origin and ventricular fibrillation (VF) may be the mechanism of death. This study designed an iatrogenic model of gastric distention (GD) to investigate (1) the prevalence of ventricular arrhythmias (VA) during acute GD and its recovery, (2) if programmed electrical stimulation (PES) may uncover tendency to VF, (3) if the QTc of the electrocardiogram (ECG) predicts tendency to VF, and (4) if hemodynamic changes predate VF. Eleven healthy beagles, anesthetized with morphine and alpha-chloralose, and instrumented so that vascular pressures, cardiac output, and PES could be recorded, were used. Five were unperturbed, while acute gastric distention to a pressure of 30mmHg for 1.5 hours was produced in six others. The results were (1) No dogs with GD developed spontaneously occurring arrhythmias. (2) Ventricular fibrillation was produced in no dogs by conventional PES, but in all dogs (pϽ0.05) with GD and none of the controls, using accelerated ventricular pacing. (3) The QTc of the ECG did not change in dogs with GD, but it shortened in (pϽ0.05) in controls. (4) There were no hemodynamic changes that achieved statistical significance. In conclusion, dogs with acute GD have a tendency for VF which may be uncovered by a robust protocol of PES. There are no hemodynamic prodromata of VF. Future studies will be conducted using various specific autonomic probes to determine the putative mechanism for the vulnerability to arrhythmia with GD. Arterial thromboembolism is a common sequalae to cardiomyopathy in cats. A safe and effective method to prevent thrombus formation and subsequent embolization does not currently exist. Low-molecular-weight heparin (LMWH) has been used in humans as long-term prophalaxis for individuals at risk of thromboembolic conditions. The purpose of this study was to document the effects of dalteparin sodium (Fragmin) on laboratory values in cats. In humans, the therapeutic range for anti-Xa is 0.3-0.7 IU/ml. Eight healthy cats were studied. Cats were divided into two groups randomly. Each cat had a normal physical examination and a CBC, platelet count, prothrombin time (PT), activated partial thromboplastin time (aPTT), and anti-Xa activity prior to study admission. Group 1 received a single subcutaneous injection of dalteparin sodium at 200 IU/kg once daily for 5 days, while Group 2 received 100 IU/kg once daily for 5 days. Blood samples were collected for analysis prior to study admission and then 4 hours after the final dose on the fifth day. One cat in Group 2 had additional samples for anti-Xa activity at 2, 8, 12 and 24 hours post-injection. Samples were processed using routine laboratory methods. Values were compared using a t-test with a p value of Ͻ0.05 considered significant.

No treatment effects were seen on the PT, CBC or platelet counts at any dose. For all cats, anti Xa-activity was not detected in baseline samples (Ͻ0.01 IU/ml)

Post aPTT Post Xa activity Therapy significantly affected the aPTT and anti-Xa activity in Group 1 (pϽ0.01) and the anti-Xa activity in Group 2 (pϽ0.01). The anti-Xa activity for the single cat in Group 2 demonstrated a loss of the therapeutic level between 4 and 8 hours after administration. No clinical signs of bleeding or other problems related to drug administration were detected in our cats.

The results of this study suggest further evaluation of dalteparin sodium in cats at clinical risk of thromboembolic disease is warranted. Our data supports an initial dose of 100 IU/kg, but further research is necessary to determine dose frequency and efficacy. Beta cell antibodies and insulin antibodies are involved in the pathogenesis of diabetes in human patients. Beta cell antibodies have also been found in about 50% of newly diagnosed diabetic dogs.

The objective of this study was to examine the role of these antibodies in feline diabetes. The serum of 15 newly diagnosed untreated diabetic cats and of 30 cats with diseases other than diabetes was examined for beta cell and insulin antibodies. For beta cell antibody testing purified beta cells from a radiationinduced transplantable rat insulinoma were used. Serum from cats in which antibeta cell antibodies were induced by injecting a purified beta cell suspension subcutaneously was used as positive control. Following incubation with test sera, fluorescein-labeled anti-cat immunoglobulins were used to visualize binding between the beta cells and cat gamma globulins. Each serum was tested on 2 different tumor preparations. For the detection of insulin antibodies, a charcoal separation method was used.

It was found that none of the diabetic cats and none of the cats with diseases other than diabetes had antibodies against beta cells or against endogenous insulin. It is concluded that immune-mediated processes are not causing diabetes in the cat. Further studies are needed to determine the etiology of feline diabetes.

MENTS BY CAPILLARY BLOOD SAMPLING. G. Wess and C. Reusch. Clinic for Small Animal Internal Medicine, University of Zurich, Switzerland.

Serial blood glucose measurement is an integral part in the management of diabetes mellitus. However, hospitalization and difficult veni-puncture are often stressful for the animal and thus, concentration of blood glucose may not reflect the animal's status at home.

The purpose of this study was two-fold: first, to develop a method for obtaining an adequate drop of capillary blood from the ear of dogs and cats to measure blood glucose concentration using a portable blood glucose meter (PBGM), and second, to evaluate two PBGMs using either capillary or venous blood.

Capillary blood was collected using two different methods. The first method (group size: 40 adult dogs) consisted in prewarming the ear and used a lancing device (Softclix Pro). The second method (used in 40 adult dogs and 80 adult cats) employed a new commercial vacuum lancing device (Vaculance). The PBGMs used in this study were Glucotrend and Glucometer Elite. Capillary PBGM readings were compared with PBGM values, using venous blood and with those of a hexokinase reference method.

Both methods of capillary blood sampling were fast, easy to perform and yielded an adequate amount of blood to reliable measure the glucose concentration. Sampling of capillary blood using the Vaculance device was tolerated very well in all animals. Using the Softclix method, a second person was required to hold the animal's head in a few cases. The Vaculance method was faster and easier to perform. Varying performance of the PBGM was found in different glycemic ranges. Both PBGM underestimated the reference values in most cases. The underestimations were small in the low, slightly higher in the normal and highest in the high glycemic range. Capillary glucose readings of Glucometer Elite were in most cases slightly lower, compared to the corresponding venous glucose values, whereas Glucotrend capillary glucose readings were overall slightly higher (and therefore closer to reference values) than Glucotrend venous glucose readings. 100% of estimations of both PBGM were within clinically acceptable zones.

The measurement of capillary blood glucose using PBGM is cheap, clinically accurate, easy and fast to perform. These simple methods may allow the owners of diabetic patients to measure blood glucose at home and hence, it could serve as a new and important tool in the management of diabetic dogs and cats. Exertional rhabdomyolysis (ER) occurs most often in mares and is suggested to occur more frequently during estrus than diestrus. The effect of one week of 10 mg/day 17␤ estradiol or 200 mg/day progesterone on pre-and 4 hr postexercise serum CK activity and muscle glycogen concentrations was evaluated in ovariectomized mares fed either hay only or hay and 5 kg/day of grain. Ovariectomy was performed 1 month prior to the study on 5 normal Thoroughbreds (TB) and 2 mares (TB and Arabian) with a history of ER. Muscle glycogen was assayed from percutaneous gluteal biopsies taken before, during and after 30 min (4-8 m/s) of exercise.

Post exercise CK activity was Ͻ 800 U/L in 5/6 TB horses for all exercise tests. Post-exercise CK in 1 ER mare was between 1000-5200 U/L in 4/6 tests and 3,800-138,000 U/L in 6/6 tests for the other ER mare. No clear association between change in CK and hormonal supplement was apparent in the 5 TB or 2 ER susceptible horses apart from a tendency to lower CK with estradiol in normal horses. Muscle glycogen concentrations on the hay-only diet were unaffected by estradiol supplementation but mean concentrations were 50-60 mg/ kg dw lower at all time points with progesterone supplementation. Feeding sweet feed had little effect on muscle glycogen concentrations with estradiol or no hormonal supplementation. However, mean muscle glycogen concentrations were restored to normal in grain fed mares on progesterone. In conclusion, ovariectomy or hormone supplementation did not prevent ER in susceptible horses. Estradiol did not induce greater changes in CK with exercise in either normal or ER susceptible horses. Supplementing mares with 200 mg of progesterone IM /day may reduce muscle glycogen concentrations if horses do not receive grain supplementation. The Syndrome of Inappropriate Secretion of Antidiuretic Hormone (SIADH) is a rare disorder in dogs characterised by hypo-osmolality and persistent arginine vasopressin (AVP) production, in the absence of hypovolemia and/or hypotension. Polydipsia is the presenting clinical sign common to all previously reported cases of canine SIADH. Current management involves the restriction of the patient's water intake so that ongoing urinary and insensible losses induce a negative water balance and body fluid volume is restored toward normal. The dog in this case did not present with polydipsia so water restriction was not considered a practical therapeutic option.

The purpose of this study was to evaluate the efficacy and safety of the nonpeptide selective AVP V 2 receptor antagonist OPC-31260 in a dog with naturally occurring SIADH. Oral administration of OPC-31260 at a dose rate of 3 mg/kg resulted in marked aquaresis with a rise in urine output and a decline in urine specific gravity within one hour. Corresponding increases in the levels of plasma sodium, plasma osmolality, and plasma renin activity were recorded over a four hour period. The AVP level remained inappropriately elevated throughout the study. The results were similar when the trial procedure was repeated after a stabilisation period of twelve days. Long-term therapy with OPC-31260 at a dose of 3 mg/kg PO q 12 h resulted in good control of clinical signs with no deleterious effects detected during a three year follow-up period. Despite the sustained clinical benefits observed in this case, plasma sodium did not normalize with continued administration of the drug.

We concluded that: 1) Treatment of a dog with naturally occurring SIADH with the AVP receptor antagonist OPC-31260 at a dose of 3 mg/kg PO q 12 h resulted in marked aquaresis and significant palliation of clinical signs with no discernible side effects detected over a three year period. 2) OPC-31260 appears to offer a feasible medical alternative to restriction of water intake for the treatment of dogs with SIADH. 3) Higher doses of OPC-31260 may be required in order to achieve and maintain normal plasma sodium in dogs with SIADH. Under physiologic conditions, a rise in intracellular free calcium ([Ca 2ϩ ] i ) is the trigger for insulin release from pancreatic ␤ cells. Norepinephrine (NE), a potent inhibitor of insulin release, acts in part by lowering [Ca 2ϩ ] i . We investigated the mechanisms by which NE lowers [Ca 2ϩ ] i using indo-1 microfluorimetry to measure [Ca 2ϩ ] i in single HIT-T15 cells, a hamster-derived ␤ cell line. The possibility that NE directly inhibits calcium influx via voltage-dependent Ca 2ϩ channels (VDCC) was tested using a depolarizing concentration of potassium chloride (KCL) to open VDCC. We found no effect of NE (10M) on [Ca 2ϩ ] i in the presence of 35 or 20 mM KCL or in cells depolarized by the incremental addition of 3 to 5 mM KCL. In the event that NE interacts with VDCC only in the presence of glucose (GLU), we depolarized cells using 20 mM KCL in the presence of diazoxide (DIAZ) and 10 mM GLU. Again, NE had no effect on [Ca 2ϩ ] i . We next examined the possibility that NE lowers [Ca 2ϩ ] i by direct activation of KATP channels. Activation of KATP channels indirectly lowers [Ca 2ϩ ] i by preventing VDCC from opening. In GLU-stimulated HIT cells, DIAZ The Burmese breed was reported to be overrepresented amongst cats with diabetes mellitus in Australia. The purpose of this study was to investigate whether there was evidence for a genetic aetiology amongst Burmese diabetic cats from New Zealand.

Pedigrees were obtained for 336 Burmese cats. Of these, 17 cats were diagnosed with diabetes mellitus and 17 showed no evidence of diabetes. The remaining 302 cats were unobserved relatives of the affected individuals. All affected cats were born between 1974 and 1989, and where the age of onset was known, this was always above 10 years.

Diabetic pedigrees were analyzed according to criteria by Nicholas (1987) for evidence of a genetic aetiology and type of inheritance. Evidence for a genetic aetiology was based on the finding that the prevalence of diabetes in some families was greater than in others. Thirty-five animals in the data had more than 10 descendants. Of these, 23 cats had more than 10% of all their offspring affected with diabetes. The highest proportion of affected progeny was 29%, and the lowest proportion of affected descendants was 0%. Males and females were both affected, suggesting that the gene or genes causing diabetes are autosomal rather than sex-linked. Of the 17 affected individuals, 16 were of known gender, of which 4 were female and 12 were male. The disorder showed few signs of dominant gene action: it was rarely seen in sequential generations and nearly always skipped at least one and often more generations; and apparently unaffected offspring from apparently unaffected parents sometimes produced affected progeny. Recessive inheritance of diabetes could not be disproved, nor, however, could it be supported conclusively.

This study demonstrated that there is clear evidence of genetic aetiology with some cats having more than 10% of their offspring affected. The condition was not sex linked and was unlikely to be dominant, but the study was unable to prove recessive, polygenic or multifactional inheritance. The aim of this study was to compare a variety of clinical and clinicopathological parameters for monitoring insulin treated diabetic cats over a period of up to 12 months for each cat.

Results from a total of 19 diabetic cats recorded over a treatment period ranging from 2 to 12 months are reported. Cats were treated with porcine lente insulin (Caninsulin) twice daily. Samples were taken at 4, 8, 12, 26, and 52 weeks of therapy. Parameters studied included 24 hour water intake in hospital, excluding water in food (W), blood glucose, fructosamine (Fr), betahydroxybutyrate (B-OH), cholesterol (Chol), and triglycerides blanked for free glycerol (TG). Serial blood glucose curves measurements were taken every 2 hours for 24 hours to obtain mean blood glucose (MBG), the standard deviation of blood glucose (SDBG), and the J index (J), which arithmetically combines the MBG and the SDBG into a single value. The parameters were correlated against each other in pairwise fashion using Pearson Product Moment correlation.

Parameters which were significantly correlated were MBG and Fr (nϭ45, pϭ0.003, coeffϭ0.439), W and Fr (nϭ42, pϭ0.037, coeffϭ0.323), pϭ0.010, coeffϭ0.384), MBG and W (nϭ42, pϭ0.0001, coeffϭ0.562), pϭ0.01, coeffϭ0.385), and W and J (nϭ42, pϭ0.001, coeffϭ0.511) . The values of Fr and J were not significantly correlated (nϭ45, pϭ0.151, coeffϭ0.218) despite both these values being well correlated to water intake.

It was concluded that the parameters MBG, J, W, and Fr were the most closely matching indicators of control in insulin-treated diabetic cats. Measurement of water intake over a 24 hour period correlates well to MBG and Fr, and provides a simple, cost effective indicator of diabetic control. The purpose of this study was to establish reference values for the glucose tolerance test, insulin tolerance test and insulin sensitivity test in clinically normal cats, and to determine the variability in the tests over a 6 week period.

Thirty-two clinically normal, non-obese cats (as determined by body weight and body mass index), were acclimatised for two weeks to the holding facilities and a standard diet (32%protein, 9.9% fat, 2.6% C.F., 6.7% ash, 8.0% moisture). An intravenous glucose tolerance test (0.5g of glucose /kg), insulin tolerance test (0.1U of regular human insulin/kg) and an insulin sensitivity test (0.3g of glucose/kg at 0-min, followed by 0.05U of regular human insulin/kg at 20-min) were performed on consecutive days in each cat via a jugular catheter. In eight cats, the tests were repeated after an interval of six weeks.

During the glucose tolerance test, the fasting plasma glucose concentration (mean Ϯ SD) was 71 Ϯ 14 mg/dl, fasting plasma insulin was 8.3 Ϯ 4.4 U/ ml, glucose half-life (T1/2) was 56.8 Ϯ 8.8 minutes and the glucose disappearance coefficient (K) was 1.25 Ϯ 0.2%/minute. During the insulin tolerance test the mean glucose disappearance coefficient (K itt ) was 3.83 Ϯ 1.67%/min. The mean insulin sensitivity index (determined by minimal modeling) was 2.98 Ϯ 1.84 x 10 Ϫ4 (min Ϫ1 /U/ml). There were no significant (PϽ0.05) differences in any of these values after an interval of six weeks. The coefficient of variation was low for most values but was moderate for S I (47%) and high for K itt (60%) possibly reflecting the marked changeability of in vivo insulin sensitivity which may occur as part of the maintenance of normal glucose tolerance.

We conclude that standardization of test protocols and establishment of a validated range of reference values for these tests will assist in the identification of cats with impaired glucose tolerance and insulin insensitivity. Sporadic reports in human medicine have linked furosemide to the development of glucose intolerance in normoglycemic patients and deterioration of glycemic control in diabetic patients. This study was designed to evaluate parameters of glucose homeostasis in normal (Part I; nϭ6) and diabetic (Part II; nϭ6) dogs receiving furosemide therapy. In Part I, glycemic parameters (fasting serum glucose and insulin concentrations, insulin sensitivity, and glucose effectiveness) were assessed in healthy beagles following acute and chronic furosemide administration. The acute trials evaluated the effects of intravenous furosemide administration (0 mg/kg (saline), 2 mg/kg, and 6 mg/kg q8 hours for 24 hours; randomized crossover design) and the chronic trials evaluated the effects of oral furosemide administration (2 mg/kg and 4 mg/kg q12 hours for 21 days; randomized crossover design). Glycemic parameters were not significantly affected by furosemide administration (pϾ0.05). In Part II, alloxan was used to induce insulinopenic diabetes mellitus. Following stabilization with exogenous insulin therapy, three acute furosemide trials (0 mg/kg (saline), 2 mg/kg, and 6 mg/kg IV q8 hours for 24 hours; randomized crossover design) and two chronic furosemide trials (0 mg/kg (empty capsule) and 2 mg/kg PO q12 hours for 21 days; randomized crossover design) were performed. As in the normal dogs, no significant changes were seen in the assessed glycemic parameters following furosemide administration (pϾ0.05).

In conclusion, furosemide had no effect on glucose tolerance at the doses administered to this group of dogs. This is the first study to evaluate the effects of furosemide on glucose tolerance in dogs, and the results suggest that furosemide can be used in the treatment of diabetic dogs with no adverse effects on glycemic control. Insulin-dependent diabetes mellitus (IDDM) usually occurs as a sporadic disease in dogs. There is evidence for a genetic contribution to developing the disease in some dogs; the genetic aspects of inherited IDDM have been previously reported in the Keeshond. Though Samoyed dogs are among the many breeds that develop spontaneous diabetes mellitus of undetermined etiology, a familial or genetic predisposition has yet to be reported. This investigation provides evidence for a familial disposition to diabetes mellitus in Samoyed dogs.

Five adult Samoyed dogs from two unrelated litters were diagnosed with diabetes mellitus. Two affected full-sibling male dogs from a litter of 9 dogs (Litter A) were raised in the same household. The other three dogs (2 male, 1 female) from an unrelated litter of 6 dogs (Litter B) were raised in a similar geographic area but in different households. Persistent hyperglycemia and glucosuria at the time of initial diagnosis confirmed diabetes mellitus in all dogs. In addition, plasma insulin C-peptide concentrations were determined when possible from insulin treated dogs as an estimate of endogenous insulin production.

Age at the time of diagnosis ranged from 3.5 to 7.8 years (median ϭ 6.0 years). All five dogs demonstrated fasting hyperglycemia ranging from 341 to 711 mg/dl (median ϭ 490), and glucosuria (Ն 2,000 mg/dl), at the time of diagnosis. All 5 dogs initially presented with clinical signs of polyuria and polydipsia. Three of 3 dogs tested (2 from Litter A and 1 from Litter B) had insulin C-peptide concentrations less than 0.05 pmol/ml (reference range 0.17Ϯ 0.01 pmol/ml). Long term administration of an intermediate-acting insulin resolved clinical signs in all dogs.

In conclusion, these results provide evidence for a familial predisposition to adult onset, insulin-dependent diabetes mellitus in Samoyed dogs. Further analysis of pedigree information, breeding studies, and investigation of additional biochemical and pathologic abnormalities are necessary to fully characterize this finding. In June 1998, the Michigan State University Animal Health Diagnostic Laboratory began running a commercially available (Oxford Laboratories, Oxford MI) canine thyroglobulin autoantibody (TgAA) assay as part of routine thyroid function testing. A retrospective study was done on the first 27,548 laboratory samples to determine some factors related to positive results obtained from the assay. In addition, age of TgAA positive dogs was compared to age of dogs with idiopathic hypothyroidism.

Results indicated that 8.3% of samples were positive (Ͼ200% of negative control). Less than 5% of samples from dogs weighing Ͻ10 kg. were TgAA positive while Ͼ9% of samples from dogs Ͼ10 kg. were positive. Dogs Ͻ2 years of age had few (Ͻ5%) TgAA positive samples; samples from dogs 2 to 6 years of age were positive 9.5 to 12% of the time and samples from dogs older than 6 were positive less often. No sex predilection was found. Over 50% of TgAA positive samples were from dogs Ͻϭ5 years of age while it took until 8 years of age to obtain Ͼ50% of samples from dogs with idiopathic hypothyroidism. This supports the hypothesis that idiopathic hypothyroidism may be a sequelae of autoimmune thyroiditis. Eight breeds with significantly higher ( This study was undertaken to 1) identify clinical signs associated with subclinical thyroiditis (SCThyr; normal T4 and TSH with thyroid hormone antibody (THAA)) and subclinical hypothyroidism (SCHypoT4; normal T4, increased TSH), 2) assess the effect of THAA status on the clinical presentation of hypothyroidism (HypoT4) and 3) evaluate some signs which often initiate thyroid investigation. The lab records of 58,322 cases in which clinicians had checked at least one of 32 pre-printed clinical signs on the request form were reviewed. These were categorized based on T4, TSH and THAA results into: healthy (Norm); antibody positive (ϩve) and negative (Ϫve) HypoT4; SCThyr; ϩve-SCHypoT4 and ϪveSCHypoT4. Chi-square analysis compared rates of each sign to its reference in the Norm group. A p-value of 0.05 inferred statistical significance and odds ratios of Ͼ 1.10 or Ͻ 0.91 arbitrarily inferred biological significance. In the SCThyr group, obesity was more common than in Norm cases, but crusts, dermatitis-moist, dermatitis-erythema, hyper-pigmentation, lichenification, pyoderma, papule and pruritis were under-represented. Lethargy was more frequent in both SCHypoT4 groups but ϩveSCHypoT4 had less pruritis, otitis, pyoderma, crusts, and seizures and more obesity and diarrhea, than Norm dogs. The -veSCHypoT4 group had more hyperpigmentation, seborrhea, crusts, hyperkeratosis, lichenification and acanthosis. Comparison between the two HypoT4 groups indicated more obesity and lethargy in the ϩve group but less abrasions, acanthosis, crusts, dermatitis-moist, dermatitis-erythema, hyperkeratosis, infertility, lichenification, polydipsia, polyuria, pyoderma, pruritis, seborrhea and weight loss. Between the two SCHypoT4 groups there was more obesity, lethargy and diarrhea in the ϩve group but less crusts, otitis, pyoderma, pruritis and seborrhea. In conclusion, subtle differences in clinical presentation between the antibody ϩve and -ve dogs with thyroid disease are limited to higher rates of obesity and lethargy, and fewer cutaneous manifestations in the antibody positive dogs. None of the 32 signs in this study could be used to help identify suspect cases of subclinical thyroiditis. In addition, despite being common initiating signs for thyroid investigation, infertility, otitis and seizures were not overrepresented in any disease group suggesting that there are much more common causes for these signs other than thyroid disease or dysfunction. Summer pasture-associated pulmonary disease (SPAOPD) is a recurrent seasonal disease observed in horses residing on pasture in southeastern region of United States. It is a naturally-acquired progressive, obstructive pulmonary disease of the small airways characterized by coughing and pronounced abdominal lift at the end of exhalation. The clinical signs, laboratory and histopathologic findings were studied in 8 adult horses affected with SPAOPD and compared to 6 adult horses without evidence of respiratory disease. The clinical score was calculated by assessing the nostril flare and abdominal lift. The change in pleural pressure (⌬Ppl) was measured indirectly by an esophageal balloon during tidal breathing. Cytology and bacterial culture were performed on bronchoalveoar fluid (BALF) collected via fiberoptic endoscopy. Light microscopy of pulmonary parenchyma was performed on samples collected via percutaneous lung biopsy and at postmortem from each lung lobe.

The clinical score (CS) for SPAOPD-affected horses (median 5.75) were significantly greater than for normal horses (median 2.0). Cytology of BALF from SPAOPD-affected horses yielded predominantly non-degenerative neutrophils. Histopathologic lesions were identified diffusely throughout the lung lobes and included bronchiolar goblet cell metaplasia, marked accumulation of basophilic mucus and mild peribronchiolar inflammatory infiltrate. Histopathology of percutaneous biopsies compared well with samples collected at post-mortem. The CS was highly correlated to ⌬Ppl; and CS and ⌬Ppl were highly correlated to mucus accumulation in SPAOPD-affected horses. Therefore, clinical scoring is a valid estimation of disease severity; BALF, although variable, was diagnostically useful; and lung biopsy was consistently useful diagnostically. Moreover, lung biopsy procedure was safe as no complications were observed. It has been previously demonstrated that ionized hypocalcemia occurs in cats with urethral obstruction. The purpose of this study was to measure serum PTH concentrations in cats with urethral obstruction to evaluate the parathyroid response to changes in ionized calcium.

Blood was collected from 19 cats with urethral obstruction prior to any therapy. Measurments included iCa 2؉ (mean 1.065 mmol/L, median 1.12, SD 0.155, range 0.71-1.25), PTH (mean 11.0 pmol/L, median 5.3, SD 12.0, range 1.7-41.7), 25 OH Vit D (mean 115 nmol/L, median 101, SD 72.9, range 34-316), pH (mean 7.29, median 7.34, SD 0.12, range 7.07-7.43), K ؉ (mean 5.29 mmol/ L, median 4.90, SD 1.49, range 3.89-8.60), BUN (mean 88 mg/dl, median 37, SD 95, range 20-301), Creatinine (mean 5.5 mg/d, median 1.9, SD 5.9, range 0.6-18.2), Phosphorus (mean 8.2, median 5.5, SD 5.9, range 4.5-24.1), Total Calcium (mean 9.2 mg/dL, median 9.7, SD 1.3, range 6.6-10.7), and albumin (mean 3.6 g/dL, median 3.6, SD 0.3, range 2.8-4.1). Statistically significant inverse correlations were found between ionized calcium and both PTH and phosphorus.

It appears that parathyroid gland secretion of PTH in response to ionized hypocalcemia in cats with urethral obstruction is appropriate and low PTH is not the cause of ionized hypocalcemia in these cats. The pathogenesis of feline hyperthyroidism is not understood. We have attempted to further characterize this endocrinopathy on a molecular basis by investigating the abnormalities of signal transduction at the G protein level. Through previous studies, we have shown that thyroid tissue from hyperthyroid cats have decreased expression of the G-i class of G proteins, classically thought to inhibit cAMP production. The purpose of this study was to develop an in vitro system in which to investigate activation of these G proteins in isolated membranes from hyperthyroid tissue, and to examine differential activation of the G proteins in response to treatment with TSH agonist.

Enriched membrane preparations from euthyroid and hyperthyroid cats were prepared. Activation of G proteins was assessed by measurement of specific binding of a poorly-hydrolyzable GTP analog, GTPg35S that binds to activated G proteins. The amount of binding was measured by 35S scintillation counting. Nonspecific binding was quantified by addition of a 100-fold excess of cold GTPgS under identical experimental conditions.

Feline thyroid membranes were treated with bovine TSH at concentrations ranging from 1-300 mIU/ml. A maximal response of approximately 65% increased GTPgS binding over background was seen at 100 mIU/ml TSH. Mastoparan, a receptor-independent G protein agonist, resulted in a increase of GTPgS binding of 115% over background indicating that it stimulated a population of G proteins not activated by TSH.

In conclusion, we have demonstrated a significant and specific activation of thyroid cell G proteins in response to an appropriate agonist, TSH, in an in vitro system. This system can be used to examine the role of G protein activation in thyroid membranes from hyperthyroid cats and possibly to examine the effect of potential goiterogens in an in vitro system. Both SARD and HAC are well recognized syndromes in dogs. An association between the two has been suggested in the literature and amongst veterinary practitioners. The purpose of this study was to determine prevalence of HAC in dogs diagnosed with SARD at our hospital. For inclusion, dogs must have been diagnosed with SARD between 1/1/1990 and 12/31/1998. Records of each dog were evaluated for: 1) any owner or clinician observations suggestive of HAC: polyuria (PU), polydipsia (PD), polyphagia (PP), or nonpruritic hair loss (NPHL); 2) a serum biochemistry profile and urinalysis (UA) with changes typical of HAC: urine specific gravity (SG) Յ1.020, BUN Յ20mg/dl, or increases in SAP, ALT or cholesterol (CHOL). All dogs with an abnormality consistent with HAC must have undergone at least 1 of 3 screening tests for HAC: ACTH stimulation; low dose dexamethasone; urine cortisol:creatinine. 44 dogs (3-14 yrs old; mean: 8.1 yrs; 30 females) were diagnosed with SARD. 16/44 dogs had at least one abnormality consistent with HAC. 15 dogs were thought to be PU/ PD, 11 PP, 1 had NPHL, 9 had low SG, 10 had decreased BUN. Increases in SAP, ALT & CHOL were documented in 10, 9, and 5 dogs, respectively. 8 of the 16 dogs (18% of 44; 50% of dogs with suspect HAC) had at least one screening test result consistent with the diagnosis of HAC suggesting that owners of dogs with SARD be carefully questioned regarding signs of HAC and that all dogs with SARD be evaluated with at least a serum biochemistry profile and UA.

PANCREATIC ␤ CELLS T. Schermerhorn, M. Noda, K. Sooy*, S. Christakos*, and G.W.G. Sharp. NYSCVM, Cornell University, Ithaca, NY. and the UMDNJ-NJ Medical School, Newark, NJ(*).

Calbindin-D 28K is a 28 kD Ca 2ϩ -binding protein that is expressed in the pancreatic islets of many mammals, including dogs and cats. Since a rise in cytosolic free calcium ([Ca 2ϩ ] i ) is an important stimulus for insulin release, we investigated the role of calbindin in Ca 2ϩ -mediated insulin release. Methods: Two experimental systems were used: 1) pancreatic islets isolated from mice that lack the gene for calbindin production [knockout mice (KO)] and 2) a calbindin overexpression system using a transfected mouse pancreatic ␤ cell line HC-13 cells). Fluorimetry was used to measure cytosolic free calcium ([Ca 2ϩ ] i ) and insulin was measured using a standard RIA. Depending on the experiment, either potassium chloride, which causes insulin release via cell depolarization, or glucose was used as the stimulus for insulin release. Results: Potassium chloride (KCl) caused a larger increase in peak [Ca 2ϩ ] i in islets from KO mice than in control islets from wild type mice (WT) that had normal production of calbindin (1260 nM vs 670 nM, respectively; p Ͻ 0.05). The greater increase in [Ca 2ϩ ] i in KO islets was accompanied by an altered pattern of KCl-induced insulin release. Although the 1st phase of insulin release was the same in both types of islets, the 2nd phase of insulin release was sustained in islets from KO mice relative to WT islets, as measured by the time required for rate of insulin release to fall to 25% of the peak rate (45 min. in KO vs 29 min. in WT; p Ͻ 0.05). In experiments using HC-13 cells, we found that calbindin overexpression lowered the resting [Ca 2ϩ ] i (180 nM vs 215 nM in controls) and markedly inhibited KCl-induced changes in [Ca 2ϩ ] i (225 nM vs 820 nM in controls). Calbindin overexpression also decreased KCl -stimulated insulin release by 80 to 95% from control levels. In another series of experiments, [Ca 2ϩ ] i and insulin release were measured in glucosestimulated islets. In these studies, glucose elicited greater insulin release from KO islets than from WT islets. Even though the glucose-induced rise in [Ca 2ϩ ] i was the same for both KO Fecal occult blood testing may be necessary to detect gastrointestinal hemorrhage, before melena becomes visible. However, dietary contents can influence these tests, so it was the purpose of this study to evaluate various diets in a guaiac based (HemoFEC, Boehringer) and o-tolidine (Hemotest, Bayer) based test kit.

Six cats were fed eight different diets for one week and feces were collected and analyzed always during the last three days. Cats were fed cottage cheese as negative control and cottage cheese with canine blood as positive control. For results see Pepsinogens are unbranched polypeptides that are synthesized in chief cells of the gastric body and fundus. Under acidic conditions pepsinogens autoactivate spontaneously to pepsins. Serum immunoreactive pepsinogens are useful markers for several distinct gastric disorders in human beings and cattle. Pepsinogens have been purified in several species but to our knowledge its purification in horses has not previously been reported. The aim of this work was to purify and partially characterize equine pepsinogens as a prelude to developing immunoassays for quantification of pepsinogens in horse serum.

Mucosa was scraped from the stomach of a freshly slaughtered horse, homogenized, and the homogenate centrifuged. The supernatant was further purified using weak anion exchange on diethylaminoethyl-sepharose (DEAE), strong anion exchange on mono-Q, and size exclusion chromatography on Sephacryl-S100. The N-terminal amino acid sequences of the purified proteins were obtained by the Edman degradation method and the use of a gas phase amino acid sequencer.

Two distinct peaks of equine pepsinogen were identified after weak anion exchange chromatography. Both isoforms migrated as single bands on sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). The two pepsinogens were labeled equine pepsinogen A (ePG A; migrated furthest towards the anode on agarose gel electrophoresis) and equine pepsinogen C (ePG C) according to their elution profile. The N-terminal amino acid sequence of the first 25 amino acids of ePGA and ePGC are Leu-Ile-Tyr-Lys-Val-Pro-Leu-Val-Lys-Lys-Lys-Ser-Leu-Arg-Gln-Asn-Leu-Arg-Glu-Asn-Gly-Leu-Leu-Glu-Asp and Leu-Ile-Tyr-Lys-Val-Pro-Leu-Val-Lys-Lys-Lys-Ser-Leu-Arg-Gln-Asn-Leu-Arg-Glu-Asn-Gly-Leu-Leu-Ala-Asp, respectively (the only difference between these two isoforms is in position 24). Equine pepsinogens showed good homology with pepsinogens from human beings, pigs, and other species.

In conclusion, the purification method utilized in this work yielded two electrophoretically distinct isoforms of equine pepsinogen with similar molecular weight and N-terminal amino acid sequence compared with the pepsinogens purified from other species. The availability of these pepsinogens will facilitate the development of immunoassays for equine pepsinogens in serum as a diagnostic tool for the diagnosis of gastric disorders in horses. The use of nuclear scintigraphy and the validity of Acetaminophen (AP) absorption in measuring liquid-phase gastric emptying in horses was investigated.

Twelve experiments were conducted in 6 horses. Technetium-DTPA (10 mCi) and AP (20 mg/kg body weight) were administered in 200 ml of water. Gamma camera images of the stomach and serum samples were obtained over a 4-hr period. Half times of gastric emptying (T 50 ) were determined from right and left lateral images and their geometric mean using power exponential curves. Maximum plasma concentration (C max ), time to C max (T max ), area under the concentration vs time curve (AUC) and the appearance rate constant (K a ) for AP were determined using a parameter estimation program (RStrip). Correlations between T 50 and pharmacokinetic parameters of AP absorption were calculated using Spearman's rank correlation coefficient.

Counts derived from left lateral images showed the best fit to power exponential curves. The strongest and most significant correlations were between T max and T 50 , and between K a and T 50 for the left side.

In conclusion, T 50 is best determined by left lateral imaging. T max and K a are the most useful parameters when using the AP absorption method. The application of 99m Tc-HMPAO labeled white blood cells to support the diagnosis of right dorsal ulcerative colitis (RDC) was studied in two horses with a history and clinical signs consistent with phenylbutazone toxicity. Blood was collected aseptically in heparinized syringes from the patients for in vitro leukocyte radiolabeling. The buffy coat was separated out and radiolabeled with 99m Tc-HMPAO. The radiolabeled blood was re-injected IV and four images of the right and left side of the patient's abdomen were acquired at 4 hours and 20 hours post-injection.

Results of the nuclear study revealed no abnormal findings in the abdomen at the 4 hour post-injection images in either horse. Images obtained 20 hours postinjection revealed a linear uptake of labeled white blood cells in the right cranioventral abdomen in the region of the right dorsal colon in both horses. The radiolableled white blood cell uptake in Horse 1 was more intense than in Horse 2. Horse 1 was euthanatized, and RDC was confirmed at necropsy. Horse 2 recovered with medical management. At this point, the severity of detectable RDC lesions with this technique is unknown. This nuclear imaging study offered a rapid, non-invasive diagnostic tool for identifying right dorsal colon inflammation. These findings not only supported the diagnosis of RDC, but also facilitated appropriate medical management of each horse. The aims of this study were to characterise the morphology and neurochemical expression of the equine enteric nervous system (ENS) using tissue culture and immunohistochemistry, with a view to investigating autonomic neuropathies such as grass sickness.

Intestinal samples were harvested fresh from euthanased horses free from gastrointestinal disease. The tissues were microdissected to prepare both wholemount preparations for immunohistochemistry and explant and dissociated culture systems of the ENS. Immunoreactivities for cell markers and neuropeptides were revealed using a standard indirect immunofluorescence technique. These included: anti-VIP (vasoactive intestinal polypeptide), anti-CGRP (calcitonin gene-related peptide), anti-D45 (calcium binding protein), anti-PAN and anti-NFM (neurofilaments), anti-GFAP and anti-S100 (glial and Schwann cell markers). Wholemount preparations were very difficult to prepare in the adult equine intestine and positive results were only achieved using the submucous plexuses.

Both explant and dissociated cell ENS culture systems were successful in the horse, but only those derived from the submucous plexus. This is in contrast to small mammal models where enteric neurons have been cultured from both myenteric and submucous plexuses. This reflects the difficulty in accessing the myenteric plexus in the adult horse. Neurons were grown successfully in culture for 5 days and there is the potential to make this period longer. Three main cell types were evident in dissociated culture: neurons, enteric glia and fibroblasts. Neurons appeared to be bedded down in clumps and non-neuronal cells proliferated markedly after 2-3 days in culture. Double labelling experiments revealed that the enteric glial cells are very similar to the Schwann cells of the peripheral nervous system. This is the first report of equine enteric neurons being grown in tissue culture. The difficulties in accessing and harvesting these neurons in the equine intestine mean that further work is necessary in order to produce a repeatable, quantifiable in vitro model. Magnesium (Mg), an important intracellular cation, has numerous physiologic roles, but the most critical ones are associated with production and utilization of adenosine triphosphate (ATP), function of the sodium-potassium ATPase pump, and regulation of intracellular calcium. Hypomagnesemia has been reported to be common in critically ill human patients. Hypomagnesemia often accompanies other electrolyte abnormalities. The purpose of this study was to survey a population of 75 horses suffering from gastrointestinal disease to determine the incidence of plasma magnesium abnormalities. A total of 90 horses were evaluated and divided into 5 groups: small intestinal strangulation (nϭ27), large colon torsion (nϭ14), enterits (nϭ15), colitis (nϭ19) and clinically normal horses (nϭ15). Total plasma magnesium was determined using a colorimetric procedure.

Thirty-three horses with gastrointestinal disease (44%) were hypomagnesemic at hospital admission. Hypomagnesemia was present in the following percentages: small intestine strangulation (63%), large colon torsion (14%), enterits (33%) and colitis (47%). Eight of the 75 horses (11%) were hypermagnesemic. All clinically normal horses were normomagnesemic and had electrolytes within the normal ranges. Hypokalemia was present in 30% of hypomagnesemic horses, whereas hypokalemia was present in 20% of normomagnesemic horses with gastrointestinal disease. Hypochloremia occurred in 75% of hypermagnesemic horses, compared with 18% in normomagnesemic horses. These results suggest that Mg abnormalities are important in the critically ill horses suffering from gastrointestinal abnormalities. The prognosis and management of leukemia depend in part on the lineage of the leukemic cells. Immunophenotyping using monoclonal antibodies (mAbs) specific for leukocyte differentiation antigens permits definitive identification of cell lineage. The cells from 3 horses diagnosed with lymphocytic leukemia on the basis of peripheral leukocyte cytology or bone marrow histopathology were studied using a panel of monoclonal antibodies and FACS analysis. All horses were subsequently euthanized, and immunohistochemical staining of neoplastic tissues was performed.

By FACS analysis the cells in all 3 cases were confirmed as leukocytes (EqCD11a/18 ϩ, EqCD44 ϩ). However, based on expression of EqCD13 the cells in one of the horses proved to be myeloid, rather than lymphocytic. The two remaining leukemias were both lymphoid (EqCD13 -, EqWC1 ϩ). One of these neoplasms was poorly differentiated, but likely of B cell origin (MHC IIϩ). The other leukemia was of T cell origin (EqCD2 ϩ, EqCD3ϩ, EqCD5ϩ) and on further evaluation was found to be EqCD4 ϩ/EqCD8 -. In addition, up to 20% of the EqCD4ϩ cells were found to be EqCD3-, a phenotype not previously observed in the horse. This latter observation was confirmed by 2-color flow cytometry. Immunohistochemical staining of neoplastic tissues using the same panel of mAbs permitted visual identification of the distribution of neoplastic cells within affected lymphoid organs.

This study demonstrates the utility of mAbs in combination with FACS analysis and immunohistochemistry in defining the lineage and distribution of leukemic cells in horses. Correlation of immunophenotype with biologic behavior and response to therapy may enhance the management of leukemia in the horse. Antimicrobial peptides exist in the intracellular environment and are critical components of the innate immune response. NK-lysin is a novel antimicrobial peptide that has been identified in porcine intestinal tissue, originating from natural killer (NK) cells and cytotoxic T lymphocytes (CTL). Similar peptides have been identified in human NK cells and T lymphocytes. Endogenous antimicrobial killing properties of equine cytotoxic cells have been previously recognized; however, the exact mechanisms of microbial killing remain unknown. The purpose of this investigation was to identify the presence of an NK-lysin homologue in equine NK cells and CTLs, and to determine whether expression of this molecule was related to cell activation.

Lymphocytes were isolated from whole blood using density-gradient centrifugation. Magnetic-bead separation was used for positive selection of CD8ϩ lymphocytes. Cells were stimulated in vitro with the mitogens concanavalin A and phythemagglutinin, and interleukin-2 (IL-2). All cells were washed with 0.1 M PBS and lysed in Trizol reagent. RNA isolation was performed from all populations of cells. Cloning of the cDNA for equine NK-lysin was achieved with RT-PCR using primer pairs selected from the conserved region of porcine and human homologues.

Sequencing analysis revealed that equine NK-lysin shares 87% sequence homology with the porcine peptide. Equine-specific primers revealed constitutive peptide expression in CD8ϩ and CD8-lymphocytes, and in mitogen, and IL-2 stimulated lymphocyte populations. Inducible expression following mitogen and IL-2 stimulation was limited, although expression appeared greater for mitogen stimulated lymphocytes when compared to resting cells.

These data suggest that equine NK-lysin is present in resting and activated lymphocytes. We hypothesize that this peptide is an effector molecule of equine NK cells and CTLs and is a component of the innate immune response. Radiation therapy plays a central role in the management of brain tumors in animals. Conventional treatment protocols vary but typically involve administration of radiotherapy in multiple fractions of 3 to 4 Gy to a total dose of 45 to 50 Gy. A complete treatment course requires multiple anesthetics over periods of 3 to 6 weeks necessitating prolonged hospitalization. Fractionation is required to minimize the damage to normal brain tissue which is also repeatedly exposed with each treatment.

Stereotactic radiation therapy is a technique of providing radiation therapy in one treatment. Cranial computed tomography performed with a stereotactic localizer secured to the skull allows creation of a three dimensional image of the tumor. Using the localizer and the tumor coordinates, radiotherapy is planned and performed by focusing the radiation beam at the tumor while the radiation source rotates in an arc around the tumor. The radiation treatment is applied in three to five arcs with the tumor at the center of each arc. The non-intersecting arcs minimize exposure of normal overlying tissue allowing a larger single treatment dose to be applied (and therefore a lower total dose).

Three dogs were treated with stereotactic radiotherapy using a total dose of 10-15 Gy. A LINAC was used to provide the radiation therapy. Three to five non-intersecting arcs were used in each dog. Two dogs with meningiomas survived 3 1/2 years and 1 year after therapy. The third dog is alive 8 months after therapy. No complications have been observed following use of this technique. Intracranial oligodendrogliomas are a commonly reported neuroectodermal tumor of dogs. The purpose of this study is to report the clinical, imaging, and pathological features of intracranial oligodendrogliomas in 22 dogs.

The medical records of 22 dogs with histopathological confirmation of oligodendroglioma were evaluated retrospectively. Signalment, initial complaint, and results of cerebrospinal fluid (CSF) analysis were recorded. Computed tomography (CT) images were evaluated for the presence of hypo-or hyperdense mass lesions both before and after contrast administration. Magnetic resonance (MRI) images were evaluated for the presence of the following characteristics: location, hyperintensity, isointensity and hypointensity of mass lesions, masseffect, edema, ventricular conformation, contrast-enhancement, and axial versus extra-axial appearance.

Eighteen of 22 dogs were brachycephalic (14 of 22 were boxers). Ages ranged from four to 11 years. The primary complaint by the owners was seizures in 21 dogs, and apparent cervical pain in one dog. MRI was done in 14 dogs, and CT in seven dogs; one dog was not imaged. Mass lesions were identified within the following divisions: rostral fossa 17 dogs, middle fossa 2 dogs, and caudal fossa 2 dogs. MRI characteristics were those of intra-axial mass lesions, usually with a mass-effect. Hyperintensity was noted on PD and T2 weighted images, and hypointensity on T1 weighted images. Non-uniform ring-enhancement was identified in nine dogs; poor enhancement in two dogs, and in three dogs the mass did not enhance with contrast. Irregular ring enhancement was identified in two dogs. Appearance on pre-contrast CT images varied from hypodense to hyperdense. Tumors were variably contrast enhancing on CT images. In two dogs the mass failed to show contrast enhancement.

CSF was analyzed in 15 dogs and despite variable results, 10 dogs showed albuminocytological dissociation. Histopathologic diagnosis was oligodendroglioma in all dogs: seven by means of stereotactic CT-guided brain biopsy, and 15 at necropsy. Five dogs had additional neoplasms unrelated to the intracranialoligodendroglioma. Three dogs had metastasis within the ventricular system.

It is concluded from this study that canine intracranial oligodendrogliomas do have some frequently occurring clinical and diagnostic features, however such features are not common to all oligodendrogliomas. Oligodendrogliomas are rarely reported tumors of the feline central nervous system (CNS). The purpose of this report is to describe the clinical, imaging, and pathological characteristics of oligodendrogliomas affecting the caudal fossa of two aged cats. Results of physical and neurological examinations were consistent with a lesion causing dysfunction of the brainstem and cerebellum. Results of a minimum database (complete blood count, serum chemistry panel, urinalysis, thoracic radiographs and abdominal ultrasound) were unremarkable.

Magnetic resonance imaging (MRI) of the brain of each cat revealed a contrast-enhancing, heterogeneous space-occupying lesion involving the brainstem, fourth ventricle and cerebellum. The lesion in one cat appeared to comprise two separate and discrete parts, while the lesion in the other cat had poorly defined margins. Hydrocephalus was present in both cats. Cells with characteristics consistent with a diagnosis of oligodendroglioma were identified in cerebrospinal fluid (CSF) collected from each cat. Neuropathological diagnosis was confirmed histologically at necropsy, and was supported by immunocytochemical staining of fresh and formalin fixed tissue.

Results of this report suggest that oligodendroglioma should be included on a differential diagnosis list for cats with clinical signs of brainstem and cerebellar dysfunction, and poorly marginated or multi-focal CNS lesions on MRI. In cats, oligodendrogliomas may have a predilection for the caudal fossa. Furthermore, cytological examination of the CSF may provide useful information in the antemortem diagnosis of oligodendrogliomas of cats. In 1997-98, approximately 434 roadkill or trapped opossums were collected in Florida. Opossums weighed from 0.2 to 4.5 kg (mean 1.9 kg) and were equally divided between genders. Feces and gut scrapings were examined for sporocysts by flotation on Sheather's solution, then intestinal sporocysts were harvested from positive animals. Sporocysts were cleaned, counted, and characterized on the basis of 6 genomic DNA sequences that previously have been shown to distinguish S. neurona from S. falcatula. Isolates were either S. neurona, S. falcatula, or dissimilar to both. The last category included 3 distinct Sarcocystis genotypes (species?).

Approximately 22% of opossums were sporocyst-positive. Counts ranged from 6.4 ϫ 10 4 to 6.3 ϫ 10 7 with median recovery of 5.3 ϫ 10 5 sporocysts/animal. S. neurona was recovered from 4.5% of opossums, S. falcatula from 3%, other Sarcocystis ''species'' from 1.7%, and, in 9.9%, isolates were not characterized (usually because of low recoveries). Only 0.5% of opossums had mixed infections. A lower proportion of opossums were S. neurona-positive in the fall and winter than was the case in the spring and summer. Surprisingly, most S. neurona-positive opossums came from within or close to cities rather than from farms.

This study provides compelling molecular evidence that the opossum is host to multiple Sarcocystis species, including S. neurona, S. falcatula, and several previously unknown species. The 4.5% incidence of S. neurona infection in opossums stands in contrast to the reported high rate of exposure of horses to S. neurona (50% by serology). Additional work is required to elucidate the ways in which sporocysts shed by opossums are acquired by horses. Canine erythrocyte (RBC) survival times range from 86 to 122 days as measured by a variety of RBC labeling techniques. Recently, greyhound RBC survival times measured by in vitro biotinylation were reported to be 53.6 Ϯ 6.5 days as compared to 104.3 Ϯ 2.2 days for non-greyhound control dogs (AJVR, 57(5):739-42, 1996) . An inherently shorter RBC lifespan for greyhounds would suggest that, in spite of their frequent use, greyhounds may not be optimal RBC donors for conditions requiring repeated RBC transfusions. The purpose of this study was to reassess RBC survival in greyhounds using in vivo, instead of in vitro, biotinylation.

RBC survival times were determined in 6 greyhounds and 3 non-greyhounds (2 Labrador Retrievers, 1 mixed breed). Each dog was screened for disease with physical examination, complete blood count, serum chemistry profile, urinalysis, heartworm test, fecal flotation, and serology for Ehrlichia canis, Babesia canis, and Rickettsia rickettsii. Each dog appeared free of disease before use. In vivo biotinylation was done by infusing 30 mg/kg biotin-NHS (150 mg/mL in DMSO) through a jugular catheter at 0.1 mL/min. Blood was collected 12 hrs later and then weekly thereafter to determine the percentage of biotin-labeled RBCs at each time. Each blood sample was washed twice in sample buffer (phosphate buffered saline, 1% bovine serum albumin, 180 mg/dL glucose, 0.025% NaN 3 ) before about 10 8 RBCs were incubated with 25 g avidin-FITC in 750 L sample buffer for 1hr. After the RBCs were washed twice with sample buffer to remove unbound avidin-FITC, the percentage of biotinylated RBCs was determined using a Becton-Dickinson FACS Vantage flow cytometer, evaluating 50,000 RBCs per sample.

A survival curve was generated for each dog by plotting ''% biotinylated RBCs'' vs. ''days'' and calculating a least-squares fitted line over the linear portion of the curve (first 11 weeks, r 2 ϭ 0.94-0.99). RBC survivals, defined by the x-intercept of the best-fit lines, were 95, 99, and 117 days for the 3 nongreyhounds, matching well with reported values. Greyhound RBC survival times ranged from 87 to 109 days, with mean and median of 95 and 90 days, respectively. In this study using in vivo biotinylation, RBC survival times in greyhounds were similar to RBC survivals in non-greyhound dogs. Newer, nonradiometric methods to measure survival of red blood cells and platelets use biotinylation of these blood elements as a kinetic marker. Shortened survivals of red blood cells are reported secondary to antibodies produced against the biotinylated red cells. Serial survivals of biotinylated platelets were performed to determine if a similar antibody against biotinylated platelet survivals could be identified.

Initial control experiments showed a reproducible lifespan of approximately seven days, comparable with published data utilizing other methodologies. Six months after obtaining normal autologous, biotinylated platelet survivals on two dogs, repeat biotin platelet survival showed rapid removal of labeled platelets from the blood. Two hours after infusion none of the labeled platelets were detected by flow cytometric means. The dogs' platelets were evaluated for the presence of an antibody directed against biotinylated platelets. Platelet rich plasma from the two dogs was incubated with either N-hydroxysuccinaimide-biotin (NHS-biotin) 1mg/ml final or, for control purposes, NHS-biotin vehicle (DMSO). Platelet bound antibody was detected with 125 I Staph A, 10ng.

Antibodies directed towards biotinylated platelets were detected based on an increase in 125 I Staph A binding. NHS-biotin or a neoantigen created by platelet bound NHS-biotin elicited an antibody response in these dogs. These data suggest that using NHS-biotin platelet canine kinetic studies has a time limitation set by the immune response. We conclude that to avoid anti-NHS-biotin antibody producing artifactual shortening of measured platelet survivals, serial platelet survivals in the same dog should be designed so that the last measured survival is the normal control. Leukocyte reduction of blood products is a technique used at human blood centers to aid in the prevention of leukocyte induced transfusion reactions. It is considered an important precaution for people who are transfused multiple times. The filters currently used for human blood products generally achieve a 99.9% reduction in the number of white blood cells per unit (450 ml) of blood. The goals of this study were 1) to determine if leukoreduction of canine blood could be effectively achieved using an in line, pre-storage leukoreduction filter, and 2) to determine if the leukoreduced red blood cell product would maintain its viability after 35 days of storage. Use of leukoreduction has not previously been documented in dogs.

Two units of blood were drawn from each dog and filtered with a Sepacell-RS2000 in line filter either immediately at room temperature (6 dogs), or after the blood was cooled for 4 hours to 4ЊC (5 dogs). Filtration efficacy was determined by measurement pre and post filtration leukocyte counts from filtration at the two different temperatures. In vitro viability of the red blood cells filtered at room temperature and stored in Adsol was determined by comparing red blood cell ATP level and percent hemolysis before and after the storage period. In vivo viability of the stored cells was determined using a biotin-streptavidin-phycoerythrin labeling technique and flow cytometry.

Filtration of canine blood immediately post collection versus filtration of blood cooled to 4ЊC, achieved mean reductions in leukocytes of 87% and 99.9% respectively. The mean ATP content was 1.90 mol/g Hb pre-storage and 1.51 mol/g Hb post storage; mean hemolysis was 0.08% pre-storage and 0.32% poststorage. These values are comparable to those obtained in previous studies of canine red blood cells stored for 35 days. The mean in vivo 24 hour survival was 85%, which is acceptable according to previously established transfusion standards.

We conclude that the use of the Sepacell-RS2000 leukoreduction filter does not adversely affect in vitro or in vivo viability of canine red blood cells. It effectively removes leukocytes from blood, and maximal efficiency of filtration was achieved when the blood was cooled to 4ЊC prior to filtration. There is potential for this leukoreduction filter to be beneficial for use in multiply transfused canine patients. Erythrocyte morphology was evaluated in 18 greyhounds, 10 with azotemia (creatinine 1.8-19.6 mg/dl) and 8 nonazotemic, with cutaneous and renal vasculopathy. Wright's stained blood smears were evaluated (minimum of 5 fields) by light microscopy and digital imaging. Erythrocytes were classified per 250 erythrocytes as acanthocytes, microcytes, schizocytes, spherocytes, echinocytes, and keratocytes. Type I echinocytes (crenation) were evaluated as the percent of erythrocytes affected.

The number of azotemic dogs with erythrocyte changes were acanthocytes Ն 5/field ϭ 6, microcytes ϭ 3, schizocytes ϭ 6, spherocytes ϭ 2, keratocytes ϭ 1, and type I echinocytes ϭ 1 with 1-5 %, 2 with 50-60%, and 7 with Ն 80%. The number of nonazotemic dogs with erythrocyte changes were acanthocytes Ն 5/field ϭ 3, microcytes ϭ 1, schizocytes ϭ 3, spherocytes ϭ 1, keratocytes ϭ 0, and type I echinocytes ϭ 4 with 1-5 %, 2 with 50-60%, and 1 with Ն 80%. Rare eccentrocytes were noted in 1 azotemic and 1 nonazotemic dog. The erythrocyte changes were increased in association with azotemia, increased fibrinogen concentrations, and decreased hematocrits. All dogs had acanthocytes present, but the striking feature was the number of notched, pinched, and irregularly spiculated acanthocytes in azotemic and nonazotemic dogs. Occasional very small microcytes, round erythrocyte micro-fragments, were seen in 2 azotemic dogs and 1 nonazotemic dog.

It is currently unknown if the atypical acanthocytosis is due to direct erythrocyte membrane damage from endotoxin/bacterial toxins, secondary to microangiopathic damage, oxidative damage, or a combination of these factors. Decreased serum concentrations of urea nitrogen (BUN) and creatinine, low urine specific gravity, and enlarged kidneys are common in dogs with portosystemic vascular anomalies (PSVA). These features suggest increased glomerular filtration rate (GFR) and / or increased water turnover. A prospective study was done to examine the relationship between GFR and renal volume and typical clinicopathologic features of PSVA, before and after surgical attenuation of the anomalous vasculature. Clinical assessments included pre-and post-surgical determinations (CBC, routine serum biochemical analyses, serum bile acids (fasting and postprandial), complete urinalyses, abdominal ultrasound (renal volume determination), per rectal scintigraphy, and GFR). The GFR was estimated by plasma 99m Tc-diethylenetriaminepentaacetic acid ( 99m Tc-DTPA) clearance before (nϭ21) and after (nϭ12) surgical attenuation of PSVA.

Pre-ligation 99m Tc-DTPA GFR was increased (median 5.64 ml/min/kg, range 3.53-8.49 ml/min/kg, reference range 2.83 to 4.47 ml/min/kg) in 81% of dogs. Post-ligation 99m Tc-DTPA plasma clearance decreased significantly in each of 12 dogs assessed (median % change was Ϫ42%, pϽ 0.001). Pre-ligation renal volume was above the expected size for the left and right kidney in 71% (10/14 dogs) and 69% (11/16) of dogs, respectively. Right renal volume decreased significantly (nϭ5, median % change Ϫ45%, pϭ0.003) following surgical attenuation of PSVA.

These findings document that increased GFR exists in dogs with PSVA and substantiates the previous clinical impression of renomegaly in this disorder. We propose that increased GFR is related to increased renal size, the subnormal serum BUN and creatinine concentrations, and low urine specific gravity in affected dogs. The International Feline Heartworm Disease Council advocates the use of chemoprophylaxis for cats at risk of heartworm (Dirofilaria immitis) infection, because it is unknown which cats and how many cats are at risk, however, published guidelines fail to be universally applicable. Knowledge of regional prevalence of heartworm infection could more accurately guide heartworm prophylactic recommendations for cats. The goal of this study was to determine the prevalence of heartworm infection in a healthy client-owned cat population in lower Michigan.

Serum from 1332 healthy cats was tested for the presence of heartworm antigen using an ELISA test kit. Cats included in the study were greater than 8 months old, clinically healthy, and never on preventive heartworm medication. Samples were obtained from 100 participating private practices throughout lower Michigan during the period of July to December 1998. The heartworm antigen test, which is highly specific for adult female heartworms, was used to establish a definitive diagnosis of heartworm infection. However, due to the nature of feline heartworm infection, this test has a low sensitivity in cats and may underestimate the prevalence of feline dirofilariasis. Nonetheless, the antigen test has significant diagnostic utility via its ability to predict the minimum number of infected cats. The prevalence of infection was determined by the number of antigen positive cats.

In this population, 26 of 1332 cats were positive for heartworm antigen. Therefore, the prevalence of heartworm infection in healthy cats in lower Michigan is 1.9%. Many of the antigen positive cats (80%) were from the southeastern part of the state which closely reflects the concentration of canine heartworm disease in Michigan. These findings suggest that knowledge of the prevalence of regional canine heartworm disease can accurately predict the risk of infection for a local feline population. Establishing the incidence of infectious diseases of horses is essential to giving accurate advice to local owners in development programs. Since brucellosis exists in horses in Central America, investigating the incidence of this zooinotec disease also has humane health importance. Husbandry data, ticks, and serum samples were collected on 497 horses presented at clinics in eight communities. Serum was tested for antibodies to B. caballi and B. equi,, using an ELISA. The Standard Brucellosis Card test was used on site for brucella antibody testing. Serum antibodies to EIAV were tested by Coggin's AGID test.

Of the horses, 36% used for packing, and 41% were used both for packing and riding. Median load carried, six days a week, was 90 kgs. A median of one kg. per day of corn was fed to 70% and leaves of Brosimum alicastrum (Moraceae) were fed to 12 %. The mean and median body score was 2.5 (scale of 1-5). 10% of the horses were emaciated. Fistulous withers (grade 4 back score) occurred in 2.4% of the horses. All horses tested (100%) were positive for Babesia equi and 96% were positive for B. caballi. The high frequency of babesia infection was related to the prevalence of ticks of the genus Boophilus and Amblyoma. Only 3% of horses were positive for EIAV and all of these were from one community. No horses were positive for Brucella abortus. This was true even for horses with fistulous withers.

The absence of brucella positive serum indicates that Brucella abortus is either very rare or absent in this population. The presence of EIAV, even at low incidence, may contribute to the debilitation in some horses. Further, study to identify vector populations is warranted. Widespread hemoparasitism in horses in heavy work, on a low plain of nutrition, contributes to their poor physical condition.

The purpose of this study was to evaluate the relationship between Bartonella spp. and uveitis in cats by assaying aqueous humor from cats with and without uveitis for Bartonella spp. antibodies and for presence of Bartonella spp. DNA by polymerase chain reaction (PCR).

Bartonella spp. IgM, IgG, and IgA antibodies were measured by ELISA in serum and aqueous humor of 49 client-owned cats with uveitis, 49 healthy shelter cats, and 9 cats experimentally inoculated with either B. henselae or B. clarridgeiae, 454 days after inoculation. Aqueous humor from some cats was assayed for the presence of Bartonella spp. DNA by polymerase chain reaction (PCR; HESKA Veterinary Diagnostic Laboratories, Fort Collins, CO).

Ocular production of Bartonella spp. IgG (C value Ͼ 1) was detected in 7 of 49 cats with uveitis, 0 of 49 healthy shelter cats, and 4 of 9 experimentally inoculated cats. Bartonella spp. IgM C value Ͼ 1 were only detected in cats with uveitis and Bartonella spp. IgM and IgA antibodies were detected in serum of a greater number of cats with uveitis than healthy shelter cats. The organism was detected by PCR in aqueous humor of 3 of 24 cats with uveitis, 1 of 49 healthy shelter cats, and 4 of 9 experimentally inoculated cats.

Results of this study document that Bartonella spp. infect the eyes of cats following natural exposure or experimental inoculation. However, since Bartonella spp. antibodies or organismal DNA can be detected in aqueous humor from cats with and without evidence of uveitis, these test results cannot be used to definitively document uveitis due to ocular bartonellosis. The ability of tissue culture media-propagated equine rotavirus (ERV) to induce clinical signs of rotavirus infection in 9 healthy colostrum-fed foals Ͻ16 days of age was evaluated after administration of 10 4.2 Ϫ10 6.1 FAID50/kg ERV via nasogastric tube (NGT). Four control foals Ͻ16 days of age were challenged with a placebo of tissue culture media (TCM). All dams but one had serum neutralizing anti-rotavirus antibody titers Ͻ1:768 at foaling; 8 dams had titers Յ 1:192. Foals were monitored daily from 3 days prior to challenge to 28 days post challenge with ERV or TCM. Monitoring included physical examination and assignment of a score for fecal consistency (from 0 ϭ normal to 4 ϭ watery). Neutralizing anti-rotavirus antibody titers were assessed in serum samples harvested weekly from dams and foals, in colostrum, and in weekly milk samples. Daily fecal samples were collected from foals for detection of rotavirus antigens via a solid phase semi-quantitative enzyme immunoassay. 1 Mean values for fecal scores for test foals were significantly higher (fecal consistency looser) than those of control foals after challenge. Rotavirus antigen could not be detected in the feces of control foals before or after TCM challenge. All test foals had detectable rotavirus antigen in feces during the first 14 days post challenge. Dams of 6 test foals showed at least a threefold increase in serum neutralizing anti-rotavirus antibody titers to rotavirus 2-3 weeks after their foals were challenged; this pattern was not seen in the dams of control foals. Two test foals experienced a fourfold rise in serum neutralizing anti-rotavirus antibody titers 3-4 weeks following challenge with rotavirus. There was a trend toward detection of more rotavirus antigen in the feces of foals with lower serum neutralizing anti-rotavirus antibody titers. No clinically significant differences were seen between the test and control foals with regards to rectal temperature, heart rate, or body weight after challenge. We conclude that oral challenge with our tissue culture media-propagated rotavirus induces a reproducible model for rotavirus infection in foals Ͻ 16 days of age.

1 Rotazyme II, Abbott Laboratories, Abbott Park, IL Protein-energy malnutrition occurs in patients with chronic renal failure (CRF) primarily due to loss of appetite. Leptin, a 16-kDa protein recently identified as the ob gene product, is secreted by adipocytes and regulates body adipose mass by affecting food intake and energy expenditure. Leptin has been shown to accumulate in end-stage renal disease in humans and rats and may contribute to uremic anorexia. Plasma immunoreactive leptin was measured by a previously validated radioimmunoassay (Linco Research, St. Louis MO) in 10 healthy cats, 13 cats with naturally occurring CRF and 28 cats with surgically induced renal mass reduction (RMR). Serum creatinine concentrations were significantly higher in 13 cats with naturally occurring CRF compared with 10 healthy cats (3.8 Ϯ 3.0 mg/dl vs 1.4 Ϯ 0.2 mg/dl, pϽ0.05). Serum creatinine concentrations were also significantly higher in 28 cats with RMR compared with 10 healthy cats (3.2 Ϯ 2.1 mg/dl vs 1.4 Ϯ 0.2 mg/dl, pϽ0.05). There were no significant differences in plasma leptin concentration in 17 female cats compared with 11 male cats with RMR (2.5 Ϯ 1.5 ng/ml Human Equivalent (HE) vs 2.1Ϯ 0.9 ng/ml HE, pϭ0.46) indicating that gender is not a major determinant of leptin concentration in cats. Leptin concentrations in 28 cats with RMR were not significantly different than that of the 10 healthy cats (2.3 Ϯ 1.3 ng/ml HE vs 2.4 Ϯ 0.4 ng/ ml HE, p ϭ 0.84). Leptin concentrations in 13 cats with naturally occurring CRF were significantly higher than that of the 10 healthy cats (8.5 Ϯ 7.3 ng/ml HE vs 2.4 Ϯ 0.4 ng/ml HE, pϽ0.05). Furthermore there was a strong positive correlation between plasma leptin and serum creatinine concentration in 13 cats with naturally occurring CRF (R 2 ϭ0.84, pϽ0.0001, leptin ϭ 0.15 ϩ 2.2 creatinine). Gel filtration chromatographic evaluation of plasma from 2 cats with naturally occurring CRF verified that most (81.1, 83.4%) of the observed immunoreactivity was from leptin and not products of leptin degradation or nonspecific crossreactivity of the RIA antisera. Some (13.7, 18.8%) immunoreactivity was found in fractions that would contain proteins of relative molecular weight greater than albumin, possibly leptin bound to a feline form of the soluble leptin receptor. While the mechanism of accumulation of leptin in feline CRF appears to be independent of decrements in glomerular filtration rate, hyperleptinemia could contribute to uremic anorexia and poor nutritional status commonly seen in spontaneous feline CRF. The retina and central nervous system of mammals are highly enriched in long chain polyunsaturated fatty acids (LCPUFA) including arachidonic acid (AA, 20:4n-6) and docosahexaenoic acid (DHA, 22:6n-3). Human milk contains DHA and AA at levels high enough for their rapid accumulation in developing nervous tissues. Infant formulas provide 18 carbon precursors of LCPUFA but these appear to be inefficiently converted and the need for LCPUFA supplementation to reflect human milk remains controversial. The objective of this study was to investigate fatty acid (FA) profiles of total milk lipid extracts from dogs with emphasis on their LCPUFA content and compare them with plasma phospholipid (PL) and diet FA. Milk samples were obtained from four nursing, hereditary nephritis carrier female dogs as follows: Dog A, during weeks 1 and 2 of lactation; dog B, during week 2; dog C, during week 1 and 4; and dog D at week 5. In this way preliminary longitudinal data was also obtained in two animals over time. Diets were a mixture of premium canned and dry puppy growth products. Plasma samples were obtained from dog B at week 2 and dog C at week 4. Total lipids were extracted from all samples, phospholipids were fractionated from sera, and FA methyl esters were prepared and subjected to capillary gas chromatography. Total milk fat was determined gravimetrically.

Milk FA profiles closely reflected the diets fed; both fractions are primarily composed of triglycerides. Plasma PL 18:0 and 20:4n-6 was higher and along with 16:0 accounted for approx. 61% of total PL FA consistent with active de novo synthesis and ␦-6 desaturation during PL synthesis. Milk contained approximately 10% total fat and moderate amounts of AA and DHA. Over time, total milk LCPUFA decreased 10%(Dog A, 1 to 2 weeks) and 18%(Dog C, 1-4 weeks) similar to humans. Calculated % AA and DHA in dog milk were approx. 1.8% and 0.07% respectively. By comparison, recommendations for human infant formula based on human milk are 0.3-1.1% AA and 0.25-0.76 % DHA. Levels of AA in canine milk in this preliminary study are moderately higher while those of DHA are markedly lower. What amounts of n-6 and n-3 LCPUFA are necessary for optimal puppy neonatal development requires further study.

There was no significant difference in the plasma vitamin C or retinol concentrations between groups, however mean plasma vitamin E concentration differed significantly between groups following supplementation (S: 75.3 ug/ml vs. control: 44.3 ug/ml), (pϭ0.006) and after days 1 and 2 of exercise. Mean plasma vitamin E decreased significantly in both groups after day 1 of exercise: group S (75.3 ug/ml vs. 61.1 ug/ml), (pϽ0.001) and control group (44.3 ug/ml vs.35.3 ug/ml), (pϭ0.04), however there was no further decrease. Plasma CK activity increased significantly following exercise in both groups (see figure) however there was no significant difference in CK activity at any time between the groups. Supplementation with dietary anti-oxidants increased plasma vitamin E, but not vitamin C concentrations but did not attenuate exercise-induced muscle damage in these sled dogs. Prolonged exercise, food and water deprivation, and acute enterocolitis can all produce substantial depletion of body fluid and electrolyte stores. Treatment of these problems, especially equine colitis, often requires large (and expensive) amounts of intravenous fluids. We recently demonstrated that administration of a mixture of NaCl and KCl, as a hypertonic oral paste, attenuated body weight loss by increasing voluntary water in horses performing 60 km of endurance exercise on a treadmill. Thus, we hypothesized that oral electrolyte pastes would enhance voluntary water intake in dehydrated horses and that the composition of electrolytes would further influence the rehydration process. After overnight dehydration (4-5% body weight loss) was induced by furosemide administration and withholding of water; voluntary water intake and plasma electrolyte concentrations were determined every 6 hours for 36 hours after administration of 3 oral paste doses of NaCl (total dose of 0.5 g/kg), KCl (total dose of 0.5 g/kg), a mixture of NaCl and KCl (total dose of 0.25 g/kg of each salt), or water (no electrolyte control) in 6 horses. Administration of NaCl or a mix of NaCl and KCl resulted in greater (p Ͻ0.01) voluntary water intake and body weight recovery during the first 18 hours of the rehydration period in comparison to KCl or water administration. Although plasma electrolyte concentrations remained within normal reference ranges, sodium and potassium concentrations were greatest with NaCl and KCl treatments, respectively. In addition, no adverse effects of electrolyte administration in the form of hypertonic oral pastes were observed. In conclusion, administration of oral electrolyte pastes improved rehydration of furosemide-dehydrated horses and the degree of rehydration was influenced by composition of the electrolytes administered. Thus, use of oral electrolyte pastes, in combination with intravenous fluid therapy, could reduce the cost of treatment of horses with severe fluid and electrolyte depletion. Healthy and diseased cats were used to begin to evaluate the effects of Feliway, a synthetic facial pheromone, on behavior and food intake of cats caged in The Ohio State University Veterinary Hospital.

Both client-owned cats with lower urinary tract signs and healthy cats provided by hospital staff were studied. 20 Cats were assigned consecutively to exposure to the pheromone or vehicle, which were provided by the manufacturer in spray bottles marked ''A'' or ''B'' so the investigators were blinded to their contents. Cats were placed in a ward cage containing a small cotton towel that had been sprayed with solution A or B 30 minutes previously. Cats were then videotaped for 165 minutes; food intake during the period was measured to the nearest gram. Videotapes were scored at 5-minute intervals for occurrence of any of a catalog of 5 emotional, 6 activity, 3 resting, 4 consumption and 2 elimination behaviors.

No differences between the behavior of healthy and sick cats were identified. For all cats, highly significant positive correlations were found between grooming and rubbing (0.8), walking and rubbing (0.6), food interest and rubbing (0.8), eating and rubbing (0.8), grooming and food interest (0.94), grooming and eating (0.96). Exposure to Feliway resulted in significant ( 2 , pϽ0.05) increases in episodes of grooming food interest and eating. Food intake also was greater (pϭ0.1, Student's t-test) in cats exposed to Feliway (meanϮs.d. 9.8Ϯ17.6 vs. 0.2Ϯ0.6 gm/165 min).

These results suggest that exposure to Feliway may improve food intake of hospitalized cats, and that increased grooming activity could be a useful indicator of feeding behavior. The primary objective of this pilot study was to determine if partial peripheral parenteral nutrition (PPN) improves nitrogen balance (NB), as an indication of protein sparing, in dogs under-going short term nutritional restriction. Treatment effects on serum folate and insulin-like growth factor I (IGF-I) concentrations were also examined.

Three healthy adult dogs were randomly assigned to treatments in a cross over design. Treatments used were: 5% amino acid (AA), 5% glucose (Glu) solutions, and a control group using an electrolyte (Elec) solution. Solutions were administered intravenously into cephalic or saphenous veins at 60 ml/kg/day for 10 hours/day for 4 days. Serum folate and IGF-I were determined on days 0 and 4; total urine collection was performed on days 3 and 4.

Dogs receiving AA had a positive mean NB (1.38 g) over the last 2 trial days. NB was less negative with Glu (Ϫ8.41g) than with Elec (Ϫ10.08g) infusion. On day 4, serum folate was markedly reduced after AA (35% of day 0 values) but only mildly decreased after Glu (76%) and Elec (78%). IGF-I decreased by day 4 with all treatments, but less with AA (86% of day 0 values) and Glu (80%) than with Elec (73%).

In summary, AA infusion resulted in a positive NB, and Glu infusion appeared to provide some protein sparing compared to Elec. AA infusion decreased serum folate. PPN with AA or Gluc appeared to slightly improve serum IGF-1. In conclusion, these findings suggest that PPN improves NB in healthy dogs undergoing short term caloric restriction, but results need to be confirmed with a larger study. Greyhound trainers believe that thin dogs run faster. This experiment was designed to determine if this was true. Nine racing greyhounds (2-5 years old, 23-33 kg, both sexes) were offered once daily free choice for 30 min a dry diet containing 27% metabolizable energy (ME) protein, 36%ME fat and 27%ME nitrogen free extract for 9 weeks until body weight and food intake had stabilized. Dogs were then randomly assigned to receive either free choice food or 85% of the free choice amount for 9 weeks. Dogs were then crossed over: restricted fed dogs were fed free choice and free choice fed dogs were fed 85% of this free choice amount for 9 weeks. Dogs were weighed weekly and food intake was measured daily. Food intake and body weight stabilized after the first 4 weeks of each diet period. Dogs were exercised twice daily for 15 min in a paddock and raced on an oval sand track over 500 m twice weekly. Race times were measured with a photo-finish camera. Race times, body weights and food intake were compared over the last 5 weeks of each diet period. Total body water was measured by deuterium dilution on a rest day, and blood gases, lactate, CBC and chemistries were measured, before and after racing, during the final (9th) week of each diet period. When food intake was mildly restricted, race times were shorter (32.1Ϯ0.4 vs. 32.5Ϯ0.6 secs; pՅ0.03)), ME intake was less (137Ϯ11 vs. 155Ϯ17 kcal/kg 0.75 ; pՅ0.0001), dogs were lighter (28.2Ϯ2.9 vs. 29.9Ϯ3.3 kg; pՅ0.0001) and there were fewer segmented neutrophils (2194Ϯ794 vs. 2772Ϯ553/L; pՅ0.005). There was no effect on total body water (71Ϯ6 vs. 67Ϯ3%; ␤Յ0.2) or other blood parameters. In conclusion, greyhounds run markedly (0.4 sec or 0.2 m.sec Ϫ1 ) faster over 500 m when food intake is mildly restricted. This is equivalent to 6 m over 500 m. Intraperitoneal (IP) nutrition has been previously reported to successfully maintain dogs. The principal objective of this study was to determine the inflammatory response of the peritoneum to IP administration of nutrient solutions. Twelve healthy adult dogs were given 20% of resting energy requirements via the peritoneal cavity using a once daily, repeat-puncture technique for four days. Four dogs received a 10% dextrose solution, four dogs a 5% amino acid solution, and four dogs a 10% lipid emulsion. The remaining caloric requirements were given orally. On day 1, a baseline diagnostic peritoneal lavage (DPL) was performed. On days 2, 3, and 4, prior to nutrient infusion, a DPL was repeated. The DPL fluid was analysed for total white cell count (TWCC) and differential. Comparisons between groups were made using ANOVA. Twice daily each dog was assessed for abdominal pain, body temperature, heart rate, respiratory rate, mucous membrane colour, pulse quality, and capillary refill time.

The mean bodyweight in the dogs receiving amino acids increased significantly (pϽ0.05) due to residual peritoneal fluid. All dogs remained bright and alert, maintained a good appetite, and tolerated the repeat-puncture technique well. There was no evidence of abdominal pain, nor any changes to the cardinal signs. No episodes of sepsis occurred. Mean peritoneal TWCC in dogs given lipid were significantly higher (pϽ0.05) than those given dextrose or amino acids during most days with the exception of baseline. Administration of dextrose, amino acids, and lipid increased the mean TWCC over baseline with the most marked increase occurring in the lipid group. The predominant cell type on each day was the neutrophil. The neutrophils remained non-degenerate over the fiveday period. Large mononuclear cells became activated with numerous intra-cytoplasmic vacuoles, especially in the dogs receiving lipid. Sudan/methylene blue staining of the DPL sediment from dogs receiving the lipid emulsion identified numerous lipid-containing vacuoles in the large mononuclear cells.

It was concluded that a repeat puncture technique for administering peritoneal nutrients was well tolerated. Dextrose, amino acids, and a lipid emulsion produced evidence of peritoneal inflammation with the lipid emulsion associated with the greatest inflammatory response. Recent research has showed that there are two pools of glycogen in human and rodent skeletal muscle. The glycogen molecules in the two pools differ in their protein to carbohydrate ratios. The proglycogen (PG) molecule contains 10% protein and therefore precipitates in perchloric acid (PCA), while the macroglycogen (MG) molecule only contains 0.35% protein, which makes it soluble in PCA. Therefore, extraction of freeze-dried powdered muscle tissue in icecooled PCA allows separation of MG and PG.

The aims of this study were 1) to establish if MG and PG exist in horse muscle; 2) to compare analysis of total glycogen by acid hydrolysis (AC) with total glycogen obtained by adding MG and PG; and 3) to evaluate the reproducibilty of the AC, MG and PG determinations.

Glycogen concentration in muscle biopsies from 44 normal horses were analysed using each of two different methods; AC and MGϩPG determination. There was a strong correlation between total muscle glycogen values obtained by AC and MGϩPG (rϭ0.99). The error of the analytical methods (within biopsy variability) was calculated from duplicate analyses of individual muscle biopsies (nϭ44). The coefficient of variation (CV) was 3.6%, 3.8%, 6.7% and 4.6% for AC, MGϩPG, MG and PG respectively. The between biopsy variabilty (CV), obtained from two repeated biopsies of the m. gluteus medius (nϭ9), was 3.9%, 8.8% and 6.5% for MGϩPG, MG and PG respectively. The average concentration (Ϯsd) of PG in resting horses was 304 (Ϯ43) mmol glucosyl units/ kg dry weight. The corresponding value for MG was 186 (Ϯ54).

Our data showed that MG and PG exist in horse muscle and can be measured reliably in biopsy-sized samples. With this separation technique, it is now possible to study each pool of glycogen and determine how the two glycogen fractions change under conditions of breakdown and resynthesis. In 4 experimental studies, postparturient problems during the 1st 4 wk of lactation were monitored in 36 control cows and 38 experimental cows that were fed a fatty liver-inducing regimen during the dry period. Selected blood and liver parameters were compared in these cows to characterize the degree of fatty liver. Correlation between blood and liver parameters was also evaluated.

Before parturition, blood and liver parameters were similar between the two groups. After parturition in all cows, blood NEFA and liver triacylglycerol concentrations increased and liver glycogen decreased. Compared with control cows, experimental cows had higher concentrations of blood NEFA (1.01 Ϯ 0.08 v.s. 0.50 Ϯ 0.04 mmol/L, P Ͻ 0.001) and lower concentrations of liver lycogen (0.09 Ϯ 0.01 v.s. 0.13 Ϯ 0.01 mmol of glucose/g wet wt of liver, P Ͻ 0.001), and accumulated greater amounts of triacylglycerols in the liver (93.0 Ϯ 7.6 v.s. 32.5 Ϯ 2.7 mg/g wet wt of liver, P Ͻ 0.001) between 1 and 2 wk postpartum. These results indicate that experimental cows developed more severe fatty liver than did control cows. Experimental cows experienced postparturient problems including milk fever (38%), acetonemia (8%), abomasal displacement (8%), mastitis (10%), and foot problems (8%). Whereas 3%, 6% and 3% of control cows suffered from milk fever, mastitis and foot problems, respectively. Results of pooled data indicate that blood NEFA concentrations positively correlated with liver triacylglycerols (r ϭ 0.57, P Ͻ 0.001) and negatively correlated with liver glycogen (r ϭ Ϫ0.26, P Ͻ 0.05). In conclusion, dairy cows that developed fatty liver postpartum are likely to suffer from postparturient problems. In practice, blood NEFA concentrations postpartum can be used as a routine predictor for the development of fatty liver in dairy cows. The presence of telomerase enzyme activity in a body cavity effusion is a sensitive and specific marker for the presence of neoplasia in humans. Previous reports also indicate that telomerase activity can be detected in samples of effusions collected from dogs with neoplasia. The purpose of this study was to determine if telomerase activity is a specific feature of malignant effusions in canine and feline veterinary patients. Effusion samples were collected from client-owned animals presented to the Texas A&M Veterinary Medical Center. Inclusion in the study required that routine fluid analysis, including cytology, be performed, and that a definitive diagnosis be reached through standard diagnostic tests or necropsy. A total of 42 cases were included in the study. In each case, a sample was collected into a serum tube and centrifuged to obtain a cell pellet, which was frozen at Ϫ80ЊC until the telomerase assay could be performed. Storage time for samples had no evident impact on ability to detect telomerase activity. Each sample was assayed in tow independent experiments to determine the presence or absence of telomerase activity using a commercially available kit (Trap-eze kit; Oncor, Inc.). For telomerase negative samples, a further experiment was performed to rule out the presence of an inhibitor of telomerase activity. In no case was significant inhibition of telomerase activity detected.

We compared results of routing cytologic evaluation with results of the telomerase assay, to determine if either test was superior for the identification of neoplasia. We find that the telomerase assay is only marginally more sensitive than cytologic evaluation, and is less specific for the identification of neoplasia in patients with effusions. (Cytology: sensitivity ϭ 36%, specificity ϭ 100%; telomerase activity: sensitivity ϭ 50%, specificity ϭ 79%). The results of this study indicate that although the telomerase assay may constitute a useful adjunctive test, this test alone is not a sufficient basis to conclude whether a neoplastic or benign process underlies the presence of an effusion in veterinary patients. The purpose of this study was to determine if any decrease in antiviral titers due to vaccination or natural exposure occurred in dogs undergoing immunosuppressive chemotherapy for treatment of cancer. This study was intended as a pilot study to determine if further investigation of titer status in cancer patients is warranted. Serum samples were obtained prior to initiation of chemotherapy and again at least two weeks after treatment with an immunosuppressive chemotherapy agent. No dogs were vaccinated between pretreatment and post-treatment sampling times. Canine distemper virus (CDV) antibody titers were determined using a serum neutralization assay. Canine parvovirus (CPV) antibody titers were determined using a hemagglutination inhibition assay.

Pre-and post-treatment serum samples were evaluated from 11 dogs. Diagnoses included lymphoma (nϭ3), mammary carcinoma (nϭ2), and one case each of transitional cell carcinoma, hemangiopericytoma, apocrine gland adenocarcinoma of the anal sac, prostatic carcinoma, nasal carcinoma, and osteosarcoma. Chemotherapy agents administered included doxorubicin, mitoxantrone, cisplatin, carboplatin, cyclophosphamide, vincristine, and cytosine arabinoside. Time between pre-and post-treatment samples ranged from 16 to 139 days (median ϭ 66 days, mean ϭ 69 days). Parvovirus titers remained unchanged in eight dogs, increased one-fold dilution in two dogs and decreased from Ͼ1:1024 to 1:512 in one dog. Distemper titers remained unchanged in seven dogs, decreased one-fold dilution in two dogs, and decreased two-fold dilutions in two dogs. No significant associations were found between chemotherapy agent, number of days between sampling times, and tumor type with regard to changes in CDV titers. Decreases in CDV titers were not statistically significant. However, the finding of a two-fold or greater decrease in CDV titers in two dogs followed 36 and 73 days warrants further investigation in a greater number of dogs for a more lengthy study period. Strong epidemiologic evidence exists for an association between the administration of feline inactivated vaccines (primarily feline leukemia and rabies virus vaccines) and subsequent soft tissue sarcoma development at injection sites. Although additional epidemiologic evidence also suggests that postvaccinal sarcomas develop in areas of inflammation at vaccine injection sites, the studies have thus fair failed to identify a specific brand of vaccine responsible for tumor development. Inflammation is considered by many to be a necessary antecedent to tumor production at vaccine sites in cats. All currently available subcutaneously administered rabies vaccines are adjuvanted and produce injection site reactions. A new nonadjuvanted canarypox rabies vector vaccine has recently been approved for use in dogs and cats in the United States. This study evaluated the injection site reactions of five nonadjuvanted feline vaccine combination products, four of which contained the new canarypox rabies vector fraction in a rodent model that has previously been shown to mimic the local inflammatory response as observed in cats after the subcutaneous administration of feline vaccines.

Thirty rats were divided into five groups of six. Each received a sham subcutaneous injection of saline and, on the opposite side, one of five feline vaccine combinations. Group A vaccine contained panleukopenia and calicivirus. Group B contained recombinant rabies with panleukopenia, rhinotracheitis, and calicivirus. Group C contained recombinant rabies with panleukopenia, rhinotracheitis, calicivirus, and a killed nonadjuvanted feline leukemia. Group D contained recombinant rabies, panleukopenia, rhinotracheitis, calicivirus, Chlamydia, and a killed nonadjuvanted feline leukemia. Group E contained recombinant rabies panleukopenia, rhinotracheitis, calicivirus, and Chlamydia. Twenty-one days postinjection the rats were killed and all injection sites were clipped and palpated for the presence of granuloma formation. The skin was tented and skin fold thickness over the injection sites was measured and tissue was removed for histologic evaluation. No evidence of granuloma formation was found on palpation, nor was a significant difference detected in skin fold thickness between vaccine groups or saline controls. Histologic evaluation of injections failed to detect any evidence of injection site inflammatory reactions.

Etoposide is a poorly water soluble anticancer agent, which uses polysorbate 80 in its vehicle. Polysorbate 80 is known to have potent histamine releasing properties in the dog (Masini et al., Agents Actions 16(6):470, 1985) , which has limited the use of Etoposide in veterinary oncology. Histamine release in the dog produces a dose-limiting effect due to hypotension, cutaneous urticaria and pruritus (Ogilvie et al., Am. J. Vet. Res. 49(8):1367 -1370 , 1988 ). These effects have not been sufficiently controlled previously with premedications to allow administration of an effective myelosuppressive dose of Etoposide (Hohenhaus and Matus, J. Vet. Internal Med. 4:239-241, 1990) . A pretreatment regimen was evaluated for use in controlling vehicle-associated clinical signs during Etoposide administration. The regimen consisting of prednisone, prednisolone, diphenhydramine and famotodine was used in a 12 dog study. Approximately 12 hours prior to the first Etoposide dose, animals were premedicated with prednisone (1 mg/kg) orally. Immediately prior to Etoposide administration on the first and second day of dosing, animals were premedicated with diphenhydramine (2 mg/ kg, IM), famotidine (0.5 mg/kg, IV) and prednisolone acetate (1 mg/kg, IM). Immediately prior to Etoposide administration on the third, fourth and fifth day of dosing, animals were premedicated with diphenhydramine (2 mg/kg, IM) and famotidine (0.5 mg/kg, IV).

This pretreatment regimen allowed repeated continuous intravenous dosing (2 hours) for 5 successive days at doses of 20, 30, 40, or 60 mg Etoposide/m 2 . Dose administration was accomplished by the use of a Walkmed ambulatory pump. The high dose of Etoposide (60 mg/m 2 over 2 hours daily for 5 days) caused lymphopenia (50.3-69.4 % decrease), reticulocytopenia (64.9-88.1 % decrease), slight thrombocytopenia (19.6-25.5 % decrease), and neutropenia (49-54 % decrease). This pretreatment regimen controlled the adverse reactions sufficiently to allow administration of a myelosuppressive dose. The plasma exposure (AUC) of Etoposide increased with dose and there was no significant difference in exposure between the first and last day of dosing indicating that this pretreatment regimen did not interfere with pharmacokinetics. This pretreatment regimen allows increased exposure to water insoluble oncolytic compounds and histamine releasing excipients in the vehicle. The pharmacokinetic disposition of a drug depends to some degree on the duration of time over which the drug is given as well as the total dose. It is likely that different dosing regimes (infusion rates) for the same total dose of drug may result in varied toxicity and efficacy. The purpose of this study was to evaluate doxorubicin pharmacokinetic disposition and toxicoses in a large number of normal and tumor-bearing dogs of varying body weights given a single dose of doxorubicin calculated at varying body weights given at varying infusion durations (10-60 minutes). A single doxorubicin dose (0.75-1.5 mg/ kg; 25-35 mg/m 2 ) was delivered at a concentration of 1 mg/ml in 0.9% saline as a 10-, 15-, 20-, or 60-minute infusion. Plasma samples were collected from each dog over a 3-hour period, centrifuged immediately, and analyzed using previously described methods in our laboratory for doxorubicin pharmacologic analysis.

Fifty-six dogs were evaluated (31 normal, 25 tumor-bearing). For all dogs, infusion rate (mg/m 2 /min) inversely correlated with clearance, Cl (Rϭ Ϫ0.81, pϭ0.0001). Infusion rate positively correlated with the intercept of the distribution phase, A (Rϭ0.62, pϭ0.001), half-life of the elimination phase, t 1/2 (Rϭ0.41, pϭ0.002), area under the plasma concentration versus time curve, AUC (Rϭ0.65, pϭ0.0001), and hematopoietic toxicity (Rϭ0.34, pϭ0.01). As expected, clearance inversely correlated with hematopoietic toxicity (Rϭ Ϫ0.28, pϭ0.04). A faster infusion rate resulted in greater hematopoietic toxicity and a characteristic pharmacokinetic profile. Greater toxicity is likely due to higher and more prolonged doxorubicin levels in blood and bone marrow. The results of this study show the importance of normalizing dosage regimes by infusion rate rather than by infusion duration when considering dose-response phenomena in veterinary patients. Aggressive surgical removal with adequate margins is the treatment of choice for perianal adenocarcinomas in the dog. Recurrent disease is difficult to resect. For inoperable local or regionally confined (lymph node) disease, radiation therapy may be effective in slowing the disease progression but previous reports do not describe long-term survival in these dogs.

Seven dogs with histologically proven recurrent perianal adenocarcinoma with no evidence of enlarged regional lymph nodes (radiographic and ultrasonographic examination) and no evidence of other parenchymal metastases were treated with localized external beam irradiation and evaluated. In all 7 dogs, the recurrent neoplasm was resected and neoplastic cell extension into surgical margins was confirmed. External beam irradiation using a Cesium-137 teletherapy unit was performed in 25-30 fractions of 200-250 cGy each.

Dogs ranged in body size from 7 to 35 kg (mean, 22 kg), age from 9 to 17 years (mean, 11 years), and in breed (2 mixed breed, 5 purebreed). There were 3 male-intact, 2 male-neutered, and 2 female-neutered dogs. All dogs completed the planned teletherapy protocol and were physically examined every 2-3 months thereafter. Thoracic and abdominal radiography with abdominal ultrasonography was performed at each visit.

Regrowth of the perianal neoplasm occurred in 1 of the 7 dogs four months following the completion of the therapy protocol. None of the other 6 dogs had tumor regrowth; however, 5 of the 6 dogs had regional lymph node enlargement and subsequent confirmation of nodal metastatic disease within 11 to 17 months following treatment. The remaining dog died at 10 months with no evidence of local or nodal neoplastic involvement.

Local regrowth of invasive perianal adenocarcinoma can be effectively managed with irradiation; however, our results strongly suggest concurrent irradiation of regional lymph nodes. A world wide web site was created to enhance instruction associated with the small animal problem solving elective course offered to third year veterinary students. Our goal was to provide students with increased opportunities to improve their clinical problem solving skills.

Materials for 58 clinical cases were accessible from the course web site (education.vetmed.vt.edu/education/curriculum/VM9144/probhome.htm). Students could view history/physical examination findings, photographs of patients, and results of diagnostic tests such as images of radiographs and cytologic specimens. In addition, radiographs were made available for the students to evaluate. Before class, students were to list problems for each case, including the most likely causes for each problem, interpret results of laboratory tests, and recommend additional diagnostic tests. Students then met as a group to discuss the case(s) with the instructor.

At the end of the course students rated 6 items of the web site on a scale from 1 (not useful) to 6 (very useful). Mean scores of student ratings were: use of e-mail for asking questions (5.51), grades accessible from web site (5.31), having diagnostic test results before class (5.98), availability of diagnostic images (5.75), availability of radiographs for viewing (5.70), and overall rating of the web site (5.64). Students commented that having results of diagnostic tests before class discussions was very important because it allowed them to research all findings and consult their reference texts and class notes prior to making a diagnosis.

We feel that web-based case materials increased opportunities for students to practice their problem solving and diagnostic interpretation skills. Based on the positive response, we plan to continue this format and add additional case materials in the future. Overo coat coloration in the horse is thought to be genetically heterogeneous. The endothelin B receptor mutation responsible for Overo Lethal White Syndrome (OLWS) commonly results in overo white patterning in the coat of heterozygote carriers. The purpose of this study was to determine heterozygote carrier incidence by white patterning phenotype. Carrier incidence was determined by allele-specific PCR in 656 horses of white patterned breeding or phenotype and 49 solid colored horses. Phenotypes were assigned by consensus of two observers.

Heterozygote incidence appeared to divide into four general categories by frequency: Ͼ95% (frame overos, frame blend overos, extremely white calico overos), 36-75% (bald-faced, breeding stock white, calico, medicine hat, toveros), 7-17% (breeding stock Paints, tobiano, sabino overo, splashed white overo), and Ͻ1% (non-frame overo blends, minimal calico overos and solids). Carrier phenotype is most commonly frame overo, but can vary widely in the amount of white patterning. Augmentation of frame patterning occurs in some carriers such as extremely white calico overos. Suppression of frame patterning is less common (breeding stock), as is fusion with another prominent white patterns (tobiano, sabino overo or splashed white overo). The variation in incidence of the OLWS mutation within overo phenotypes is evidence of the genetic diversity of overo patterning and suggests the presence of other genes that affect white patterning. We believe that frame, calico, splashed white and sabino are distinct overo patterns. Other overo and overo blend white patterns are probably produced by combinations of factors to which the OLWS mutation can contribute, but is not essential. Activated coagulation time (ACT) is used to assess the coagulation of whole blood via contact activation. Because ACT testing is simple, inexpensive, and rapid, it is often recommended as an in-clinic hemostatic screen for congenital or acquired disorders involving the intrinsic and/or common coagulation pathways. It is also used to monitor heparinization. Feline ACT reference values have been widely reported as Ͻ65s, but these reports have been based largely on a single study of 22 cats from which samples were collected via jugular catheters.

The primary purpose of this study was to establish feline ACT reference values using jugular venipuncture and direct collection into Becton-Dickinson ACT vacuum tubes. The protocol described on the ACT tube insert was modified such that inspection for clots was first done 45s after blood entered each tube, and subsequently at 10s intervals. Blood for ACTs was collected from 95 apparently healthy cats presented for elective surgery at a private practice. Three samples (S1, S2, S3) were attempted for each cat: S1) pre-sedation (nϭ41); S2) tube 1 of 2 consecutive samples from a single venipuncture of the contra-lateral jugular after sedation with acepromazine/ketamine, IV or IM (nϭ79); and S3) tube 2 post-sedation (nϭ57). Collection success was limited by cat temperament and adequacy of blood flow. Venipuncture quality was rated subjectively on a 3point scale.

Median ACTs were 95s for each sample group, with ranges of 45-245s (S1), 55-185s (S2), and 45-225s (S3). The middle 95% of values ranged inclusively from 55-185s (S1), 65-135s (S2), 45-145s (S3), and 55-165s overall (177 ACTs). There were no statistically significant differences (Wilcoxon Signed Rank tests, non-normal data) between the pre-and post-sedation ACTs (pϭ0.42) or between ACTs for tubes 1 and 2 post-sedation (pϭ0.14). There were no statistically significant relationships between ACTs and venipuncture quality (Spearman rank coefficient ϭ Ϫ0.03) or cat gender (Kruskal-Wallis test, p-values Ͼ 0.05). The 6 ACTs Ͼ165s (185-245s) occurred in 4 cats, but in only 1 cat were values repeatedly Ͼ165s (245, 185, 185s) . No cat had clinical evidence of a hemostatic disorder. With the protocol used, cats with ACTs repeatably Ͼ165s should be further evaluated for hemostatic disorders, though clinical disease may be absent. A 1-tube sampling method appears to be adequate, with or without acepromazine/ketamine sedation. The purpose of this investigation was to determine arterial blood flow characteristics and interobserver variability in the distal thoracic limb of normal horses using angle-corrected pulsed-wave Doppler ultrasonography (PWD). PWD was used on 8 horses to establish reference ranges for peak systolic, end diastolic and mean velocities (MV), resistive and pulsatile indices. Interobserver and patient variability was determined by repeating similar measurements on the same horse weekly for 8 weeks.

The multiple horse study established mean Ϯ std and reference ranges of velocities and indices for five distal thoracic limb arteries. Correlations were moderate to strong in all horses for each arterial site, and gradual decrease in vascular velocities from the proximal to the distal limb was noted. Over time mean velocity was the least variable parameter (PϽ0.05 ANOVA, see table). Horses had blood flow characteristics consistent with either a resistive or non resistive pattern type. The classification was based upon the overall degree of baseline elevation of the diastolic portion of the tracing. The single horse study showed there were no operator effects.

It was concluded that different operators can reliably measure PWD characteristics at any site on the equine distal limb. MV is the most consistent single parameter to monitor in a patient over time. Larger number of horses are needed to see if the resistive/non-resistive categories are consistent over a larger population. If so, it could suggest a fundamental difference in downstream resistance characteristics of forelimb arteries in normal horses. It has been assumed that, for some drugs, disposition may differ between pregnant and nonpregnant animals, which may necessitate a change in dose rate. We hypothesized that volume of distribution may be larger, or clearance faster, for aminoglycoside antibiotics in pregnant mares vs nonpregnant mares, which would result in lower plasma concentration. To examine this hypothesis, we administered gentamicin sulfate to seven Thoroughbred and Quarterhorse mares on two occasions, followed by plasma drug gentamicin assay and pharmacokinetic analysis. The first dose was administered 1-4 weeks before parturition (mean weight 578 kg) and the second dose was administered in the period 1-4 weeks after parturition (mean weight 518 kg). The dose administered at each time was approximately 6.6 mg/kg, IV. Plasma gentamicin concentrations were determined using fluorescence polarization immunoassay and pharmacokinetic analysis was performed using a two-compartment model. The plasma concentration vs time profiles were similar, and total area-under-the-curve was almost identical for mares at late gestation vs early lactation. Mean volume of distribution at steady-state was 0.153 (Ϯ 0.02) and 0.156 (Ϯ0.03) L/kg, systemic clearance was 1.06 (Ϯ 0.17) and 1.11 (Ϯ 0.17) mL/kg/min, and mean elimination half-life was 2.2 and 2.1 hr, for pregnant and nonpregnant mares, respectively. We concluded that there were no differences in drug distribution and clearance between pregnant and nonpregnant mares. Plasma gentamicin was also assayed in plasma of newborn foals after an injection of 6.6 mg/kg to three of the mares within 60 min of parturition. Gentamicin was undetectable in plasma samples from these foals. We conclude that gentamicin distribution does not change in pregnancy, and apparently does not cross the placenta of mares at term. Chloramphenicol has been used for treating a variety of bacterial infections in dogs and cats, but because of decreased availability of some dose forms, there has been interest in substituting florfenicol, which is pharmacologically similar. Florfenicol (Nuflor) is registered for use in cattle, but pharmacokinetics for dogs and cats has not been reported. This study was conducted to determine the disposition of florfenicol in order to examine its potential as a therapeutic agent in dogs and cats. The NCCLS quality control ranges of MIC for florfenicol are 2-8 mcg/ml. Florfenicol 300 mg/ml solution was administered IM and SC to four dogs at a dose of 20 mg/kg, and a 100 mg/ml solution was administered to 6 cats IV, IM, and oral at a dose of 22 mg/kg. Florfenicol plasma concentrations were determined with high pressure liquid chromatography (HPLC). In dogs after IM injection, florfenicol mean peak plasma concentrations were 2.2 mcg/ ml and mean elimination half-life was 4.6 hr. Concentrations were above a MIC of 2.0 mcg/ml for less than 2 hours. After SC administration, florfenicol was absorbed poorly and inconsistently with peak concentrations less than 1.0 mcg/ ml in all dogs. By contrast, the 100 mg/ml solution in cats was absorbed well from both IM and oral routes, with peak concentrations of 19 mcg/ml and 22 mcg/ml, respectively. Absorption was high from both routes (96% and 89% from IM and oral, respectively). IV elimination half-life was 3.75 hr and volume of distribution was 0.6 L/kg. The half-life was 3.4 hr and 4.7 hr for IM and oral dose, respectively. In cats, the 100 mg/ml florfenicol formulation produced concentrations above 2 mcg/ml for 12 hr and 18 hr, after IM, and oral doses, respectively, and concentrations were maintained above an MIC of 8.0 mcg/ml for 10 hr and 6 hr after IM and oral doses, respectively. The objectives of this study were: (1) to compare the SC and IM pharmacokinetics of oxytetracycline approved for IM use (OXY shot LA) with those of another oxytetracycline product approved for SC use (BioMycin); and (2) to compare SC and IM pharmacokinetics of these long-acting oxytetracycline products. Each of the products was administered to 6 cattle IM and SC, using a crossover design, and blood samples were collected at frequent intervals thereafter. Concentrations of oxytetracycline in serum were determined by microbiological assay and pharmacokinetic values were calculated using a model-independent approach.

Irrespective of formulation or route of administration, oxytetracycline was rapidly absorbed and maintained concentrations Ͼ 0.5 g/ml for 72 hours after administration. Based on confidence intervals for differences in mean AUC and C max values, products were bioequivalent whether administered IM or SC. The similarities between IM and SC pharmacokinetics were surprising in light of previous assumptions that IM administration would result in a higher rate of drug absorption.

The purpose of this study was to adapt forced expiratory maneuvers to horses in order to detect lung function changes due to small airway inflammatory disease (SAID) or chronic obstructive pulmonary disease (COPD). Horses were sedated after collection of lung mechanics data including resistance (Rl) and dynamic lung compliance (Cdyn). Forced expiration was induced from total lung capacity by exposure of the horse's airways to a negative pressure reservoir. Flow and volume were computed from the instantaneous changes in pressure in the reservoir yielding forced expiratory flows at 80 to 95 % (FEF 80-95% ) of the forced vital capacity, and other parameters of the forced expiratory flow-volume curve.

Lung function tests were performed in 21 horses (7 controls, 5 SAID, 5 COPD in remission, and 4 COPD in crisis). Rl and Cdyn of COPD horses in crisis were significantly different from control values (PϽ0.05). FEF 80-95% in horses with SAID, and COPD in remission and crisis were significantly lower than in control horses (PϽ0.05). FEF 80% was significantly lower in COPD horses in remission than in horses with SAID (PϽ0.05). FEF 85-95% was significantly lower in COPD horses in crisis than in horses with SAID (PϽ0.05). Forced expiratory flowvolume curves demonstrate flow limitation in horses with SAID and COPD in remission. But flow limitation is more severe in COPD horses in crisis. Tilmicosin has anti-inflammatory activity that reduces the damage to the lung associated with bacterial infections. The use of bacterial infection as a model to study the anti-inflammatory activity of a drug may alter cellular morphology of BALF cells suggesting a mode of drug action. Bronchoalveolar lavage (BALF) cell populations in calves were studied after saline lavage. Cell numbers, recovery, differential cytology and chemotaxis were determined. After 2 treatments (Tx; Tilmicosin 15 mg/kg) or nothing (Control) the calves were re-lavaged and the same parameters determined. Treatment with tilmicosin did not alter the differential cytologic features (PMN control: 27 Ϯ 11; PMN Tx: 34 Ϯ 13; Macophage control: 53 Ϯ 30; Macrophage Tx: 64 Ϯ 12) or the chemotactic index when compared to control (PMN control:2.9 Ϯ 2.1; PMN Tx: 5.5 Ϯ 5.3; Macrophage control: 4.6 Ϯ 6.4; Macrophage Tx: 7.4 Ϯ 10.9). Unlike traditional macrolides (erythromycin), tilmicosin modulates inflammation by mechanisms that do not appear to involve the ability of cells to migrate into the lung associated with mild inflammatory stimuli. The differential cytology did not suggest that apoptosis was a predominant feature of the neutrophil obtained from the lungs of calves treated with tilmicosin. The temporal variations in bronchoalveolar lavage fluid (BALF) analysis and variations due to separate aliquots and lung sites were studied in 5 horses with chronic obstructive pulmonary disease (COPD) and in 5 horses free of respiratory disease (controls). Horses were stabled in dusty conditions before (five months) and throughout experimental period. Bronchoalveolar lavage were performed as a standard method described in literature. In study 1, BALF were collected from the right lung monthly in February, March and April. In study 2, BALF analyses were performed using 2 incremental instillation of 250 ml of isotonic saline in the same bronchial site during the first monthly evaluation. In study 3, BALF were collected from both lungs and compared. BALF analysis included return volume, total count cells and differential cytologic evaluation. In study 1, COPD affected horses had significantly (p Ͻ 0.05) more neutrophils and epithelial cells, and had lower return volume and lymphocytes counts than control horses. Although not significant, there were individual variations for neutrophils in BALF in COPD affected horses throughout monthly evaluation. In study 2, the second aliquot of BALF obtained from COPD affected horses and from control horses, had signiticant less neutrophils than in the first one. In study 3, no significant difference were found in cytology and cell count from BAL fluid obtained from both lungs, in both COPD affected horses and in control horses. In studies 1, 2 and 3, COPD affected horses had neutrophils percentage Ͼ 10% and the number of neutrophils and the volume return remained significantly different between groups over time. Result of this study suggest that despite temporal effects and variations due to separate aliquots, BAL fluid analysis of COPD affected horses are consistently different from thoses of control horses. This study was funded by Le Groupe de Recherche en Médecine Equine du Québec (GREMEQ) and Le Fonds du Centenaire de la Faculté de Médecine Vétérinaire.

From the HESKA Corporation, Fort Collins, CO (Jensen) and the College of Veterinary Medicine and Biomedical Sciences

Blood samples were collected from client-owned cats by veterinarians, placed into EDTA, and transported to the laboratory (HESKA Veterinary Diagnostic Laboratories, Fort Collins, CO) for PCR testing. Samples from cats with suspected haemobatonellosis (n ϭ 66) were submitted based on presence of appropriate clinical findings. Samples from cats without clinical suspicion of haemobartonellosis (control cats ; n ϭ 137) were submitted as a cohort to a case with suspected haemobartonellosis or were selected from samples for which a complete blood cell count was performed for other reasons. Primers that detect a segment of the 16S rRNA gene common to both sequenced strains (California and Ohio) of H. felis were utilized in either a nested PCR or timed-release PCR. Cytologic evidence of red blood cell infection by H. felis was present in 5 of 66 cats (7.6%) with suspected haemobartonellosis and in o of 137 control cats (0%)

All 5 cytologically positive cats were positive for DNA by PCR. More cats with suspected haemobartonellosis were PCR positive than control cats (X 2 ϭ 16

Of the PCR positive suspect group cats, 9 were infected with the California strain, 6 were infected with the Ohio strain, and 2 had dual infection. Of the PCR positive cats in the control group, 7 were infected with the California strain and 1 had dual infection. Results of this study suggest that H. felis infection in cats is common and PCR is more sensitive than cytology for detection infection

But these effects on pulmonary inflammatory responses are less documented in vivo. The objectives of this study were to evaluate the effects of NO inhalation on bacterial clearance during bacterial pneumonia and on the alveolar neutrophil functions. A severe pneumonia was induced by alveolar instillation of live Pseudomonas aeruginosa

Several parameters were studied at 24 hours post-infection including mortality, cellularity and protein concentration in bronchoalveolar lavage, bacterial clearance (bacteriologic culture of BAL and lung parenchyma) and ex-vivo alveolar neutrophil functions (proteases, oxidants)

Protein in the BAL fluid was not modified by NO inhalation (10 ppm). The alveolar neutrophil functions were preserved in O2-NO group. In conclusion, these results suggest the beneficial effects of NO inhalation on bacterial clearance of Pseudomonas aeruginosa and the potential implication of increase recruitment of alveolar neutrophils to improve the pulmonary clearance

Signalment, historical information, hematologic and serum biochemical values, milk culture results, and outcome (discharged from hospital or died) were obtained from the medical record. Cows with gram-negative mastitis had significantly lower blood leukocyte (meanϮSD; 5,220Ϯ3,850 cell/l; Pϭ0.01)

Logistic regression indicated that a blood segmented neutrophil concentration Ͻ2,500 cell/l was the best indicator of gram-negative mastitis, with a sensitivity of 87%, a specificity of 93%, and an overall accuracy of 89% for predicting mastitis type. The values for sensitivity and specificity were higher than those previously reported for tests differentiating gram-negative and gram-positive mastitis

Integrated Livestock Management Group

Bacteremic cows have a pronounced leukopenia (2350 cells/ml) compared to non-bacteremic cows (6400 cells/ml), largely due to neutropenia (150 cells/ml). Creatinine is significantly higher (pϭ0.001) in bacteremic (1.35mg/dl) compared to non-bacteremic cows (1.1mg/dl) though still in the normal range. For comparison of CFU between groups cows were grouped as Ͼ100,000 or Ͻ100,000 CFU/ml on 0hr milk culture. Significant differences in the percent of cows with Ͼ100,000 CFU/ml existed (pϽ0.005). Seventy-four and 38 % of bacteremic and non-bacteremic cows had Ͼ100,000 CFU/ml respectively. Bacteremic cows had significantly fewer DIM (99) compared with non-bacteremic cows

University of California

The objective of this study was to determine whether intravenous glucose infusion alters carbohydrate oxidation (CHOox) or muscle glycogen use in horses during exercise. In random order, 6 horses completed two trials consisting of 90 min of treadmill exercise at 34 Ϯ 1% of peak oxygen uptake

CO 2 production, and respiratory exchange ratio (RER) were measured by indirect calorimetry. From these measurements and use of standard equations, rates of CHOox were calculated. Biopsies of middle gluteal muscle for measurement of glycogen concentration were obtained before and after exercise. Plasma glucose was higher (PϽ0.05) in Glu than in Con throughout exercise. Net muscle glycogen utilization was similar in Glu and Con (164 Ϯ 30 and 161 Ϯ 24 mmol/kg dry muscle, respectively). Whereas RER declined as exercise duration increased during both trials, RER was significantly (PϽ0.05) greater in Glu than in Con between 30 and 90 min of exercise. Consequently

We conclude that glucose infusion in horses does not alter muscle glycogen use during 90 min of low-intensity exercise. However, the increased blood glucose availability in Glu causes CHO oxidation to be maintained above control. Inasmuch as muscle glycogen use was similar in Glu and Con, the higher rate of CHOox in Glu can be attributed to increased utilization of blood glucose. 215 INFLUENCE OF DIETARY ANTI-OXIDANTS ON EXERCISE-INDUCED MUSCLE DAMAGE IN SLED DOGS

41 dogs were exercised on each of 3 days in teams of up to 16 dogs pulling a sled and musher over snow for 48 miles each day. Two groups of age-, weight-, and sex-matched dogs were used: with the investigators blinded to treatment, a supplemented group (S) (nϭ21) received, in addition to their regular diet, vitamin E (460 iu/day), vitamin C (1 g per day) and ␤-carotene (5 mg/day) for 6 weeks prior to and during exercise; a non-supplemented (control) group, (nϭ20) received the same diet without supplementation. Blood was drawn from the dogs at the beginning of the experiment (A), prior to exercise (B) and following each day of exercise (C, D and E). Plasma was analyzed for vitamin E and C and retinol concentration, and creatine kinase (CK) activity

Numerous studies have investigated hemodynamic changes in the laminitic equine digit, however little is known about the biology of the cellular components of the equine digital vasculature. In this study, we cultured palmar digital vessel endothelial cells (EC), and characterized the expression pattern of 3 mediators important in endo-toxemia-related disease mechanisms: endothelin-1 (ET-1), interleukin-1 beta (IL-1b) and cyclooxygenase-2 (COX-2)

ET-1 mRNA was expressed equally in AEC and VEC; and no change in expression was noted upon LPS exposure. IL-1 message was not detected in either control or LPSexposed AEC or VEC (fidelity of technique was confirmed using LPS-stimulated monocyte mRNA as positive control)

AEC) may be related to the purported role of the venous component of the digital microvasculature in the hemodynamic changes described in laminitis models. MINISTRATION OF CEFTAZIDIME IN THE TREATMENT OF PSEUDOMONAS AERUGINOSA INFECTION IN DOGS K

After the subcutaneous administration of ceftazidime, the mean elimination half-life was 0.8 hours and the mean serum drug concentration exceeded the MIC for P. aeruginosa for only 4.3 hours. Two dogs had adverse gastrointestinal side effects. After the loading bolus and during continuous infusion of ceftazidime, mean serum drug concentration exceeded 16g/ml (2 times MIC) in all dogs. The mean serum concentration at steady-state was 22g/ml. No adverse effects were observed. Due to the short elimination half-life and observed adverse effects, it was concluded that subcutaneous administration of ceftazidime is likely to be unsatisfactory in the treatment of P. aeruginosa infection in dogs. We predict that administration of ceftazidime as a loading bolus (4.4mg/kg, IV) and continuous infusion (4.1mg/kg/hr, IV), will be effective in the treatment of dogs with P. aeruginosa infections which are resistant to, or in dogs which experience toxicity from, aminoglycosides and fluoroquinolones

Two of the thoracic radiographs were interpreted as normal. A diagnosis of ELP was confirmed on histology if there were intra-airway aggregates of lipid-laden macrophages that did not appear to be primarily responding to an insult. All histologic lesions were classified according to size (microscopic, nϭ7; Ͻ1cm, nϭ9; Ն1 cm, nϭ5), location (subpleural, nϭ20; parenchymal, nϭ4; perivascular, nϭ3), distribution (focal, nϭ3; multifocal, nϭ16; diffuse, nϭ1) and lung lobe involvement (1 lobe, nϭ6; Ն2 lobes, nϭ10; unknown, nϭ5)

School of Veterinary Medicine

University of Illinois College of Veterinary Medicine and Brendan C

This study was designed to evaluate the use of Saccomanno cell transport fluid media in the preservation of cells obtained from canine bronchoalveolar lavage (BAL) samples. Our hypothesis was that adding the preservative to the BAL fluid would be beneficial in preserving the samples for future analysis when compared to control samples taken concurrently and maintained without preservative. The Saccomanno fluid is methanol based and is used in human medicine primarily for transport and preservation of bronchial brush samples. This fluid is reported to increases diagnostic cell yield, decrease obscuring mucus, maintain cellular integrity, and limit cellular degeneration when compared to samples prepared with no preservative.BAL samples were collected using standard technique, and were then split into a study group (Saccomanno fluid added) and a control group (no additions). Samples were analyzed (total nucleated cell counts [TNCC] and cytocentrifuge differential [CYTO] counts) immediately following collection and then every 24 hours for 5 days. Comparison of the study (Saccomanno) samples to the control (non-treated) samples found that TNCC decreased daily in all samples but were not different between groups, while on CYTO there were more ruptured cells identified on the non-treated samples when compared to the treated samples, suggesting cellular deterioration of the untreated samples. While additional samples are continuing to be obtained, it appears that Saccomanno cell transport fluid media immediately added to canine bronchoalveolar lavage samples will improve cellular preservation over time when compared to similar samples not maintained in Saccomanno fluid. This should be helpful in maintaining the quality of BAL samples when transported and not processed immediately. Summer pasture-associated obstructive pulmonary disease (SPAOPD) is a recurrent seasonal obstructive pulmonary disease observed in horses residing on pasture the in southeastern region of United States. In order to identify environmental factors associated with the occurrence of SPAOPD in horses residing in Louisiana a population of 21 SPAOPD-affected horses and 8 non-affected horses were studied. The horses were evaluated clinically to determine if there was a correlation between changes in clinical signs and changes in selected climatic factors during the period of 1992 through 1994. The daily assessment included the nostril flare, abdominal lift and respiratory rate. The clinical score was calculated based on the nostril flare and abdominal lift.

Unaffected horses kept at pasture conditions had no appreciable changes in clinical scores throughout the years. The SPAOPD-affected horses kept at pasture had a clear seasonal onset of clinical signs during late spring, especially the month of May. The clinical signs persisted until late autumn, i.e., November. The daily clinical scores and respiratory rates were positively correlated with measurements of temperature (maximum temperature and dew point temperature) in all 21 SPAOPD-affected horses. However, the degree of correlation estimated in this exploratory data suggests that mere fluctuations in daily temperature or dew point temperature are unlikely to be the sole determinants of clinical severity.The seasonal occurrence of SPAOPD and the correlation with elevations in temperature and humidity, both conditions that are conducive to mold growth and increased vegetation, are consistent with the concept that the disease may be due to a hyperresponsiveness to mold spores and/or pollens.

Ovine pulmonary carcinoma (OPC) (jaagsiekte) is a naturally-occurring contagious bronchioalveolar adenocarcinoma most likely related to type D/B-retrovirus infection. OPC is a well-differentiated tumor of alveolar type II or nonciliated bronchiolar (Clara) cells that occasionally metastasizes to regional lymph nodes. Affected sheep are typically adults and present with tachypnea and coughing that worsen with exercise and bilateral nasal discharge. The purpose of this retrospective study was to describe the clinicopathologic and histopathologic findings in 5 cats presented to the Teaching Hospital from 1988-1995 with a proliferative, pulmonary disease resembling OPC. No gender or breed predilections (mean ageϭ9.6 years) were evident. Owner complaints included a 6-10 month history of progressive weight loss and a 2-week to 5.5-month history of lower respiratory signs (dyspnea (3/5), cough (3/5), tachypnea (2/5), wheezing (2/5)). In all cats, clinical signs had improved temporarily with various combinations of antibiotics with corticosteroids, bronchodilators, and diuretics. On physical examination, tachypnea (rangeϭ55-130 BPM) was the most frequent finding. Dyspnea (2/5), harsh lung sounds (2/5), cachexia (3/5), dehydration (2/5), and respiratory stridor with a serous nasal discharge (1/5) also were noted. No significant hematologic or biochemical abnormalities were observed. All cats were FeLV and FIV seronegative. Thoracic radiographs revealed a diffuse interstitial-nodular pattern with multifocal bronchoalveolar infiltrates. Lung aspirate or bronchoalveolar lavage fluid cytologies revealed mild to moderate nonseptic inflammation. Microbial cultures from the deep lung did not yield clinically significant bacterial or fungal growth.Gross and histologic features of lung tissue revealed striking similarities to OPC. Affected lung was pale tan and firm with multifocal white punctate foci scattered over the pleural surface. Lung parenchyma contained multiple unencapsulated, coalescing nodules containing dilated alveolar spaces lined by variably differentiating cuboidal cells resembling type II alveolar cells and columnar bronchiolar cells with patchy fibrosis. Alveolar histiocytosis, lymphocytic interstitial inflammation, and smooth muscle hypertrophy along terminal airways were common features. Hilar lymph node metastasis was found in 1 cat. Electron microscopy of lung tissue (1 cat) revealed a proliferating cell population with features suggestive of alveolar type II epithelial cells. No microbial organisms were identified by special stains.As with OPC, the prognosis for untreated feline pulmonary carcinomatosis (FPC) was poor. Four cats died or were euthanatized due to progressive disease within 4 days of diagnosis; while one cat survived 5 months with symptomatic therapy.